CURRENT PRACTICE, FINANCING AND POLICY ON TERMINALLY ILL

PATIENTS IN THAILAND by Akaleephan, Chutima
  
 
 
CURRENT PRACTICE, FINANCING AND POLICY ON TERMINALLY ILL 
PATIENTS IN THAILAND 
 
 
CHUTIMA AKALEEPHAN 
 
 
 
 
 
 
Thesis submitted in fulfillment of the requirements 
For the degree of Doctor of Philosophy 
 
University of East Anglia 
 
School of Medicine, Health Policy and Practice 
Faculty of Health 
 
August 2010

 i
ABSTRACT 
Understanding the issue of mortality could better serve policies related to health and 
social services. Recently, major health care reform and population changes in the Thai 
context raised interest on this issue at the policy level. This research, therefore, aims to 
reveal and to explore the nationwide cost of treatment, utilisation and its disparity; 
current practice and coping mechanism of households; and important factors related to 
expenditure during the terminal period of life. 
The research employed mixed quantitative and qualitative methods to explain 
characteristics of Thais dying between 2005 and 2006. Four studies encompassing this 
research were multivariate analyses of claimed data and household survey on last period 
expenditure and utilisation; in-depth interviews of terminally ill cancer patients and 
their care givers; and in-depth interviews of health professionals. Both multivariate 
analyses revealed that the main factors determining the inequality in access to and 
expenditure incurred by health insurance schemes and households for ambulatory care 
and acute care during the last period of life included age at death, health insurance 
scheme, cause of death and place of death. In addition, comorbidity and gender in 
claimed data also played a significant role in determining utilisaiton and claimed 
expenditure among decedents who sought acute care. Use of complementary medicine, 
being head of household, region, municipality, gender, occupation, education and living 
standards played significantly different roles on propensities and intensities of 
utilisation of and expenditure for those who sought both types of care. In-depth 
interviews of patients, care givers and health professionals confirmed the disparity 
across health insurance schemes. These findings revealed that differences among health 
insurance schemes strongly determined both utilisation and household expenditure and 
there was likely equality across different living standards.  
It was indicated that home is likely the best place for caring and dying. Thus, 
strengthening comprehensive palliative care at home by informal care givers with 
support from a home health care team was recommended with occasional visits to 
conventional hospital care will improve the quality of care for the terminally ill patients. 
Financial constraint in the Universal Coverage Scheme related to access to pain relief 
substances requires further exploration. 
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CHAPTER ONE 
INTRODUCTION 
 
This chapter aims to introduce the background of mortality in Thailand, the importance 
of death as a determinant of health and its societal meaning. These led to findings of the 
knowledge gap, the development of the research questions and purposes of the thesis. 
1.1 The meaning of mortality to the health system 
Death is unavoidable and affects society as a whole. Mortality, particularly premature 
mortality, is a social and health concern of every country around the world. This seems 
to be an important indicator for health assessment, both at population and individual 
levels.  On one hand, five out of eight goals (goal numbers 1, 4, 5, 6 and 8) of the 
Millennium Development Goals (MDGs)1 set by the United Nations and eight targets 
are directly related to health. Regarding death, the 4th goal aims to reduce child 
mortality, in particular the under-five mortality rate (U5MR), with the target of a two-
third reduction, between 1990 and 2015. The 5th goal aims to improve maternity health 
with the target of a three-quarter reduction in maternal mortality ratio, over the same 
period. On the other hand, the Commission on Social Determinants of Health provides 
evidence on the health inequities and poor health including premature mortality of the 
poor, regardless of gender across and within countries. To some extent, mortality and 
inequity remain and both are related to health problems. The Commission also urged 
that it is time to tackle the inequitable distribution of power, money and resources by 
‘closing the gap in a generation’ (World Health Organization 2004; Commission on 
Social Determinants of Health 2008). To achieve this task, countries should measure 
and understand their specific problem, take appropriate action and assess the impact of 
action.  
                                                 
1 The international community in 2000 General Assembly has adopted a United Nations Millennium 
Declaration which its one aims is to eradicate poverty. In that regard, a Millennium Development Goals 
(MDGs) was developed with the theme as ‘End poverty 2015, make it happen’. To achieve that, eights 
goal, eighteen targets and forty eight indicators have been stated United Nations (2000). Resolution 
adopted by the General Assembly, 55/2. United Nations Millennium Declaration. A/RES/55/2.  
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1.2 Change in Thai population structure to ageing and population indicators 
1.2.1 The population changes to an ageing population 
Like many developed countries nowadays, the population pyramid of Thailand is 
shifting to be a picture of an ageing society. Life expectancy at birth is increasing as 
data from 1974-6 and 2005-6 shows. Male life expectancy has increased from 58.0 to 
69.9 and from 63.8 to 77.6 among women while the population size is growing slowly. 
Although figures doubled from 30 million in 1965 to 60 million in 1996, the 2006 de 
jure mid year Thai population is estimated to be 65.1 million. The natural growth rate of 
the Thai population has become smaller, compared to 30 to 40 years ago. Figure 1.1 and 
Table 1.1 illustrate  the crude birth rate2, crude mortality rate3 and natural growth rate4 
during the  past four decades since 1964; and proportion of the Thai population by age 
groups and dependency ratio5, respectively, during the two past decades since 1985. As 
a result of the effective population policy and family planning campaign started in 1970, 
the natural growth rate of the country has now fallen to less than one percent annually. 
Birth rate decreases whereas mortality rate increases, so natural growth rate falls. Age-
specific proportion of the population in Table 1.1 confirms the reduction trend in 
childhood (aged 0-14 years), adolescent (aged 15-19 years) and young adult (aged 20-
39), and an upward trend in older age groups (Vapattanawong and Prasartkul 2006a; 
Economic and Social Statistics Bureau 2007).  
Projections indicate that the Thai population is nearing zero or below zero growth rate 
and would stagnate at around 65 million within 15 years. Additionally, dependency ratio 
is falling because of a decreasing childhood dependency ratio. However, it was 
predicted that this ratio will increase in the next 25 to 30 years. This is due to the delay 
in marrying of fertile-aged women and the fall  in child per woman, increasing life 
expectancy statistics and the increasing number of old-age people (Vapattanawong and 
Prasartkul 2006b; Economic and Social Statistics Bureau 2007). 
                                                 
2 Crude birth rate (CBR) is the number of births in a year per 1,000 population ignoring age and sex. 
3 Crude mortality rate (CMR) is the number of deaths in a year per 1,000 population ignoring age and sex. 
4 Natural growth rate (NGR) is the number of increase (or decrease) of population (the difference between 
birth and death) in a year per 100 population. 
5 Dependency ratio is the ratio of children (aged 0-15) and elderly (aged 60 and above) populations to 
working age (aged 15-59) population. 
Source: Vapattanawong, P. and P. Prasartkul (2006b). Thai population in the future. Mortality... the 
reflection of population security. K. Archavanitkul and V. Thongthai. Bangkok, Plan Printing: 34-41, 
Economic and Social Statistics Bureau (2007). Report on the 2005-2006 Survey of Population Change. 
Bangkok, National Statistical Office, Ministry of Information and Communication Technology. 
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Figure 1.1 Changes in crude birth rate, crude mortality rate and natural growth rate in 
Thailand during 1964 to 2006 
Crude birth rate (CBR), mortality rate (CMR) and natural 
growth rate (NGR)
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Note: 1) crude birth rate (CBR) per 1,000 population; crude mortality rate (CMR) per 1,000 population; and 
natural growth rate (NGR) per 100 population 
2) no crude birth rate (CBR) and natural growth rate (NGR) data  is available in the year 2000 
Source: Population Survey Division (1977), Population Survey Division (1987), Population Survey 
Division (1990), Economic and Social Statistics Bureau (2007) and Faramnuayphol et al (n.d.a) 
 
 4
Table 1.1 Proportion of the Thai population by age groups and dependency ratio during 
the past decades (1985-2006) 
Age group (years) 1985-19861/ 1995-19961/ 20002/ 2005-20061/ 
0-14 34.4 27.2 24.4 23.1 
15-19 11.4 9.0 7.6 
20-29 18.3 17.3 13.4 
30-39 13.3 16.8 16.3 
40-49 9.2 12.3 16.7 
50-59 6.9 8.1 
66.1 
12.0 
≥ 60 6.5 9.3 9.5 10.9 
Dependency ratio     
All age groups 69.3 57.5 51.2 51.4 
Childhood (0-14) 58.3 42.9 36.8 34.9 
Elderly (≥ 60) 11.0 14.6 14.4 16.5 
1/ estimation based on mid year population in Survey of Population Change in 1985-1986, 1995-1996 and 
2005-2006 (Economic and Social Statistics Bureau 2007) 
2/ based on 2000 Census (National Statistical Office 2002) 
 
1.2.2 Mortality variations and factors determined 
In general, the statistical records illustrate changes in mortality rate over time indicating 
that pre-mature death in Thailand is falling. Figure 1.2 shows the age-specific mortality 
rate of the whole kingdom (A), of males (B) and of females (C) during the past four 
decades (1964 to 2006). There is a clear declining trend in the infant mortality rate, the 
under-five mortality rate and an increasing trend in mortality rate of the old age 
population. As a result, the U-shaped curve of the adjusted mortality rate gradually 
shifted to be a J-like curve. Death in adolescence and of young adults (10 to 34 years) 
has fewer alterations than other groups but men in all age groups have a higher 
mortality rate than women. 
Mortality was found to be varied according to geography, demographics and socio-
economics, for instance. Some population studies on death by geography, geographical-
socioeconomics, and household-socioeconomics a few years ago show a disparity of 
mortality across gender, area and household income. The crude mortality rate in Table 
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1.2 revealed that during the past 20 years, people living in non-municipal (or rural) 
areas had a higher mortality rate than those living in municipal (urban) areas. People in 
the Northern part of Thailand had the highest mortality rate compared to other parts of 
Thailand, particularly in the latest 2005-2006 Survey of Population Change. As a result 
of a low birth rate and high mortality rate, the natural growth rate of the Northern part 
was lower than zero. However, naturally, older people die more, so in areas where there 
are more elderly people, the mortality rate is higher. Data for crude mortality rate is 
limited in geographical comparisons to areas with varied age structures. Apparently, 
municipal areas had less mortality rate than non-municipal areas. Faramnuayphol and 
Vapattanawong (n.d.) also found from 2000 census data that districts in the upper North 
of Thailand still had the highest standardized mortality ratio6. In addition, the 30-34 
year old age group is the group with influence on the marked differences of mortality 
rates across provinces (Economic and Social Statistics Bureau 2007; Faramnuayphol 
and Vapattanawong). 
                                                 
6 Standardized Mortality Ratio (SMR) is the indirect standardization for mortality rate. This ratio 
compares crude mortality rate to geographical age-adjusted expected death rate. 
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Figure 1.2 Age-specific mortality rate between 1964 and 2006 
A: The whole kingdom 
Age-specific mortality rate of the whole kingdom
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Note: Mortality rates of children under 5  in 2005-6 was  unable to be  
estimated by gender (Economic and Social Statistics Bureau 2007) 
Source: (Population Survey Division 1966; Population Survey Division 
1977; Population Survey Division 1987; Population Survey Division 1990; 
Economic and Social Statistics Bureau 2007) 
B: Male 
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C: Female 
Age-specific female mortality rate
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Table 1.2 Age specific mortality rate by municipality 
Year 
1964-5 1974-6 1985-6 1989 1995-6 2005-6 Age group 
Urban Rural Urban Rural Urban Rural Urban Rural Urban Rural Urban Rural 
< 1 65.3 90.8 29.7 74.3 30.5 52.5 26.9 49.4 15.8 31.7 7.5 11.4 
1-4 1.5 1.8 1.1 1.3 1.2 1.4 0.3 1.2 
5-9 
 1.3 2.4 5.1 
0.5 1.4 0.4 1.2 0.8 1.0 0.3 0.8 
10-14 0.2 1.0 0.4 0.9 0.7 0.9 0.2 0.6 
15-19 
 2.5 1.0 2.0 
0.5 1.7 0.6 1.5 1.3 1.8 0.9 1.3 
20-24 1.4 1.8 1.4 1.7 1.3 2.5 1.0 0.8 
25-29 
 4.1 1.4 2.7 
1.5 2.8 1.5 1.9 1.5 2.8 0.8 3.1 
30-34 2.2 2.8 1.7 2.7 2.3 3.0 1.7 1.0 
35-39 
 5.0 2.4 5.4 
2.6 3.2 2.2 3.3 2.6 3.1 1.8 4.8 
40-44 2.7 4.5 2.5 4.3 2.7 3.9 3.0 4.1 
45-49 
5.4 8.2 7.2 8.8 
3.3 6.3 3.1 5.7 3.0 4.9 3.1 4.0 
50-54 7.4 9.1 6.5 9.3 5.2 7.1 6.1 5.7 
55-59 
7.8 11.9 13.9 13.7 
9.3 16.3 8.8 13.9 8.3 11.9 10.1 11.3 
60-64 12.8 25.3 11.3 18.9 14.5 15.7 15.4 17.0 
65-69 20.4 35.2 18.1 27.3 19.8 22.2 16.9 20.1 
70-74 46.1 54.3 29.6 46.2 36.9 37.7 28.5 42.2 
75-79 43.6 67.6 41.9 67.6 61.1 62.7 47.8 58.0 
>=80 
38.6 50.4 60.3 47.6 
77.9 109.2 58.6 100.2 66.8 82.7 99.7 118.4 
Source: (Population Survey Division 1966; Population Survey Division 1977; Population Survey Division 
1987; Population Survey Division 1990; Economic and Social Statistics Bureau 2007) 
 
Disparities in mortality are found multifactorially. Geographical distribution of age-
adjusted mortality rate at district level was estimated using 2000 census data. Death 
caused by traces of 12 diseases, both communicable and non-communicable diseases 
and injuries were selected for the study. The researchers categorized such diseases into 
4 groups by various factors such as geography, epidemiological data and transportation 
profiles. The first group represented distribution of mortality related to epidemiological 
characteristics, including liver cancer which is predominant in north-eastern Thailand, 
and chronic obstructive pulmonary disease (COPD) in northern Thailand. The second 
group is related to multifactored distribution including accessibility to health services 
and death from diabetes mellitus or renal failure. The third group represents death from 
leukemia which is unrelated to any geographical characteristics because of its scattered 
distribution. The final group is death from traffic accidents which is higher in some 
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provinces and is linked to traffic load, law enforcement and road behaviour of residents 
in such areas. This research suggested that policy for these public health problems 
should be specific to each of these 4 characteristics. In addition, the authors undertook 
further studies on mortality rates and geographical socioeconomics. It was suggested 
that geographical socioeconomics has both positive and negative effects to mortality 
rate. Good economics increases health risks as well as increases health resources for 
services and its accessibility. Mortality from some diseases, for example, HIV/AIDS, 
cardiovascular diseases and chronic obstructive pulmonary disease is prone to wealthier 
areas. Meanwhile, mortality from liver cancer becomes small in those areas. However, 
the socioeconomics impact is neutral to death from leukemia, renal failure and 
drowning (Faramnuayphol and Vapattanawong; Faramnuayphol and Vapattanawong). 
The authors recommended that further studies on the effects of underpinned 
multifactors of geographical socioeconomics and multilevels of socioeconomics (e.g. 
provincial and household socioeconomics) were required. 
1.3 Cause of death and place of death are important determinants 
1.3.1 Cause of death is important but divergent 
One crucial factor influencing death and motivating household reaction and change is 
illness which was concluded as a major cause of death of household members. Illness 
and external causes leading to mortality or ‘cause of death’ differ and vary by 
specificage groups, gender, geography, country, and income level, etc. The World 
Health Organization reported in 2004 that people in low-income countries 
predominantly died from infectious diseases, i.e. lung infections, diarrhoeal diseases, 
HIV/AIDS, tuberculosis and malaria, as well as complications during  pregnancy and 
childbirth leading to mortality in infanthood and motherhood. More than one-third of 
decedents were aged less than 14 years old. In contrast to low income countries, people 
in high-income countries, with longer lives, substantially died from chronic diseases, i.e. 
cardiovascular disease, chronic obstructive pulmonary disease, cancers, diabetes or 
dementia. Like low-income countries, tuberculosis and road traffic accidents were 
leading causes of death in middle-income countries. However, similarly to high-income 
countries, chronic diseases are a major cause of death as well. Besides, a study on global 
patterns of mortality in young people (10 to 24 years) in the 2004 data of Global Burden 
of Diseases revealed that low and middle-income countries had a mortality rate that was 
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nearly four times higher than that of high-income countries across WHO regions. Africa 
and Southeast Asia in which countries are low-income and middle-income accounted 
for two-thirds of the global youth mortality rate while accounting for only 42 percent of 
the youth population. Maternal causes, communicable diseases, mainly HIV/AIDS and 
tuberculosis, including nutritional disorders accounted for the highest proportion (48 
percent) of young female mortality, particularly in Africa and Southeast Asia regions in 
which member states are low- and middle-incomes. However, these causes of death 
accounted for only 4 percent of mortality in high-income countries. Traffic accidents, 
suicide and violence were the major causes in both male and female death in high-
income countries (World Health Organization 2008; Patton, Coffey et al. 2009). 
Cause of death is reported annually in Thailand by the Bureau of Policy and Strategy7, 
Office of the Permanent Secretary, Ministry of Public Health, on the basis of WHO 
International Classification of Diseases, and the coding and selection rules and 
tabulation list8(Bureau of Health Policy and Planning 1998). Data has been retrieved 
from death certificates in civil registration database held by the Bureau of Registration 
Administration, Department of Provincial Administration, Ministry of Interior, since 
1996. It was found that in 2006 the top three ranking causes of death were: cancers, 
accidents and poisoning, hypertension and cerebrovascular diseases with mortality rates 
at 83.1, 59.8 and 24.2 per 100,000 population, respectively. This cancer mortality rate is 
increasing yearly. However, the data also revealed 30 to 40 percent of ill-defined 
causes. Among known causes, some errors were found as mode of death was reported 
instead of cause of death and that diminished the quality and accuracy of the data. This 
is due in part to inadequacies of the current death certificate system, especially with 
regard to death outside health facilities, and registrars having limited health-related 
knowledge. Some national and area-specific studies tried to correct such errors and 
limitations found in the death certificate database as well as to improve the guidelines 
for verbal autopsy (Chooprapawan, Porapakkham et al. 2000; Pimsab 2002; Sublon, 
Chaithum et al. 2007; Thai working Group on Burden of Disease and Injuries 2007; 
Project on Setting Priorities Using Information on Cost-Effectiveness (SPICE 2004-
2009) ).  
                                                 
7 Previously, the Bureau of Policy and Planning 
8 The latest version is the Tenth Revision (ICD-10) 
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1.3.2 Leading causes of death in Thailand  
After the corrections, the top ranking causes of death in the Thai population were 
summarized in Table 1.3, which was compiled from 3 studies from the past decade. 
Causes of death were reported in inconsistent age-specific classifications, level of 
disease classifications, unit of mortality measurements, i.e. as mortality rate per 
population and percentage to all leading causes of death. Nevertheless, such ranking 
indicated trends by two different dimensions, age and time horizon. According to age,  
from infancy (<1 year) to childhood (1-14 years) and young adult (15-49 years), data 
shows that leading causes of death gradually moved from communicable diseases and 
congenital malformation to external causes of death, e.g. drowning and traffic accidents. 
Later from adult to old age, dying from external causes of death shifted to non-
communicable diseases or chronic diseases, such as hypertension and cerebrovascular 
disease, neoplasms or cancers, and chronic obstructive pulmonary disease. According to 
the latter dimension, a decade later from 1997 to 2005, the first leading causes of death 
gradually shifted from communicable diseases, i.e. HIV/AIDS, to chronic diseases, i.e. 
stroke. Neoplasms were still in the top ten even though they were disaggregated into 
specific-sited cancers, particularly the liver and lung cancer (Chooprapawan, 
Porapakkham et al. 2000; Pattaravanich and Jarassit 2006; Thai working Group on 
Burden of Disease and Injuries 2007). 
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Table 1.3 Top ranking causes of death by age and gender between 1997 and 2005 
Cause of death 
1997-1998 Study on cause of death in 
Thailand* 2004 Burden of disease
$ 2005 SPICE-BOD§ Age-specific 
Male Female Male Female Male Female 
Overall 
1. CD (HIV/AIDS, TB) 
2. External causes (TAs) 
3. Neoplasms 
4. Blood circulation 
5. LRI 
1. Blood circulation 
2. Neoplasms 
3. CD (HIV/AIDS, TB) 
4. Diabetes 
5. External causes (TAs)
1. HIV/AIDS 
2. Stroke 
3. TAs 
4. Liver & bile duct 
cancer 
5. COPD 
6. IHD 
7. Bronchus & lung 
cancer 
8. Diabetes 
9. Cirrhosis 
10. LRIs 
1. Stroke 
2. Diabetes 
3. IHD 
4. HIV/AIDS 
5. Liver & bile 
duct cancer 
6. LRIs 
7. COPD 
8. Nephritis & 
nephrosis 
9. TAs 
10. Cervix uteri 
cancer 
1. Stroke 
2. TAs 
3. HIV/AIDS 
4. IHD 
5. COPD 
6. Cirrhosis 
7. ill-defined 
8. Lung cancer 
9. Diabetes 
10. Emphysema 
1. Stroke 
2. Diabetes 
3. IHD 
4. ill-defined causes 
5.HIV/AIDS 
6. chronic renal failure 
7. Emphysema 
8. Cervix cancer 
9. Liver cancer 
10. Hypertension 
Pre-school 
children 
0-4 yrs. 
1. CD 
2. Accidents 
3. CM 
Children 
5-14 yrs. 
1. Accidents (traffic, drowning) 
2. CD (dengue hemorrhagic fever, HIV/AIDS) 
3. na 
0-15 yrs. 
1. Birth trauma & asphysia 
2. TAs 
3. Drowning 
Young adult 
15-24 yrs. 
1. Accident (traffic) 
2. ISH & assaults 
3. CD (HIV/AIDS) 
Adult 
25-44 yrs. 
1. CD (HIV/AIDS, TB malaria) 
2. Accidents (traffic) 
3. Neoplasms 
Na 
 15-49 yrs. 1. HIV/AIDS 
2. TAs 
3. Liver cirrhosis 
15-49 yrs. 
1. HIV/AIDS 
2. TAs 
3. Cervical cancer 
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Table 1.3 Top ranking causes of death by age and gender between 1997 and 2005 (cont.) 
Cause of death 
1997-1998 Study on cause of death in 
Thailand* 2004 Burden of disease
$ 2005 SPICE-BOD§ Age-specific 
Male Female Male Female Male Female 
Older adult 
45 – 59 yrs. 
1. Neoplasms 
2. HT-CVD 
3. CD (HIV/AIDS, TB) 
Elderly 
60 – 74 yrs. 
1. Neoplasms 
2. HT-CVD 
3. COPD 
50 – 74 yrs. 
1. Stroke 
2. IHD 
3. Liver cancer 
50 – 74 yrs. 
1. Diabetes 
2. Stroke 
3. IHD 
Older elderly 
75+ yrs. 
1. Senility 
2. HT-CVD 
3. COPD 
Na 
75+ yrs. 
1. Stroke 
2. COPD 
3. IHD 
75+ yrs. 
1. Stroke 
2. IHD 
3. Diabetes 
Sources:  (Chooprapawan, Porapakkham et al. 2000; Thai working Group on Burden of Disease and Injuries 2007; Project on Setting Priorities Using Information on 
Cost-Effectiveness (SPICE 2004-2009) 2009) 
CD = communicable diseases; TAs = traffic accidents; RI = respiratory infections; LRI = lower respiratory tract infection; CM = congenital malformation; LBW = low 
birth weight; CHD = congenital heart disease; DD/HU = drug dependence/harmful use; AD/HU = alcohol dependence/harmful use; ISH = Intentional self-harm; HT = 
hypertension; CVD = cerebrovascular disease; TB = tuberculosis; COPD = chronic obstructive pulmonary disease; IHD = ischemic heart disease; na = not available 
* mortality rate (per 100,000 population); $% of numbers of death to all causes; § % share of numbers of death among all leading causes 
Disease in parenthesis is majority of such core cause of death 
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1.3.3 Place of death, another important determinant to heath care for terminally ill 
patients 
Place for end-stage care or place of death plays some role in the health service provided 
to terminally ill patients and in acute care hospitals. At the same time, such health 
service is affected by health financing policies and hospital service for all patients in 
general. Terminally ill patients require comprehensive care through palliative care and 
further advanced terminal care at the end of patients’ lives. The patients who are likely 
to die in hospital usually have long hospitalisation periods. As a result, to some extent, 
bed occupancy in acute care hospitals by this patient group affects other patients who 
may need hospitalized intensive services by the same group of health professionals. 
Policy makers as well as hospitals do need policies, planning and ability to serve such 
hospitalized terminal stage patients. Otherwise, policies for alternative place of care and 
place of death should be taken into account.  
There were two concepts mentioned in determinating place of death. One facet is that 
people have rights and dignity to choose their preferred place, even at the end of their 
lives. With this respect, Thailand first provided citizens with legal rights in respect to 
health in the National Health Act B.E.2550 (2007). The Act includes the right to refuse 
any health services used to prolong a terminal stage of life9. Another is that a patient 
home is believed to be the best place for dying. At home, patients feel most comfortable 
in a familiar environment among their beloved families until the end of their lives.  
Nonetheless, many studies reveal variations in place of death, depending on country. 
For instance, in some developed countries, like Canada, during 1992 to 1997, trends in 
adults with cancers dying out-of-hospital in Nova Scotia rose from 19.9 percent to 30.2 
percent. Patients who are more likely to die out-of-hospital include women; the elderly 
aged more than 75 years; those in a palliative care programmes and those living longer 
than 60 days after diagnosis (Burge, Lawson et al. 2003). Similarly, a descriptive data 
analysis of the death certificate database of the USA shows declining trends of in-
hospital deaths from 54 percent in 1980 to 41 percent in 1998. In contrast, upward 
                                                 
9 ‘Section 12. A person shall have the right to make a living will in writing to refuse the public health 
service which is provided merely to prolong his/her terminal stage of life or to make a living will to refuse 
the service as to cease the severe suffering from illness. ...’(2007). National Health Act B.E. 2550 (2007). 
The Kingdom of Thailand. 
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trends were found in home deaths, from 17 percent to 22 percent, and in nursing home 
deaths, from 16 percent to 22 percent. Furthermore, different tendencies were noted in 
the race and region subgroup of causes of death. Unlike strokes, COPD, AMI and heart 
disease, death from cancers shows a marked decrease in in-hospital deaths from 70 
percent in 1980 to 37 percent in 1998 (Flory, Young-Xu et al. 2004). Across the 
Atlantic in England, there was a slight change found in the percentage of cancer deaths 
at home from 27 percent in 1985 to 26.6 percent in 1994. Cancer patients aged less than 
75 years were more likely to die at home than older patients. More men died at home 
than women in all 9 regions across England. In addition, compared to other specific 
types of cancers, patients with breast cancer or lymphatic cancer or cancer of the 
haematological system were less likely to die at home. This may be due to the nature of 
the illness and the treatments (Higginson, Astin et al. 1998). In Asia, Yang L, et al 
analysed trends of home deaths of Japanese, vital statistics during the five past decades, 
between 1951 and 2002. Generally, the proportion of deaths at home dropped from 82 
percent in 1951 to 13 percent in 2002; meanwhile, the percentage of in-hospital deaths 
increased. Trends in dying-at-home, of three leading causes of death, i.e. 
cerebrovascular disease, heart disease and cancer as well as in all elderly groups (65-74 
years, 75-84 year and older than 85 years) decreased over time.  
Place of death of Thai people was reported in a series of the Surveys of Population 
Change. Figure 1.3 illustrates trends in place of death over the past 15 years. 
Apparently, the percentage of home deaths is falling from 59.2 percent in 1989 to 51.5 
percent in 2005-6 while the trend in in-hospital deaths is upward (Population Survey 
Division 1990; Social Statistics Division 1997; Economic and Social Statistics Bureau 
2007). To compare with other studies mentioned earlier, further subgroup analysis by 
cause of death is required. 
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Figure 1.3 Place of death percentages during 1989 to 2006 
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Source: (Population Survey Division 1990; Social Statistics Division 1997; Economic and Social 
Statistics Bureau 2007) 
 
1.4 The impacts of mortality to households and health facilities 
Death may well impact households strongly. Once a household member dies, change in 
the livelihood of individuals, change in household size and composition or even 
household dissolution, and household financial stress can be found. Significantly, a 
critical reduction in household size is affected by the death of working-aged, male 
household heads and the death of working-aged female household heads/spouses. By 
contrast, partial coping of household size was noted with the death of other household 
members at working age. It was also reported that household heads aged less than 60 
years or small households were prone to household dissolution within one year after 
death of the heads (Urassa, Boerma et al. 2001; Yamano and Jayne 2004). 
It is debatable whether the death of a household member, especially the head of 
household, really affects the income and socioeconomic status of households. However, 
in small-scale farm households in Kenya between 1997 and 2000, there was a 68 
percent reduction found in the net value of crop production related to the death of a 
male household head aged between 16 and 59 years. Small animals and farm equipment 
are assets that households have to commonly sell to cope with the mortality of a 
working-aged member. Death of a working-aged male head causes suffering in off-farm 
income to the household. In addition, loss in those household assets and incomes from 
mortality of working-aged male heads has a considerable negative impact on poor 
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households (Yamano and Jayne 2004). In Thailand, Ford K, et al explored the 
relationship between the death of a household member, household income and its 
change in Kanchanaburi province. The 2001 and 2002 panel data shows that age at 
death and the decedent’s relationship to the head of household influenced changes in 
household income. In the case of a decedent who needed intensive care from household 
members prior to death, household income would increase after his/her death because 
such household members could earn money afterwards. On the other hand, if the 
decedent was the breadwinner, the household would lose income after his/her death. As 
a result of premature death of the adult head of household, household income declined 
(Ford, Rakumnuaykit et al. 2006). 
Health facilities are also affected by mortality, in their responsibility of health care 
services as well as health expenditure. In general, health services should facilitate care 
and improve the quality of life for patients but should not be a ‘one size fits all’ service. 
Near the end of life, illness can be theoretically classified into 4 patterns, i.e. physical 
function over time, mostly in the last year of life. This classification of so called 
‘theoretical trajectories of dying’ was initiated by Glaser and Strauss (1968) cited in 
Lunney et al (2002). It aims to facilitate health professionals to provide tailor-made 
health services, specifically palliative care to terminal stage patients. In addition, in 
understanding the natural deterioration of activities of daily living and cognitive 
function due to diseases, and increasing in dependency, both sides, i.e., health 
professionals, and patients and carers probably facilitate a practical care plan for a 
‘good’ death. Figure 1.4 depicts the pattern of four types of trajectories demonstrated in 
Davies and Higginson (2004), Lunney et al (2002), Lunney et al (2003) and Murray et 
al (2005). The first trajectory, is sudden death (panel A) in which the patient’s function 
is substantially normal and independent when approaching death. The second represents 
terminal illness (panel B); cancer is typically the most suitable. These are patients in a 
clear terminal phase in which they have no response to treatment but rather require 
increasing palliative care, and suffer a rapid decline in physical function. This phase 
usually includes the last few months to the last six weeks of life. The third group, organ 
failure, patients at the end stage of chronic heart failure or chronic obstructive 
pulmonary disease follows the pattern of this trajectory (panel C). Patients experience 
deterioration of functional status which is dependently related to hospitalisation and 
intensive treatment. In the meantime, acute exacerbation of the organ function 
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occasionally troubles severity and probably results in death. The prognosis of this group 
is uncertain. Finally, frailty (panel D), members of this fourth trajectory includes 
patients with dementia, stroke, or generalized frailty of multiple organ system. Patients 
encounter slow progressive disabilities and die from acute complications such as 
pneumonia during the last 3 months of lives (Lunney, Lynn et al. 2002; Murray, 
Kendall et al. 2005). Lunney et al (2003) confirmed these theoretical trajectories of 
dying with a study on physical functions of elderly during their last year of life in some 
area of the U.S. (Lunney, Lynn et al. 2003).  
Figure 1.4 Theoritical trajectories of dying 
A: Sudden death B: Terminal illness  
C: Organ failure  D: Frailty 
 
Source: (Lunney, Lynn et al. 2003) 
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1.5 Knowledge gap 
The information presented in the previous sections highlights that mortality is crucial to 
health at both international and national levels. It illustrates potential impacts to the 
whole population and individuals of households/families. It is also an indicator to 
monitor the quality of the public health of a country, healthcare service of health 
facilities, and as a monitor for population change. By understanding this issue, policies 
related to health service and other social services can better serve the population. It 
could be said that mortality has impacts to both population level and individual level. At 
population level, the related factors underpinned and reflected in this interesting issue 
mostly include socio-economics, demography and geography at different scales of 
interest, i.e. the world, region, economy level of country groups. At individual level 
which refers to the decedent and his/her household or family, apart from socio-
economics and geography of the decedent, cause of death, place of death and position in 
the household are mentioned in many studies. In addition, expenditure for caring for 
terminal stage patients might be a burden to the health system, i.e. health purchasers, 
providers and households. Some studies focusing on the last year of old-aged people 
lives revealed that the cost of care incurred by the U.S. federal health insurance 
programme ‘Medicare’ shared 27 percent to 30 percent of its overall expense, between 
1976 and 1988 (Lubitz and Riley 1993). The 2004 data shows that such last year of life 
per capita is four times greater than in any other year of the beneficiary’s life (The 
Henry J. Kaiser Family Foundation 2007). 
Looking back to Thailand, this significant cost might be overlooked in budget 
estimations for health service since the estimation is partially based on the data of the 
Health and Welfare Survey10. This survey is a routine national survey which is related 
to health and household payment. It is aimed at every household member but disregards 
decedents whom are already absent during the survey period. As a result, such budget 
estimation might be underestimated. In addition, no research or information of 
expenditure during the last period of life has been found in Thailand. 
                                                 
10 The Health and Welfare Survey is a national survey on health and expenditure on the biennium or 
annual basis.  It focuses on the Thai people accessibility to and utilisation to health service, out of pocket 
payment and morbidity rate related to health insurances. The survey conducted by the National Statistical 
Office with close consultation with the Ministry of Public Health. 
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An overview of international studies further reflects what is going on in the Thai health 
system regarding mortality. Some research groups have followed mortality related to a 
group of population in view of geographical, demographical and socio-economic 
factors. A longitudinal study on the impact of a household member’s death to the 
household in a province of Thailand is an example of the relationship between mortality 
of a member and some of such factors. However, no research on factors determined at 
the individual level was found. Specific to the recent major health care reform in 
Thailand, among other concerns as a lower-middle income country with scarcity of 
financial resources, health expenditure and cost containment are also a concern for 
policy makers. Many queries have been raised, for instance, the expenditure for the last 
period of life in the Thai context, the magnitude that the households pay out of pocket, 
and the cost incurred  to health facilities and insurance companies. Additionally, the 
Thai context is changing, i.e. the old-age population as well as mortality is in an upward 
trend, and the changing patterns of causes of death from communicable diseases to 
chronic diseases. Death from chronic diseases might require more health resources and 
longer term health services than death from serious communicable diseases. 
Owing to the many research questions mentioned previously, this thesis, therefore, 
focuses on some specific issues described in the following research questions (section 
1.6.1). The thesis is the first cross-sectional study on expenditure on the last period of 
life in Thailand, during 2005 to 2006. This period is three to four years after a major 
health care reform (details of this event are presented in the next Chapter). As it was 
recommended that policy for health service to terminally ill patients should fit to a 
specific trajectory pattern, death from cancers is an example for this circumstance. As a 
consequence of such recommendation, cancers have most clear terminal stage among 
four patterns of trajectory, so it was selected for further study on policy 
recommendation. The qualitative study among the stakeholders provided that whether, 
and to what extent the current service should be improved. 
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1.6 Research questions, purposes and content of the thesis 
1.6.1 Research questions of the study 
1) Is there any inequity among Thai people in health care during the end of life 
period?  
2) What are the factors influencing that inequity? 
3) How do terminally ill cancer patients and their families cope with financing and 
their preferences for healthcare during that period? 
4) What new policy directions need to be developed or changes need to be made in 
the current policy and practices in Thailand? 
1.6.2 Purpose of the thesis 
In order to focus on some issues within the research questions, the thesis mainly aims to 
explore the equity in terms of expenditure, in a particular, the period before death. The 
objectives, therefore, include: 
1) To estimate costs of treatment prior to death to the health system (3 main 
insurance schemes), i.e., UC, SSS11, CSMBS during 2004 and 2005. In particular, to 
investigate: 
o disparity of the cost among the three schemes 
o admission episode and cost comparison of decedents and the general 
population 
2) To estimate household health expenditure (direct medical cost, indirect 
medical cost and indirect non-medical cost) of the last three months for outpatient care 
and last six months for inpatient care prior to death of Thai decedents during 2005-2006 
(2006 Thai fiscal year) and the proportion to household incomes.  In particular, to 
investigate: 
o expenditure  not covered by health insurance schemes; UC, SSS, 
CSMBS, private and uninsured decedents 
o expenditure and health seeking behaviour prior to death categorized by 
five household incomes quintiles 
                                                 
11 Dataset of SSS may not be able to access by this study. 
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3) To explore current practice on disclosure of diagnosis, preferences on quality 
of life or care, place for dying and perception on advance directive among health 
professionals, terminally ill patients and the patients’ relatives  
4) To explore factors considered important when people are dying  
5) To describe health service for terminally ill patients at several types of health 
facilities  
6) To recommend, accompanied with cost and consequences from quantitative 
studies; views of health professionals, terminally ill patients and the patients relatives 
from a qualitative approach; and policy makers perspectives, policy options for 
improving healthcare services for terminally ill patients 
1.6.3 Contents of the thesis 
The thesis comprises of nine chapters. The following chapters start with a background 
of the Thai healthcare system. This second chapter provides an overview of: the Thai 
healthcare service system, the history on healthcare reform in Thailand, three major 
health insurance schemes and the health service specific to cancer patients. Chapter 
Three reviews literature linked to theory related to equity from a health perspective; 
healthcare cost and expenditure on the last year of life which may be different from the 
expenditure on other periods of life; and the definition of terminal care and end of life 
care and palliative care, particularly for cancer patients; . Chapter Four reveals the 
methodology of the thesis. This thesis consists of four studies, i.e. two quantitative 
studies on expenditure of health insurances and households and two qualitative studies 
on current practice among health professionals, patients and their carers including the 
preferences of the patients.  This chapter starts with the conceptual framework and is 
followed by available sources of data, general quantitative and qualitative methods used 
in the four studies of the thesis. 
The results are separately presented through the four studies, accordingly, i.e. Chapter 
Five, Six, Seven and Eight. Chapter Five presents the expenditure of the health 
insurance schemes or hospital charges, while Chapter Six provides details of health 
seeking behaviour and household expenditure for the decedents. Chapter Seven reports 
the patients’ perspective on cancers and their preferences and how the households and 
patients accommodate to patients illness. Chapter Eight looks at current practice among 
health professionals in telling the truth about the illness of and the health services 
provided to the terminally ill patients. These two chapters probably revealed the reasons 
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underpinning the findings from the two quantitative studies as well as further 
comprehension of the patients and health professionals understanding and practice. The 
overall main findings of the separate research studies reported in this thesis are 
discussed in light of the previous literature, in Chapter Nine. Finally, the 
recommendations for improving policy on health service, in particular for cancer 
patients and future researches are presented in this chapter. 
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CHAPTER TWO 
BACKGROUND OF THE THAI HEALTH SYSTEM 
 
In order to better understand Thailand and its health system, this chapter provides a 
brief overview of the country’s location and population characteristics as well as 
background information on the Thai health system. The health system in this thesis 
refers to its composition of policy, infrastructure and service delivery, manpower and 
financing which is presented in detail. The focus was on updated information of the 
current system and the era of last health system reform during 2001-2002. This Chapter, 
however, also notes the situation a few decades prior to this reform. In addition, the 
thesis aims to provide a view of terminal phase of lives with a particular picture of a 
selected disease that is cancer, with the last section of this chapter presenting the health 
system for cancer in Thailand. 
2.1 Overview information of the Kingdom of Thailand: location, the population and 
economics 
Briefly, Thailand is a democratic country with a constitutional monarchy and a King as 
the Head of State. Among the Southeast Asian nations, Thailand is the third largest 
country with a population of 65.1 million in 2006. Approximately, 94.5 percent of the 
population is Buddhist followed by 4.5 percent Muslim and 0.7 percent Christian. 
Ninety eight percent of residents are Thai nationals and the rest from China, Myanmar 
and Laos. The country is administrated by 3 levels of government: central, provincial 
and local. With Bangkok as the capital, Thailand is divided into 75 provinces, 796 
districts and 81 minor districts, 7,255 sub-districts or ‘tumbons’ and 74,944 villages. 
Twenty five provinces (not including Bangkok) are located in the Central region; 17 
provinces in the North; 19 provinces in the North-east; and 14 provinces in the South. In 
2006, the majority of the population (21.953 million) resides in the north-eastern region 
(Ekachampaka and Taverat 2008). 
Since 1987, Thailand has been classified as a lower middle income country12 with an 
average economic growth rate of 7.8 during the past three decades. However, the 
                                                 
12During the period of 1 July 2009 to 1 July 2010, the World Bank classification considers 2008 gross 
national income (GNI) per capita. Four groups of countries are low income, $975 or less; lower middle 
income, $976–3,855; upper middle income, $3,856–11,905; and high income, $11,906 or more 
(www.worldbank.org; accessed 28/09/2009) 
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country faced an economic crisis during 1996-1997, and as a result, the growth rate 
dropped to -10.8 percent in 1998 but 1-2 years later, it rebounded to more than 4 percent 
during 1999 and 2000. In 2007, the economic growth rate was approximately 4.5-5 
percent. The gross domestic product (GDP) per capita in market price has increased 
from 2,239 Baht in 1960 to 124,997 Baht in 2006. The Thai economy comprises of 3 
sectors, agricultural, industrial and service, with the biggest proportion of GDP earned 
from the service sector (Ekachampaka and Taverat 2008).  
Poverty in Thailand is a major governmental concern. Starting from 57.0 percent in 
1962, there has been a downward trend of people living in poverty over the past four 
decades though this was interrupted twice due to two economic crises. In 2006, the 
poverty prevalence was as low as 9.6 percent. Even though the proportion was 
obviously promising, poverty in rural areas was three times greater than in urban areas, 
and the gap between the rich and the poor has been widening. During 1996-2006, on 
average, the wealthiest group (5th quintile) shared 56.5 percent of the national income 
meanwhile the poorest group (1st quintile) shared 4.2 percent. In 2006, the income 
disparity between both groups was 14.8 times, representing the highest figure among 
south-east Asian countries (Ekachampaka and Wattanamano 2008). 
The economic situation has affected and is closely related to health financing and 
policies. Inequity in health had been reported, however, with no alteration to the 
economy, for instance, health expenditure has been in an upward trend, increasing from 
3.8 percent of GDP in 1980 to 6.1 percent in 2005 but inequity has remained the same. 
The 2004 national health account also indicated that the burden of health expenditure 
(the out of pocket payment in relative to income) of the poor was 2.1 times higher than 
that of the rich (Ekachampaka and Wattanamano 2008). Further information on health 
expenditure is presented in subsection 2.2.4.2. 
Improvements in education in terms of literacy, learning and reading rates were rapid. 
In 1970, the literacy rate of the Thai population aged 15 years and above was 78.6 
percent, but, in 2005, it rose markedly to 93.5 percent. In addition, it is estimated to 
grow to 97 percent by the year 2010. The learning rate, however, was only 60.0 percent 
in 2005 and disparities were found across regions and municipalities. Reading rates as 
in regular reading were also low at 61.2 percent in 2003, but this figure improved 
slightly to 69.1 percent in 2005 (Ekachampaka and Wattanamano 2008). 
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Health is also a right of Thais stated in the Constitution. The two recent Constitutions, 
the 1997 and the 2007, indicate that the individual Thai has the equity in receiving 
appropriate and stardard health services. The public sector has the responsibility to 
ensure the access to health services of the Thai (1997; 2007).  
2.2 Health system 
Starting in the nineteenth century, alongside traditional medicine, western medicine has 
played a role in Thai healthcare since 1828. The first health related law, sanitation, was 
enacted in 1870 with the first western hospital, Siriraj Hospital, being established a year 
later. Following the support of Prince Mahidol of Songkla—who is considered the 
father of modern medicine and public health in Thailand, infrastructures and education 
in western medicine, i.e. government medical stock, departments and ministries, various 
schools for health professionals were established and developed. By 1950, there was a 
hospital in every province (Ekachampaka, Taverat et al. 2008; Bureau of Health Policy 
and Strategy 2009).  
It was defined that a well functioning health system comprises of six domains, i.e. 
leadership and governance, health inforamtion systems, health financing, human 
resources for health, essential medical products and technologies, and service delivery 
(World Health Organization 2010). Currently, the Thai health system is mainly run by 
the government with, to some extent, a public-private mix which is described later. The 
public sector includes several organizations, i.e. the medical schools under the Ministry 
of Education, the Ministry of Interior, local administrative organisations, for instance. 
However, the Ministry of Public Health is the main authority and is the focal point for 
national health policy and planning, in particular relating to public health. 
2.2.1 National health plan 
Health has been an issue included in the country’s development plan which the health 
plan is a part of. As a road map for economic development of Thailand, the national 
development plan was commenced in 1961. This operational plan aimed for 
development in many aspects including health. The plan included social development 
since the 4th plan, and as a result, the plan was renamed and is now known as the 
“National Economic and Social Development Plan” (NESDP). This medium term plan 
is now in the fourth year of the 10th plan, 2007-2011. In the health section of the 
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NESDP, this national health plan gears for the development of all six components of the 
health system depending on its priority during the period of each plan. 
Among the health plans, the first three were mainly aimed at infrastructure development 
and included some major health programmes, for example, the sanitization and hygine, 
elimination of epidemic communicable disease. The period of the Fourth and Fifth 
Plans coincided with two global health policies, i.e. the ‘Health for All by the Year 
2000’ in 1977 and ‘Declaration of Alma Ata’ in 197813. As a consequence, both health 
development plans stated that primary health care is the strategy for the goal of the 
‘Health for All’. The Sixth Plan responded to the transition of the population structure, 
from pyramid to a bell shape, and the increase in non-communicable diseases. 
Meanwhile the Seventh Plan aims shifted to the health financing and health economics. 
Owing to the economic crisis, the Eighth Plan was an era of a major health care reform 
followed by the Ninth Plan which emphasised on a people-centred approach. The 
philosophy of a ‘sufficiency economy’ was adapted to a ‘health sufficiency system’ in 
the Tenth Plan. The key features of all 10 health development plans as part of the 
NESDP (Anonymous 2005; Ekachampaka and Taverat 2008; Bureau of Health Policy 
and Strategy 2009; National Economic and Social Development Board 2009) are 
outlined below. 
First Plan, 1961 – 1966: This plan focused on improving capacity of existing health 
centres and controlling the epidemic of malaria and other communicable diseases. 
Existing hospitals were improved in services, numbers of beds and numbers of health 
personnel were increased; provincial hospitals were upgraded to regional hospitals and 
new district hospitals and health centres were established. Improvements in the 
efficiency of supplies for medicines were another action undertaken. 
Second Plan, 1967 – 1971: This continued the projects of the first plan by expanding 
and developing health facilities and in controlling communicable diseases. 
Third Plan, 1972 – 1976: This plan placed an emphasis on expanding new health 
centers and their responsibility over the country. In order to reduce morbidity and 
mortality, the plan continued to be aimed at the prevention and eradication of some 
communicable diseases. It included improving sanitisation and increasing clean water 
                                                 
13 Health for All by the Year 2000 is aimed to protect and promote the health for all the people of the 
world. 
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supplies in rural areas, the promotion of family planning and birth control, expanding 
maternal and child healthcare services, and strengthening local capacity in medicine 
production and improving laboratory diagnostics. 
Fourth Plan, 1977 – 1981: Due to concerns about the population in rural areas, this 
plan highlighted increasing numbers and strengthening the capacity of the health 
workforce, particularly village health volunteers and village health communicators, 
improving efficiency and expanding the coverage of services for maternal and child 
healthcare, improving plans for medicines and pharmaceutical administration. In 
addition, other projects from previous plans were also carried on. 
Fifth Plan, 1982 – 1986: Fostering primary health care as well as the continuation of 
constructing a health centre in every sub-district and a district hospital in every district 
were the principal tasks in this health development plan. On the other hand, the plan did 
not ignore reducing morbidity and mortality rates from  preventable communicable 
diseases, children immunization, capacity strengthening of the health workforce, 
medicine supplies and pharmaceutical administration, clean water supply and 
sanitisation, and maternal & child health and child malnutrition. 
Sixth Plan, 1987 – 1991: The plan continued to target the main focuses of the last plan 
but each target was more quantitatively figured out. 
Seventh Plan, 1992 – 1996: In order to improve quality of life, both physically and 
mentally for ‘health for all’, the plan concentrated on coverage, equity, harmonisation, 
flexibility and self-reliance of the individual and community. It aimed to support the 
continuation of primary health care in rural areas, and improving the quality and 
efficiency of health facilities at every level. In addition, its aim was to promote and 
support health insurance in special populations, i.e. low income groups, labourers, 
elderly, children, handicapped and other vulnerable groups. The amendment of health 
related legislations was mentioned in this plan. 
Eighth Plan, 1997 – 2001: People were the target of this five-year development plan 
instead of the economy. This human centred plan changed the previous segmented 
development into integrated development. The aims in the plan were related to behavior 
for good health; decreasing morbidity and mortality from risk behaviour and 
preventable diseases; health insurance and accessibility to efficient and good quality 
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health services; consumer protection; pleasant and safe environment for living and 
working; special protection for pregnant women and children; and health for the elderly. 
Ninth Plan, 2002-2006: This gave attention to all stakeholders’ participation in strategy 
determination. The plan comprised of 4 factors, i.e. concepts of health development, 
linkage between the vision of the NESDP and Health Development Plan, the vision and 
strategies of health development, and the guidelines of management and monitoring. 
The ten goals targeted in this plan emphasised health promotion and prevention, health 
insurance for ensuring accessibility and equity, decentralisation, capacity strengthening, 
fostering primary health care, improving quality of service system and promoting 
intellectual and knowledge of Thai medicines. 
Tenth Plan, 2007 – 2011: This plan still follows the main direction of the previous one 
but it was prioritized according to the new concept of health, unity of the health system 
and holistic health. The philosophy of a ‘sufficiency economy’ was adapted to be a 
‘health sufficiency system’ as the concept of this plan. Ten development goals were 
highlighted as balanced and sustainable unity and good governance in health system, 
proactive health promotion, holistic health, strong health community and primary care 
network, efficient health system, equitable and quality universal health insurance, 
strengthening of health system against disease and health impact, variation in alternative 
medicines and self care, knowledge management and research supported health system, 
and care for the poor and vulnerable groups regarding their dignity. 
2.2.2 Health infrastructure and its service delivery 
Health infrastructure focuses on health facilities for modern medicines. In fact, there are 
complementary medicines, and its facilities are the same as traditional medicines and 
alternative medicines. However, these are out of the scope of this review. 
2.2.2.1 Level of care and types of health facilities 
This subsection focuses on hospitals, health centres as well as clinics and 
pharmacies/drug stores in the perspective of administrative level, level of health 
facilities, and geographical distribution. The following information is mostly based on 
the Thailand Health Profile 2005-2007 (Anonymous 2005; Faramnuayphol, 
Ekachampaka et al. 2008). 
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Health services are provided by many organisations, for example, the Ministry of Public 
Health (MoPH), the Ministry of Education, the Ministry of Interior, the Ministry of 
Defence, state enterprises, local administrative organisations and private sector. Health 
services are classified into 5 levels of care. Self care is the fundamental level of 
individual capacity in self prevention and protection from harmful substances to health. 
Primary health care level is the services provided in the community by individuals, 
village health volunteers or non-governmental volunteers. The care is mostly health 
promotion, disease prevention rehabilitative care and simple curative care.  
Next, the primary care level is provided by health personnel. At present, holistic care is 
promoted to be a suitable primary care for Thais. This level comprises of four types of 
units, i.e. community health posts; health centres and primary care units; health centres 
of local administrative organisation, private clinics and outpatient departments of 
hospitals; and pharmacies or drugstores. At present, a community health post in a 
village, mostly in remote areas is operated by a community health worker. Services 
include health promotion, disease prevention and simple curative care. Health centres 
and primary care units are usually located in sub-districts or ‘tambons’; one health 
centre for one sub-district. Services are provided by a technical nurse, a midwife and a 
health worker including a dental nurse. Additionally, a professional nurse and a health 
specialist are available in the large health centres. These front line units provide similar 
services as mentioned earlier but their health programme follows the MoPH practice 
guideline and standard operational procedures accordingly. Besides, the units are under 
supervision of community hospitals. Services at health centres of local administrative 
organisations, outpatient departments and private clinics are provided by physicians, 
likely to be general practitioners and other health professionals. Pharmacies and 
drugstores are also units where pharmacists or staffs with basic training provide primary 
care. 
Fourth, secondary care is operated by medical and health professionals with 
intermediate level of specialisation. Service provided by doctors and other health 
professionals is rather curative care than prevention and health promotion. Hospitals 
providing this service include community hospitals, general or regional hospitals or 
other large public hospitals, and private hospitals. Finally, the tertiary care level is 
medical services for curative care provided with all fields of medical specialties and 
super-specialties, for example, hematology and oncology. Health facilities which serve 
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tertiary care include large general or provincial hospitals, regional hospitals, medical 
school hospitals and specialised institutes. There is no clear boundary between levels of 
care, however. Tertiary care hospitals could provide primary as well as secondary care. 
In addition, secondary care hospitals could be upgraded to upper level of care in 
condition of numbers of beds, doctor specialties, health technologies provided and 
requirement in geographical distribution. 
A community hospital is situated in a district town or minor-district with the number of 
beds ranging from 10 to 150 but more than half are 30-bed hospitals. A general or 
provincial hospital is located in a provincial city or downtown of a big district. The 
hospital is usually 200 to 500-beds and its medical service is provided by doctors with 
main specialties, i.e. surgery, pediatrics, medicines and obstetrics and gynecology. A 
regional or a large public hospital, one with 500-beds or above, is also located in 
provincial city centres. Besides providing services to local people in these provinces, the 
hospitals take responsibility as regional hubs of more advanced care for neighbouring 
provincial hospitals. Each level of care is linked together by a referral system in both 
directions from a simple level to a more advanced level and vise versa. 
2.2.2.2 Agencies and distribution of health facilities 
As of 2007, Thailand has 1,338 hospitals with 140,007 beds and 41,983 other health 
facilities for a population of approximately 65 million. The largest hospital in Thailand 
is Siriraj Hospital, the 2,600-bed, oldest medical school hospital located in Bangkok. 
Table 2.1 shows that the MoPH is the main in-patient service provider, i.e. 882 hospitals 
(66 percent of hospitals), followed by the private sector and other ministries. In 2007, 
under the MoPH, 51 specialised hospitals/institutes, 25 regional hospitals, 70 
general/provincial hospitals, 730 community/district hospitals and 9,758 health centres 
are distributed over the country. Whilst almost all of MoPH hospitals serve people 
residing outside Bangkok, private hospitals and others mainly serve people living in 
Bangkok and in the central region. In addition, private hospitals play a role in offering 
services for people in urban areas and foreign patients. Table 2.2 illustrates the 
geographical distribution of most types of health facilities classified by level of care. 
From one-third to half of tertiary care hospitals, i.e. medical school, specialized 
hospitals/institutes, general hospital and private hospitals including a quarter of primary 
care, i.e. private clinics and pharmacies/drug stores are located in Bangkok. More 
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MoPH tertiary hospitals, i.e. 36 regional hospitals and general hospitals are located in 
the central region with 25 provinces meanwhile more secondary hospitals, i.e. 267 
community/district hospitals are located in the north. In contrast, the north-east has the 
greatest numbers of health centres or health facilities for primary care. 
Table 2.1 Geographical distribution of hospitals by agencies in 2007 
Region 
Agency Total Bangkok
Central North North-east South 
MoPH 882 12 225 192 296 157 
Other ministries 121 19 37 23 22 20 
State enterprises 2 2 - - - - 
Autonomous public 
organization 5 1 4 - - - 
local administration 10 9 - 1 - - 
Private sector 318 89 105 50 42 32 
Total 1,338 132 371 266 360 209 
Source: Bureau of Health Policy and Strategy (2007) 
 
Table 2.2 Geographical distribution of health facilities by level of care in 2007 
Region 
Type of care Bangkok
Central North North-east South
Medical schools 5 2 2 1 1 
Specialized hospital/institutes 14 47 
MoPH regional hospitals - 9 5 6 5 
General hospital under other 
Ministries and state enterprises 22 60 
MoPH general/provincial hospitals 4 27 14 15 14 
MoPH community/district hospitals - 174 267 163 129 
Private hospitals 89 105 50 42 32 
Health centres (branch) 68 (77) 2,556 2,228 3,464 1,510
Private clinics* 3,687 13,113 
Pharmacies/drug stores** 8,960 2,179 2,751 1,535
Note: *data in 2006; **data in 2005 
Source: Department of Medical Services (2005), Bureau of Health Policy and Strategy (2007) and 
Faramnuayphol et al (2008) 
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Table 2.3 illustrates population per bed ratios of all hospitals and of MoPH hospitals 
across the country. The figures partially support previous information that people living 
in Bangkok have better access to hospitals than people living outside. People in the 
north-eastern region have the highest ratio which indirectly indicates the least 
accessibility to hospital care. However, these ratios view only provinces/regions and 
people residing there. In fact, as a result of the referral system, health facilities with 
advanced care have responsibility beyond their local patients.  Regional hospitals, 
specialised institutes and medical school hospitals, particularly in Bangkok may get 
patients referred from other less advanced hospitals. Therefore, these ratios indicate 
partial loads only. The data also indicates that within MoPH hospitals, people in the 
central region have been served by regional hospitals and general/provincial hospitals 
than the rest. On the contrary, people in the north-east are provided by 
community/district hospitals than regional hospitals and general/provincial hospitals. 
Table 2.3 Population per bed ratios by levels of hospital in 2007 
Region 
Level of hospital Bangkok
Central North North-east South 
Total 196 386 490 723 497 
Ministry of Public Health 
? Regional hospital 
? General/provincial hospital 
? Community/district hospital 
 
- 
- 
- 
 
2,647 
1,748 
1,852 
 
3,234 
2,172 
1,639 
 
4,154 
4,030 
1,704 
 
2,807 
2,017 
1,649 
Note: no available data for hospitals under other agencies 
Source: Bureau of Health Policy and Strategy (2007) 
 
2.2.3 Health manpower 
This section focuses on medical doctors and professional nurses who play a crucial role 
in the function of health services delivery. Updated cross-sectional information on 
geographical distribution as well as distribution across level of care and agency are 
described below. This information depicts health professionals who are a key factor in 
the health system. 
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2.2.3.1 Medical doctors  
To respond to the health needs of Thais and the insufficiency of doctors in rural areas, 
the Royal Thai Government launched a policy on compulsory government services for 
new medical graduates from the public universities in 1965. The first batch started 
providing health services since 1971. These medical graduates were mandated to work 
at least 3 years in community/district hospitals. Later, this policy was extended to 
nurses, dentists and pharmacists. Despite a deficiency of doctors in rural areas remains, 
the severity was alleviated. Up to now, this policy has played a crucial role in the recent 
major health system reform (Anonymous 2005; Faramnuayphol, Ekachampaka et al. 
2008; Prakongsai, Limwattananon et al. 2009).  
Currently, there are 14 medical schools in which thirteen are public and one is private. 
Among other policies including national education, the Ministry of Public Health and 
the Higher Education Commission established a 20-year ‘Collaborative Project to 
Increase Production of Rural Doctors’.  As a result, approximately 1,300 to 1,500 new 
students are admitted per year (Collaborative Project to Increase Production of Rural 
Doctor; Faramnuayphol, Ekachampaka et al. 2008). 
Doctors provide medical services in various health facilities under the 5 groups of 
agency. Similar to health facilities in subsection 2.2.2, MoPH is the main agency of 
doctors. Figure 2.1 illustrates the proportion of medical doctors among the five agencies 
during the past thirty years. During first decade, the proportion of doctors in MoPH and 
other ministries fluctuated in opposite directions. Later on, however, it was not until the 
economic crisis in 1997 that the proportional trend of doctors in other ministries was 
secondly downward but the proportion of doctors in private sector rose markedly. The 
proportion among these three main agencies changed again during the two years after 
the crisis. That is, the proportion of MoPH doctors rose but the proportion of doctors in 
other ministries and private sector dropped. In 2001, the proportions of other ministries 
and private sector are trough and peak, respectively, and their trends have been in an 
opposite direction since then. The proportion trend of the MoPH dropped from the peak 
in 1999. Fluctuation of the proportion of such agencies along the pre- and post- 
economic recession might partly be due to the internal brain drain during the economic 
boom of the country including the increase of new hospitals and demand on health 
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services and a policy promoting medical hub in private sector and the reverse brain 
drain, thereafter.  
As of 2007, half of all doctors are working in health facilities under the MoPH. Nearly a 
quarter of them are working in other ministries and one-fifth is working in the private 
sector. Approximately 3 percent of doctors work in local administrative agencies and 
nearly 1 percent works in health facilities of state enterprises (Anonymous 2005; Bureau 
of Health Policy and Strategy 2007; Faramnuayphol, Ekachampaka et al. 2008).  
Figure 2.1 Proportion of medical doctors by five agencies between 1979 and 2007 
Proportion of professional nurses by agencies, 1979 - 2007
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Source: (Anonymous 2005; Bureau of Health Policy and Strategy 2007; Faramnuayphol, Ekachampaka 
et al. 2008) 
 
The latest data in 2007 revealing the distribution of doctors across the country is shown 
in Table 2.4. By population per doctor ratio, one doctor is responsible for 2,778 people 
over the whole country in 2007. It indicated that doctors in Bangkok had the lowest 
workload, meanwhile doctors in the north-east had the highest workload and the gap is 
6.2 times. However, this lowest workload of doctors in Bangkok might be 
overestimated. This is due to the fact that the most advanced health facilities which are 
the final referred hospital in the referral system are located in Bangkok. As a result, 
doctors and other health personnel in Bangkok are likely to shoulder such referred 
patients residing outside Bangkok. Across regions, mal-distribution gap is narrower, i.e. 
twice in difference between the highest and lowest ratio, the north-east and central 
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region. According to the health infrastructure, focusing on the three main agencies, less 
than 10 percent of MoPH doctors work in Bangkok meanwhile the central and north-
eastern regions have more than half of MoPH doctors. In contrast, it was found that half 
of doctors in other ministries as well as in the private sector work in Bangkok. 
Table 2.4 Geographical distribution of medical doctors by agencies in 2007 
Region 
Agencies 
Total 
(%) 
Bangkok 
Central North North-east South 
Population per doctor ratio 2,778 850 2,683 3,279 5,308 3,354 
MoPH 
11,415 
(50.4) 
720 
(6.3) 
3,473 
(30.4) 
2,343 
(20.5) 
3,150 
(27.6) 
1,729 
(15.1) 
Other ministries 
5,583 
(24.6) 
2,806 
(50.3) 
781 
(14.0) 
839 
(15.0) 
626 
(11.2) 
531 
(9.5) 
State enterprises 
31 
(0.1) 
19 
(61.3) 
- 
12 
(38.7) 
- - 
Autonomous public 
organizations 
153 
(0.7) 
24 
(15.7) 
128 
(83.7) 
- 
1 
(0.7) 
- 
Local administrations 
735 
(3.2) 
690 
(93.9) 
21 
(2.9) 
13 
(1.8) 
8 
(1.1) 
3 
(0.4) 
Private sectors 
4,734 
(20.9) 
2,452 
(51.8) 
1,314 
(27.8) 
416 
(8.8) 
243 
(5.1) 
309 
(6.5) 
Total 22,651 6,711 5,717 3,623 4,028 2,572 
Source: Bureau of Health Policy and Strategy (2007) 
 
Figure 2.2 illustrates the ratio between the number of specialists and general 
practitioners. Thirty years ago, the majority of doctors were general practitioners rather 
than specialists. The trend of this proportion in 2006 is markedly inversed, with nearly 
four-fifths of doctors being specialists. This proportion also indicates the current trend 
in specialized care rather than integrated services. In 2007, the Health Resource Survey 
revealed that two-fifths of specialists are located in Bangkok and nearly one-quarter 
works in the central region. Among 79 specialties, the highest proportion is in 
medicines making up 10.1 percent, followed by pediatrics, obstetrics-gynecology, 
surgery and orthopedics at 9.3 percent, 8.6 percent, 7.5 percent and 6.7 percent, 
respectively (Anonymous 2005; Bureau of Health Policy and Strategy 2007; 
Faramnuayphol, Ekachampaka et al. 2008).  
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Figure 2.2 Proportion of general practitioners and specialists, 1971 - 2006 
Proportion of general practioners and specialists, 1971 - 2006
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Source: The Medical Council of Thailand, in (Anonymous 2005; Faramnuayphol, Ekachampaka et al. 
2008) 
 
2.2.3.2 Professional nurses 
The main nursing care providers in Thailand include professional nurses and technical 
nurses. However, technical nurses have received training for higher education and have 
been promoted to be professional nurses since the end of 2006 (Office of the Permanent 
Secretary 2006). As a result, this thesis presents details of professional nurses only. 
In 2007, Thailand had 76 nursing schools of which 60 schools have graduated nurses. 
Of these, 16 belong to the Higher Education Commission, Ministry of Education, 29 are 
MoPH schools, 3 are under the Ministry of Defence, 1 is of the Ministry of Interior, 1 is 
of the Bangkok Metropolitan Administration and 10 are private schools. The numbers 
of nursing schools have increased to 80 in 2009 and the current production capacity is 
6,000 new graduates per year. As a result of previous insufficiency of nurses, the 6-year 
national plan to increase production of nurses was launched and  2,320 more graduated 
nurses per year are to be  added on between 2010 and 2016 (Thailand Nursing and 
Midwifery Council 2009).  
Figure 2.3 illustrates the trend in professional nurses distributed in health facilities. 
Similar to medical doctors, professional nurses provide health care services at health 
facilities among the 5 groups of agency. The MoPH is the principal agency with an 
upward trend since the past three decades, proportionately. Whilst professional nurses in 
other ministries is 12 percent less than the MoPH in 1979. Thirty years later the gap was 
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broadened because of the relatively declining proportion of the other ministries’ and the 
increasing trend of the MoPH’s nurses. This is mainly due to national health policy on 
expanding the primary care and secondary care services delivery to rural areas as 
mentioned in section 2.2.1 (Anonymous 2005; Faramnuayphol, Ekachampaka et al. 
2008).  
In contrast to doctors, the proportion of professional nurses in the private sector has 
increased slightly during the past three decades, from 10.4 percent to 14.4 percent. It is 
likely that this is due to the fact that professional nurses are less needed in private 
hospitals and they might be replaced by other health personnel in some minor duties. 
However, a similar pattern to doctors in private sector is shown with a peak and trough 
of the proportion during a few years pre and post the 1997 economic crisis. A Long 
falling trend in the proportions of professional nurses in hospitals of  state enterprises 
and local administrative agencies follows the trends of health facilities and doctors as 
described in subsection 2.2.3.1 (Anonymous 2005; Faramnuayphol, Ekachampaka et al. 
2008).  
Figure 2.3 Proportion of professional nurses by agencies, 1979 - 2005 
Proportion of professional nurses by agencies, 1979 - 2007
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Source: Report on Health resource survey in Anonymous (2005) and Faramnuayphol et al (2008) 
 
The 2007 geographical distribution of professional nurses is presented with population 
ratios and numbers and percentages as shown in Table 2.5. By population per 
professional nurse ratio, the national ratio is 597 people per nurse. The ratio indicates a 
4.2 times disparity between the lowest and the highest ratio, i.e. Bangkok and the North. 
However, the disparity is small among the 4 regions, which is around two times 
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between the north and the central region. Almost all professional nurses (86.6 percent) 
are working in public health facilities and two thirds are MoPH health personnel. 
Approximately 14 percent of the professional nurses deliver nursing care in other 
ministries and private health facilities. Across the country, nearly one-third of MoPH 
professional nurses provide their nursing care in the central region meanwhile nearly 
two-thirds of nurses in other ministries as well as over half of the nurses in private 
health facilities are working in Bangkok. At present, it is estimated that there is a 
shortage of professional nurses in rural areas. However, the increase in production of 80 
nursing schools may well fill this gap soon. 
Table 2.5 Geographical distribution of professional nurses by agencies in 2007 
Region 
Agencies Total Bangkok 
Central North North-east South 
Population per 
professional nurse ratio 597 240 554 999 638 619 
MoPH 
70,822 
(67.2) 
2,762 
(3.9) 
21,772 
(30.7) 
19,191 
(27.1) 
15,094 
(21.3) 
12,003 
(16.9) 
Other ministries 
14,913 
(14.1) 
9,212 
(61.8) 
1,565 
(10.5) 
1,318 
(8.8) 
1,903 
(12.8) 
915 
(6.1) 
State enterprises 
70 
(0.1) 
60 
(85.7) 
- - 
10 
(14.3) 
- 
Autonomous public 
organizations 
574 
(0.5) 
58 
(10.1) 
478 
(83.3) 
14 
(2.4) 
16 
(2.8) 
8 
(1.4) 
Local administrations 
3,884 
(3.7) 
3,253 
(83.8) 
261 
(6.7) 
103 
(2.7) 
148 
(3.8) 
119 
(3.1) 
Private sector 
15,135 
(14.4) 
8,412 
(55.6) 
3,613 
(23.9) 
768 
(5.1) 
1,454 
(9.6) 
888 
(5.9) 
Total 105,398 23,757 27,689 21,394 18,625 13,933 
Source: Bureau of Health Policy and Strategy (2007) 
 
2.2.4 Health financing 
2.2.4.1 Health insurance system and their payment mechanisms 
1) Overview of the health insurance system prior to 2002: the major health care reform 
Historical records indicate that the insurance system was first introduced to Thailand in 
1929 as a private-own insurance business. Fifty years later, the first private health 
insurance company started its business in 1978. In the public sector, the policy on out of 
 39
pocket payment for drugs and medical services or user charges in public health facilities 
was initiated in 1945. Nevertheless, the poor were considered for informal user fee 
exemptions by health workers (Tangcharoensathien, Srithamrongsawat et al. 2002).  
Apart from private health insurance which seems to be the first health insurance scheme 
in Thailand, various health insurance schemes were formed in line with other 
components of health system developments. Based on the nature and objectives, 
Supachutikul A in Tangcharoensathien et al (2002), classified the schemes into 4 
groups, i.e. Medical Welfare Scheme (MWS) with free medical care; Voluntary 
Schemes (VS) which includes private health insurance and Health Card Scheme (HCS); 
Civil Servant Benefit Scheme (CSMBS) is a fringe benefit to compensate the lower 
public salary; and Compulsory Social Insurance (CSI) is a compulsory scheme which 
includes the responsibilities of stakeholders, for example, the Social Security Scheme 
(SSS) which consists of a component of the Social Health Insurance (SHI), the Traffic 
Accident Insurance (TAI)14. Besides, it was also noted that other small scale community 
financing provided some health benefits or other benefits to its members were available 
in Thailand15. An overview on the MWS and the HCS are presented in this subsection 
whereas details of the CSMBS and CSI (Social Health Insurance: SHI) can be found in 
later subsections.  
Table 2.6 summarises the chronological events of the four health insurance scheme 
developments. It was not until 1975 that government policy on the MWS was 
established with an aim to reduce inequity. At the beginning, free medical care was 
provided to low-income (the poor) individuals. Later, it was expanded to the elderly, 
children under 12 years old, veterans, the handicapped, and religious and community 
leaders. In 1994, the name of the scheme was changed from ‘the Medical Welfare 
Scheme for Low Income Individuals’ to ‘the Medical Welfare Scheme for 
Underprevileged Groups’, so called ‘the Low Income Card: LICS’. During operations 
and development to achieve the goal, many problems and attempts to get better 
performance of the Scheme were reported. Targeting the poor is an unfinished agenda 
that the scheme encountered every year in terms of definition and criteria of poverty, 
                                                 
14 The TAI covers to all owners of automobile vehicles for the responsibility of traffic accidents via 
annual compulsory premium payment. It ensures access to medical care of the victims in traffic accidents. 
15 Small scale community financing includes the community saving group in Songkhla province aim for 
improving quality of life. The members pay small premium routinely. Health welfare scheme is a part of 
this saving group Phongphit, S. (2002). Chapter 9: Community saving and health welfare scheme. Health 
insurance systems in Thailand. P. Pramualratana and S. Wibulpolprasert. Bangkok, Desire.. 
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population coverage, and leakage in card issuance. The inequity within the scheme was 
mentioned as annual disparity of per capita government budget and per capita 
expenditure between the poor and other underpreviledged groups; and causing an 
imbalanced resource allocation across provinces. Across insurance schemes and 
uninsured groups, less outpatient and inpatient utilisation rates and expenditures per 
capita and poorer health status of the LICS cardholders were reported. However, the 
LICS evaluation indicated its potential in the cases of high cost inpatient care with DRG 
reimbursement. This implied to the promising accessibility of the cardholders to high 
cost care. In summary, the Scheme partially achieved its goals, however, problems 
existed, i.e. under funding compared to other public schemes, and ineffectiveness in 
card issuance to the poor whom were the main target (Pannarunothai 2002). 
The Health Card Scheme (HCS) is a subsidized voluntary health insurance scheme 
developed for people in the informal sector of labour market. This was established in 
1983 under the circumstances of the WHO policy on ‘Health for All by the Year 2000’. 
The Mother and Child Primary Health care (MCH) Fund was the project initiated for 
this low-price prepaid health card in seven provinces. A few years later, using a risk 
sharing concept, it was expanded to be a nationwide health card phase II. It was 
designed to be a community based revolving fund providing loans for households to 
build latrines. The debtors returned the collection to health facilities at the end of the 
year. Beyond the MCH card, there was also a family card for curative care which was 
limited to a maximum of eight episodes and 2,000 Baht per episode. During phase III 
(1987-1991), this community financing project was less popular and also faced 
uncertainty in continuation under the MoPH policy, and was renamed ‘the Voluntary 
Health Insurance Project’. The benefit was reduced to six episodes per card per year. 
Later on, in phase IV (1993-1998), the project was reformed to be a national public 
subsidized health card with 500 Baht subsidy per matched household and 100 percent 
coverage. Previous limitations of using episodes were removed but coverage was 
restricted to a maximum 5 household members. Health services were directly available 
at community hospitals. As a result of the economic downturn in the post-period of the 
1997 crisis, the Scheme in its phase V was reformed again due to a rise in households’ 
demands but with limitations in government subsidies. The reform included increasing 
the subsidy to 1,000 Baht but limiting the number of cards sold to 3 million annually; 
duplicating the validation period for adverse selection; replacing the referral letter with 
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the cross-boundary card and changing the level of the reimbursement fund. To better 
serve the poor, the benefit package did not cover hospitalisations in private rooms. 
Finally, the fee-for service reimbursement for high cost care cases was replaced with the 
DRG system (Srithamrongsawat 2002).  
In assessment, the HCS achieved its goal in coverage to the uninsured group which 
includes farmers, fishermen, blue-collar workers in small enterprises, public drivers, 
street venders, etc. It reached 10 percent to 15 percent of population over 18 years old, 
however, under-coverage in Bangkok and other urban areas was reported. In financing 
evaluation, the selection bias was based on increasing demand and intention in covering 
households in which members had chronic diseases. Discrimination in providing health 
services was noted in the limitation of prescribed drug items. Compared to the CSMBS 
and the SSS, this Scheme and the WHS received a lower subsidized government budget 
(Srithamrongsawat 2002). 
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Table 2.6 Chronological events of the health insurance developments in Thailand  
MWS HCS CSMBS SSS 
1975: Free medical care for the poor 1983: Commencing the  Health Card 
phase I (the Maternal and Child Health 
Development Fund) 
1980: Issuance of the Royal Decree on 
CSMBS 
1954: First Social Security Act 
(without implementation) 
1981: First issuance of the Low Income 
Card 
1984 – 1986: Expansion of the Health 
Card Project phase II 
1998: Introducing co-payment of the 
CSMBS beneficiaries; reimbursement 
limited to medicines in the national 
essential list; hospital stay limited to 
private room and board 
1974: Issuance of Workmen 
Compensation Fund 
1992: Expansion to the elderly 1987 – 1991: Expansion of the Health 
Card Project phase III 
 1990: Implementation of  the Social 
Security Act for enterprises with ≥20 
employees 
1993: Expansion to other children under 
12 years old, handicapped and religious 
leaders 
1993 – 1998: Changing  to a national 
public subsidized voluntary health 
insurance with equal matching fund 
(the Health Card Project phase IV) 
 1993: Law enforcement of ‘the 
Protection for Motor Vehicle 
Accident Victims Act 1992’ 
1994: Changing its name from Medical 
Welfare Scheme for the Low Income to 
Medical Welfare Scheme for 
Underprivileged Groups 
1994: Expanding of the Health Card to 
community leaders and health 
volunteers 
 1994: Amendment of the Social 
Security Act for coverage expansion 
to enterprises with ≥10 employees 
1998: financing and management reform 
of the Scheme, i.e. management 
decentralization, per capita budget 
allocation, and reinsurance for high cost 
care using the DRG and global budget 
1999: Increasing in the matching fund 
but limiting the card selling, adding 
cross-boundary card, using the DRG 
for high cost care reimbursement (the 
Health Card Project phase V) 
 2000: Amendment of the Social 
Security Act for coverage expansion 
to old age pension and child benefits 
Source: Adapted from Supachutikul cited in Tangcharoensathien et al (2002); Srithamrongsawat (2002) and Pannarunothai (2002) 
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2) Post-achieving universal coverage era (2002 to present) 
Various health insurance schemes were initiated and developed in the past few decades, 
however, it seems that many attempts were tried but lots of problems remained. 
Achieving each scheme’s goals in targeting population, population coverage, financing, 
and equity were difficult and/or unsustainable as well as the system management was 
also inefficient. These were reflected with the existance of many uninsured people, 
inequity and vast catastrophic households. The health insurance systems were 
characterized by fragmentation and duplication. The HCS project was an attempt for 
universal coverage and social welfare but it had many limitations; and had difficulties in 
expansion, merging with the MWS and financial management. This concept of 
universal coverage had been found interesting among some MoPH policy makers, 
health system researchers and academia since 1993. However, it was not until 2001 that 
there was a suitable environment and composition for a significant change in the health 
system.   
Some policies on the major health system reform in Thailand had been implemented 
since 1999 but the substantially new health insurance scheme ‘the Universal Coverage’, 
socalled ‘the UC Scheme’16 was the robust outcome. The scheme was implemented to 6 
pilot provinces in April 2001 and was fully expanded to the whole country in April 
2002 during the leadership of the ex-Prime Minister Thaksin Shinawatra. In addition to 
the commencement of UC scheme, in October 2002, the MoPH had also officially been 
reorganized in its role, function and structure. At present, three main health insurance 
schemes are available in Thailand. Details of the UC Scheme and the two former 
schemes, i.e. the CSMBS and the SHI are described in the following pages 
(Pitayarangsarit 2004; Bureau of Health Policy and Strategy 2009). Table 2.7 
summarises characteristics including target population, financing and functioning of 
such schemes.  
                                                 
16 At the beginning, the Scheme is called ‘the 30 Baht Scheme’ to promote politically by the Thai Rak 
Thai Party which agreed to the concept of the universal coverage. The Party committed the UC to the 
Thais when they won the landslide victory over 2001 general election. The 30 Baht is the out of pocket 
copayment per episode by means of moral hazard prevention, however, it was abolished in October 2006 
Bureau of Health Policy and Strategy (2007). Minutes of the Ministry of Public Health meeting 7/2550. 
MoPH. Bureau of Health Policy and Strategy..  
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? UC Scheme 
Up to 2009, the newest but biggest health insurance scheme operated for eight years. 
With the spirit to achieve and ensure access to health care for all, Dr Sanguan 
Nitayarumphong and colleagues always kept in mind the universal coverage concept 
and put efforts to bring it forward on the agenda of national policy. It was concluded 
that success through policy implementation requires support from various stakeholders; 
the generation of evidence to guide policy formulation; strong and functioning health 
system infrastructure over the country; system design and implementation capacity; and 
knowledge management as well as political support with the economic context as a 
catalyst (Tangcharoensathien, Prakongsai et al. 2009). 
In addition to the equitable access to quality health care, other objectives of the 
universal coverage include health system reform to achieve equity, efficiency, and 
accountability; single standard on the same benefit package; and sustainability of policy, 
financing and institution. The scheme is funded by general taxes via annual government 
budgets and was designed to use a close-ended payment mechanism as capitation for 
upstream budget estimation and downstream payment to health providers. The payment 
for inpatients care employed the diagnosis related group (DRG) with global budget 
method since the scheme establishment in 2001. However, payment for high cost care, 
some special diseases and services uses point system plus point system with ceiling and 
global budget. The National Health Security Office which is the autonomous public 
organisation is the administrating body of the Scheme which was recommended by the 
National Health Security Boards (Pitayarangsarit 2004; Prakongsai 2008; Sornchumni, 
Kiatthanaphun et al. 2009). 
? CSMBS 
This scheme provides fringe benefits for civil servants and government employees 
including retired employees and their dependents. Such dependents include parents, 
spouse and up to 3 children less than the legal age (20 years old). The scheme was 
launched in 1980 and aims to compensate the lower public salary employees compared 
to private employees. Since it was designed for government staff, its financial source, 
therefore, is general taxes via annual government budgets. It has been a fee for service 
reimbursement system and allows broad medical services for treatment but excludes 
pre-exposure prevention, and cosmetic surgery. As a result of the 1997-economic crisis, 
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in 1998 there were many attempts to contain the cost, for example, by limiting 
reimbursed medicines to the national essential list but these were ineffective measures. 
Ceiling free reimbursement for hospitalisation by DRG system was introduced to the 
scheme 1 July 2007. The expenditure of the scheme dramatically increased from an 
annual growth rate of 12 percent up to 33 percent. Recently in 2008, the total 
expenditure was 54.9 billion Baht and the per capita expense of the scheme was nearly 5 
times higher than the two other schemes. In addition, CSMBS beneficiaries also have a 
greater utilisation rate than the other two schemes. This is driven by the broader benefit 
package of medicines which is reflected by the higher out-patient expense than 
hospitalisation expense and two-thirds of this out-patient expense is expenditure for 
medicines (Sriratanaban 2002; Tangcharoensathien, Srithamrongsawat et al. 2002; The 
Comptroller General's Department 2007; Limwattananon, Limwattananon et al. 2009; 
Soranastaporn 2009).  
• SHI Scheme 
The law enforcement of the Social Security Act took 46 years since its first enactment 
in 1954. This compulsory insurance is beneficial to the employees of private enterprises 
which have more than 20 employees in the formal sector. The Social Security Fund 
shared by tripartite contribution among government, employers and employees with the 
ratio of 2.75: 5: 5, respectively. However, contributions from employees have long been 
limited to a maximum of 15,000 Baht monthly wage. Currently, the Social Health 
Insurance (SHI) is one of seven benefits in the Fund. Medical care is provided under the 
contract between health facilities and the Social Security Office through the registered 
beneficiaries to such health facilities annually. The scheme’s payment system is the first 
initiative of capitation in Thailand. In addition, however, payment for listed high cost 
care is reimbursed by a reference price and limited to a set number of episodes per year. 
This high cost care includes chemotherapy, radiation therapy, renal replacement 
therapy, and bone marrow transplantation. Health care providers tend to be private 
health facilities rather than public health facilities, particularly in Bangkok and its 
vicinity (Itivaleekul 2002; Bureau of Health Policy and Strategy 2009; Meekrut 2009; 
Research and Development Division 2009; Tangcharoensathien, Prakongsai et al. 
2009). 
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Comparing the three schemes, as of 2008, seventy eight percent of the population are 
UC beneficiaries and have the least expenditure per capita. CSMBS beneficiaries, in 
contrast, spend the highest expenditure; have the highest utilisation rate of both 
ambulatory care and hospitalisation. The CSMBS is also claimed to have the least 
efficiency in cost containment and over-utilisation of the beneficiaries particularly in the 
appropriateness of medicine use. 
 47
Table 2.7 Characteristics of target population, function and financing of major three health insurance schemes, as of 2008 
 CSMBS SHI UC 
Establishment 1980 1954 but first enforcement in 1990 2001 
Management body The Comptroller General’s Department, Ministry of Finance 
The Social Security Office, Ministry 
of Labor and Social Welfare  National Health Security Office 
Goals/ objectives fringe benefit compulsory insurance universal coverage 
Target population 
civil servants, government 
employees, and their dependents 
(parents, spouse and maximum 3 
children)  
employees of private enterprises in 
formal sector  
the rest population uninsured 
from the CSMBS and SSS  
Coverage in millions of the 
Thai population (%) 5.0 – 5.6 (8.1) 9.29 (14.0) 46.95 (75.7) 
Source of funding General tax 
tripartite contribution among 
government, employers and 
employees in ratio of 2.75: 5:5 with 
ceiling  
General tax 
Budget/expenditure per 
capita per year (Baht) 9,782.63 - 10,000 1,900.98 - 2,131 1,631.50 - 2,100 
Utilisation rate: OP/IP per 
person per year 7.5 /0.14 2.61/ 0.053 2.75/ 0.11 
Payment mechanism 
Fee for service with DRG system 
for IP commencing since 1 July 
2007 (2550 B.E.) 
capitation with high cost care 
reimbursement and additional 
payment for 25 chronic diseases 
exclusive capitation for OP and 
for IP with DRG system (since 
2001) plus point system with 
ceiling and global budget for 
special diseases and services* 
Healthcare providers 960 public health facilities main contractors: 153 public + 104 
private 
network health facilities: 963 public 
+ 1,499 private 
hospitals: 836 MoPH + 75 
other ministries + 55 private 
health facilities: 13 MoPH + 80 
other ministries + 150 private 
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Table 2.7 Characteristics of target population, function and financing of major three health insurance schemes, as of 2008 (cont.) 
 CSMBS SHI UC 
Service providing Any health facilities Registered beneficiaries to contracted health facilities 
Beneficiaries reside in the 
catchment area of health 
facilities 
Benefit package medical care except pre-exposure prevention 
medical care with national essential 
medicines, basic dental care, kidney 
treatment and bone marrow 
transplantation 
medical care including health 
prevention and promotion with 
national essential medicines, 
traditional and alternative 
medicines, basic dental care 
* In 2008 special diseases and services include renal replacement therapy, leukemia, lymphoma, cleft palate and cleft lip, cardiac surgery; 
and diseases/interventions in some specific areas include epilepsy surgery, haemophilia, cataract surgery, stroke, and diabetes  
Source: (Bureau of Health Policy and Strategy 2009; Meekrut 2009; Research and Development Division 2009; Soranastaporn 2009; 
Sornchumni, Kiatthanaphun et al. 2009) 
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2.2.4.2 Health expenditures 
Health expenditure in Thailand has long been closely monitored in relation to the 
national economy as stated in the national health account (NHA). Table 2.8 illustrates 
some indicators in the annual national health account during the past fourteen years 
(1994-2007). Estimated overall health spending at the current price was 127 billion Baht 
in 1994 and rose more than two-fold to 315 billion Baht in 2007. The upward trend in 
health expenditure was highest in 1997, the year of the economic crisis. It was indicated 
as the percentage of the total health expenditure (THE) to GDP and the percentage of 
real growth rate of operating health expenditure. However, the trend has dropped since 
then. It was not until 2002 that the national economy and THE growths recovered to the 
same level as before the 1997economic crisis. Comparing national health expenditure to 
national income, i.e. the GDP, the average THE is 3.7 percent of the GDP within the 
last five years which is slightly over the 2006 average of the WHO Southeast Asian 
Region countries (3.4 percent) but is lower than the average of lower middle income 
countries (4.5 percent) and is vastly different to high income countries (11.2 percent). In 
the aspect of financing agencies, prior to establishment of the UC Scheme, a higher 
proportion of THE was incurred by private agencies mainly through household out of 
pocket payments but this has reversed to the public sector, thereafter. The economy also 
affected the  proportion of the THE between expenditure in investment and operating 
expenditure, that is prior to the 1997-economic crisis, the proportion of investment was 
more than 10 percent but it has been reduced to less than 10 percent after the crisis. 
Trend in THE per capita was dramatically upward in both Baht and USD after the crisis; 
however, the exchange rate between both monetary units has played a significant role. 
As a result, this current price has limited interpretation.  
In addition to the aspect of financing agencies, four financing sources almost equally 
contribute to the 2007 THE, i.e. the UC Scheme, the central government, the CSMBS & 
state enterprises as well as households in the proportions of 22 percent, 20 percent, 19 
percent and 19 percent, respectively. The remaining 20 percent includes the SSS plus 
the Workmen Compensation Fund, local governments and others. International financial 
aid contributed less than 0.1 percent of the 2007 THE. Out-patient and in-patient health 
services have shared the highest proportion of the THE. The latest proportions in 2007 
were 41 percent and 37 percent respectively. The estimated expenditure on medicine 
was 186 million Baht, 42.8 percent of the THE (Tangcharoensathien, Vasavid et al. 
2004; Faramnuayphol, Ekachampaka et al. 2008; Vasavid, Janyapong et al. 2009; 
World Health Organization 2009).  
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Table 2.8 Total health expenditure at current year price (THE) by various sources of financing, 1994-2007 
Indicator 1994 1995 1997 1999 2001 2002 2005 2006 2007 
THE (million Baht) 127,655 147,837 189,143 162,124 170,203 201,679 251,693 290,603 314,796 
THE as %GDP 3.5 3.5 4.0 3.5 3.3 3.7 3.5 3.7 3.7 
% real growth rate of GDP na 9 -3 0 3 6 5 6 6 
% real growth rate of 
operating health expenditure na 11 0 2 1 18 8 14 8 
Proportionate THE from 
public and private financing 
agencies 
45 : 55 53 : 47 54 : 46 55 : 45 56 : 44 63 : 37 64 : 36 68 : 32 73 : 27 
Proportionate THE between 
investment and operating 
health expenditure 
14 : 86 14 : 86 18 : 82 6 : 94 5 : 95 5 : 95 4 : 96 4 : 96 4 : 96 
Annual THE per capita (Baht, 
USD) 
2,160 
(86) 
2,486 
(100) 
3,110 
(99) 
2,629 
(69) 
2,732 
(61) 
3,211 
(74) 
4,032 
(100) 
4,625 
(122) 
4,994 
(144) 
Source: Adapt from Table 3.1.1 and Figure 3.2.2 in Tangcharoensathien et al (2004), Table 2 and Figure 1 in Vasavid et al (2009) 
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2.3 Cancers and health services for cancers 
This section presents cancer related issues including the health service system for cancer 
patients in Thailand, i.e. human resources, health facilities and financing. 
2.3.1 Incidence and burden of cancers 
It was estimated from population-based cancer registration in Thailand that during 
1995-1997, the age-standardized incidence rate (ASR)17 per 100,000 population is 149.2 
in males and is 125.0 in females. In males, liver was the first leading site with ASR at 
37.6 in 1996; lung and colon & rectum are the second and third with ASR at 25.9 and 
10.8, respectively. In females, cervical, breast and liver were the first to third rank and 
nearly equal in ASR, i.e. 19.5, 17.2 and 16.0, respectively. The geographic variation 
based on 5 provinces18 shows that highest cancer ASR in males was in Khon Khaen, a 
province in the north-east (182.5) with marked ASR of liver cancer (85.0) meanwhile 
the lowest ASR is in Songkhla in the south (91.4) with first leading site of lung cancer 
(13.6) as well as oral cavity & pharynx cancer (12.9). Whereas in females, Chiang Mai 
and Lampang in the North had the highest ASR (148.6 and 146.1) with the first leading 
site of lung cancer (25.3) as well as cervical cancer (23.6) and the lowest ASR in 
Songkhla with cervical cancer (16.1) and breast cancer (12.1). At the end of the first 
decade of the 21st century, Thailand is estimated to have approximately 103,000 new 
cancer cases per year with the highest number of new cases of liver cancer in males and 
breast cancer in females. Towards the previous decade, trends in the incidence of cancer 
were upward with a sharp rise in breast cancer and colorectal cancer cases. Meanwhile, 
new cases of liver cancer which had long been in the first rank increased slightly. This 
was due to a falling number of the incidences of liver cancer in the north-east (Martin 
and Patel 2007; Sriplung 2007). Even though these estimations are based on only 5 
provinces which are regional hubs and the capital of Thailand, they might not truly 
represent the incidence of each region which includes other provinces as well. Only this 
                                                 
17 Age-standardized incidence rate reported in unit of ‘per 100,000 population’ is the incidence of 
population with standard age structure. This age standardization is the risk of cancer adjustment related to 
age. The world standard age structure was referred in this estimation. ASR is necessary for comparison 
among different populations Patel, N., N. Martin, et al. (2007). Chapter I: Registry procedure and 
statistical methods. Cancer in Thailand, Vol. IV, 1998-2000. T. Khuhaprema, P. Srivatanakul, H. 
Sriplunget al. Bangkok, Bangkok Medical Publisher. 4. 
18 Five provinces include Chiang Mai and Lampang in the north, Khon Khan in the south, Songkhla in the 
south and Bangkok, the capital. 
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report, however, provided the largest and latest multicentre population-based 
registration for cancers in Thailand. 
In Thailand, studies on the 1999 and 2004 burden of diseases indicated that Year of Life 
Lost (YLL) which is due to premature death, cancer attributed 14-16 percent in males 
and 17-19 percent in females to overall YLL (4.2-3.95 million in males and 2.6 million 
in females). In terms of Disability Adjusted Life Year (DALY), cancers contributed 10-
12 percent and 11-13 percent to overall DALY which were the second to third rank in 
both genders. Of these, liver cancer is the 4th cause of disease burden in males in both 
years and was the 5th, in 1999, and 7th, in 2004 cause in females. In addition, it caused 
4-5 percent of in males and 3 percent of DALY loss in females during that period. This 
DALY loss were mostly due to the YLL of those aged 30-59 and 60 or above (Thai 
working Group on Burden of Disease and Injuries 2002; International Health Policy 
Program-Thailand 2007). It could be concluded that from 1999 to 2004, the burden 
from cancer has not changed. In Thailand, loss from cancer has been burdened by 
premature morbidity and death in working age population rather than old age 
population.  
2.3.2 Health professionals with specialty related to cancers 
Updated information from Medical Council revealed maldistribution in medical doctors 
with specialties related to cancers19 across regions in 2007. Table 2.9 shows that the 
population per specialist ratio is highest in the north-east (22,321) and is lowest in 
Bangkok (5,317) meanwhile the average of the whole country is 8,692 people for one 
specialist. Bangkok has a 3 times higher number of specialists than in the north-east. 
                                                 
19 These specialties include clinical pathology, pathology, radiology, radiotherapy and nuclear medicine, 
anesthesiology, obstetrics and gynecology, general surgery, cardio-thoracic surgery, urology, oncology, 
hematology, for instance. 
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Table 2.9 ASR incidences of males and females in some provinces during 1995-1997 
and population per specialist ratio in 2007 
 Bangkok Central North North-east South Total 
Male (ASR) 143.6 na 142.5*, 178.0** 182.5
§ 91.4# 149.2 
Female (ASR) 125.9 na 148.6*, 146.1** 125.3
§ 81.3# 125.0 
population per 
specialist ratio 5,317 12,126 11,846 22,321 13,054 8,692 
*Chiang Mai; **Lampang; §Khon Khan; # Songkhla  
Source: adapted from(Martin and Patel 2007) and Medical Council in (Bureau of Health Policy and Strategy 
2007) 
 
2.3.3 Health facilities and health services 
It was not until 2002 that the health services for cancer patients concomitantly to health 
care reform for universal coverage were developed comprehensively. Prior to 2002, 
health facilities for cancer care had independently served patients over the country. 
Such health facilities are tertiary care or super tertiary care level under many 
organizations including the private sector. Except for the National Cancer Institute and 
its regional cancer centres which are specialized health facilities, medical school 
hospitals, regional hospitals gained financial support from government budgets and their 
funding agencies for cancer integrated with other care. Almost all of the high 
technology equipment attained was dependent on annual government budgets for 
investment. Patients were supported according to their health insurance benefit 
packages and paid out of pocket for some expensive cytotoxic drugs classified as non-
essential drugs. In other words cancer treatment is classified as high cost care.  
As a result of the UC scheme established in 2002 and the reform of government budget 
reallocation for the health sector, financial resources has been pooled in capitation 
payment mechanism and focused on system operations rather than investment. The ten-
year national master plan for three service systems20 including cancer was developed 
under the UC scheme. The plan aims to improve the service and bring it into standard; 
strengthen the capacity of health professionals; and improve access to service of people 
                                                 
20 Three service systems are cancer centre for excellence or cancer centre; trauma center; and cardiac 
center. These three diseases were selected as priority according to the study of Thai burden of diseases. 
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in all regions. Regardless of whatever Ministries the health facilities belong to, public 
health facilities for cancer care have been classified into three levels as follows.  
1) First level (Excellence Cancer Center, ECC): Twelve super-tertiary health facilities 
which are mostly medical schools and located in Bangkok providing comprehensive 
services for cancer21, research and model development have also been indicated. 
2) Second level (Advance Cancer Center, ACC): Eight health facilities coordinated as 
5 ACCs provide complete services and conducting clinical research have been classified 
into second level. All health facilities are regional hospitals and regional cancer centres. 
3) Third level (General Cancer Center, GCC): Ten health facilities coordinated as 7 
GCCs provide only services for cancer patients. All health facilities are regional/general 
hospitals and regional cancer centres. 
Such health facilities have been supported financially from the UC budget in four 
categories, i.e. medical and laboratory equipment, fringe benefits for health 
professionals for related cancer care provisions, expenditure for short course training of 
health professionals and activities for service improvement.  In addition to capitation 
payment and the concept for excellent center development, additional payment through 
the disease management payment system for some chronic diseases and high cost care 
for leukemia and lymphoma was introduced in October 2006. Another attempt to 
increase the access to high cost treatment for cancer care, the UC Scheme has supported 
3 medicines for breast cancer and lung cancer since 2008 through the government use of 
patents by the Ministry of Public Health (Rungkijkarnwattana and Yamprom 2007; 
Puttasri 2008; Sornchumni, Kiatthanaphun et al. 2009). Maldistribution of the excellent 
centres was noted. No health facility under the excellent center is available in the 
catchment area of three National Health Security Regional Offices. Patients have to 
seek services from centres in Bangkok or other regions which are convenient. In a 2008 
evaluation, it was reported that less than half of the health facilities have improved in 
terms of the service provided and their referral systems. Insufficiencies in equipment 
and in health professionals were the reasons which underpinned this lack of 
improvement (Puttasri 2008). 
                                                 
21 The services include diagnosis and planning treatment, cancer screening, surgery, chemotherapy, 
radiotherapy, palliative and terminal care, risk factor screening, risk factor screening in community, and 
community prevention programme. 
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Beneficiaries under the CSMBS and SHI schemes received chemotherapy through the 
current essential medicines on the National List of Essential Medicines. Since 2006, the 
Comptroller General’s Department, however, has expanded the benefit package to 
include 6 high cost non-essential chemotherapeutic medicines for leukemia, 
gastrointestinal stromal tumor, lymphoma, breast cancer, large intestine cancer and lung 
cancer (The Comptroller General's Department 2006). 
2.4 Conclusion 
2.4.1 Lessons learnt from the development of the Thai health system 
In conclusion, even though Thailand is a lower middle income country and is dearth in 
resources, its health system, i.e. policy, infrastructure, manpower and financing, has 
been strengthened continuously. It has been seen, however, that the health system has 
developed dependently from the economic situation of the country, particularly over the 
past 20 years. National health planning and policy making is a part of the National 
Economics and Social Development Plan which provides guidance for development. 
The system has been developed on the basis of equity in access to health service 
accordingly. In addition, the development has focused on the poor. Following the 
national health plan, health facilities and service system was first invested in, followed 
by distribution of health professionals. Concomitantly, the financing system to reduce 
the financial barrier of the poor as well as cost containment with efficient payment 
mechanism has been developed and implemented. The referral system is a tool for 
seamless health service between rural and urban areas, the primary care level and 
tertiary or advance care level. The latest system reform in 2002 brought significant 
changes to the health system, the introduction of the universal coverage, which ensures 
more equity in health than before. From seven years ago to now, three main insurance 
schemes subsidise and ensure that approximately 97 percent of the population has 
access to health care. However, many issues continue to be a challenge and the system 
requires further long term and comprehensive monitoring including the sustainability of 
the financial system, inequity and improving the quality of health service through the 
goal of this system reform accordingly. 
The health service system for cancer care is one of interest in national policy. Cancer, a 
chronic disease, causes great DALY loss, is in high rank of cause of death, needs long 
term of care and requires many resources, for example health professionals with 
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specialty and cost of care. In addition, to almost all patients, the disease usually causes 
great impact to mental and physical health as well as requires attention from patients’ 
family. Attempts to improve the health service for cancer care and treatment have been 
recognized. However, death is a certainty and could not be avoided by every ordinary 
people. 
2.4.2 Research gap 
With the amount of information and knowledge provided from literatures, it could be 
concluded that bird-eye view of the national system financing has been closely 
monitored and health services for some problematic diseases have been taken into 
consideration. However, there is a room for researches and evaluations in, for example, 
equity in other aspects, cost containment, improvement of quality of health services in a 
particular period, i.e. the terminal stage of life. It is perceived that in this critical period 
of life, as much as resources (cost, high health technology and workload) of health 
providers and households are pooled to survive or prolong the patients’ lives. However, 
no data provides this picture in the Thai health system and that this will be the focus of 
the remaining chapters. 
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CHAPTER THREE 
EQUITY IN HEALTH CARE, COST OF AND CARE FOR THE TERMINAL 
PHASE OF LIFE 
 
This chapter focuses on three areas related to health system development regarding 
terminally ill cancer patients. First, equity in health care, which is the desired goal of the 
health system reform, is presented. It starts with its origin and concept, followed by 
definition and types, particularly from a health perspective and its measurement. Next, a 
review on the cost of care at the terminal phase of life in several countries is explored in 
the scope of magnitude, measurements and trends. Finally, it looks at the common 
health services provided to terminally ill patients in other countries which could be 
applied to Thai patients. 
3.1 Equity, the ultimate goal of health care 
The term ‘equity’ is widely used and is now often applied to health care. Its origin is 
from philosophy and social justice which is one of the human rights principles. Health is 
valued as a critical building block, or means to a better and more meaningful life and ill 
health is a threat to social and economic well-being (Peter and Evans 2001). It has long 
been a worldwide concern in many international organizations including the UN, the 
World Bank and the WHO. The equal right to health and opportunity to be healthy are 
stated in the 1948 UN22 and the 1946 WHO constitutions and its amendments23. In 
Thailand, the right to health is also stated in its 1997 Constitution and in its latest 2007 
Constitution stating that ‘A person shall enjoy an equal right to receive public health 
services…’  That is equity in health is an ultimate goal and a fundamental result within 
                                                 
22 Preamble, paragraph 5: Whereas the people of the United Nations have in the Charter reaffirmed their 
faith in fundamental human rights, in the dignity and worth of the human person and in the equal rights of 
men and women and have determined to promote social progress and better standards of life in larger 
freedom, 
Article 2: Everyone is entitled to all the right and freedoms set forth in this Declaration, without 
distinction of any kind, such as race, colour, sex, … 
Article 25 (1): Everyone has the right to a standard of living adequate for the health and well-being of 
himself and of his family, including food, clothing, housing and medical care and necessary social 
services, and the right to security in the event of unemployment, sickness, … 
23Paragraph 3: The enjoyment of the highest attainable standard of health is one of the fundamental right 
of every human being without distinction of race, religion, political belief, economic or social condition. 
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and between nations (The United Nations 1948; Braveman and Gruskin 2003; 2005; 
2007).  
From the ‘Health for All’ policy commenced in 1977 and oriented in the 1978 
Declaration of Alma Ata24 to the most updated information, there are clear indications 
of the existence of a widening gap in inequity which is an embedded problem of health 
care. Many organizations including WHO have been attempting to alleviate such 
inequity which can be seen in the new generation of research undertaken since the 
beginning of the twenty first century. The Commission on Social Determinants of 
Health of the WHO summarised that equity in health is in relation to social 
determinants like socio-economics, nutrition, education, and environment such as daily 
living and working conditions. The Commission urged countries to combat inequity and 
called for 3 measures: improve daily living conditions; tackle the inequitable 
distribution of power, money and resources; and measure and understand the problem 
and assess the impact of action (Commission on Social Determinants of Health 2008). 
This issue of health equity was therefore started on these grounds.  
3.1.1 The grounds of equity: philosophy and concept 
It was noted that concern about equity and the avoidance of deprivation presumably 
came from principles in religion. Islam, Catholicism, Christianity, and Buddhism, for 
instance, indicate this norm and social justice in their teachings. Equity or fairness has 
been interpreted differently depending on the basis of various views on ideology25. It 
could be defined differently by different people in different settings. Some of these 
social justice issues emphasize opportunities and outcomes such as welfare, utilities and 
capability while others emphasize the fairness of processes. However, philosophies 
which are the grounds of human societies and political affairs as well as the principles 
of social justice related to health were also mentioned and discussed.  Four main 
ideologies mentioned include utilitarianism, libertarianism, egalitarianism and Rawl’s 
concept. Brief concepts of these ideologies are described below particularly those 
                                                 
24 See detail in Chapter Two section 2.2.1 
25 Beyond the three main ideologies, Marxist and Desert were mentioned. The Marxist emphasizes on the 
meeting of need; and Desert emphasizes the reward of merit Wagstaff, A. and E. van Doorslaer (1993). 
Equity in the finance and delivery of health care: concepts and definitions. Equity in the finance and 
delivery of health care, an international perspective. E. van Doorslaer, A. Wagstaff and F. Rutten. New 
York, Oxford University Press: 7-19, Williams, A. (1993). Chapter 16: Equity in health care: the role of 
ideology. Equity in the finance and delivery of health care, an international perspective. E. van Doorslaer, 
A. Wagstaff and F. Rutten. New York, Oxford University Press: 287-98. 
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related to health (Wagstaff and van Doorslaer 1993; Williams 1993; Peter and Evans 
2001; The World Bank 2006; Morris, Devlin et al. 2007). 
Utilitarianism is claimed to be the oldest concept and is the background concept of 
health economics which emphasizes welfare maximization, i.e. maximizing the sum of 
individual well-being, utilities or welfare. In other words, in health it is the concept of 
efficiency of resource allocation towards medical success. Two features of utilitarianism 
were mentioned, i.e. weighted utilitarianism and strict utilitarianism. The former allows 
application of differential weights to the utilities of different individuals or groups. The 
latter interprets that society’s welfare is the equal-weighted sum of the every member’s 
utilities.  
From the perspective of strict utilitarianism, to achieve the greatest distribution of health 
care refers to the greatest number of individuals as such. It was commented that while 
strict utilitarianism attends to the main concern of treating everybody equally with 
social welfare contribution, inequality in outcomes may be worse. Nonetheless, this can 
be less unequal if more weight of an individual of society is accounted for. 
Utilitarianism was also critiqued about its inability in dealing with distributive justice, 
particularly if health losses are weighted by the income lost due to illness or disability 
and so attaching greater value to the health of the rich than that of the poor. 
Libertarianism emphasises individual liberty or natural rights, particularly the rights to 
life as well as to possessions. For further explanation, the former means an individual is 
not unjustly killed whereas the latter refers to possessions acquired and transferred 
without violation of others’ rights.  
From a health perspective of libertarians, access to health care is part of society’s 
reward system. With their own income and wealth, individuals could get more or better 
health care. In other words, ones willingness and ability to pay would be the 
determinant of access. This ideology would be achieved in a private system which is 
market oriented. It seems that this ideology is the grounds of the current US health 
systems. 
Egalitarianism on the basis of Marxist theories emphasizes the considerations for 
independent distribution of aggregate population health. Thus, it was claimed to be 
more suitable for equity judgment than utilitarianism. This concept also supports a 
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public provided system. However, there are many differences of egalitarianism 
depending on perceptions of social obligation on individual health or health care. 
In contrast to libertarians, a view on access to health care of egalitarian is an 
individual’s right and therefore should not to be influenced by income or wealth. Equal 
opportunity of access for equal needs is its achievement from a health perspective.  
Rawl’s concept is the ‘maximin’ principle based on distributive justice initiated by John 
Rawls. It is also known as the difference principle. Its concept refers to a ‘veil of 
ignorance’ in which everybody ignores his/her position in society. That is, he/she does 
not know their socioeconomic or health condition, so the individual would adopt a risk-
minimising strategy that maximizes the position of the least well-off. This concept 
emphasizes that resources are distributed in a way that the least well-off group in 
society gets the maximum gain. Individuals should have the maximal liberty in the same 
degree of everyone’s liberty. Intentionally engaged inequalities are unjust if it 
disadvantages the least wealthy group.  
3.1.2 Definition and achievement of equity in health 
It should be noted that at the beginning there was no uniquely correct route to define 
equity (Morris, Devlin et al. 2007). However, equity is generally defined as ‘social 
justice’; ‘fairly consistent’; ‘justice according to natural law or right specially freedom 
from bias or favoritism’; and ‘the state, ideal, or quality of being just, impartial, and 
fair’  
Equity in health can be defined as ‘equity refers to differences in health which are 
considered unfair and unjust’; ‘the absence of socially unjust or unfair health 
disparities’ which could not be directly measured. As a consequence, the operational 
and measured definition was defined as ‘the absence of systematic disparities in health 
between social groups who have different levels of underlying social 
advantage/disadvantage’; and ‘striving to eliminate disparities in health between more 
and less-advantaged social group’ 
Health equity is a multidimensional concern and has been discussed in relation to two 
main aspects of health context, i.e. health and health care. Health or good health which 
relates to achievement and capability is actually indicated as health needs and health 
outcomes (or health status or health conditions). Meanwhile, health needs or the need 
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for health care is the capacity to benefit from it. Such health outcomes are focused on 
life expectancy, mortality, morbidity, and health risk, for instance. In terms of health 
care or treatment or the facilities that society offers to achieve health, financing and 
delivery are focused on. Regarding financing, equity mostly refers to the meaning of the 
ability to pay, avoidance of absolute deprivation, budget allocation, financing subsidies 
from public resources, and out of pocket payments. The delivery usually refers to 
resource allocation, access or receipt/utilisation of health care services.  
Many factors beyond health care could affect health achievement such as genetic 
propensities, individual incomes, food habits and life style as well as epidemiological 
environment and work conditions. Some are unavoidable but others could be. 
Whitehead (2000) clearly distinguishes these into seven categories: 
1) natural, biological variation; 
2) health-damaging behaviour if freely chosen, such as participation in certain sports 
and pastimes; 
3) the transient health advantage of one group over another when that group is first 
to adopt a health-promoting behaviour (as long as other groups have the means to catch 
up fairly soon); 
4) health-damaging behaviour where the degree of choice of lifestyles is severely 
restricted; 
5) exposure to unhealthy, stressful living and working conditions; 
6) inadequate access to essential health and other public services; 
7) natural selection or health-related social mobility involving the tendency for sick 
people to move down the social scale. 
The author states that health differences due to factors in categories 1, 2 and 3 would 
not normally be indicated as inequities in health meanwhile in categories 4, 5 and 6 
which could be avoidable are unjust. Factors in category 7 have two features of 
consideration, that is, the original ill health may have been unavoidable, but being poor 
of sick people is preventable and unjust (Whitehead 2000). 
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Pursuing equity in health and health care does not mean elimination of all health 
differences. In equity in health, the policy for equity should aim to reduce or eliminate 
such avoidable and unfair factors and their result. This policy should also aim to provide 
a fair opportunity for everybody to achieve their full health potential. To achieve equity 
in health care, it was suggested that the ultimate goal is to closely match service to the 
level of health needs. As a consequence, however, this may result in disparity of access 
to and utilisation of services between groups, particularly in favouring the 
disadvantaged groups which usually have greater need (Mooney 1987; Gwatkin 2000; 
Whitehead 2000; Bambas and Casas 2001; Sen 2002; Gruskin and Braveman 2003; 
Whitehead and Dahlgren 2007; O'Donnell, van Doorslaer et al. 2008a). 
3.1.2.1 Equity (or inequity) versus equality (or inequality) in health 
Sometimes, equity and equality have been used interchangeably. However, it was 
clearly explained in various literatures that both are not synonymous. Meanwhile equity 
means fairness and it is a multidimensional concept with broader notions, equality 
means the state of being equal. Equality was criticized in that it is an ideal and does not 
have much cutting power and it needs to be specified on what is to be equalized. The 
term ‘inequity’ or ‘inequality’ is usually interpreted and presented rather than directly 
indicated as ‘equity’ or ‘equality’. 
The violation of health equity can not be judged by considering only inequality in 
health. In other words, health inequalities are not necessarily inequitable. Achieving the 
concept of equity in the success of health outcomes may conflict with the principle of 
equal access. That is, in order to judge inequity and inequality, it requires consideration 
on such principles mentioned earlier in section 3.1.1 and the context of scope or focus 
of the concern. Apparently, it is often the case that the country health system needs to 
mix concepts of equity and equality. However, most views on equity are referred to the 
egalitarianism because of the fact that health is a basic human need and unlike other 
goods where a competitive market could be applied. 
Despite the fact that inequality in health cannot provide adequate information for health 
equity assessment, it is an important part to understanding health equity. It is considered 
to be a case of inequality if two individuals are exactly similar in having health 
predispositions, including a shared proneness of illness, but the very rich gets cured by 
some expensive medical treatment whereas the poor suffers from illness and could not 
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get the treatment due to unaffordability. This is also prone to be a violation of health 
equity since the rich have privileged treatment. To distinguish inequity and inequality, 
another simple case which identifies a minimum or basic level of health achievement 
can be looked at. Equity is marked if all regions of a country achieve life expectancy at 
birth of at least 70 years but it is inequality if some regions have life expectancy values 
above 70 years.  
To summarise, the issue of equity and equality in accordance with equity from a health 
perspective described in subsection 3.1.2, three areas which are usually discussed; 
finance of health care (ability to pay, subsidies received through the use of services, and 
payment people make for health care); health outcomes (mortality rate, life expectancy, 
illness status, number of days ill, for instance); and health care (access and utilisation). 
The first issue of equity is determined to the extent that health care is financed 
according to ability to pay. The last two issues are usually measured in terms of 
equitable distribution.  
In view of health economics, this distribution focuses on equality in five features 
including equal health, equal expenditure for equal need, equal use for equal need, equal 
access for equal need, and equal quality of care for all. Equal health is measured in 
terms of quality adjusted life year (QALY) and disability adjusted life year (DALY), 
mortality and morbidity, for instance. Equal expenditure emphasises equal expenditure 
for equal need. Regardless of preferences for health and health care and attitudes to risk 
behaviour, it aims for individuals to receive the same share of health spending. 
Similarly, equal use for equal need does not take such preferences and attitudes into 
consideration. Equal access is implicated to opportunities to health care access. Two 
individuals who need the same treatment would be seen as having equal access if their 
costs for access to health care incurred are valued equally. Hence measuring access is 
difficult, empirical studies on equity prefer equal use for equal need. Finally, ‘equal 
quality of care for all’ means that everybody has an equal opportunity of being selected 
for attention through a fair process based on need rather than social influence’ 
(Pannarunothai and Rehnberg 1998; Pannarunothai 2000; Whitehead 2000; Peter and 
Evans 2001; Sen 2002; Braveman and Gruskin 2003; Morris, Devlin et al. 2007; 
Whitehead and Dahlgren 2007).  
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In sum, the choice of approaches to equity is a normative judgement. That is, as 
mentioned earlier the best definition depends on the value system of the society for 
which decision is being made. 
3.1.2.2 Horizontal versus vertical equity 
Two types of equity are categorised; horizontal and vertical. Horizontal equity refers to 
the equal treatment of the equals and vertical equity is the unequal treatment of 
unequals. Both dimensions of equity must be evaluated against factors affecting a 
feature of health or health care, which mostly include wealth status, gender, ethnicity, 
geography, education, and social class. Identifying these two types of equity is again, 
dependent on the concept and objective of equity in mind. In the assessment of health 
care financing, horizontal equity concentrates on people who have the same ability to 
pay the same amount. In contrast, vertical equity would be indicated if payment for 
health care varied with ability to pay. This equity which is normally employed in the 
health care system is determined in terms of progressivity. This could be interpreted as 
progressive, regressive and proportional of the payment and income level. The health 
finance system is considered to be progressive when the proportional payment rises as 
income rises; to be regressive when proportional payment falls as income rises; and to 
be proportional when the ratio of payment is not varied by income. 
Within the assessment of health outcome and health care which aims for equity in 
distribution by means of equal distribution, horizontal equity is just in respect to one of 
the non-need variables. These variables which should not have any influence on health 
outcomes and health care include factors mentioned in the previous paragraph. With 
respect to ethnicity, for example, horizontal equity should be addressed if there is no 
difference in health care utilisation among ethnic groups. However, if one group, i.e. 
Caucasians have more use than others, that is pro-caucasian horizontal inequity. In 
contrast, vertical equity should be regarded if different groups have different health care 
utilisation with explicitly sensible requirements. That is in case of vertical equity, the 
Caucasian would be treated relatively favourably if they had a worse health status. 
However, it was indicated that vertical equity is more difficult in terms of measurement 
and interpretation. Measuring methods for both types of equity and inequality are 
discussed in the following subsection (Culyer 1993; Morris, Devlin et al. 2007). 
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3.1.3 Methods used in measurement of equity in health 
In evaluation, equity and equality are comparative principles. Thus, both are measured 
relative to other people or other groups, at least two of interest, e.g. the poor-the rich, 
men-women, ethnic minority-majority as well as compared to the average value. It was 
also suggested that in addition to this measuring across groups, policy makers should 
evaluate the absolute value changed of each group which may be basically unequal at 
the beginning. As a result, more information on the gap widened or narrowed is 
provided including which group gained more advantage from the policy intervention on 
equity.  
Hence health is a product of the complexity of social condition and biological valuation 
stated in subsection 3.1.2, and ignoring either aspect will hinder the assessment of 
health equity. It was suggested, therefore, that this combination of both factors in 
assessing health equity is necessary. According to the three areas of equity in health of 
interest mentioned earlier, i.e. health outcomes, health care and finance of health care, 
two sets of data were required, i.e. grouped or individual health status, health use, health 
expenditure against their socioeconomic status (or living standards or wealth status)26, 
demography and geography, and so forth. Mostly, this data could be retrieved from 
health surveys related or linked to socioeconomic surveys. Measuring for equity was 
also discussed and that it should assess both self-assessment health status and externally 
observed medical findings. This is due to that some studies found different gradients of 
health status through socio-economic level between both data sources. Moreover, two 
approaches that is health differences between population groups (intergroup disparities) 
and health distribution across individuals (interindividual variations) were recom- 
mended for measuring inequality in health. 
The methods employed to look at intergroup differentials include simple measures and 
measures based on the entire health distribution. In simple measures, for instance, health 
outcomes, rate ratios and rate differences are used. Both give a valuable interpretation 
on the gap between two groups like the poor and the rich. Nevertheless, these two 
methods exclude other groups in between the poorest and the wealthiest. In addition, it 
requires a reference group defined for interpretation of the equality or inequality 
                                                 
26 Socioeconomic status or living standards or wealth index includes direct approaches (e.g. income, 
expenditure, consumption) and proxy measure (e.g. asset index). 
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meaning. On the other hand, measures based on the entire health distribution include 
slope index of inequality, relative index of inequality and concentration index. Such 
methods account for everyone’s level of health and the social determinant. In brief, the 
slope index of inequality is based on histograms depicting groups ranked by 
socioeconomic status. Its height represents health status whereas the width indicates 
population size. The curve is the absolute difference in health status between successive 
groups in the social hierarchy which accounted for all health status of all groups. The 
larger the absolute value of the slope, the greater the inequality. Whereas the relative 
index of inequality is the ratio of the health status of the poorest and the wealthiest. 
These measures fix the limitation in the simple measures. Detail of the concentration 
index is explained later in this subsection. 
Other measures for inter-individual health distribution are referred to as the Atkinson 
index and Gini coefficient. These measures could assess the inequality in longevity. The 
Atkinson index takes into account the difference of arithmetic mean, geometric mean 
and harmonic mean of health outcome (e.g. lifespan). The Gini coefficient will be 
presented in the subsection of concentration index. Hence these inter-individual 
measures leave the issues of defining population group (in other words, socioeconomic 
group), more reliable to international and inter-temporal comparison. Furthermore, these 
measures could be developed to provide the indirect estimation of the contribution of 
the social group. 
Empirical assessment with bivariate relationship between health and one social 
determinant is a popular approach for determining inequity in said three areas of health. 
Socioeconomic status, followed by age group and gender, is the determinant mostly 
monitored for equity in health. Methods employed in this assessment include 
concentration curve and concentration index. However, another approach which takes 
into account several variables at one time is multivariate analysis. These measures are 
described further in the following paragraphs.  
3.1.3.1 Concentration curve and concentration index 
Instead of assessing the health inequality by a descriptive mean across quintiles of one 
type of living standards, the concentration curve is adapted to display health variations 
across the full distribution of living standards. This concentration curve and index is 
originally used for measuring the inequality in income and payment of population. It 
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gives the graphical presentation of such data distribution. The curve could be used to 
assess not only inequality in health financing but also in other health variables, for 
example, child mortality, child immunization, adult health status and health care 
utilisation. It can also be used to make comparisons of inequality across time and 
countries. This concentration curve plots between the cumulative percentage of the 
health variable of interest (y-axis) and the cumulative percentage of the population, 
ranked by living standards in a gradient of the poorest to the wealthiest (x-axis). It is 
appropriate that such health variables should be the related socioeconomics and are 
measured in ratio scale with nonnegative value. Figure 3.1, for example, is a graphical 
presentation of a concentration curve done by Prakongsai (2008). The 45-degree line 
running from the zero origin to the top right corner is the line of equality27. It means that 
without taking into account living standards, everyone has exactly the same value of 
health variable. In fact, there is no perfect equality or 45-degree line and as a 
consequence, it has another line known as the concentration curve. In the case that this 
concentration line is above the line of equality, such factor takes a higher value among 
the poor. It is regressive in terms of health financing or it is pro-poor in terms of the 
other two areas of health, i.e. health status and health care. In contrast, the line below 
the line of equality, the variable takes a lower value among the poor, or is progressive, 
or pro-rich, in the meaning of health financing and of the other two areas of health, 
respectively. However, these scattered plots of mean have a limitation in comparison to 
the difference of one line against another line because the method could not account for 
the standard error of those means. For this comparison, i.e. dominance, many 
approaches for calculating the difference were suggested. However, this is out of the 
scope of this thesis. 
                                                 
27Specifically, it calls Lorenz curve for income in measurement of income inequality. The line is plotted 
between the cumulative proportion of the population, ranked by the gradient of income from lowest to 
highest, against the cumulative proportion of income. 
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Figure 3.1 Graphs depicting concentration curves in line with Gini coefficient. 
Kakwani index and concentration index 
 
Source: Figure 7.1, page 194; and Figure 7.4, page 198 in (Prakongsai 2008) 
 
To add a more meaningful analysis to the visual value of the concentration curve, the 
concentration index28 is concomitantly calculated for the magnitude of inequality 
against the line of equality. It takes into account the statistical method related to the area 
under the curve, variance and covariance between and within data groups of the 
compared lines. The index is twice the area under the curve between the line of interest 
and the equality line and this value is in between -1 and +1. The -1 means that the health 
variable measured only favours the poorest meanwhile +1 means favouring only the 
richest group. If the concentration index equals zero, it indicates either equality or the 
curve crosses the line and there is some area above and below, the line is 
counterbalanced.  
                                                 
28 Continuing from analysis of income of the population (in footnote 27), the twice of areas under the 
curve between this Lorenz curve and the equality line is called Gini coefficient for income.  
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The concentration index could be further calculated by means of the horizontal equity 
index29. This index is the equality comparison between the curves representing different 
time periods, countries, and geographical areas, health care against health need, for 
instance, in the same or different health variables. The value of this index is in between 
-2 and +2. In the case of health care provided against health need (or uses),  -2 means all 
health care is provided to the poorest individual, and all the need is concentrated to the 
richest, +2 means vise versa. 
3.1.3.2 Multivariate analysis 
The approaches mentioned earlier measure only a bivariate relationship between health 
variables and the living standards which might not account for other health-related and 
health equity related variables stated in section 3.1.2. In addition, the relationship 
among those variables, in particular their causality is often of interest among researchers 
and policy makers. Evidence based explanation on health related variables and health 
problems or health outcomes could lead to better policy recommendations and decisions 
on policy.  Under this circumstance, a multivariate analysis on quantitative data as in a 
health survey could serve this objective. Multivariate analysis provides better 
understanding to the extent which health-related variables affect inequality. Controlling 
other variables in multivariate analysis, the result will provide the effect of the 
remaining variable on the dependent health variable of interest. In other words, this 
analysis type not only provides the broader view of health variables relationship but also 
the magnitude of inequality and the direction of such relationship at one time. 
Nonetheless, this complicated analysis is more advanced in statistical or econometric 
techniques and requires more data, in terms of the number of variables, than univariate 
analysis for a bivariate relationship. This analysis series basically derives from a linear 
regression model and an ordinary least square equation. Further, it could include various 
families of both linear and non-linear regression models specifically depending on the 
characteristics and types of health variables of interest. Those models include, for 
instance, logistic regression for a binary dependent variable which gives the probability 
of the two distinct choices like dead or alive; the negative binomial which is suitable for 
count data like numbers of out patient visits; and the generalized linear model which is 
                                                 
29 In addition to the Gini coefficient for income, in the case of comparing the inequality of payment 
against income (e.g. tax payment, household health expense), the difference between the twice of both 
areas under these two curves refers to Kakwani’s progressivity index. 
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appropriate for continuous data like health expenditure (Anand, Diderichsen et al. 2001; 
Peter and Evans 2001; Sen 2001; Morris, Devlin et al. 2007; Prakongsai 2008; 
O'Donnell, van Doorslaer et al. 2008a; O'Donnell, van Doorslaer et al. 2008b; 
O'Donnell, van Doorslaer et al. 2008c; O'Donnell, van Doorslaer et al. 2008e; 
O'Donnell, van Doorslaer et al. 2008f). Table 3.1, O'Donnell et al (2008b) summarizes 
data requiring for health equity analysis in various types of analysis mentioned above. 
Table 3.1 Data required for health equity analysis 
 Health variables 
Utilisation 
variables 
Living 
standards 
measure 
(ordinal) 
Living 
standards 
measure 
(cardinal) 
Unit 
subsidies 
User 
payments 
Background 
variables 
Health inequality ?  ?     
Equity in utilisation  ? ?     
Multivariate 
analysis ?    or ?  ?   ? 
Benefit incidence 
analysis  ? ?  ?  (?) 
Health financing        
? progressivity    ?  ?  
? catastrophic 
payments    ?  ?  
? poverty impact    ?  ?  
Source: Table 2.2 page 16 in O'Donnell et al (2008b) 
 
3.1.4 Monitoring equity in health and health care in Thailand 
Equity in health and health care has long been the concern of many public 
organisations, academia and civil societies in Thailand. As mentioned in Chapter Two, 
section 2.1 that equity in health and individual right in access to health care is an 
ultimate goal stated in the two latest Constitution of the country. It is also part of the 
mission of the health systems indicated in the national health plan (Chapter Two, 
section 2.2.1). Fairness and goodness is the target of the health system performance. 
The fairness or equity of the system has been monitored for the past few decades, 
particularly when introducing new health financing insurance schemes (Chapter Two, 
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subsection 2.2.4). In addition to empirical studies on disparity (or equity) of the health 
outcomes (mortality rate) indicated in Chapter One, section 1.2.2 and of health facilities, 
health manpower and health financing in Chapter Two, section 2.2.2, 2.2.3 and 2.2.4, 
respectively, there are some recent studies in the country aimed specifically at 
monitoring the equity in health and health care. 
In those studies, the equity in the Thai health system was defined differently depending 
on the health system mentioned. However, such studies concur to the current 
constitution and the goal of the UC scheme, two health systems were emphasized, that 
is health financing and health services. In health financing, it aims for vertical equity or 
progressive inequality in tax payment and public subsidies as well as out of pocket 
payment. In other words, equity desired in health financing is inequality proportionate 
to ability to pay. On the contrary, the goal for health outcomes and opportunity in access 
to health care utilisation aiming for horizontal equity. Regardless of the personal 
characteristics, the individual would have similar health and opportunity to access 
health care equal to others who have the same need. 
Continuing from Chapter Two, studies in inequity concentrate on financing and use of 
health services. After the significant health financing and health systems reform in 
2002, most inequity studies were targeted to closely monitor the impact of the newest 
scheme, UC, itself and compare it against the two older schemes, i.e. CSMBS and SSS. 
Using descriptive analysis in an empirical cross-country study in inequality of the needs 
for, use of and spending on health services, the Thai 1986 and 1991 household surveys30 
show an upward trend by consumption quintile in health care use of the self-reported ill 
people. The health expenditure proportionate to consumption expenditure was 
considered regressive. Two other studies indicate the equity in utilisation of health care 
with similar methods, i.e. concentration index, and databases but for different periods 
(1986 and 1991 in Pannarunothai et al (1998) versus 2001 and 2003 in Prakongsai 
(2008)). In addition to the concentration curve, the latter study also employed benefit 
incidence analysis. Even though both studies used the same surveys, they could not be 
totally comparable because of the different manipulation of the health facilities. 
Compared to the former period of each study, both studies indicated less inequality in 
health care use against income level. It was reported that the UC policy implementation 
                                                 
30 Those surveys include the nation-wide health and welfare survey (HWS) and the nation-wide 
socioeconomic survey 
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had improved insurance coverage and inequality in health care use of the poor in both 
directions, i.e. more regressive of pro-poor and less progressive of pro-rich. Compared 
to income, the direct tax payment was more progressive, the indirect tax payment was 
less regressive and out of pocket payment was significantly less regressive. The 
contribution to social health insurance was less progressive and the payment for private 
health insurance premium was more regressive. The benefit incidence analysis shows an 
increase in the pro-poor net public health subsidies across income and geographical 
area. There was also another small scale study in 3 low-income provinces in 3 regions 
to monitor the impact of the UC policy on inequality and disparity in the early period 
after the UC implementation in 2002. The analysis with the probit model shows that the 
probability of seeking care has a positive relationship with income and the uninsured 
person less likely to seek care than others with insurance. Recently, an analysis on 
longitudinal data during 1996 to 2006 with OLS regression shows that the UC 
implementation increased use of ambulatory care both in numbers of patients and 
numbers of visits but did not have a significant impact on hospitalisation. The trend was 
negatively related to the geographical socio-economic status and hospital size. 
However, the increasing trend gradually reduced in a few years after the UC. The study 
also reported more of beneficiaries of insurance schemes prior to the UC access to the 
health service than uninsured group. This led to the suspicion in inequality in the service 
provided. On the impact of the UC on drug utilisation, a study reported that after two 
years of the policy implementation, the UC beneficiaries had less chance of receiving 
new drugs or expensive drugs than the CSMBS beneficiaries. In addition, the UC 
beneficiaries had received a fewer  amount of new drugs or expensive drugs per year 
than the CSMBS beneficiaries (Pannarunothai and Rehnberg 1998; Makinen, Waters et 
al. 2000; Pannarunothai 2000; Limwattanon, Limwattananon et al. 2004; Pannarunothai, 
Patmasiriwat et al. 2004; Suraratdecha, Saithanu et al. 2005; Panpiemras, Sampuntharak 
et al. 2007; Prakongsai 2008). 
3.2 Utilisation and Cost of care at the terminal stage of life 
The costs of health care in the last period of life as well as the cost of care for the aging 
are a concern and often reported on in developed countries. Perhaps, such costs play 
some role to the growth of overall health budget or health expenditure. Cost of care for 
dying patients might be driven by the aggressive treatments for patients in crisis or 
treatments for prolonging life. Treatment cost with new technologies are always more 
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expensive than conventional ones. As well as cost of treatments themselves, the 
growing ageing population and the majority age of dying people might enlarge the 
magnitude of the expenditures particularly in an unhealthy aging population. As a 
result, the studies towards such topics related to future health expenditure projection 
including last period of life were conducted during the 1980s through 2000s where the 
‘baby boom generation’ were coming into retirement age within the next decade. 
3.2.1 Magnitude of the medical care expenditure; patterns and determinants affected 
to utilisation and expenditures prior to death 
This subsection presents studies related to expenditure (or cost) of care at the terminal 
stage of life. The topics include the magnitude of the cost incurred to the health 
systems; pattern of health care utilisation and cost component; characteristics of the 
decedents; and determinants of the utilisation and cost at the terminal stage of life. Since 
most studies examined many dimensions and the relations of utilisations and 
expenditures to factors of interest at one period of time, it is difficult to distinguish and 
present those issues without a reiteration of their study design. In addition, it seems that 
the studies in the United States of America are the pioneer studies on these issues which 
mostly provide an analysis of Medicare data. Medicare is a public insurance scheme 
which mostly provides health care costs for the elderly, so there were concerns about its 
budget for such care for beneficiaries. Studies based in Canada and the EU including the 
UK, the Netherlands, Switzerland, Sweden and Germany were also obtained. In order to 
understand the background knowledge of the cost last period of life which is related to 
the context of population and health service systems, this subsection presents, firstly, 
studies in the US followed by other OECD countries. However, such studies in other 
OECD countries were mostly intended to adapt the US findings and recommendations 
to the non-US health systems as well as to improve the methodology used in cost 
estimation and prediction, so there were no or few country-specific studies from other 
countries present that were similar in manner to that of the US. 
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3.2.1.1 The United States of America 
Expenditure for decedents prior to death of Medicare31 was intensively assessed 
particularly during the 1980s to 1990s. Annually, elderly decedents accounted for 5 to 6 
percent of Medicare beneficiaries. Expenditures for last month of life rose from $5,400 
in 1988 to $7,400 in 1995 (in 1995 dollars). However, the last year of life spending was 
reported as virtually stable during 1976-1999, range from 26 to 30.8 percent of the total 
Medicare outlays. The average last year per capita (in current value) of decedent 
increased from $3,488 in 1976 to $26,300 in 1997, and dropped to $24,856 in 1999 and 
$22,107 in 2006 but it was $37,581 (in 1996 dollars) during the period of 1992-1996. In 
contrast, spending per survivor was from $492 to $4,400 and dropped to $3,669 and 
increased to $5,694 in the same years. In terms of expenditure ratio, Medicare spending 
for decedents ranged from 4.3 in 1979 to 6-6.3 times in 1992-1997 on the survivor. In 
addition, on non-Medicare spending and of out of pocket payment this ratio was 3.7 and 
3.2 times during the period of 1992-1995, respectively. By health services, expenditure 
for institutions for continuous stay had the highest expense ratio, 13.2 times, whereas 
acute care costs in hospital was 7.6 times and ambulatory care was 3 to 3.4 times (Calfo, 
Smith et al.; Riley and Lubitz 1989; Lubitz and Riley 1993; Garber, MaCurdy et al. 
1998; Hogan, Lunney et al. 2001; Hoover, Crytal et al. 2002; Lunney, Lynn et al. 2002; 
The Henry J. Kaiser Family Foundation 2007). 
Inference from mentioned studies to national figures should be done cautiously. This is 
because Medicare includes mainly elderly aged 65 and above and does not incur all 
spending of the beneficiaries. As a consequence, these costs of medical care in the US 
comprises of various components32, such studies represents national data reported in the 
last year of life cost mostly focused on the Medicare which limited its benefit package 
and beneficiaries to mostly those aged over 65 years. One of its survey data revealed 
that while Medicare accounted for 61-63 percent of total expenditures for decedents, 
Medicaid and other payers accounted for 10-13.4 percent and 5.6-12 percent, 
respectively. Out of pocket payments shared 13.9-18 percent of decedents expenditure 
                                                 
31 Medicare is a federal health insurance programme covers both acute and post-acute care of Part A and 
Part B but excluding non-skilled nursing home and prescription drug, for instance. Beneficiaries include 
American ages 65 years or over including person age less than 65 years with certain disabilities and 
person at any age with end stage renal failure. 
32 In the US health system, the medical care expenditure usually comprised of five main components, i.e. 
inpatient hospital services, physician services, nursing home services and home health care services and 
others. Others include drug and prescriptions, medical supplies, and rarely used miscellaneous services 
such as speech therapy and counselling. 
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in which the major payment was for nursing home care. That is, the oldest individuals 
paid the highest proportion of out of pocket payments. It was argued that decedents of 
Medicare aged 65 and above accounted for two thirds of all deaths in the United States 
which was less than one percent of the population. On the other hand, Medicare 
decedents accounted for 21-25 percent of its total expenditures and expenditures for all 
decedents were estimated to account for only 10-12 percent of the total health care 
expenditure. However, the 2006 spending of Medicare accounted for 20 percent of the 
national total health expenditure (Scitovsky 1984; Emanuel and Emanuel 1994; Hogan, 
Lunney et al. 2001; Emanuel, Ash et al. 2002; Hoover, Crytal et al. 2002; Riley 2007; 
The Henry J. Kaiser Family Foundation 2007). These figures were indirect estimations 
and there was likely an alteration in estimation of decedents’ expenditure. To some 
extent, estimations from the previous decade might not precisely predict estimations for 
the present decade. 
Characteristics of people, patterns of health care utilisation and costs of care when death 
approached were reported on a time trend and cross-sectional basis. Not all of decedents 
were hospitalized in their last year of lives but an upward trend was found in seeking 
care as well as the number of days in using health services. For example, during 1989-
1995, decedents who died without using any Medicare services fell from 40 to 25 
percent. A cross-sectional study on Medicare beneficiaries in two urban states of the 
United States died in 1996 showed that 77 and 55 percent of decedents were admitted 
for acute care.  
Of deaths during 1996-1999, less than 1 percent of Medicare beneficiaries had no 
expenditure in their final year before death while 4.7 percent and 6.5 percent had zero 
expenditure in their second and third year before death. According to a population-
based study on hospital care for children and young adults in Washington State, 35 
percent of old children and young adults with complex chronic conditions were 
hospitalised during the last year of life and two-thirds were infants. During the second 
month to the last month of life, hospitalisation rates doubled during the first half of the 
last year of life. Additionally, hospitalisation increased to four times higher in the last 
month of life. However, it was noted that patients who died from cancer had last-month 
hospitalisation at 2.4 times greater than the first half of the last year of life. The median 
length of stay of such cases was 18 days and the 75th percentile was 52 days (Garber, 
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MaCurdy et al. 1998; Emanuel, Ash et al. 2002; Feudtner, DiGiuseppe et al. 2003; 
Shugarman, Campbell et al. 2004). 
In accordance with health care utilisation, the cost was typically exponentially 
increasing during the seventh month to the last 30 days prior to death. Figure 3.2 depicts 
the trend of utilisation probability and expenditure over the proximity to death. On 
average, the cost of last six months, last three months and last month of life accounted 
for 70-71, 51 and 30 percent, respectively, proportionate to the cost for the last entire 
year. Nearly the same proportion was found in Medicare expenditure but was different 
for out of pocket, that is 67, 43 and 19 percent, respectively. Among different types of 
services, expenditure for acute care in hospital within the last six months of life 
accounted for 80 percent of such expenditure for the last year while the portion for acute 
care for the last three months and last month was 66 and 51 percent, respectively. 
Almost the same portion was found for hospice care but differences were found in 
ambulatory care of which its portion was 54-69, 31-48 and 16-25 percent in respect to 
such period of life. In comparison, for expenditure across types of service in the last 
year, acute care services were higher than the physician services as indicated by the 
reimbursement ratio of Medicare, i.e. 5 versus 2.8. 1988 data, (Scitovsky 1994) 
indicated the percentage distribution of Medicare payment for the last year of life for 
beneficiaries aged 65 and over by type of service, i.e. acute care, physician visit, skilled 
nursing, home health and all others was 69.8 to 71.7, 19.0 to 20.8, 1.2 to 3.2, 2.1 to 2.9 
and 3.3 to 6.8, respectively. This was markedly different to the survivor’s payment 
pattern over similar types of service, i.e. 52.5 to 56.3, 29.2 to 34.8, 0.4 to 3.3, 1.5 to 4.5 
and 6.6 to 10.2, respectively. Another study on last-year-of-life utilisation and 
expenditure of Medicare decedents dying from lung cancer between 1996 and 1999, a 
multivariate regression technique revealed that women were more likely to use inpatient 
care than men but there was no difference in expenditure by gender. However, while 
gender was not associated with utilisation of outpatient services as well as physician 
services, expenditure did. Expenditures for both services for women were $216 and 
$500 less than men, respectively. The older aged and women had a greater likelihood in 
using skilled nursing home care than the younger aged and men. Expenditure for 
women was $722 higher than men. Similar results of gender were observed in home 
health services and hospice services. It was found that women were more likely to use 
the services and had higher expenditure than men, i.e. $900 and $830, respectively 
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(Riley and Lubitz 1989; Scitovsky 1994; Hogan, Lunney et al. 2001; Hoover, Crytal et 
al. 2002; Shugarman, Campbell et al. 2004).  
Figure 3.2 Pattern of expenditure during the last period of life 
 
Source: Figure 1 in (Seshamani and Gray 2004b) 
 
As indicated in a study on top ranking academic medical centres in the United States by 
Wennberg et al (2004), high variations were found in services provided for Medicare 
beneficiaries with certain chronic conditions who died during 1999-2000. This variation 
in services during the final period before death included, for example, staying in an 
intensive care unit. This specific care was always expected because of its crucial role in 
health care use and high cost of care of decedents during when death was being 
approached. However, Barnato et al (2004) could partly indicate a relationship between 
intensive care and the patients at terminal stage in their nationwide study of Medicare 
decedents dying between 1985 and 1999. It was found that in absolute terms, the 
decedents were more likely to receive intensive care. During such period, decedents 
who received any intensive procedure increased from 20.9 to 31.0 percent, while 
survivors use increased from 5.8 to 8.5 percent. However, other indicators including 
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per-capita use of intensive services, per-capita expenditures, hospital and intensive care 
unit admission rate and the likelihood of undergoing an intensive procedure did not 
increase more than the changes of survivors. Further, alteration in the intensive care use 
was monitored by diseases. In nearly a similar period between 1988 and 1995, the 
researchers reported that overall, the trend in numbers of days in intensive care use was 
likely not to change. Meanwhile, Medicare decedents with acute myocardial infarction 
had the highest numbers of days in this unit which was similar to decedents with 
haemorrhagic stroke; decedents with lung cancer spent the least numbers of days in 
such unit. (Garber, MaCurdy et al. 1998; Barnato, McClellan et al. 2004; Wennberg, 
Fisher et al. 2004)  
The cost decreased as the age of decedents increased, and this was opposite to the cost 
of survivors which increased with age. Some other studies reported a similar fashion 
where medical expenditure, which included not only expenditure for hospital services 
but also physician services, nursing home, for instances, reduced after age above 80. For 
example, the very elderly group’s expenditure was 80 percent of the expenditure of the 
younger groups. As shown in (Lubitz, Beebe et al. 1995), Medicare expenditures for the 
last two year of decedents who died at  70, was $22,590 but for those aged 101 or above 
was $8,296 (in 1990 dollars). This was due to the marked reduction in hospital and 
physician services with aggressive care whereas the nursing home services as well as 
home health care significantly increased. Gender is always a factor of interest as well. 
By gender, men were less likely to access health care services than women. One study 
examined Medicare data during 1982-1986 which indicated 10.1 and 6.2 percent of no 
billed services of women and men, respectively, within the 90 days of death. Moreover, 
a multivariate regression analysis of the Medicare data of Beneficiaries who died during 
1996-1999 shows that expenditure for women was higher than men during the three 
years before death. Further analysis, however, revealed that across age groups, the 
expenditure for women to men ratios in the second and third year before death were 
higher than 1. Meanwhile, these ratios in the last year of life were lowest and were less 
than 1 in the group aged 90 and above. (Calfo, Smith et al.; Scitovsky 1984; Scitovsky 
1988; Riley and Lubitz 1989; Gaumer and Stavins 1992; Scitovsky 1994; Lubitz, Beebe 
et al. 1995; Levinsky, Yu et al. 2001; Hoover, Crytal et al. 2002; Shugarman, Campbell 
et al. 2004). 
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Expenditure also altered with the functional status of the decedents before death which 
was assessed by the decedents’ next of kin. In general, there was no significant 
difference found in average expenditure of decedents with different functional status 
prior to death. Nevertheless, compared with decedents aged between 65 and 79 with 
total impairment, the group aged 80 and over with the same functional status had higher 
expenses. In contrast, the younger group with unimpairment or partial impairment had 
higher average medical expenses than the older age group. By types of service, 
expenditure during the last year of life of the unimpaired decedents was mostly for 
hospital services whereas the same expense of the totally impaired decedents was 
dominantly for nursing home and home health care, particularly for decedents aged 80 
and over. That is, holding age constant, expenditure for hospital and physician services 
sharply reduced in line with declining functional status. Further analysis in hospital 
services shows that partially impaired decedents were the highest admitted with highest 
numbers of admission, with greatest average length of stay but had a lower mean charge 
per day than unimpaired group. Similarly, the partially impaired group had greatest 
numbers of physician visits but paid less per visit than the unimpaired group (Calfo, 
Smith et al.; Scitovsky 1988).  
Cause of death was usually reported concomitantly with age and gender in analysis of 
cost for and utilisation of decedents. Descriptive data shows that typically in Medicare, 
diseases reported including heart disease, cancer, stroke, chronic obstructive pulmonary 
disease (COPD), pneumonia/influenza and dementia. Expenditure by those causes had 
different patterns within the period before death. For example, it was indicated that, 
among others, malignant neoplasms or cancers, decedents had the highest Medicare 
reimbursement ratio during the last two years. Meanwhile, nephritis and COPD 
decedents were the most expensive because of their consistently high reimbursement 
within the 6-year period before death. This finding was supported by the following 
figures. Among three leading causes of death in 1979, cancer showed the highest 
reimbursement ratio of acute care as well as physician services in the last year, i.e. 7.7 
and 4.3 while the ratios of stroke and heart diseases were 4.3 and 2.1, and 3.8 and 2.2, 
respectively. Another study found high costs during the last year of life care of male 
Medicare beneficiaries dying from cancer aged 65 to 74. In last year before death in 
1988, Medicare beneficiaries who died from nephritis had an average per capita of 
$8,362 and $8,021 from malignant neoplasm. Oppositely, per capita of beneficiaries 
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who died from heart diseases costs amounted to $4,018, from acute myocardial 
infarction, which was due in part of many sudden deaths, $3,170 and from accidents, 
$4,508. In 1996, the mean last year of life expenditure per decedent in two urban states 
was approximately $35,000-$36,000 for dying from COPD, $34,500-$35,000 for 
cancer, $28,000-$30,000 for pneumonia/flu, and $23,600-$24,800 for heart disease and 
stroke (Riley and Lubitz 1989; Scitovsky 1994; Hogan, Lunney et al. 2001; Emanuel, 
Ash et al. 2002)  
Considering proximity to death, types of services and specific diseases, over the three 
months before death between 1988 and 1995, trends of hospital expenditure were 
reported as sharply increasing. In monetary terms, this expenditure for the final month 
of decedents with AMI rose by nearly 50 percent in real terms to $10,000 per capita 
while expenditure for the final two years before death was heavily weighted to the use 
of outpatient services, i.e. $235 in 1988 to $707 in 1995. Similar findings were found in 
decedents with haemorrhagic stroke but a different pattern was found in lung cancer. 
Expenditures of these cancer decedents rose up sharply for nonacute hospital care and 
inpatient and outpatient hospice (Garber, MaCurdy et al. 1998).  
Comorbidity levels or number of chronic conditions of the decedents was also 
mentioned in the studies, in particular, those using multivariate regression analysis. 
Because it was kept as a control for burden of diseases in the model, none of such 
studies discussed its influence to utilisation and expenditure prior to death. It 
descriptively presented that the mean comorbidities by age groups were similar in the 
range of 3.0 to 3.6. However, a study of two states in the US shows that Medicare 
expenditure increased with increasing levels of comorbidity. Within each of those 
levels, expenditure decreased with increasing age (Levinsky, Yu et al. 2001; 
Shugarman, Campbell et al. 2004; Wennberg, Fisher et al. 2004). 
Last year of life costs were also high in beneficiaries who were in a minority group or 
who lived in socioeconomic status of residential area or area of high poverty rates. In 
multivariate regression analysis of Medicare beneficiaries who died between 1996 and 
1999, the result shows that expenditures for blacks were lower than those for whites in 
the last second and third year before death, but there was no statistical difference in the 
last year of life. Owing to the unavailability of household or decedent socioeconomic 
data, all studies were aimed at the socioeconomic status of decedents’ residential area. 
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Decedents residing in the wealthiest area had 16 percent and 7 percent higher 
expenditure in the third and second year, respectively, than those in the poorest areas. 
However, an inverse pattern of expenditure was revealed in the last year before death, 
that is, decedents in the wealthiest area had 5 percent less expenditure than those from 
the poor areas. On the supply side, location of hospitals and hospital capacity, for 
instance,  the number of beds which had an influence to physicians decision on patient 
admission could determine the utilisation of health services and physician to patient 
ratio (Hogan, Lunney et al. 2001; Shugarman, Campbell et al. 2004; Wennberg, Fisher 
et al. 2004).  
Place of death was often mentioned in cost analysis among decedents. In the analysis of 
15-year records of Medicare beneficiaries who died during 1985-1999, death in hospital 
shows a declining trend from 44.4 to 39.3 percent. This is similar to a national study in 
1980-1998 mentioned in the Chapter One (subsection 1.3.3) as well as a study of 
Medicare beneficiaries who died between 1989 and 1995. The latter study found that the 
percentage of hospital deaths fell dramatically from 42 to less than 35 percent during 
such period. However, place of death was also determined by causes of death and types 
of services before death. Disease-specific trends in place of death revealed that in acute 
myocardial infarction and haemorrhagic stroke, 70 percent of patients died in an acute 
care hospital. While the trend of both diseases decreased very slightly over such time, 
the trend of decedents with lung cancer dramatically reduced from 52 percent to 36 
percent. A cross-sectional study on the 1996 decedents of Medicare beneficiaries in two 
urban states shows variation in the last year of life where costs were different according 
to use of hospice care and place of death. This hospice care was concentrated on 
patients with terminal stage cancer. That is, more than 35 percent of cancer decedents 
accessed hospice care or 60 percent of hospice users were cancer decedents. This kind 
of care also determined death at home and death outside hospital; for example, 43 
percent of decedents who did not use hospice care died in hospital, but 5-11 percent of 
hospice users died in hospital. Surprisingly, it was concluded that hospice and home 
health care did not significantly reduce expenditure on other types of services during 
1988-1995. Additionally, in 1996, using hospice care did not reduce cost of care during 
the last year before death except for cancer decedents where 13-20 percent of 
expenditure during such period was saved. The findings of another study on Medicare 
data between 1993 and 1998 partially supported the former study. Forty six percent of 
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terminal illness cases which were mostly cancer patients still had a high average of 
Medicare expenditure, with 52 percent exceeding $25,000 in last year of life 
reimbursement. (Garber, MaCurdy et al. 1998; Emanuel, Ash et al. 2002; Lunney, Lynn 
et al. 2002; Barnato, McClellan et al. 2004; Flory, Young-Xu et al. 2004). 
3.2.1.2 Canada 
A study in a province of Canada reported that during one decade (1991-2001), the 
spending on decedents was 20-22 percent of the expenditure for the population aged 65 
and above. This narrow range of proportion is due to the crude death being unchanged 
and expenditure in monetary terms for the final year of decedents’ life was stable but 
the cost for survivors dropped between 5 and 30 percent. Expenditure included publicly 
funded hospitals, physicians’ services, prescription drugs and home and facility based 
continuing care. In contrast to the US, the absolute term of inflation-adjusted costs 
increased with age, i.e. from C$25,000-C$30,000 to over C$40,000 per capita for all 
services. This cost increase was due to the dramatic rise of cost for continuing care from 
C$5,000 for decedents aged 66-70 to over C$25,000 for those aged 93 and above. On 
the other hand, the expenditure for the other three services fell 40-70 percent with 
declining age. The greatest, 23 percent, change of decedent/survivor ratio over 1991 and 
2001 was the expenditure for all services of population aged 81-90. In 1984-1985 data 
of another province supported the positive association of health care cost and age. It was 
estimated that the per capita expenditure for hospitalisations including nursing homes 
and ambulatory visits to physician in four years before death was C$35,300 for 
decedents aged 45 and over. Further, those aged 45 to 64 spent C$23,600 while 
decedents aged 85 and over would have expenditure of C$49,400 per annum during the 
final 4 years before death. However, this estimation was calculated from data on 
utilisation by the very elderly which was very likely overestimated since the researchers 
found that this age group was more likely to be admitted in small rural hospitals where 
the cost might be cheaper than their estimation. In decedents’ utilisation, average length 
of hospitalisation per year was greater than the survivors, particularly in the last year of 
life (41.4 versus 1.8 days). This marked disparity between survivors and decedents was 
found in the youngest group (45 to 64 years). There is no relation between age and 
utilisation in females and in very elderly males in the last year before death, nonetheless 
younger male decedents spent less admitted days than females. In contrast, a strong 
relation between age and utilisation was found in nursing homes but a negative relation 
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between both factors was found in ambulatory visits to physicians. Trends of days spent 
in nursing homes and numbers of ambulatory visits is upwards through the year 
proximity to death (Roos, Montgomery et al. 1987; Payne, Laporte et al. 2009). 
3.2.1.3 The United Kingdom 
In the UK, some significant studies on the utilisations and expenditures on the last 
period of life were found. In 2002, it was noted that one percent of the population was 
decedents and accounted for 28.9 percent of hospital expenditures. More than half of 
these costs were spent on the oldest age group which was the biggest group (Seshamani 
and Gray 2004c). 
 A descriptive study on NHS admissions of all decedents aged 45 years and above 
during 15-years prior to 1991 in the Oxford Record Linkage Study indicated some 
findings. About a quarter of all decedents at each age spent little or no hospitalisation 
expenditure whereas minority decedents were very heavy users. Numbers of days in 
hospital before death increased with increasing age and were different by gender. Over 
such period, however, it was not accumulated uniformly. Another longest panel data 
using a similar dataset by tracking the general and psychiatric hospital data of 
population in Oxfordshire aged 65 and above since 1970 until 1999 shows that 26.8 
percent of decedents did not have any hospitalisations before death. The proportion of 
place of death was similar to the national statistics, i.e. 53 percent, 16 percent and 30 
percent of decedents died in hospitals, nursing homes and private addresses, 
respectively. With the two part model, it was estimated that decedents which were one 
percent of the population shared 28.9 percent of hospital expenditures in the year 2002. 
Compared to the younger age groups, the oldest age group had marked costs of dying. 
In particular, the 5 percent of decedents aged 65 and above who were in the last year of 
life accounted for half of the hospital expenditures of all patients in the age group. 
Similar findings to the US were found in the trend of probability of being in hospital 
and the expenditure for hospitalisation. That is the exponential increase near the last 
period of life, as shown in Figure 3.2. in expenditure was partly due to a significant 
increase of the probability of hospitalisaiton. Such probability was expected to increase 
as time close to death increased, in particular from quarter 2 to the last quarter of life 
which was three fold increasing. In addition, within 15 years of death, nearly half of 
decedents aged 65 and above had never had hospitalisation except in their last year of 
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life. Age had a significant effect on expenditure in the last year of life in a parabolic 
upward trend between ages 65 and 80 before declining to age 95. However, the 
proximity to death also revealed its significant interaction with age on their effect to 
expenditure as shown by the ten year expenditure figures prior to death. That is hospital 
expenditures increased in the oldest women due to increases in the probability of being 
hospitalised (Himsworth and Goldacre 1999; Seshamani and Gray 2004a; Seshamani 
and Gray 2004b; Seshamani and Gray 2004c). 
Socioeconomics was another factor studied in the UK. In two different social classes 
(middle class and working class), the 1987 sample of deaths in 10 areas shows a higher 
proportion of middle class death in the older age group while a higher proportion in the 
younger age group was found in the working class, i.e. 60 percent versus 50 percent at 
aged 75 years and 25 percent versus 17 percent of aged under 65. No significant 
differences were found in mortality according to marital status and proportion of contact 
with general practitioners in both classes. Similar proportions of both classes were also 
found in admission to residential homes, to hospitals and hospices and receiving nursing 
care at home during the last year of life. However, a higher proportion of middle class 
decedents died at their home or nursing home than the working class, in particular 
decedents aged 85 and above. The British Household Panel Study in 1991-2003 shows 
that over 90 percent of decedents aged above 16 years had seen their general 
practitioner in their final year of life. Numbers of utilisation across age groups were also 
parabolic, i.e. the highest proportion, a quarter of frequent users was found in decedents 
aged under 65 and then dropped to 24 percent of the 65-74 year age group and 19 
percent of aged over 75. Moreover, this study found that health status and functional 
ability of decedents were important determinants of the utilisation of general practice 
and hospital services. Decedents who felt insecure financially were less likely to pay for 
health and social services but were more likely to be frequent attendants in general 
practice. Decedents aged 75 years or decedents who had limited activities were more 
likely to pay for services (Cartwright 1992; Hanratty, Jacoby et al. 2008). 
3.2.1.4 The Netherlands 
Expenditures for the last year of life of the Dutch dying nationwide during 1992-1994 
were approximately 16 times of the survivors (29,676 versus 1,801 guilders). Within six 
years before death, the expenditure for decedents was more than three times of the 
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population. Further, this ratio in elderly group was 4.7 and markedly higher in the non-
elderly group, i.e. 27.3. One percent of sickness fund decedents accounted for 7.8 
percent of all expenditure. Decedents aged 65 and older shared 15 percent of 
expenditure for this age group while the younger decedents shared 4 percent only. By 
gender and age, the average last year of life expenditure for both men and women in 
the youngest age group were 10-20 times higher than for the average population. 
Similar to some studies, this expenditure ratio decreased when age increased. There was 
a marked difference in expenditure ratio between men and women in younger group 
aged less than 40 years which was likely to be explained by accident related deaths. 
Later in 1998-1999 national samples of all ages excluding newborn, the expenditure of 
decedent to population ratio were 13.5 times (14,906 versus 1,192 Euros). It was 
estimated that per capita expenditures per life time was 94,233 Euros. By services, the 
proportions of decedents’ expenditure attributed to hospitalisation and medical 
specialists, nursing homes, pharmaceutical cares, home cares and general practitioners 
were 54, 19, 7, 7 and 1 percent, respectively. Of all decedents, 28 percent dying from 
cancers accounted for 35.3 percent whereas 8.8 percent dying from stroke accounted for 
8.2 percent and 9.6 percent dying from myocardial infarction accounted for 5.2 percent 
of total estimated expenditure of 2.1 billion Euros. Including expenditure for cure and 
care, this study found that expenditure increased when age increased. Meanwhile 
expenditure for cure in decedents sharply dropped as age increased, increasing in 
expenditure for cure in survivors was found as age increased. In addition, expenditure 
for care of both groups increased with age but such expenditures for decedents were 
more expensive in monetary terms. By gender, expenditure for younger decedents, both 
men and women were 30 times higher than survivors. The ratios dropped to less than 5 
times at age 70 and over. The ratio for women was higher than for men aged 45-65 but 
was less than men in ages over 75 years. This pattern was also present in mainly death 
from cancer, diabetes and diseases of the urinary tract. It was also found in the 1997 
data that the last month expenditure accounted for 36 percent of expenditure of the last 
year of life. Meanwhile, cure costs for last year of decedents shared 10 percent of total 
cure costs, care costs shared 5 percent of total care costs (van Vliet and Lamers 1998; 
Stooker, van Acht et al. 2001; Polder, Barendregt et al. 2006). 
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3.2.1.5 Other European countries 
Apart from studies aimed to discuss methodology (details in subsection 3.2.2), one in 
Switzerland, one in Germany and two studies in Sweden were found. 
Payments for last year of life in Switzerland attributed 18-22 percent of the total health 
care expenditure for the retired group. The average per capita expenditure ratio of 
decedent to survivor was 5.6 to 1. Owing to this payment being part of the total health 
expenditure, it accounted for only  insurance companies but excluded public financing, 
so the ratio was lower than the US data which is based on public expenditure. For 
decedents aged 65 and over dying in the period of 1987-1992, a significant decrease in 
expenditure was found as age increased as well as women had higher expenditure than 
men. For example, a 65-year woman had an estimated expenditure of 1,850 Swiss 
francs while a 85-year woman would have 1,450 Swiss francs. Due to the small number 
of young decedents, this study could not reveal certain positive relation between 
expenditure and younger ages (Felder, Meier et al. 2000).  
In Germany, the 1997 data of AOK, the largest public health insurer, revealed that 1.1-
1.4 percent dying beneficiaries accounted for 10-12 percent of total annual hospital 
costs. In addition to age group and gender, hospital expenditure was different by region, 
i.e. the youngest group (20-49 years) in Western Germany had higher expenditure 
compared to the older group (55-59 years) which accounted for  the highest expenditure 
in the East. It was found that expenditure of decedents was 4-5 times higher than 
survivors in the youngest female group which was 3 times different from men. The gap 
narrowed as age increased. By diseases, cancer was the first cause of death in males 
aged 60-64 years and the cause proportion declined after this age group. In females, 
over one third of those aged 55-59 years died from cancer. Approximately, cancer cost 
23,700 DM for females and 23,500 DM for males in the last year of hospitalisation, 
whereas expenditure for other diseases was 14,000-16,000 DM. Compared to survivors, 
estimated expenditure for decedents dying from cancer and cardiovascular diseases was 
6,178 DM and 5,755 DM, respectively. Similar to previous studies, comorbidity could 
not show any effect to expenditure of decedents in the multivariate regression except in 
decedents with 4 comorbidities. Types of health facilities also plays a role in 
expenditure, for example, hospitals with more departments or university hospitals had 
higher expenditure than hospitals with only one department. The regression also 
 87
confirmed descriptive results of the relation of age and expenditure, i.e. for suffering 
from the same disease, elderly cost less than younger decedents. It was concluded that 
findings on determinants of the last year of life expenditure in German data was similar 
to the US but was different in the level of per capita expense of which the US was 
higher and its declining pattern was lower (Brockmann 2002). 
The 1992-1997 Swedish data also revealed that less than 1 percent of the dying 
population accounted for 11 percent of total annual expenditure for acute care. This 
decedent per capita was 14 times higher than the rest of population. Meanwhile the last 
year of life expenditure accounted for 11.3 percent of the entire life longevity, life 
before 6 years prior to death accounted 63.5 percent of acute care expenditure. Men had 
a higher proportion of expenditure for the last year of life than women. The study also 
found that 88 percent of length of stay was accounted for by patients with five or less 
years of life (Batljan and Lagergren 2004). Recently, Jakobsson et al (2007) examined 
an explorative survey of a Swedish county in 2003 to reveal the utilisation of health care 
services during the last three months of life. In their decedent samples, 79 percent used 
hospital care, 60 percent used primary care and 72 percent used community care. In 
addition, approximately 71 percent used 2-3 health care facilities during such period of 
life. On average, decedents had 1.23 admissions in which it correlated to age, residence 
and mental disorders. It was also found that the probability of using hospital-based care 
varied upon type of resident (for inpatient care); type of living arrangement (for 
outpatient care) and presence of mental disorders (mostly dementia). Age was found to 
have a negative correlation to hospital based care but a positive correlation to general 
practitioner services and care at residential care facilities. Probability of using care in 
private homes was mainly seen in decedents with cancers and with musculoskeletal 
diseases. 
Table 3.2 summarises all major findings in ulitisation and expenditures in sourced 
literature. 
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Table 3.2 Summary of findings about the utilisation and expenditure during the last period of life (particular last year) 
 USA (1) and 
Canada (2) 
UK Netherlands Switzerland (1), Germany 
(2), and Sweden (3) 
Data study period ? 1976-1999; 1985-1999; 
1988-1995; 1996-1999 (1) 
? 1984-1985; 1991-2001 (2) 
2002, 1976-1991; 1970-1999; 
1991-2003 
1992-1994, 1997, 1999 ? 1987-1992 (1); 
? 1997 (2) 
? 1992-1997; 2003 (3) 
Decedent population ? 5-6 of Medicare beneficiaries 
(1) 
 
? 1% of population ? 10.2 enrollees per 1,000 
(2.5 in younger; 56 in 65+) na 
Access to care ? 55-77% had admission (1) 
? <1% no expenditures on 
hospitalisation (1) 
? 26.8% non-hospitalisation 
? 90% of decedents met GP 
during the last year 
na 
? In last 3 mths, 79% access 
to hospital care; 60% access to 
primary care; 72% access to 
community care (3) 
Magnitude of expenditures 
(%decedents to %total health 
expenditures: THE)  
? 26-30.8% of Medicare (1) 
? 10-12% of THE (1) 
? 20-22% of THE for age 65+ 
(2) 
? Hospitalisation: 41.4 days of 
decedent versus 1.8 days of 
survivor (2) 
? 1% of population accounted 
for 28.9% 
? 16% shared 64.6% costs in 
85+ 
? 5% share 50% of hospital 
expenditure of age 65+  
? 0.89-1% accounted for 7.8-
11.1% 
? 15% shared costs for 65+; 
4% shared for younger  
? 36% of last year incurred to 
the last month 
? 18-22% of the THE in 
retired person group (1) 
? 1.1-1.4% accounted for 10-
12% of hospital cost (1) 
? 1.1-1.4% of AOK 
beneficiaries accounted for 10-
12% of annual hospital costs 
(2) 
? <1% accounted for 11% of 
acute care costs (3) 
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Table 3.2 Summary of findings about the utilisation and expenditure during the last period of life (particular last year), (cont.) 
 USA (1) and 
Canada (2) 
UK Netherlands Switzerland (1), Germany 
(2), and Sweden (3) 
Expenditures of decedent to 
survivor ratio 
? 4.3-6.3 times of Medicare (1) 
 
na 
? 13.5-16 times for all ages;  
? 4.7 times in elderly;  
? 27.3 times for nonelderly 
? 3 times for all ages in year 6 
before death  
? 5.6 times for all ages (1) 
? 4-5 times in youngest 
women and 3 times in men (2) 
? 14 times for all ages 
% source of payment ? Medicare: 61-63; Medicaid: 
10-13.4; others: 5.6-12; OOP: 
13.9-18 (1) 
na na na 
%expenditures by types of 
health service  
? acute care: 69.8-71.7; 
physician visit: 19.0-20.8; 
skilled nursing: 1.2-3.2; home 
health: 2.1-2.9; others: 3.3-6.8 
(1) 
na 
? hospital: 54; nursing home: 
19; pharmacy: 7; home care: 7; 
GP: 1 na 
Factors of interest likely affected to utilisations and expenditures 
Age and gender ? Positive relation to age 65+, 
and negative relation to age 
80+ (1) 
? very elderly expenditure was 
80% of the younger (1) 
? expenditures for women > 
men (1) 
? positive relation of 
expenditures to age 65+, and 
negative relation to age 95 
? positive relation of 
utilisations to age <65, and 
negative relation to age 65+  
? Ratio of decedents’ 
expenditure to population: 20 
for aged 60-69; 10 for aged 
80+ 
? Expenditure for cure 
decreased with age increased 
? Expenditure for care 
increased with age increased 
? negative relation to age 65+ 
(1) 
? expenditures for women > 
men (2) 
? expenditures for men > 
women (3) 
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Table 3.2 Summary of findings about the utilisation and expenditure during the last period of life (particular last year), (cont.) 
 USA (1) and 
Canada (2) 
UK Netherlands Switzerland (1), Germany 
(2), and Sweden (3) 
Age and gender (cont.) ? positive relation to age 66+ 
because of continuing care (2) 
? positive relation between 
age and use of nursing home 
(2) 
? negative relation between age 
and use of ambulatory care (2) 
  ? negative relation between 
hospital utilisation and age but 
positive relation between GP, 
residential care and age (3) 
Proximity to death  ? last 6 mths acute care: 70-
71%; last 3 mths: 51%; last 
mth: 30% (1) 
? upward trend in use of 
nursing home and ambulatory 
care and proximity to death (2) 
na na na 
Socioeconomics ? wealthiest area had 7-16% 
higher expenditures than 
poorest area (1) 
? 60% of middle class and 
50% of working class died at 
age 75 
? Bad off financial group: less 
likely to pay for health and 
social services but more likely 
to use GP 
na na 
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Table 3.2 Summary of findings about the utilisation and expenditure during the last period of life (particular last year), (cont.) 
 USA (1) and 
Canada (2) 
UK Netherlands Switzerland (1), Germany 
(2), and Sweden (3) 
Cause of death (proportion of 
decedents accounted for 
proportion of expenditures for 
all patients) 
? reimbursement ratio, cancer:  
4.3-7.7; stroke: 2.1-4.3; heart 
diseases: 2.2-3.8 (1) 
 % cause shared % expense 
? cancer: 28% shared 35.3% 
? stroke: 9% shared 8% 
? MI: 9.6% shared 5.2% 
? cancer paid highest costs (2) 
? probability of using private 
care was higher in cancer and 
musculoskeletal diseases (3) 
Place of death ? hospice care for cancer 
reduced 13-20% of 
expenditure (1) 
na na na 
Comorbidity ? Means 3.0-3.6 diseases (1) 
na na 
? no effect to expenditures 
except decedents with 4 
diseases (2) 
Coverage of sources of 
expenditures in most studies 
? Medicare cover 44 millions 
of elderly and disable 
American in 2006(1) 
na 
The Dutch Sickness fund cover 
62-64.1% population na 
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3.2.2 Methods discussed for expenditure estimation and the significant effect of 
proximity to death 
In estimating the expenditure for the last period of life, some issues found in discussion 
were mainly concerns including the determination of the yearly cost for the decedents, 
specifically the last year of life. Nevertheless both methods, i.e. calendar-year and life-
year were similarly calculated from retrospective retrieval of data from date of death, 
gave different expenditure. This is due to the different proportions of expenditure 
contributed to the year of death and before in different ways. Although the calculation 
was based on the completed data of decedents who died on December 31, and its 
correction factor, the calendar-year which is the conventional method was indicated as 
an overestimation. Concern was raised on the highest expenditure in the last month of 
life which seems to be an imbalanced average simultaneously in case of decedents who 
died during the calendar year. It was indicated that this method adding a 30 percent 
overestimation of last year life expenditure on life-year method (Stooker, van Acht et al. 
2001).  
Many methods in estimation and projection of health expenditure were published as 
well as discussed on which factors should be taken into consideration. Normally, 
determinants in the simple model accounted for the population size, mortality, and age-
gender distribution in accordance with the assumption that health needs are constant 
across age-gender groups. However, van Vliet et al (1998) indicated that mortality was 
not recommended as a risk adjuster in improving the estimation of capitation payments. 
This was ascertained with their models including mortality based on 1992-1994 
decedents in the Dutch sickness fund data and revealed the disparity between predicted 
costs and higher actual costs.  
Limitations on the simple estimation of health care expenditure are that they could not 
accommodate the delayed disability and prolonged life, probably influenced by 
technological change and other social factors. Health care expenditure can affect 
longevity of life and those expenditures intrinsically related to proximity to death. 
Moreover, proximity to death can be correlated with other unobservable factors which 
correlate with health service utilisation. Some studies, therefore, hypothesized on health 
care expenditure during the last period of life as a function of time to death and/or as a 
function of age (Zweifel, Felder et al. 1999; Felder, Meier et al. 2000; Stearns and 
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Norton 2004; Seshamani and Gray 2004a; Seshamani and Gray 2004c; Werblow, Felder 
et al. 2007). Concomitantly, the appropriate models testing this hypothesis were 
evaluated and discussed as well as the different effects on different health care 
expenditure. The two-part model was claimed to be superior to the Heckit (or Heckman) 
model with inverse Mill’s ratio. Details of the two part model presents in Chapter Four, 
subsection 4.3.2.1 (4). 
It was found that time to death correlated with both age and in-hospital expenditure. For 
the reason that proximity to death showed it had a stronger effect than age in all tests, 
model predicted health expenditure accounting for proximity to death was suggested to 
accommodate the overestimation from age. With the assumption that there is no change 
in relationship between age, proximity to death and health expenditure, Stearns et al 
(2004) proved that model with proximity to death during 1998-2020 estimated 9-15 
percent less per capita health expenditure for Medicare beneficiaries aged 66-70 than 
the simple model which accounted for age only. In addition, the variation of such 
estimation depends on the increase in the longevity rate. Seshamani et al (2004c) also 
reported similar findings of the effect of proximity to death in the UK data for the 
projection through the entire age groups at death during 2002-2026. Keeping other 
factors constant, lower mortality rates and rising life expectancy could lower the 
average actual per capita hospital expenditure. These factors in expenditure estimation 
were also confirmed by a Swedish study projected in the period of 2000-2030. 
Compared to the simple estimation, the projection with such factors reduced the upward 
trend of expenditure from 18 percent to 11 percent (Batljan and Lagergren 2004). These 
findings were partly in accordance with the epidemiological theory that through 
increases in life expectancy, morbidity is slightly delayed. As a result, a healthier person 
would cost less to the health systems in the future. However, both models accounted for 
demographic change to the hospital expenditure but were limited to the effects of 
change in technology and other health or social care expenditure. Recently, Werblow et 
al (2007) tested all components of health care services in the 1999 Swiss claimed data 
compared between survivors and decedents. The findings confirmed that age had a very 
small effect, i.e. zero or a decreasing effect beyond aged 80, to the health care 
expenditure except for long term care, nonetheless, the weak effect of age was found in 
long term nursing home care. In contrast to age effect, time to death contributed a 
significant explanation to the health care expenditure.  
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3.2.3 Policy implication of the last period of life expenditure 
Two issues of the usefulness of studies in the last period of life were discussed in 
literature including projections of future health expenditure as well as capitation 
estimation; and savings from health expenditure spent for decedents. The former facet 
was initiated from concerns on the changing of factors which would have mainly 
affected growth rate of future health expenditure. Those factors which potentially 
increase the expenditure include change on population demographic structure and aging 
population; longevity of life expectancy; and change on the pattern of illness from 
communicable diseases to chronic illness mentioned earlier in this section. The latter 
concern was based on the current growth of health care expenditure with the idea of 
saving health care costs. Such costs, in particular the costs for in-hospital care, were 
questionnable in spending for prolonging the last period of life in terminally ill patients 
using high and expensive technology. Therefore, further policy on health care for 
terminally ill patients without treatment intended for cure was developed and it was 
focused on outside hospital care, for example, hospice care and advance directive. 
Details of health care for terminally ill patients are presented in the following section 
(Emanuel and Emanuel 1994; van Vliet and Lamers 1998; Stooker, van Acht et al. 
2001; Stearns and Norton 2002; Stearns and Norton 2004; Seshamani and Gray 2004c). 
3.3 Health services for the terminally ill patients 
As previously mentioned, cost of care at the end of life was reported as high cost of care 
without any cost-effectiveness by conventional measurement of a healthy life year. 
When death approached, all curative treatments, chemotherapy for example, could be 
used at this illness stage to prolong short period of life and patients finally ended with 
death. As a result, it has less value compared with chemotherapy at the first or second 
stage of cancer. On the other hand, patients might suffer much more from such 
treatments due to physical weakness at the terminal stage of life. In economic and 
policy views, there were suggestions and attempts to reduce such costs with alternative 
health care services including substituting high technology medical curative treatment 
with other treatments for medical and social care. In humanity and patient right views, 
patients should suffer less from any aggressive treatments. Palliative care and hospice 
care; and advanced directive (or living will) stated refusing life-sustaining interventions 
are those alternative interventions. Dying from cancer with no cardiopulmonary 
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resuscitation was raised as a pragmatic case for reducing useless costs. It was also 
suggested that home hospice care was cheap and could help save from 31 to 64 percent 
of medical care costs, compared to traditional care for terminally ill (Emanuel and 
Emanuel 1994). Even though this topic is a very large area with huge publications, this 
section focuses and briefly describes overview of cares for terminally ill patients. 
Advanced directive (or living will) is beyond the scope of the thesis. 
3.3.1 Health care for terminally ill patients: similarity and difference of cares 
A few terms of health care for terminally ill patients were often found in literature 
including palliative care, end of life care and hospice care. Sometimes, those cares are 
used interchangeably due to no differentiation in time horizon. Apart from the three 
terms mentioned, following subsection, terminal care as well as supportive care is also 
presented briefly.  
3.3.1.1 Palliative care 
Even though there are original patients and the majority of patients receiving such care 
including terminal stage cancers, care has been enhanced to patients with advanced 
HIV/AIDS, advanced organ failure as well as the elderly. 
Saunders’s chronological record on the evolution of palliative care indicated that 
palliative care was developed from her experience on oral and regular regimen of 
morphine. She provided clinical care and conducted research in patients with advanced 
malignant diseases at St. Joseph’s hospice during 1950s (Saunders 2001).  
Nowadays, palliative care is: 
‘An approach that improves the quality of life of patients and their families facing the 
problem associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual.’  
The WHO defined this term in 2002 indicating a shift in the traditional concept of care 
to the new one. Figure 3.3 depicts both concepts of palliative care. The new concept 
includes not only physical, emotional, social and spiritual supports for patients 
themselves but also bereavement counselling for patient families extended into the 
 96
period after patients death. That is, patients and families needs could be recognized, 
planned for and responded to. 
Actually, palliative care aims to help patients live a good quality life as actively as 
possible until death. It was originally developed for patients with cancer due to its clear 
and predictable terminal course of illness. The traditional concept distinguishes 
palliative care from curative treatment over time when effective treatments are 
beneficial. In the new concept which was developed beyond cancer, palliative care 
could start in line with continuing curative treatment, from the time of diagnosis. 
Meanwhile, the intensiveness of palliative care increases naturally, the curative 
treatment which may help to alter the progress of diseases is reduced until death. This 
integral care should be done in any health care setting or even patients’ home (Finlay 
2001; Davies and Higginson 2004; Davies and Higginson 2004). 
The WHO suggested that palliative care (World Health Organization 2009) comprises of: 
? providing relief from pain and other distress symptoms; 
? affirming life and regards dying as a normal process; 
? intention neither to hasten nor to postpone death; 
? integrating the psychological and spiritual aspects of patient care; 
? offering a support system to help patients live as actively as possible until death; 
? offering a support system to help the family cope during the patients illness and in 
their own bereavement; 
? using a team approach to address the needs of patients and their families, 
including bereavement counseling, if indicated; 
? enhancing quality of life, and positive influencing the course of illness; 
? early applying in the course of illness, in conjunction with other therapies that are 
intended to prolong life, such as chemotherapy or radiation therapy, and including those 
investigations needed to better understand and manage distressing clinical 
complications. 
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Figure 3.3 Diagrams depict palliative care in traditional concept (A) and new concept (B) 
A: Traditional concept 
 
B: New concept 
 
Source: Figure 5 and 6 in (Davies and Higginson 2004) which adapted from Lynn and Adamson. 
Living well at the end of life: adapting health care to serious chronic illness in old age. Arlington, 
VA, RAND Health 2003. 
 
The Health Committee (2004) recommended that two types of palliative care providers 
should be distinguished. General palliative care providers are the usual professionals for 
the patients and family who provided most of the palliative care. The team includes 
GPs, district nurses, hospital doctors, ward nurses, allied health professional and staff in 
care homes. Specialist palliative care is provided by specifically trained 
multidisciplinary teams including specialists in palliative medicine, nursing, social work 
and psychological care. This team is expected to provide advice on symptom control 
and pain relief and to give emotional, psychological and spiritual support to patients and 
their families, friends and carers, both during the patient illness and into bereavement.  
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3.3.1.2 End of life care 
 End of life is the term most found in literature without a clear definition stated. 
However, it was mentioned in Seymour et al (2005) and Department of Health (2008) 
that end of life originated from North America and is used in the UK and Australia. In 
North America, it has been used in the context of the care for elderly, that is: 
‘End of life care for seniors requires an active, compassionate approach that treats, 
comforts and supports older individuals who are living with, or dying from, progressive 
or chronic life threatening conditions. Such care is sensitive to personal, cultural and 
spiritual values, beliefs and practices and encompasses support for families and friends 
up to and including the period of bereavement.’ 
However, in the UK, the term is a programme supported by the NHS. The term was 
implicitly stated in the Programme’s document (Department of Health 2008) as follows: 
‘End of life is the support given to a person with advanced, progressive, incurable 
illness to live as well as possible until they die. It includes services that enable the 
supportive and end of life care needs of both patient and family to be identified and met 
throughout the last phase of life and into bereavement. It includes management of pain 
and other symptoms and provision of psychological, social, spiritual and practical 
support.’ 
In addition, it was also stated that patients approaching end of life should expect that 
their care will be: 
? pre-planned wherever possible and based on need (not diagnosis, age, sexual 
orientation, geography or other factors); 
? well coordinated and delivered in accordance with best practice to minimize 
physical, psychological or spiritual suffering; 
? equitable and delivered in a dignified and respectful way; 
? ethical with regard to preference and personal beliefs. 
Similar implications found in Thailand, however, show that end of life care is usually 
implicitly focused on the care during the time close to death. There is no definite 
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terminology but it could be holistic palliative care within weeks, days or hours before 
dying (Nimmannitya 2007; Puengrasamee 2007). 
3.3.1.3 Hospice care 
Hospice care was previously provided by nursing nuns in hospice. Later, it was a 
purpose-built model with an emphasis on offering palliative care to dying patients and 
supportive care to their families in bereavement. The term ‘hospice’ has similar roots to 
hospitality and host. In 1967, this specialised care for dying patients was first introduced 
by Dame Cicely Saunders, physician who established the modern hospice, St. 
Christopher’s Hospice in a residential suburb of London. Home care which was 
incorporated into the plan and started two years later (Oxford University 2000; Saunders 
2001; The National Hospice and Palliative Care Organization 2009). 
This concept of holistic hospice care was introduced into the US during Sauders’s visit 
to Yale University in 1963. It was expanded in the US since the 1970s to replace 
conventional curative care. In the US, hospice care was added to the Medicare benefit 
part A in 1982. Eligible patients recruited must have a prognosis of death of six months 
or less. The care could be delivered to both home and facility-based settings including 
hospice centres, hospitals, nursing homes, and other long term care facilities. (Scitovsky 
1994; Swanson and Cooper 2005; The National Hospice and Palliative Care 
Organization 2009).  
Normally, the patient’s primary caregiver is a family member who sometimes makes 
decisions for the terminally ill patient. The US on-call 24 hour staff makes visits 
routinely to assess and to provide additional care and services to the patients and family 
members. Hospice teams develop a tailor-made care plan for individual patient needs. 
The team comprises of the patient’s GP; hospice physician; nurses; home help aides; 
social workers; clergy or other counselors; trained volunteers; and speech, physical, 
occupational therapists, if needed (The National Hospice and Palliative Care 
Organization 2009). 
3.3.1.4 Terminal care 
Terminal care is limited as part of palliative care and usually refers to the management 
of the last few days or weeks or months of life starting from when the patient is in the 
downward progress (Seymour, Witherspoon et al. 2005). 
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3.3.1.5 Supportive care 
Supportive care had been introduced in the context of curative cancer care. It was stated 
as a term covering services which help people with cancer and their families in coping 
with cancer and its treatment. In addition, it is an important part of care for patients 
which the Nation Council for Hospice and Specialist Palliative Care Services, UK (The 
Health Committee 2004; Seymour, Witherspoon et al. 2005) states as: 
‘That which helps the patient and their family to cope with cancer [and other diseases] 
and treatment of it—from pre-diagnosis, through the process of diagnosis and 
treatment, to cure, continuing illness or death and into bereavement. It helps the patient 
to maximize the benefits of treatment and to live as well as possible with the effect of the 
disease. It is given equal priority alongside diagnosis and treatment.’ 
The National Institute for Clinical Excellence (NICE) suggested that in delivering care, 
it is the responsibility of all health and social care professionals. The care ranges from 
self-help to user involvement, spiritual and social support. 
3.3.2 Problems with care for terminal illness 
3.3.2.1 Equitable access 
Equitable access to high quality palliative care is a goal in the UK government health 
policy on improving patient choice. It was set as a purpose of the end of life care 
strategy mentioned earlier. Equality was evaluated in various categories, i.e. age, 
gender, religion and belief, sexual orientation, gender identity, race, disability, 
homelessness, refugee and detention in prison. Literature review by the programme’s 
equality impact assessment, for example, indicated potential inequality in end of life 
care in respect to age. Patients with cancer got better access to the care than patients 
with other long-term conditions. The hospice and palliative care were not specifically 
addressing issues of cultural and religious differences and ethnicity. Few members from 
the Black and Minority Ethnic Community used home and hospice care. No documents 
concerning gender inequality as well as equality related to religion and belief were 
found. However, it is difficult to identify inequality due to different levels of individual 
belief and practices (Department of Health 2008).  
Regulation for the financing regime and benefit package also determined utilisation of 
end of life care. For example, even though the hospice programme widely covers 
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patients with other terminal illnesses, the majority of the hospice users are terminally ill 
cancer patients in the US, limited with the enrolling condition that eligible enrollees 
should have a prognosis of 6 months or less. Patients with other terminal illnesses 
including dementia and heart diseases had difficulty with definite prognosis and mostly 
were nursing home users and were probably excluded from hospice services. In 
addition, some conditions also resulted in the unavailablity of hospice care to patients 
dying at nursing homes. Consistent findings in determinants of hospice use included 
gender and types of cancer. That is, women and lung cancer were more likely to use 
hospice care. Residing in rural areas and Medicare fee-for-service insurance reduced use 
hospice as well as shortening length of stay. Other patient characteristics which 
determined different rate of enrollment included being 75 years or older; living in areas 
with income in the top two quartiles; having metastatic cancer at diagnosis; and patients 
with different year prognosis. On the other hand, providers’ characteristics determining 
such rates included physician specialty and having oncologist visits. It was also 
indicated that rate of hospice enrollment was substantially different by health centres 
which patients received outpatient care (Byock 2001; McCarthy, Burns et al. 2003; 
Keating, Herrinton et al. 2006). 
3.3.2.2 Disparity of services 
Disparity of services provided and patients receiving hospice care was reported. In 
examining the hospice services in the US, a national survey between 1992 and 2000 
revealed time trends of patients receiving hospice services across 12 core and non-core 
services. Focusing on five key categories of palliative care including nursing care, 
physician care, medication management, psychosocial care and caregiver support, 22 
percent of hospice patients received and 14 percent of hospices provided these five key 
services in 2000. However, some services received substantially increased over the 
study period. The greatest percentage changes and probability of receiving were in 
patients receiving medication management, spiritual care, durable medical equipment 
and supplies, and social services. The difference was also found according to 
geographical variation. Patients had a higher probability of receiving skilled nursing 
services and continuous home care in urbanized hospices than in rural ones. In addition, 
patients of the hospice in the Northeast received fewer types of services than patients of 
hospices in other regions. The researchers discussed that the services delivered and what 
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patients received partly depended on the policy of the financing systems, for example, 
the condition of the reimbursement for each service (Carlson, Morrison et al. 2007). 
3.3.2.3 Quality of care 
Quality of care at the end of life is another domain often discussed and an issue of 
concern. It was recognised as a global problem for public health and health systems. 
This is because each death would affect more people who were grieving, e.g. decedent’s 
relatives and friends. As part of the health system, however, there is no definite 
indicator to measure performance and quality of this end of life care. This measurement 
should take into consideration the views of stakeholders. Conceptual domains for such 
measurement were different upon perspectives including, of experts and of patients. 
Patient perspective rather focused on outcomes than the process of care as well as it was 
simpler, more straightforward and more specific (Singer, Martin et al. 1999; Singer and 
Bowman 2002). 
3.4 Conclusion 
This chapter reviewed three topics related to health systems including health services, 
and health financing in particular to terminal illness and mortality in Thailand which 
was the area of interest indicated in Chapter One and Chapter Two.  
First, equity or fairness in health is mainly defined on the basis of the philosophy of 
social justice and political views. There are four ideologies related to health including 
utilitarianism, libertarianism, egalitarianism and Rawl’s concept. Health systems of 
individual countries are predominantly based on one ground of these ideologies but are 
also mixed with other concepts in its minor components and the target of equity 
achievement, for example, the US health systems is the libertarianism but some of the 
European country health systems are based on the egalitarianism. Two areas of equity 
were often discussed, i.e. equity in health and equity in health care. Health implied to 
health outcomes (health status, health condition and life expectancy, for instances.) and 
health care means health services, treatments, access to care and health financing. 
Pursuing equity in health and health care does not mean the elimination of all health 
differences but some avoidable or unfair factors should be reduced or eliminated, 
instead. Equity and equality are not similar but usually they are used interchangeably. 
Meanwhile equity means fairness, equality means the state of being equal. Health 
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inequalities are not necessarily inequitable. To judge inequity and inequality, it requires 
consideration with the concept of equity and the context of the scope or focus of the 
concern. For example, public health services are usually set to provide equal access for 
all citizens of the country but public financing is aimed more at subsidising the poor 
than the rich. Such samples are linked to other two terms of equity, i.e. horizontal and 
vertical equity. The former refers to the equal treatment for the equals and the latter is 
the unequal treatment of unequals. Both types are examined on factors of interest. That 
is, factors such as the socioeconomic status of all citizens. Measuring equity which is a 
comparison in principle employs a range of simple measures, e.g. rate ratio, to 
concentration curve, concentration index, and multivariate analysis. 
In Thailand, equity in the health system is highlighted as a goal of the Constitution of 
Thailand, as a mission stated in the national health plan and as an indicator of health 
system performance. As a result of Thai health systems being mainly provided by the 
public sector, it seems to be based on the ground of egalitarianism. Equity has long been 
evaluated since a few decades ago, in particular to the newest health insurance scheme--
the Universal Coverage--in which equity is an achievement (see Chapter Two, 
subsection 2.2.4.1). Meanwhile, health financing as well as use of or access to health 
services are the two focuses of equity in health system, currently mortality and life 
expectancy are also the crucial issues of equity in health monitoring (see Chapter One, 
section 1.2.2). 
A second area of interest was health expenditure of terminally ill patients. For the 
reasons that the elderly represent the greatest group of the dying every year, 
demographic change in the ageing population increases in chronic illnesses and in the 
growth rate of monetary terms of health expenditure and health expenditure for a 
specific period of life were intensively revealed in various industrialized countries 
during past three decades. It was reported that one to five percent of this population 
group, decedents, accounted for ten to thirty percent of annual national health 
expenditure or insurance’s annual expenditure. Expenditure for the last period of a 
decedent’s life was 3-16 times higher than expenditure for the equal period of survivors. 
Financial sources accounted for different proportions of health expenditure towards 
death, in particular to the elderly. This is due to the benefit package and financial 
support of the insurance scheme. For instance, in the US, the elderly paid greater out of 
pocket payments than the younger group because most of the oldest group stayed in 
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nursing homes which are mostly not included in the Medicare benefit package. By type 
of services, expenditure for acute care or in-hospital services accounted for the highest 
proportion, compared to other health services. Many factors including age, gender, 
proximity to death, socioeconomics, types of services, causes of death, comorbidities, 
and places of death related to or determined the expenditure and utilisations of health 
services. Age, gender and proximity to death are factors most examined. It was found 
that expenditure and age had a positive relation until the age of 80 and this relationship 
became negative over 80. Women had greater expenditure than men. The nearer to 
death, the higher the expenditures were. In addition, these three factors did not only 
affect health expenditure during the last period of life but were also the determinants in 
health expenditure projections. By cause of death, expenditure had different surging 
patterns. Meanwhile, cancer was the cause of death reported to have the highest 
expenditure during the period close to death, nephritis and COPD had consistent high 
costs during the longer period before death.  
 Finally, there is interest in health services provided to terminally ill patients which 
accounted for expenditure during the last period of life. Nowadays, specific care for 
terminally ill patients who were diagnosed with very least chance for curative treatment, 
receive palliative care. Palliative care and end of life care are similar. Meanwhile, the 
term palliative care is more generous to the terminal phase of all diseases and all ages, 
end of life is previously used in the context of older people dying. The new concept of 
palliative care defined by WHO in 2002 or the concept of end of life care pay attention 
to not only the pain and physical symptoms of patients, but also psychological, social 
and  spiritual aspects of patients including bereavement of families before and after 
patient death. Hospice care is a likely model for caring for people with the new concept 
of palliative care. This care could be provided at home, health facilities and hospice 
facilities with palliative care teams. For the reason that people should have dignity until 
dying and that one death could affect the people who are alive and high costs of in-
hospital expenditures, many industrialized countries raised the importance of services 
for terminally ill patients. The services have been stated in their policy for health 
services and in insurance benefit packages as well as monitoring the performance and 
problems found. Equity of access to these services, quality of care and variety of care 
provided and services received are the issues of concern.  
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3.5 Research gap 
Even though there is a lot of literature exploring expenditure during the last period of 
life, most of them evaluate data from the same databases or surveys. As a result, the 
knowledge and interpretation are limited to similar sources of financing and its benefit 
package, and more specifically to the elderly group. Learning about expenditure for this 
specific period of life is also useful to project national health expenditure.  In addition, 
there is no study in health expenditure for the last period of life while palliative care or 
end of life care in Thailand has been initiated in last decade and is in the infancy 
provocation since a few years ago. Concomitant consideration to the goal of Thai health 
systems, equity in health has long been monitored and remains the main concern of 
health systems. That is equity in health expenditure during the last period of life might 
play some role in the health financing and health services for terminally ill patients in 
Thailand. As a consequence of a knowledge gap and research questions related to 
mortality mentioned in Chapter One (section 1.5) and the health systems of Thailand in 
Chapter Two, some specific research questions had been drawn: 
1) Is there any inequity among Thai people in health care during the end of life period?  
2) What are the factors influencing that inequity? 
3) How do terminally ill cancer patients and their families cope with financing and their 
preferences for healthcare during that period? 
4) What new policy directions need to be developed or changes made in the current 
policy and practices in Thailand? 
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CHAPTER FOUR 
OBJECTIVES AND METHODOLOGY 
To detail the research questions mentioned in section 3.5 of Chapter Three, this chapter 
presents the conceptual framework, objectives, and the methodology for the whole 
thesis, respectively. The following section includes the conceptual framework and the 
main and specific objectives of the thesis. Later in this chapter, data availability and 
research design are presented, including an overview of methods used in this thesis. 
Defining terms are presented in Appendix 1 
4.1 Conceptual framework 
Based on the literature review (Chapter One, Two and Three), Figure 4.1 shows the 
conceptual framework of the thesis. There are three key stakeholders in health care 
systems which include third party payers or health funding agencies, households and 
patients, and health service providers. They determine health financing through health 
expenditure as well as health services through supplies and demands for services. 
Focusing on third party payers, in Thailand this means that for the three main health 
insurance schemes, health expenditure is paid by government revenues and tripartite 
contributions (see Chapter Two, Table 2.7). Out of the insurance payments, households 
also pay for the extra medical care costs and other indirect costs. These payments have 
direct effects on health care services. On the other hand, two key stakeholders include 
health care providers, who supply services, and the households and patients who create 
demand for the services, also play roles in the health care system for terminally ill 
patients. However, many factors could have effects on such health care system through 
their influence on supply and demand. In order to reveal the factors  influencing health 
care, the conceptual framework provides  two suggestions, i.e. the 7 categories of 
avoidable and unavoidable factors that are likely to affect health and equity suggested 
by Whitehead (2000) (see Chapter Three, section 3.1.2) and factors influencing health 
suggested by Dahlgren and Whitehead (1991) cited in (Pelaseyed and Jakubowski 
2007). Those factors were classified into 2 groups, that is, individual factors and general 
conditions. Equity or disparity including payments, access to the care and services 
provided could be monitored towards this context. As a result, findings from reviewing 
literature and data analysis in the thesis recommend improvements on health care 
services for terminally ill patients. 
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Figure 4.1 Conceptual framework of health financing and health care services for terminally ill patients 
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4.2 Objectives 
 To accommodate study time and feasibility, the objectives were adjusted and 
rearranged, in order of studies presented, from those first indicated in Chapter One, 
section 1.6.2. As a consequence, the research aims: 
4.2.1 To estimate costs of treatment prior to death for the health system (3 main 
insurance schemes, UC, SHI, CSMBS during 2006 Thai fiscal year33). In particular, to 
investigate disparity in the cost among the three schemes34; 
4.2.2 To estimate household health expenditure (direct medical cost, indirect medical 
cost and indirect non-medical cost) of the last three months for outpatient care and the 
last six months for inpatient care prior to death of Thai decedents during the 2006 Thai 
fiscal year.  In particular, to investigate: 
? expenditure not covered by health insurance schemes; UC, SHI, CSMBS, 
private and uninsured decedents; 
? expenditure and health seeking behaviour prior to death categorized by 
household incomes quintiles; 
4.2.3 To elaborate the inequity in such estimated expenditure and in views of terminally 
ill patients, their relatives and health professionals including the multitude of factors 
which are revealed important when people are dying; 
4.2.4 To explore current practice on the disclosure of diagnosis, preference for quality 
of life and care, place of dying35 among health professionals, terminally ill patients and 
the patients’ relatives; 
4.2.5 To describe the service and care pathways for terminally ill patients at several 
types of health facilities; and 
4.2.6 To recommend, accompanied with cost and consequences from quantitative study; 
and views of health professionals, terminally ill patients and the patient relatives36, 
policy options for improving the healthcare services for terminally ill patients. 
                                                 
33 2006 Thai fiscal year started from 1st October 2005 to 30th September 2006. 
34 Comparison of admission episode and costs of decedents to the general population was dropped 
35 Perception on advance directives was dropped due to too much study area under this thesis 
36 Policy makers’ perspectives was dropped due to too much study area under this thesis 
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4.3 Methodology 
To meet the objectives and conceptual framework, mixed methods and three data 
sources could be employed.  
4.3.1 Overview on data availability and research design 
The thesis was based on cross-sectional analysis of data from one year of health care in 
Thailand as well as on the qualitative data of patients and health care providers in a 
representative province. Table 4.1 summarises all feasible datasets and their details 
which was able to match the objectives. Two sources provided secondary data in this 
circumstance which include the secondary claims data submitted from the health 
providers or health facilities to the health insurance offices and a survey on household 
health expenditures for decedents in 2005-2006 conducted by the National Statistical 
Office. The claims dataset was mapped to the death certification data (details of 
mapping presents in Chapter Five, subsection 5.2.2). A qualitative approach with health 
professionals and patients and their relatives could support and fulfill the part where the 
secondary data was limited in explanation. Main outcomes of interest including 
retrospective health expenditures and service utilisation were available in both datasets, 
however, they were provided in different intervals during the same period. Length of 
hospitalisation was available in only the claimed dataset. Data for the general 
population could not be matched to data of decedents. Most of the individual factors of 
decedents could be retrieved except for socioeconomics and geography of residential 
area of decedents in the claimed dataset. In addition, some data was categorized 
differently, for example, death at home could not be identified as place of death in 
claimed data but it was reported in the household survey. For the reason that the 
research aims to provide an overview from a national outlook and aims to recommend 
improvements in health care services, cancer was selected to be a tracer disease of data 
analysis and such recommendations. Individual decedent is the unit of analysis in this 
thesis.  
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Table 4.1 Summary of objectives in accordance with data availability  
Health insurances Household survey 
Objectives Required information Availability Remarks Availability Remarks 
Qualitative study 
Expense for 
ambulatory care ?  ? 
Lump in 3 
months prior to 
death 
± 
Expense for acute 
care ? 
Admissions in 
one year prior to 
death 
? 
Lump in 6 
months prior to 
death 
± 
Costs and 
expenditures for 
treatments among 3 
schemes (O 4.2.1 
and 4.2.2) 
Length of stay ? 
Admissions 
within one year 
prior to death 
? 
 
± 
Numbers of visit ?  ? Within 3 months prior to death ± Admission episodes and health seeking 
behaviour with 
general population 
(O 4.2.1 and 4.2.2) 
Numbers of 
hospitalisation ? 
Admissions 
within one year 
prior to death 
? Within 6 months prior to death ± 
Demographics ? Age and gender  
Age, gender, 
household 
relationship 
? 
Socio-economics 
background ?  ? 
Marital status, 
education, 
occupation and 
income 
? Multitude of factors (O 4.2.3) 
Geography of 
residence ? 
 
? Region, municipality ? 
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Table 4.1 Summary of objectives in accordance with data availability (cont.) 
Health insurances Household survey 
Objectives Required information Availability Remarks Availability Remarks 
Qualitative study 
Places of death ? 
Public health 
facilities, private 
health facilities 
and elsewhere 
? 
Public health 
facilities, private 
health facilities, 
home, elsewhere 
? 
Causes of death ? Cause of death in ICD-10 coding ? 
98 diseases and 6 
groups of disease ? 
Multitude factors 
(O 4.2.3) cont. 
Health insurance 
schemes ? 
UC with various 
codes and 
CSMBS 
? 
UC with/without 
30 Baht co-
payment, 
CSMBS, SHI, 
private insurance, 
insurance by 
employer and 
uninsured 
? 
Disclosure of 
diagnosis (O 4.2.4)  ?  ?  ? 
Patients’ preference 
(O 4.2.4)  ?  ?  ? 
Service pathway (O 
4.2.5)  ?  ?  ? 
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4.3.2 Methods 
As mentioned earlier, this thesis employed mixed methods for four studies, that is,  a 
quantitative approach for the two secondary datasets and qualitative approaches—in-
depth interview with health professionals and patients and their relatives. Details of 
methods of each dataset are presented in Chapter Five, section 5.2 and Chapter Six, 
section 6.2. 
Ethical considerations: The ethical concerns on this research proposal were approved 
by the Institute of Health Ethics Committee, University of East Anglia, in August 2006. 
4.3.2.1 Quantitative method 
Analysis of two studies, health insurance expenditure and household expenditure follow 
the quantitative discipline by statistical methods. Stata10 and SPSS15 were used for 
data analysis.  
(1) Exploratory test 
For practicality in data analysis, exploratory tests or preliminary tests were performed to 
learn the characteristics of both independent and dependent variables. This provided 
better data manipulation, for example in their correlation, and an appropriate advanced 
statistical method of analysis. Following the suggestion of econometric analysis, in 
general, both independent and dependent variables of interest were first explored by 
univariate methods, i.e. Analysis of variance (one-way ANOVA) for parametric data 
and Kruskal Wallis test for non-parametric data or interval data with non-normal 
distribution, test of collinearity of independent variables when appropriate. This analysis 
guided some simple meaning, the relationship between individual independent variable 
and dependent variable, and their descriptive statistics for instance, arithmetic mean and 
standard deviation, variance, minimum and maximum values, percentage of missing 
data, median, 10th percentile, 90th percentile, range of the value, skewness, and kurtosis 
(Kennedy 1998; Dougherty 2002; Gujarati 2003; Acock 2006; Buam 2006).  
(2) Selection of independent variables 
The selection was based on the availability of secondary data; literature review of 
relevant research; exploratory tests of its significance by univariate analysis; and the 
research questions and objectives of this research. As much as possible and availablity, 
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all factors of interest of both secondary datasets were selected and manipulated 
identically. In case of categorical variables, the most common or interested category 
would be selected as the reference category. 
(3) Handling missing data 
The missing value in the regression model would be handled by listwise (or casewise) 
deletion in the two studies. That is, if there was any missing data even in one variable, 
an observation with this missing data would be dropped from the analysis. The number 
of observations in each stepwise regression analysis would not alter and have any effect 
on the parameters estimated in every analysis. However, lots of samples would be lost 
by this sort of deletion even with only one missing piece of data from one variable, and 
so will probably reduce the power of the analysis. However, this would not be the case 
for the studies because there was little missing data in exploratory analysis. The number 
and percentage of missing data would be reported in particular chapters, that is, Chapter 
Five and Chapter Six. Another manipulation because of missing values was data 
imputation which this thesis did not employ. The missing value was be replaced by 
imputed value resulting from the predicted value of other values in such variable. It is 
argued that this method works well if the non-missing data of the sample is 
representative of the entire population of that variable (Dupont 2002). In correlation 
test, the pairwise method was used. It dropped an observation when there was a missing 
value of only two variables in the analysis (Dupont 2002; Acock 2006). 
(4) Multivariate analysis and model selection  
a) Hypothesis testing for coefficients and confidence interval 
Prior to elaborating on the several models being tested in this research, it is an important 
to consider the hypothesis test for coefficient parameters of interested independent 
variables. The simple regression equation for relation between dependent variable and 
independent variable is 
εβ += xY . 
Where y is a dependent variable; x is independent variable; β is coefficient from 
i to k number; and ε = residual. The confidence interval in this research would be set at 
95 percent or p value less than 0.05. 
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Once there are more than two independent variables of interest, hypothesis 
testing would be as follows (Dougherty 2002; Gujarati 2003):  
? testing the overall significance of the estimated model; and 
? testing individual regression coefficients. 
Based on different estimation methods as ordinary least square for standard 
linear regression and maximum likelihood algorithms for generalized linear model 
family, different statistics are used for both groups of modeling. A general hypothesis 
testing of each group is explained briefly. 
b) Model selection, model specification test and goodness of fit test 
Many models were employed in multivariate analysis depending on the type of 
dependent variables. Ordinary Least Square (OLS) is the most familiar regression 
approach for continuous data including health expenditure (Details of OLS, see 
Appendix 2, A2.1 and A2.3). Some studies, for example, Brockmann (2002) employed 
the OLS to test determinants and to estimate the 1997 German hospital expenditure. 
However, health care data generally presented a skewed distribution due to a high 
proportion of no use of or no costs for health care services (zero count) and a small 
proportion of heavy use or very high costs of care. Therefore, the data usually could not 
meet the assumptions of the OLS, in particular the homoscedasticity of the residual. To 
accommodate such assumptions, log transformation of the expenditure is used in order 
to normalise its distribution. After log transformation, the popular OLS is employed. In 
the interpretation of the results, however, such retransformation of log scale is 
complicated and misleading. This is due to the fact that the expected value of the 
logarithmic term of dependent variable, is not equivalent to the logarithmic term of the 
expected value of dependent variable, E(ln(y)/x)≠ ln (E(y/x)). In other words, the 
geometric means calculated within the logarithmic term are not equal to arithmetic 
means of the raw scale. In this particular case, Duan (1983) suggested smearing factor, 
so-called Duan adjustment in retransformation (Duan 1983; Roos, Montgomery et al. 
1987; Shugarman, Campbell et al. 2004; Wennberg, Fisher et al. 2004; Koroukian, 
Beaird et al. 2006-2007). This smearing factor is estimated as mean of exponential 
residual from the regression of log transformation data. It is typically between 1.5 and 
4.0. 
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Based on updated literature review, however, retransformation with smearing factor for 
the data with heteroscedasticity of the OLS residual performs the bias in cost estimation 
(Seshamani and Gray 2004a). Alternative approaches to multivariate OLS with or 
without log transformation of the continuous dependent variable were recommended. 
That included generalized linear model (GLM) with gamma distribution and log link or 
other appropriate distributions and link functions (see details in Appendix 2, A2.4.1). In 
addition, it could be employed either as a one part model or in the second part of the 
two-part model (or hurdle model) depending on the purpose of the analysis. Various 
analysis objectives include, for example, improving understanding of the health 
systems, exploring the net effect of covariates on costs, and estimating a person’s future 
utilisation. Diehr et al (1999) and Buntin et al (2004), suggested further that if the aim is 
to understand the health systems, the two-part model seems best because the model 
allows the distinguishing of factors which affected decision making on use (probability 
of use--in other words), and factors affecting numbers of uses or costs. In contrast, in 
case that there is no interest in the probability of use but understanding the effect of 
individual covariates, one part model is more useful because it generates a single 
regression coefficient for each variable and thus can be interpreted easily. Additionally, 
the one part model is recommended for predicting future costs. The Two-part model is 
presented below, in topic c). Regardless whether the one-part model or two-part model 
is selected, some regression models and specific testing should be performed for 
selecting the most suitable and the best fitted regressions to the data (Duan 1983; 
Gaumer and Stavins 1992; Manning 1998; Diehr, Yanez et al. 1999; Cooper 2000; 
Manning and Mullahy 2001; Clarke, Gray et al. 2003; Buntin and Zaslavsky 2004; 
Seshamani 2004d; Dodd, Bassi et al. 2006; Greene 2008; Jones 2008). 
In addition to the diagnostic tests for each model mentioned in Appendix 2, section 
A2.3 to A2.4, Dodd et al (2006) suggested two other tests which calculated the natural 
scale and could be employed for comparison across non-nested models, these are OLS, 
Log OLS, GLM and median models. These two tests for the best fitting model include 
the root mean square error (RMSE) and the mean absolute error (MAE). Meanwhile the 
model revealing the lowest RMSE is the best for predicting mean costs, the lowest 
MAE determining the best predicted median costs. The authors also employed a 
residual diagnostic with scatter plot of residual against fitted values for comparison of 
random scattering of the residual could identify the good fit (Dodd, Bassi et al. 2006). 
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Similarly, scatter plot and standardized normal probability plot also might help 
identifying the good fit of the GLM (Hardin and Hilbe 2007).  
In multivariate analysis of count data, numbers of utilisations, rate data and length of 
hospitalisation, it was suggested to employ a Poisson model and negative binomial 
model. Like distribution of expenditure, both models which are members of the 
exponential family of GLM are appropriate for non-normal distribution of count data. 
Details of both models and concerns on overdispersion of the Poisson model are 
indicated in Appendix 2, section A2.4.2. Further, there are zero-truncated models of 
both Poisson and negative binomial which exclude zeros and account for the positive 
value. In contrast to the zero-truncated model, the zero-inflated model accounts for the 
excess zeros. The model takes into consideration the probability of always-zero plus the 
probability of being zero in the binary probability of the non-zero value (Hardin and 
Hilbe 2007; Cameron and Trivedi 2009).  
In addition, this study employed the robustness of standard error. This provides standard 
errors that are valid even if model errors are heteroscedastic (Cameron and Trivedi 
2009). 
c) Two-part model and hurdle model 
As mentioned, limitations of health data usually overruled the assumption of the OLS in 
topic b) model selection, the two-part model or hurdle model is a model suggested to 
deal with the problems, especially the heteroscedasticity and misspecification of the 
general Poisson or negative binomial models. The two-part model in principle generates 
separate probability function and positive outcome. The first part is to model the 
participation decision, in this study, that is the probability of having any use of health 
services or having any expense by logit or probit model. The logit is widely used. The 
second part will focus on estimations of the positive value of the count data or 
continuous data. Such data includes numbers of heath service utilisation and amount of 
expenditure. An economic modeling method for the second part depends on appropriate 
methods suitable for such data, for example, count data like number of utilisation, the 
zero-truncated Poisson model or zero-truncated negative binomial model are specified; 
for expenditure or cost as continuous data, the generalized linear model with gamma 
distribution and log link or log transformed OLS regression with smearing factor are 
recommended. However, the latter regression has limitations when there is 
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heteroscedasticity in the residuals as already mentioned in Appendix 2, A2.3. The 
expected level of individual estimation will be the multiplying of both parts (Diehr, 
Yanez et al. 1999; Cooper 2000; Greene 2008; Jones 2008; Cameron and Trivedi 2009). 
Details of logistic regression and other generalized linear model family were mentioned 
previously in Appendix 2, A2.5 and A2.4, respectively. The following is the equation 
for overall estimation from the two-part model: 
E(y| x) = Pr(yi>0|xij) x exp(βjxij) 
Following studies revealed application of the two part model to health care utilisation 
and expenditure. Clarke et al (2003) employed the two part model to analyse health care 
costs for diabetes patients with some major complications who participated in the UK 
Prospective Diabetes Study conducted in 1996-1997. The first part, logistic regression 
was employed to model the likelihood of incurring hospital costs and the GLM with 
gamma family and a log link function was used in the second part to model the positive 
hospital cost. Estimations on the expected hospital cost are the multiplication of such 
probability and conditional cost being incurred. In analysis of the effect of age and 
proximity to death on hospital expenditures in the 1970-1999 Oxford Record Linkage 
Study, Seshamani (2004d) also employed the two-part model. The study used the probit 
model to determine the effect of the covariates on the yearly likelihood of entering 
hospital with robust standard error to correct for heteroscedasticity. To examine the 
effect of the covariate on hospital expenditure, OLS regression in the second part was 
employed for the natural log of such expenditure with robust standard error. Given the 
selected condition, the prediction of the expected average expenditure, by multiplying 
the results of the two parts, more clearly illustrated the effect than the Heckman model. 
In the same series debating the influence of proximity to death on health care 
expenditure, Werblow et al (2007) applied the two-part model to the 1999 claimed data 
of the Swiss sickness fund. Employing the probit to the first part and OLS for the 
second part, the researchers revealed the effects of some covariates and estimated health 
care expenditures compared between decedents and survivors.  
An example of application on the two-part model for count data is revealed by Chang et 
al (2003). The researchers modeled the utilisation of the pharmacy in the 1992-1993 
Vietnam Living Standards Survey. For the reason that more than 70 percent of 
observations are zero data which may violate the restriction of equidispersion of mean 
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and variance, and the 'excess zeros' problem, the two-part model was selected. It 
revealed the covariate effect on the choice problem in the first part and the level of 
consumption in the second part. The zero-inflated Poisson model was also employed 
and yielded similar results.  
In summary, the two quantitative studies of the research employed the models, testing 
with some statistics recommended (details in Appendix 2). Table 4.2 summarizes the 
hypothesis test and goodness of fit within each estimation method. 
Table 4.2 Summary of hypotheses tests and tests for modeling outcome variables 
Statistic technique OLS ML ML 
Data type continuous Count Binary 
Outcome variables Hospital charge, household expenditure 
Number of visit, number 
of admission 
Probability of 
participation 
decision 
Model 
Multiple 
linear 
regression 
GLM: 
gamma log; 
Poisson log 
GLM: 
Poisson 
(ZTP) 
GLM: NB 
(ZTNB) 
Logistic 
regression 
Hypotheses test    
• Test for all joint 
coefficients within 
particular model (nested 
model) 
F LR: deviance LR: deviance LR 
• Test for individual 
coefficient t 
t (z), Wald 
test t (z), Wald test t, Wald test 
Goodness of fit test R2 LR 
Test for family na Modified Park test 
Modified 
Park test na Na 
Test for link function  na 
Pearson 
correlation; 
Pregibon link 
test; 
Modified 
Hosmer and 
Lemeshow;  
AIC and BIC 
Pearson 
correlation; 
Pregibon 
link test; 
Modified 
Hosmer 
and 
Lemeshow; 
AIC and 
BIC 
AIC, BIC Na 
Residual analysis Residual plot versus fitted value 
Overdispersion na na Deviance/df, α Na 
OLS = ordinary least square; ML = maximum likelihood; LOS = Length of stay; F = F statistic; t = t statistic; 
LR = log likelihood ratio; GLM = Generalized linear model; NB = negative binomial; ZTP = Zero-truncated 
Poisson; ZTNB = Zero-truncated negative binomial; AIC = Akaike information criterion; BIC = Bayesian 
information criterion; z = coefficient divided by standard error 
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d) Model validation 
The multivariate regressions were validated with a fifty percent random sample of the 
data. That is, the models were tested, and then estimated with the second half of such 
random samples (Buntin and Zaslavsky 2004).  
4.3.2.2 Qualitative method 
This section presents the last two pieces of the entire research which is a primary 
qualitative study.  However, in qualitative discipline, this subsection presents the study 
approach and research design in general. Like the two quantitative studies, details of the 
method are explained in Chapter Seven, section 7.2 and Chapter Eight, section 8.2.  
(1) Research questions 
? How do health professionals, terminally ill cancer patients, and their relatives 
decide on medical and non-medical intervention at the end of patients’ life? 
? How do terminally ill cancer patients and their families cope with their 
expenditure for patient care? 
? What are the preferences on quality of care, place for dying among such groups? 
(2) Study approach 
In qualitative studies, many kinds of research are proposed, i.e. grounded theory 
research, phenomenological research, focus group research, ethnography and case 
study. Each approach is suitable on the grounds of philosophy, theory and purposes of a 
research. The grounded theory method aims to construct a new theoretical concept. 
Nowadays, it is popular in the research in nursing studies and social health. 
Ethnographies are usually employed in anthropology studies. Phenomenological 
research emphasises lived experience and its meaning to such experienced people. 
Focus group research is focused on the discussion of a selected group on a topic of 
interest. However, a good focus group requires experienced facilitators and it is 
sometimes difficult to invite and to make an appointment among the group, in particular 
in groups with busy activities or shift working like physicians. Use of case study, one of 
qualitative study approaches seems to be the most appropriate approach for the research 
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questions and purposes of this research. It provides better understanding in particular 
people, problems or situations in depth. Among three types of this study including 
descriptive, exploratory and explanatory, the explanatory study focused not only on 
disclosing or revealing the phenomenon but also on gaining new explanations or to 
revise existing explanations. It is very useful as an explanation supporting findings from 
quantitative study (Hudelson 1996; Podhisita 2006). 
(3) Research design  
The research is aimed at patients with, and health professionals providing care for, 
terminal stage cancer. Cancer was selected as a tracer disease due to its trajectory of 
patients’ functional status representing terminal illness which has a certain period at the 
end stage of life. Due to its more precise prognosis, patients, their relatives and health 
professionals have some time (approximately 6 months) for good planning in terms of 
providing health care services and considering preferences of patients. One out of all 75 
provinces37 was targeted because it represents the majority pattern, excluding the 
specific pattern of metropolitan of health service system in Thailand. The North Eastern 
region was chosen because it covers a large area and has the largest population in 
Thailand. As a result, the social and cultural issues of such population which might 
afftect the health seeking behaviour would be explored and explained over the findings 
from the quantitative studies. Further, Ubonratchthani, the biggest province in the lower 
north-east with a population of 1.77 million was selected as a research site. According 
to its role as a regional hub for three neighbouring provinces, there are several levels of 
health services including from primary to tertiary and specialised care and types of 
health facilities both public and private distributed in 25 districts. To have a variety of 
participants and health services, the study was designed to cover target groups at three 
settings with different levels of health services. The 900-bed regional hospital, the 
MoPH regional cancer centre and a 30-bed district hospital, KhuangNai hospital--38-
kilometres far from provincial centre, were purposively selected. Such regional hospital 
provides tertiary care for all diseases including medical services for cancer patients as 
well as it serves as the main referral recipient for other hospitals with less advanced 
medical care in the region. The cancer centre specifically provides care for cancer 
patients referred from provincial/regional hospitals located in 9 provinces of lower 
                                                 
37 Bangkok was excluded due to it is the capital with special characteristic. 
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north-eastern region. Both health facilities, in collaboration, are advance caner centre 
(see details in Chapter Two, section 2.3.3). Even though the KhuangNai hospital, a 
community hospital, located next to city center than other community hospitals, it was 
selected due to staff availability and accommodation for the researcher during the data 
collection. 
(4) Data collection 
It was important to take into account the difficulties in researching this topic. Firstly the 
topic of research itself might add to the feeling of grief in terminally ill cancer patients, 
and their relatives, who know about the coming death during this terminal stage of the 
patients. Patients also sometimes have weakness physically and so have difficulty 
travelling. Finding several patients who meet the criteria at the same time could not be 
achieved in the research setting. In-depth interview seems to be the most appropriate 
approach at the convenience of all informants. It could also maintain the interviewee’s 
privacy. To be concise with the main information gathered from individuals, a face-to-
face informal interview was set up with semi-structured topics and open-ended 
questions. All interviews were digitally recorded. Observations and field notes were the 
supportive tools in this circumstance. 
All participants, particularly patients and relatives, were verbally invited to participate 
through verbal or/and leaflet information about the study, however, interviewing was 
not done unless the participant agreed (verbal consent). 
Issues of evidence, trustworthiness and validity: The researcher and her assistant used 
herself as a research tool, that is, the interviewers conducting the fieldwork for 
approximately six months to be familiar with informants and their community (health 
facilities). It was also to ensure a strong relationship, trustworthiness and rapport among 
the researched and the researcher. The researcher dealt fairly with all informants and 
every detail given, followed by the good practice of interviewing and the prevention of 
common interview problems. A field note was written and was used to support data 
collection and to ensure decision making for data analysis and interpretation. In 
addition, this research used a triangulation technique. Three data sources, i.e. patients 
and their relatives were interviewed and patients’ medical records confirmed the same 
issues, particularly patients’ illness. Both similar and different perspectives can be 
gained from this technique. Furthermore, there might be more than one interview with 
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an interviewee until the information provided was exhausted and no additional topics or 
information were  raised. Therefore, the informants’ narrative will be more valid than 
from just one interview.  
(5) Data analysis 
It was indicatied that the raw data from qualitative study could be analysed with many 
techniques depending on the ontological perspective and epistemological approach. 
Qualitative research typically allows the flexibility in data anlysis method in relation to 
the study approach and one study might employ more than one method of data analysis. 
However, there were generally common features indicated on data analysis, i.e. data 
reduction; data display; and conclusion drawing and verification. Either, analysis was 
cross-sectional and categorical indexing; non-crossectional data organizations; and 
using diagrams and charts. Analyses were named in literature including discourse 
analysis, thematic analysis, conversation analysis, interpretative phenomenological 
analysis, content anlysis, narrative anlysis and grounded theory. Due to its flexibility but 
probable provision of a rich and detailed data, it was suggested that thematic analysis is 
a fundamental method that researchers in qualitative approach should learn (Miles and 
Hubeman 1994; Mason 2002; Braun and Clarke 2006). 
It was commented that analysis of the qualitative raw data takes a great part of study 
time, so do this thesis as following described. First, all digitally recorded in-depth 
interviews were transcribed verbatim by the research assistant. All transcribed text of all 
interviews including descriptive indication on emotional reflection during the 
conversations were checked and confirmed in its accuracy by the researcher and her 
field note. In particular to the patients’ illness history, each patient’s medical record was 
another source of comfirmation. 
Next, the transcribed data was reduced and analysed in an interpretive manner, looking 
at what people meant by what they said. Using manual cut-and-paste technique, cross-
sectional and categorical indexing was done to establish the themes. This thematic 
analysis was in line with semi-structured topics and the opened-end quentions setting up 
for in-depth interview. The themes emerging including new found themes were 
analysed to see if there were any relationship to others and to the original research 
questions. Findings from the case studies are presented in multiple units within the 
themes (Mason 2002; Creswell 2007). 
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Cases for which their narrative was quoted in the study findings were presented in 
anonymous coding. Due to the focuses of the two qualitative studies on issues and their 
contents in detail rather than frequency and proportion of similar vesus contrasted 
events, the data were displayed in both the majority and the minority in causality and in 
relation to interested themes. 
4.4 Conclusion 
To achieve the objectives to assess equity in the access to health care in terms of 
utilisation and expenditure during the last period of life and to explain any existing 
equity or inequity, this thesis employed mixed methods, using quantitative and 
qualitative approaches. The quantitative method of multivariate regressions, i.e. the one-
part and two-part models for understanding factors affecting health care utilisation and 
expenditure, and the qualitative method --case study-- gives further explanation of these 
factors in the case of people with cancer. Preferences and coping mechanisms of cancer 
patients in the terminal stage as well as information from health professionals further 
facilitate findings from the quantitative approach. Further details on particular methods 
present in each study, Chapter Five, Six, Seven and Eight. 
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CHAPTER FIVE 
HEALTH INSURANCES’ EXPENDITURE FOR PATIENTS PRIOR TO 
DEATH BETWEEN 2005-2006 
 
5.1 Introduction 
Among industrialised countries, literature reviewed in Chapter Three revealed concerns 
about expenditure during the last period of life in which less than one percent of the 
population accounted for 10 percent to nearly 30 percent of total health expenditure. 
This sharing seems to be greater in health insurance expenditure in particular for the 
elderly. For example, 5 percent of decedents accounted for 30 percent of total 
expenditures for the US Medicare beneficiaries. However, this high and wide range of 
the proportion of expenditure depended on the types of care that the expenditure 
covered (section 3.2.1). This leads to various questions, including the magnitude of and 
per capita expenditure in Thailand. On the other hand, equity in health is a goal of the 
Thai health system, but, before the proposed development of the universal coverage 
scheme, there had not been any information about equity in health during this last 
period of life (section 3.1.4). This part of the thesis aims to explore disparity (or 
inequality) in treatment expenditure paid by the three health insurance schemes; to 
estimate such expenditure; and to explore multitude of factors which are considered 
important when people are dying. This chapter presents expenditure during the last year 
of life claimed by hospitals from two health insurance schemes, UC and CSMBS. The 
Social Health Insurance (SHI) data which was also proposed in the proposal was 
dropped from the study due to its incomparability in data collection to the other two 
databases during the study period.  In addition, this chapter reveals the factors 
influencing those disparities. 
This study on secondary cross-sectional data analysis was hypothesized that claimed 
expenditure during last year of life are affected by individual demographics and other 
determinants. The unit of analysis is based on individual decedents. 
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5.2 Methods 
This section presents details of the analytical method, data sources, data retrieval and 
manipulation for secondary data analysis, including, for instance, categorization of 
cause of death. Assumptions used in this study and all variables determined in data 
analysis and analytical method are also described. 
5.2.1 Analytical methods 
The data in this study was normally explored with univariate tests (see Chapter Four, 
subsection 4.3.3.1 (1)) and with multivariate analysis, respectively. As a result, this 
dataset contains only the positive admissions of the decedents, numbers of admissions 
were tested with zero-truncated Poisson and negative binomial and expenditures were 
tested with Generalized Linear Model of 3 families and 2 link functions, when 
appropriate, as indicated in Chapter Four, subsection 4.3.3.1 (4). 
 5.2.2 Data sources 
The study got a new mapped dataset from two institutes, the Bureau of Health Policy 
and Strategy (BPS), Ministry of Public Health and the Central Office for Health 
Information38. The former institute provided the certified death records of decedents 
who died between 1st October 2005 and 30th September 200639. This individual data 
includes Citizen Identification number (CID), code of registered residential address, 
cause of death in WHO-ICD-1040, code of dying place (in terms of hospital code) and 
hospital codes and hospital names, and date of death (separated in date, month and 
year). To accommodate the WHO ICD-10 rule and guideline, cause of death in this 
dataset was routinely verified by health staff of the institute. At the latter institute, this 
dataset was further mapped to all admissions whether or not there was a claim for the 
expenditure. Admissions within one year of individual decedent were retrieved 
backward from the date of death.  
                                                 
38 This clearance office is responsible for clearing payment data for 2 main health insurance schemes in 
Thailand, i.e. UC and CSMBS. Another main scheme, Social Health Insurance (SHI) has its own 
management by the Social Security Office. 
39 2006 Thai fiscal year 
40 ICD is International Classification of Diseases and Health Problems. The latest one is ICD-10, 10th 
revision, 2007 version. It is handled by the World Health Organization since 1948 and used for many 
purposes in health epidemiology, mortality and morbidity statistics including death certificates and health 
records. The codes are four-character subcategories within 22 chapters. 
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In the mapping process, CID and date of death were the key mapping code in the 
process of validation done by the Central Office for Health Information. In the case of 
decedent without a date of death but still had month and year of death, it was set to day 
15 of that month and year of death. The claimed data including admission episode, age 
at admission, date of birth, gender, date of admission, date of discharge, age at date of 
admission, health insurance scheme, primary diagnosis and 12 secondary diagnoses, 
hospital charges were additionally gained in accordance with new generated study 
identification numbers while the CIDs were dropped. Hospital charges in this new 
dataset included total claimable and total un-claimable expenses as well as in 
disaggregated expenditure in 16 components, e.g. laboratory service, x-ray, medical 
devices and medicines. However, only claimable expenses were accounted for in this 
study. It should be noted that this claimed amount might not be the absolute payment 
from the health insurers. Finally, observations for admissions per decedent were 
collapsed into one observation per decedent linked by the unique study identification 
numbers. This new dataset which accounted for the last year of life includes claimed 
charges, total numbers of admissions, age at death, gender, causes of death, numbers of 
comorbidity in the last admission, length of hospitalisation, places of death and health 
insurance schemes. 
Ethical consideration: In addition to the ethical approval by the University, this study 
strictly conformed to the confidentiality act under the National Registration Record Act 
B.E.2534 (1991). Even though the first dataset of death certificate records contained 
citizen ID and personal information, the study could obtain only the citizen id and some 
information mentioned earlier. Thereafter, in the mapping process, the CID of this part 
of the thesis, was replaced with new generated study ID which could not be related to 
other parts of the thesis, the survey in Chapter Six and qualitative study in Chapter 
Seven. 
5.2.3 Variables in multivariate analysis 
Variables in this study were selected in accordance with the limitations of the secondary 
data provided and information indicated in reviewed literature from other countries. 
Details of variables and data manipulation are described below.  
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5.2.3.1 Independent variables 
(1) Gender: Female is reference category. It was hypothesised that females would have 
a higher expenditure than male. 
(2) Age at death: Age at death was calculated from date of birth and date of death. In 
case of loss of exact date of birth or date of death or both dates, age at death was 
replaced by age recorded in the last admission of individuals. The primary data analysis 
naturally shows a greater number of deaths at older ages with the arithmetic mean age 
of 63.2, and a standard deviation of 18.7 years. As a result, even though continuous data 
was available, this study categorized age into eleven levels with 5-year and 10-year 
intervals shown in Table 5.1. Under five-year group was the reference point and would 
have higher expenditure than the old age group because children are expected to have 
longer life expectancy than the elderly. Therefore, spending on resources for the 
terminal stage of life might prolong life and be more expensive.  
(3) Health insurance schemes: Two health insurance schemes including the CSMBS 
and the UC were separated into three categories. This is due to two types of the UC in 
the data period, that is, the group with 30 Baht copayment exemption (UCE) and the 
group with 30 Baht copayment of user fees (UCP). CSMBS was selected as a reference 
point. Owing to differences in payment systems and benefit packages between the 
CSMBS scheme and UC scheme, it was expected that CSMBS paid greater expenditure 
than the UC. 
(4) Causes of death: Causes of death in the BPS’s dataset were recorded in ICD-10 
codes. These codes were reclassified into three principal groups including 1) 
communicable, maternal, perinatal and nutritional conditions; 2) non-communicable 
diseases; 3) injuries, poisoning, certain other consequences of external causes, and 
external causes of morbidity and mortality; and 4) a group of ill-defined causes. This 
categorisation was done through the categories in the Thai study of Burden of Diseases 
accordingly (see Appendix 3, Table A3.1) (International Health Policy Program-
Thailand 2007; World Health Organization 2008). Senility, the fifth group and cancer 
and tumour, the sixth group, were additionally selected from the ill-defined group and 
non-communicable diseases, respectively. Even though senility is rather a mode of 
death than cause, it is related to old age which is always the biggest group of decedents. 
Furthermore, it might have differences in claimed expenditure from other ill-defined 
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causes. Cancer and tumours are the leading causes of death in the country as stated in 
Chapter One, section 1.3.2 as well as being the causes of death of interest and the tracer 
case on the two qualitative studies of this thesis. Its claimed expenditure might have a 
high cost care which was different from other chronic diseases in patterns of 
expenditures across proximity to death; in particular the last year of life (see Chapter 
Three, subsection 3.2.1). Among six groups, ill-defined cause of death was selected as 
reference category. Due to differences in illness patterns of diseases along the illness 
period, cancer decedents was estimated to have greater expenditure for the last year of 
life than other causes of death (see Chapter Three, subsection 3.2.1.1, cause of death). 
Note: Communicable diseases include maternal, perinatal and nutrition conditions 
Injuries include poisoning, certain other consequences of external causes and external 
causes of morbidity and mortality 
(5) Places of death: Places where decedents died were recorded in their death 
certificates. In this study, the secondary data indicates these as 1) public health 
facilities; 2) private health facilities; and 3) elsewhere. Homes were included in the 
‘elsewhere’ category and could not be differentiated within this group which also 
accounted for death during transportation, sudden death in accidental areas, and 
homicide as well as suicide. Elsewhere was indicated as a reference category and was 
estimated to reveal the cheapest expenditure because of including dying at home in this 
group which might reduce claimed expenditure for acute care in hospitals. 
 (6) Numbers of admission: This variable aggregated all admissions at any in-patient 
units of health facilities in the final year of life. It was summed in numbers of admission 
per decedents per year. As a result of skewness in this count data in preliminary 
analysis, it was categorised into five groups indicated in Table 5.1. The first level was 
selected as reference category. It was predicted that the more admissions there are, the 
higher the expenditure (see Chapter Three, subsection 3.2.1.1).  
 (7) Numbers of comorbidity in last admission: Comorbidities were identified with the 
ICD codes of secondary diagnoses which were limited to a maximum of twelve 
illnesses. Only comorbidities in the last admission were accounted for in the analysis. 
The preliminary analysis shows that claimed expenditure in last admission accounted 
for 50-60 percent of expenditure in a year. Thus, it was hypothesised that most serious 
fatal and chronic diseases which were the significant burdens of expenditure should be 
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included in this last admission. However, the Charlson comorbidity index was also 
employed in this study to adjust risk of the severe burden of comorbidity41 (Charlson, 
Pompei et al. 1987). In contrast to the numbers of last admission, the index took into 
account of all comorbidities records in all admissions with in the final year of an 
individual. Comparing both candidate comorbidity variables in regression model in 
terms of the accountability to determine claimed expenditures, numbers of comorbidity 
in last admission is superior. As a consequence, it was selected into the multivariate 
analysis. Further, due to its skewness, this variable was categorised into 6 groups 
indicated in Table 5.1 and no comorbidity (first level) was selected as a reference 
category. It was also predicted that expenditures increase with comorbidities increase 
(see Chapter Three, subsection 3.2.1.1). 
5.2.3.2 Response variables 
Claimed expenditure or hospital charges: As mentioned earlier in subsection 5.2.2 this 
study accounted for only the total claimable hospital charges. This expenditure in all 
admissions of individuals was collapsed into one record per person per final year of life. 
Due to its highly skewed nature with a long right tail, with figures ranging from 10 Baht 
to 6,741,127 Baht, the expenditure was also taken into log-scale in testing for the best fit 
model. 
                                                 
41 The index reflects the cumulative increased likelihood of one-year mortality of 19 predefined 
comorbidities which were assigned weight of 1-6. The higher the score is, the more severe the burden of 
comorbidity.  
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Table 5.1 Variables in multivariate data analysis 
Variable name Source of data Details of categorisation and reference category 
Independent variables 
Male Death certificates and claimed data Binary data as: male and female (reference) 
Age at death Death certificates and Claimed data 
Eleven categorical data as: under 5 years; 5 to <10 years; 10 to < 
20 years; 20 to <30 years; 30 to <40 years; 40 to <50 years; 50 to 
<60 years; 60 to <70 years; 70 to <75 years; 75 to <80 years; and 
80 years and above 
Reference category: under 5 years 
Health insurance scheme  Claimed data 
Three categorical data as: CSMBS; UC with 30 Baht user fee 
exemption: and UC with 30 Baht payment 
Reference category: CSMBS 
Cause of death Death certificates 
Six categorical data as: ill-defined causes; communicable diseases; 
non-communicable diseases; injuries; senility; and cancer  
Reference category: ill-defined causes 
Place of death Death certificates 
Three categorical data as: elsewhere; public hospitals; and private 
hospitals 
Reference category: elsewhere 
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Table 5.1 Variables in multivariate data analysis (cont.) 
Variable name Source of data Details of categorisation and reference category 
Numbers of comorbidity 
in last admisison Claimed data 
Six categorical data as: no comorbidity: 1 comorbidity: 2 
comorbidities; 3 comorbidities; 4 comorbidities; and 5 
comorbidities and above  
Reference category: no comorbidity 
Response variables 
Number of 
hospitalisations Claimed data 
Count data 
Minimum = 1, maximum = 50 
Claimed expenditure Claimed data 
Continuous data (Baht) 
minimum = 10, maximum = 6,741,127 
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5.2.3 Handling missing data 
Missing data was manipulated using methods described in subsection 4.3.2.1 (3). In 
addition, due to some errors in values, such records of individuals were dropped from 
the analysis. These include records with other health insurance schemes, length of stay 
greater than 365 days (or one year), zero claimed expenditure and age less than zero. 
The study did not employ data missing imputation because after dropping records with 
missing data, there was sufficient data, in fact, more than 200,000 records, for analysis. 
5.3 Results 
Findings in this study include two main topics, that is, general findings with descriptive 
statistics and the results from multivariate analysis. The presentation was mainly 
focused on the health insurance schemes as indicated in the conceptual framework and 
objectives of the thesis (see Chapter Four, section 4.1 and 4.2). The analysis aims to 
reveal the examination of the four base models for the ‘best fit’ model selection in 
prediction for claimed expenditure as well as to reveal the determinants of the 
expenditure.  
5.3.1 General findings 
In the 2006 fiscal year, 392,750 decedents were recorded in death certificates dataset. 
Of these, 298,587 decedents (76 percent) had records of claimed data with at least one 
hospitalisation. After excluding decedents with unclear health insurance status mixed in 
the data which might have led to data duplication, there were 203,413 UC and CSMBS 
beneficiaries (51.8 percent) and the net numbers of decedents in analysis were 202,858 
(51.6 percent of total decedents or 67.9 percent of hospitalised decedents). The 
exclusion of missing data included 185 in length of stay errors, 1 in age error and 369 of 
zero claimed expenditure. Of these, 35,396 decedents (17.4 percent) were CSMBS 
beneficiaries, 118,548 decedents (58.4 percent) were UCE and 48,914 decedents (24.1 
percent) were UCP. The claimed expenditure for a total of 202,858 decedents was 
13,004,516,940.39 Baht which 32.7 percent (4.2 billion Baht) was expenditure for 
CSMBS beneficiaries, 46 percent (6.0 billion Baht) for UCE beneficiaries and 21.4 
percent (2.8 billion Baht) for UCP beneficiaries. Expenditure per decedent ranged from 
10 Baht to 6,741,127 Baht and the top decile decedents (20,285) accounted for 52.4 
percent of total expenditure (6.8 billion Baht). In addition to the claimed expenditure for 
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the last year of life, expenditure in last admission accounted for two thirds of the last 
year (63.8-66.1 percent by health insurance groups). On average, decedents died within 
35.7 days after last admissions.  
Table 5.2 presents characteristics of all decedents and claimed expenditure in three 
types of insurance and Figure 5.1 shows trends of mean expenditure across groups in 4 
variables. As a result that the UCE beneficiaries were the majority of decedents in this 
dataset, the group’s descriptive characteristics also dominated characteristics of all 
decedents. Next, findings are then mostly presented for overall decedents in comparison 
to the rest of health insurance groups, CSMBS and UCP. 
Meanwhile, nearly sixty percent was the UCE beneficiaries but spent the lowest 
expenditure per capita (50,439 Baht), only 17.4 percent of decedents was CSMBS 
beneficiaries which spent 2.2 times of expenditure over the UCE. More men died than 
women in all insurance groups, in particular in UCP beneficiaries which was the 
working age adults. In addition to gender, the UCP beneficiaries died at working age, on 
average 45.8 years, but CSMBS beneficiaries died at older ages, 71.3 years and UCE 
beneficiaries died at 67.9 years. On average, children under five years old had the 
highest expenditure for the last year of life and the expenditure had a downward trend to 
the lowest values at 30-40 years old, then the trend was slightly upward to the peak at 
70-75 years. Thereafter the trend was slightly declining. This trend represented the UCE 
decedents’ expenditure which is the largest group. Expenditure trends across the other 
two health insurances were different in some age groups, for example, the CSMBS had 
a paradox curve in ages under 5 years to 20-30 years whereas the under 5-year UCP 
beneficiaries had lower expenditure than the older children. In addition, among older 
age groups, the UCP beneficiaries aged 75-80 years had the highest expenditure, on 
average 64,312 Baht. Nearly one third of the causes of death were ill-defined causes 
including senility which is a mode of death in this group. Over a quarter of decedents 
(27.7 percent) died from non-communicable diseases excluding cancer followed by 
communicable diseases and cancer, respectively. These rankings and proportions had 
trivial differences across the three health insurance groups. It was found that 27.7 
percent of decedents dying from non-communicable diseases accounted for 28.2 percent 
of total claimed expenditure whereas 18.1 percent of decedents dying from 
communicable diseases accounted for 24.2 percent of total claimed expenditure and 
17.2 percent of decedents dying from cancer accounted for 21.6 percent of total claimed 
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expenditure. In terms of per capita expenditure, communicable diseases and cancer were 
the first and the second causes of death with the highest expenditure in CSMBS and 
UCE groups. In contrast to both health insurance groups, cancer is the most expensive 
cause of death whereas communicable diseases and non-communicable diseases were 
the second highest with nearly equal per capita expenditure (55,398 Baht and 56,187 
Baht) in the UCP beneficiaries. This claimed expenditure was 1.02-1.34 times over the 
mean.  
Nearly 52 percent of decedents died outside hospitals and they had cheapest 
expenditure, that is, 0.4 times that of dying at private hospitals which was the most 
expensive. Even though the proportions of the causes of death were slightly different 
across the three groups of health insurance, the CSMBS group revealed differences 
from the other two groups, in patterns of place of death as well as expenditure. With 
nearly two thirds of its beneficiaries, public hospitals were the major place of death 
whereas half of the UCP beneficiaries died in public hospitals. Interestingly, per capita 
expenditure for the CSMBS beneficiaries dying at public hospitals was distinguishably 
more than double of expenditure for both UC groups (2.1-2.4 times) and it was greater 
than expenditure from dying at private hospitals where was expected to be the highest 
cost of death. Only 2.1-3.8 percent of decedents died in private hospitals. Apart from the 
main cause of death, decedents usually died with some other illnesses. Approximately 
16 percent decedents had no other illness and on average, decedents had 1-3 
comorbidities in the last admissions. However, focusing on decedents with more 
comorbidity, the CSMBS beneficiaries with 5 illnesses and over had a greater 
proportion than the both UC groups (20.6 percent versus 15.4-15.9 percent). In terms of 
Charlson’s comorbidity index which emphasises 19 diseases or conditions leading to 
high risk in mortality, 34-44 percent of decedents died without high risk to death except 
their main leading cause of death. The UCP and the CSMBS beneficiaries had a higher 
score than the UCE group. This is due to the higher proportion of the category of 
Charlson’s score of 3 and above (see Appendix 3, A3.4). Over one-third of the 
decedents had one admission during their last year of life (36.7-37.5 percent), and the 
three groups of insurances revealed similar patterns in numbers of admissions. 
Expenditure by numbers of admissions revealed no difference across the three health 
insurance groups except the deepest slope of the CSMBS group. 
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Table 5.2 Descriptive statistics of decedents and claimed expenditures by variables 
Percentage of decedents and mean claimed expenditures 
Variables 
All CSMBS UCE UCP 
Numbers of 
decedents (n) 202,858 35,396 118,548 48,914 
 % n Baht % n Baht % n Baht % n Baht 
All 100.0 64,106 17.4 119,994 58.4 50,439 24.1 56,789 
Gender         
Male 54.7 64,025 55.5 119,288 52.1 51,613 60.6 53,215 
Female 45.3 64,205 44.5 120,877 47.9 49,164 39.4 62,280 
Death age (yrs.)        
Mean ± S.D. 63.2 ± 18.7 71.3± 14.6 67.9 ± 17.7 45.8 ± 11.7 
< 5 1.2 130,189 0.5 195,607 1.8 125,479 0.1 71,212 
5 to <10 0.4 104,849 0.1 270,184 0.7 96,734 0.0 103,325 
10 to <20 1.3 94,157 0.5 160,427 1.3 90,680 1.9 88,439 
20 to <30 2.6 61,085 0.3 197,220 1.0 53,331 8.3 60,236 
30 to <40 6.6 51,251 1.4 132,398 2.5 45,489 20.0 48,849 
40 to <50 10.5 62,296 5.7 144,260 4.6 46,427 28.1 56,508 
50 to <60 14.4 65,798 10.7 138,180 7.0 47,629 35.0 58,673 
60 to <70 20.0 66,903 18.2 131,601 26.6 54,188 5.4 60,556 
70 to <75 13.2 66,604 16.0 123,140 17.7 51,464 0.3 52,122 
75 to <80 12.5 62,368 18.1 109,670 15.9 46,306 0.3 64,312 
>=80 17.3 57,587 28.6 101,725 20.9 39,828 0.5 31,936 
Causes of death        
Ill-defined 21.3 50,918 20.1 93,729 24.3 41,190 15.2 47,561 
Communicable 
ds. 18.1 85,620 18.2 166,350 15.1 77,396 25.2 55,398 
Non-
communicable 
ds. 
27.7 65,350 27.3 112,431 27.2 55,308 29.1 56,187 
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Table 5.2 Descriptive statistics of decedents and claimed expenditures by variables (cont.) 
Percentage of decedents and mean claimed expenditures 
Variables 
All CSMBS UCE UCP 
Injuries 4.9 46,687 3.7 77,395 3.6 42,103 8.7 41,740 
Senility 10.8 32,381 10.8 57,344 15.2 27,130 0.2 26,101 
Cancer 17.2 80,780 19.9 156,585 14.6 55,229 21.6 72,094 
Places of death        
Elsewhere 51.6 43,699 37.4 79,264 58.8 35,970 44.7 46,819 
Public 
hospitals 45.8 84,481 60.2 145,840 39.1 68,637 51.5 61,725 
Private 
hospitals 2.6 110,973 2.4 105,667 2.1 116,083 3.8 106,561 
Comorbidity          
Mean ± S.D. 2.5 ± 2.2 2.9 ± 2.3 2.5 ± 2.2 2.5 ± 2.2 
None 15.9 36,382 13.9 72,383 16.7 27,990 15.4 34,820 
1 22.6 42,240 18.5 81,071 23.5 33,886 23.6 40,390 
2 20.0 52,169 18.8 93,520 20.0 42,421 20.7 47,879 
3 15.6 68,319 18.8 127,718 14.9 50,936 14.9 56,213 
4 9.5 73,852 9.5 121,743 9.5 61,830 9.5 68,535 
>=5 16.4 126,054 20.6 203,649 15.4 102,924 15.9 107,702 
Numbers of admission        
Mean ± S.D. 2.8 ± 2.5 2.8 ±2.5 2.7 ± 2.4 2.9 ± 2.6 
1 37.2 35,564 36.7 65,588 37.5 28,683 36.7 30,880 
2 24.8 53,306 23.9 98,257 25.2 43,573 24.6 45,911 
3 13.8 70,846 14.3 128,671 13.8 56,324 13.2 62,431 
4 8.5 86,781 8.8 156,544 8.5 69,821 8.4 75,610 
>=5 15.7 130,487 16.4 246,571 15.0 100,074 17.1 114,588 
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Figure 5.1 Patterns of claimed expenditures across 5 variables 
A: Death age groups 
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B: Causes of death 
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C: Places of death 
Mean claimed expenditures by places of death
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D: Numbers of comorbidities in last admission 
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Figure 5.1 Patterns of claimed expenditures across 5 variables (cont.) 
E: Numbers of admissions 
Mean claimed expenditures by numbers of admissions
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Focusing on the pattern of places for dying and causes of death, Figure 5.2 shows the 
proportions of decedents with different causes dying at different places. Overall, half of 
decedents died elsewhere including homes and another half died in hospitals. Nearly 
four-fifths of decedents (77.7 percent) dying from communicable diseases as well as 
over two-thirds of decedents dying from injuries died in public hospitals. In contrast, 
almost all of the decedents dying from senility died outside hospital, for which location 
was expected to be decedents’ homes. Groups of cancer and other chronic non-
communicable diseases died in public hospitals and elsewhere which was also expected 
to be decedents’ homes. Further, in dying from cancer, Figure 5.3 shows places of death 
across health insurance groups. Nearly two-thirds of CSMBS beneficiaries died in 
hospitals, mostly in public hospitals and the remaining third died at home. In contrast, 
both UC groups revealed a similar pattern of dying places, that is, two-thirds of the 
decedents died at home.  
Figure 5.2 Percentage of decedents categorised by place of death and causes of death 
Percentage of decedents categorised by places of death and 
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Figure 5.3 Percentage of cancer decedents categorised by places of death and health 
insurance groups 
Percentage of cancer decedents categorised by places of death 
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5.3.2 Multivariate analysis and the model selection 
5.3.2.1 Hospitalisations 
The base models were selected through model selection methods in Chapter Four, 
subsection 4.3.2.1 (4) b) accordingly. It was only the zero-truncated Poisson model and 
zero-truncated negative binomial were tested. The test for the significance of α 
interpreted that the zero-truncated Poisson had overdispersion. As a result, the zero-
truncated negative binomial is more appropriate (details of the statistical tests of both 
models indicated in Appendix 3, Table A3.5).  
5.3.2.2 Claimed expenditure 
The distribution of the claimed expenditure was shown in Appendix 3, Figure A3.1. Its 
distribution revealed greatly non-normal distribution with 7.5 of skewness and 142.7 of 
kurtosis. In contrast, it was in the range of normal distribution in logarithmic term (-0.05 
skewness and 3.0 kurtosis). The candidate models included the OLS, the OLS of 
logarithmic term of claimed expenditure with Duan’s smearing factor, the GLM with 
gamma distribution and log link, and the GLM with Poisson distribution and log link. 
The R2 from the OLS model indicated that this set of variables could explain 12.2 
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percent of the linear relationship of the covariates over the claimed expenditure. Details 
of coefficients of all variables, and their significance as well as all test results including 
specification test for GLM, both families and link functions, and plots were shown in 
Appendix 3 (Table A3.6 and Figure A3.2-A3.3). Table 5.3 summarises the test results 
(Root Mean Square Error: RMSE and Mean Absolute Error: MAE) and Table 5.4 
summarises predicted descriptive statistics of the four models compared to the observed 
ones. The F statistic revealed that the OLS and the OLS of log transformed data were 
superior to the model with constant only. In GLM, the specification test for family (in 
both gamma and Poission model) shows that none of the four families including 
gamma, Poisson, Gaussian and inverse Gaussian fitted the data. However, the χ2 value 
of the gamma was the lowest value which indicated that the gamma was likely better 
than other families. For the log link test, two out of the three tests in the gamma present 
insignificance meaning of the appropriate of the log link function. In addition, scatter 
plots between fitted value versus residual of the GLM gamma-log and the OLS of log 
transformed data show better fit than the other two models. Comparing the two GLMs, 
scatter probability plot of predicted value against residual and standardized normal 
probability plot of the gamma-log show better distribution and closeness to the normal 
line, respectively. In summary, it seems that GLM gamma-log based models could 
provide a better fit than others. 
Further, according to Dodd et al (2006) suggestion indicated in Chapter Four, 
subsection 4.3.2.1 (4) b), it was the GLM Poisson-log which gave the lowest RMSE for 
the best mean predicted, following with the GLM gamma-log, logarithmic term of OLS 
and OLS, respectively. The GLM with Poisson-log gave the lowest MAE meaning the 
best prediction for the median. Focusing on the mean prediction which was the expected 
value of interest, shown in Table 5.4, the GLM Poisson-log estimated the mean which 
closest to the observed one whereas the OLS estimated negative value of the minimum 
expenditure, -13828 Baht, which is impossible. The GLM with gamma-log and the 
logarithmic term of the OLS with Duan’s smearing factor estimated the greatest mean 
beyond the observed one. Even though the GLM with Poisson and log link gives best 
estimated mean, the results of misspecification tests mentioned above indicated the 
GLM with gamma and log link was superior. As a consequence, this study employed 
the GLM with gamma and log link for the reason that the overdispersion of the Poisson 
model could not be overcome. 
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Table 5.3 Diagnostic test results of root mean square error (RMSE) and mean absolute 
error (MAE) 
Candidates model RMSE MAE 
Observed na na 
OLS 117028.8 57960.8 
Ln OLS with Duan’s smearing 116896.5 57737.3 
Gamma-log 116602.9 57176.7 
Poisson-log 116456.4 57063.6 
Table 5.4 Summary statistics predicted from the observed data and four candidate models 
Candidates Mean SE Lower bound 
Upper 
bound SD Min Max Median 75Ptile 90Ptile 
Observed 64107 276.8 63564 64649 124658.0 10 6741127 25437 64289 152976 
OLS 64298 136.8 64029 64566 43556.0 -13828 280547 53030 93416 124419 
Ln OLS 
with 
Duan’s 
smearing 
66046 158.7 65735 66357 50513.6 12359 528907 49636 80586 128262 
Gamma-
log 66415 212.9 65998 66833 67785.5 8829 908281 43910 81387 140819 
Poisson-
log 64202 144.9 63918 64486 46114.3 15215 674416 49497 76116 117416 
5.3.3 The model and factors determined hospitalisation and the claimed expenditure 
5.3.3.1 Hospitalisations 
All variables including age at death, gender, causes of death, places of death, health 
insurances and comorbidities in last hospitalisation before death played a significant 
role in determining hospitalisations during the last year of life. Table 5.5 shows the 
incidence ratio of the coefficient of variables. For instance, it revealed that decedents 
aged 10 to 20 years were significantly admitted 85 percent of decedents aged less than 5 
years in the last year of life when keeping other variables constant. The hospitalisations 
decreased as age increased, particlurly marked decreasing in the age of 80 and above. 
Both UCE and UCP beneficiaries had less hospitalisation than the CSMBS. Decedents 
dying from cancer had a 51 percent hospitalisation significantly greater than dying from 
ill-defined causes. Interestingly, hospitalisations had significant positive correlation 
with number of comorbidities.  
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Table 5.5 Individual variables in zero-truncated negative binomial for hospitalisations 
Variables IRR Std. Err. 
Age 5-10 0.9628 0.0711 
Age 10-20 0.8583** 0.0486 
Age 20-30 0.9263 0.0413 
Age 30-40 0.8512** 0.0337 
Age 40-50 0.8652** 0.0328 
Age 50-60 0.8806** 0.0330 
Age 60-70 0.8224** 0.0296 
Age 70-75 0.7757** 0.0285 
Age 75-80 0.7070** 0.0263 
Age >= 80 0.5593** 0.0208 
Male 0.9121** 0.0079 
UCE 0.9687** 0.0116 
UCP 0.8842** 0.0146 
Communicable ds. 0.9850 0.0146 
Non-communicable ds. 1.0976** 0.0143 
Injuries 0.3464** 0.0124 
Senility 0.8376** 0.0168 
Cancer 1.5057** 0.0201 
Public hospitals 0.9842 0.0099 
Private hospitals 0.9483** 0.0118 
1 comorbidity 1.12409** 0.0170 
2 comorbidities 1.2079** 0.0185 
3 comorbidities 1.2869** 0.0205 
4 comorbidities 1.3031** 0.0235 
>=5 comorbidities 1.3337** 0.0208 
IRR = Incident Rate Ratio; * p < 0.05; ** p < 0.01 
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5.3.3.2 Claimed expenditure 
Table 5.6 shows all variables determining the claimed expenditure in the last year of 
life. All variables but gender had a significant role in determining the claimed 
expenditures. In addition, almost all of the categorical variables were significantly 
different over their reference category. For instance, it revealed that when keeping other 
variables constant, claimed expenditure of decedents dying at age over 5 years were 40-
70 percent of the claimed expenditure of the under 5-year group. Decedents dying at 80 
and above as well as decedents dying aged between 30 and 40 spent the least claimed 
expenditure. It is likely that the claimed expenditure decreased as age increased. 
Claimed expenditure of both UC groups was approximately half of the CSMBS 
beneficiaries. By causes of death, decedents dying from cancer were likely to have 55 
percent greater claimed expenditure than decedents dying from ill-defined causes. 
Dying at public hospitals spent 37 percent more than those dying somewhere else. The 
expenditure doubled when there were 4 comorbidities and the expenditure was over 
double with 5 comorbidities and above, compared to decedents without comorbidity in 
last admission. 
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Table 5.6 Individual variables in GLM with Gamma distribution and log link for 
claimed expenditure  
Variables Exp(b) Std. Err. 
Age 5-10 0.6945** 0.0598 
Age 10-20 0.6595** 0.0495 
Age 20-30 0.5115** 0.0350 
Age 30-40 0.4060** 0.0238 
Age 40-50 0.4474** 0.0254 
Age 50-60 0.4621** 0.0258 
Age 60-70 0.4777** 0.0260 
Age 70-75 0.4732** 0.0261 
Age 75-80 0.4446** 0.0246 
Age >= 80 0.3998** 0.0221 
Male 1.0183 0.0109 
UCE 0.4639** 0.0064 
UCP 0.4984** 0.0100 
Communicable ds. 1.2057** 0.0214 
Non-communicable ds. 1.1351** 0.0178 
Injuries 0.7639** 0.0246 
Senility 0.8617** 0.0209 
Cancer 1.5532** 0.0262 
Public hospitals 1.3731** 0.0165 
Private hospitals 0.9111** 0.0130 
1 comorbidity 1.1686** 0.0217 
2 comorbidities 1.3992** 0.0271 
3 comorbidities 1.6791** 0.0319 
4 comorbidities 1.9145** 0.0424 
>=5 comorbidities 2.9874** 0.0562 
* p< 0.05; ** p < 0.01 
 146
5.4 Summary of research findings and study limitaiton 
5.4.1 Summary of research findings 
The study revealed numbers of hospitalisation and the claimed expenditure which 
incurred the health insurances for last year of life of the Thai people who sought acute 
care during 2006 Thai fiscal year (October 2005-September 2006). Data used in this 
study was retrieved from death certificates data mapped to costs that hospitals charged 
to two health insurance offices comprising of some demographic and other factors of 
decedents (demand side) and health insurances which are the third party payers driving 
hospital services (supply side) towards their financial systems and benefit packages. 
Three main findings from this study included the pattern and characteristics of 
decedents who sought acute care during their last year of life; numbers of 
hospitalisation and claimed expenditures; and the factors which determined such 
claimed expenditure. 
During the last year of life, 76 percent of all 392,750 decedents accessed acute care in 
hospitals with at least one admission. However, this study could analyse 68 percent of 
hospitalised decedents who accessed the hospital acute care. Total claimed expenditure 
was approximately 13,004 million Baht in which approximately 18 percent of decedents 
were CSMBS beneficiaries accounting for one third of this expenditure. Fifty-eight 
percent was the UCE accounted for 46 percent of and 24 percent was the UCP 
accounted for 22 percent of the expenditure. The top decile decedents spent over half of 
the total expenditure. More than half of the decedents had 1-2 admissions during their 
last year of life with the average of 2.8 admissions. The claimed expenditure for last 
admission was two thirds of the expenditure for the last year. 
On average, decedents died aged 63.2 years with the CSMBS beneficiaries dying at an 
older age, 71.3 years, and the UCP at working age, 45.8 years. Non-communicable 
diseases excluding cancer were the top ranking causes of death, followed by 
communicable diseases as well as cancer. Half of all decedents died outside hospitals 
including homes. Most in-hospital death was at public hospitals. Almost all deaths from 
senility and nearly two thirds of decedents dying from cancer died elsewhere which was 
expected to be homes. In contrast to the UC beneficiaries, a minority of CSMBS 
beneficiaries died outside hospitals. On average, a decedent who sought acute care had 
2.8 hospitalisations in last year. Per capita expenditure was 64,106 Baht in which 
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CSMBS expenditure was double that of the UC. Trends for claimed expenditure across 
age groups revealed the highest expenditure in decedents aged under 5 years and 
declined to the lowest expenditure at aged 30-40 years and rose to the stagnant line from 
age 50. The claimed expenditure increases with numbers of comorbidity as well as 
numbers of admission increased. Claimed expenditure of CSMBS beneficiaries revealed 
different patterns from the UC across age groups and in particular in places of death.  
All six variable groups played significant role in determining hospitalisations during the 
last year of life in zero-truncated negative binomial model. Hospitalisations had a 
negative relation to age at death but had a positive relation to number of comorbidities 
in the last hospitalisation. Compared with five other causes of death, decedents dying 
from cancer had highest hospitalisations. The UC beneficiaries had less hospitalisation 
than the CSMBS.  
The Generalised Linear Model (GLM) with gamma distribution and log link which was 
the best fitted model revealed the significances of factors determined the claimed 
expenditure when keeping other factors constant. Such factors included age group, 
causes of death, places of death, health insurance schemes, and number of comorbidities 
in the last hospitalisation. The expenditure had a positive and negative relation to age at 
death but had a positive relation to numbers of comorbidities. Dying from cancer and 
communicable diseases had 55.3 percent and 20.6 percent higher than expenditure of 
dying from ill-defined causes. Dying at public hospitals had a 31.3 percent higher 
expenditure than dying outside hospitals. The UC beneficiaries incurred half 
expenditure of the CSMBS beneficiaries. 
5.4.2 Data and methodological limitations of the study 
This one year cross-sectional study revealed characteristics, pattern of utilisations and 
expenditure only of those decedents who accessed acute care in hospitals within a year 
before death. It excludes non-user decedents because of the data availability. In 
addition, the study could not reveal and discuss with concrete information and 
comparisons between decedents and the rest of the population or survivors. Hence this 
study aims to explore disparities in and to estimate treatment expenditure paid by health 
insurance schemes as well as to explore the factors considering important when people 
are dying, as this topic needs another set of research questions and study design. In 
addition, this study also could not lead to any conclusion on the prevalence of service 
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utilisation and accessibility and mortality rate by health insurance schemes. This is due 
to the fact that there is no data of other main health insurance schemes, i.e. the SHI as 
well as there is no information on the decedents without any access to health service in 
their final year. The SHI data was dropped because of differences in data collection and 
a limitation on accessibility to the database. 
As a result, the OLS model shows a low linear relationship between the covariates and 
the dependent variable, R2 = 0.122 including unclear results from specification tests for 
the GLM with both families of distribution and link function. It indicated some 
technical problems including the feasibility of lacking important variables. Other factors 
likely to improve the goodness of fit and explanation by multivariate regression were 
from both demand side and supply side. These interested variables include geographical 
variation and socio-economic data discussed in previous studies, for example, 
residential area of the decedents before death including region, urban-rural area; 
decedent living standards; proximity to death; levels of cares or types of service 
provided the acute care, i.e. secondary or tertiary or advanced tertiary care which related 
to places of death; and intensive care use (Zweifel, Felder et al. 1999; Felder, Meier et 
al. 2000; Barnato, McClellan et al. 2004; Wennberg, Fisher et al. 2004; Seshamani and 
Gray 2004a; Seshamani and Gray 2004b; Faramnuayphol and Vapattanawong; 
Faramnuayphol and Vapattanawong).  
Length of hospitalisation in preliminary analysis shows very strong relation to the 
claimed expenditure by providing great attribution in the OLS model (approximately, R2 
= 0.5). However, it was dropped from the model due to the fact that length of 
hospitalisation is a core factor in payment calculation in health payment system using 
diagnostic related groups (DRG) and adjusted related weight (adjusted RW). Further 
examinations, therefore, are required to ensure whether or not length of hospitalisation 
has endogeneity to other independent variables; or is it autocorrelated with the claimed 
expenditure, the dependent variable; or is it the instrument variable to the claimed 
expenditure. As a consequence, other based models including linear instrumental-
variable regression might be more appropriate (Cameron and Trivedi 2009). Even 
though length of stay was not included in the multivariate analysis, its descriptive 
statistics were presented in Appendix 3, Table A3.7. 
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It should be kept in mind that cause of death is not always the leading cause of 
hospitalisation and cause of overall expense in the last year of life. Decedents may have 
one disease but suddenly die from another disease. For example, a patient was admitted 
for diabetes previously but their last admission was due to a road accident. However, the 
study revealed that expenditure for last admission accounted for two-thirds of 
expenditure for the final year. That is, the last admission which should be most related 
to causes of death shared most of the expenditure through the last year. In addition, it 
already took into account the comorbidities in last admission which borne expenditure 
were included in the modeling. However, other illnesses or diseases which might also 
incur expenditure prior to the last admission were excluded. In this study, Charlson 
comorbidity index was also applied. This index took into account the risk to death of all 
illnesses recorded in 12 secondary diagnoses in all admissions in final year. 
Nonetheless, in preliminary test, it attributed to the model less than the numbers of 
comorbidities in last admission. This finding should be further explored, particularly the 
relation between widely used comorbidity index and the factors determining the 
payment mechanism of the third party. 
5.5 Discussion 
The study gave an overview of expenditure and factors related of decedents who sought 
acute care at the national level in 2006. Even though it is out of the scope of this study, 
the numbers of hospitalisations were also revealed, however, the discussion focused on 
the expenditure.  
The aim could be achieved in that it revealed the inequality of payment for acute care by 
health insurance schemes. That is the CSMBS paid more than double expenditures of 
the UC for the last year of their beneficiary life when keeping other factors constant. In 
addition, other factors determining the last year of life expenditures included death age, 
causes of death, places of death and numbers of comorbidity in last admission. It shows 
the negative relation from age under 5 to age 30-40, a slightly positive relation to age 60 
and it was stagnant during age 50-75, with a negative relation to age 75 and above. 
Focusing on the old age group, this trend was different from findings in the OECD 
countries in which the expenditure had a positive relation to age 65 until 80 or 95, and 
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negative relation after that age. This might relate to life expectancy of each country42 
whose population lives longer than average life expectancy indicated in this study. Such 
older age group in developed countires might have less expenditure for in-hospital 
services but greater expenditure for other institutional services, for example, hospice 
care and nursing home. This is due to the fact that health service models vary from 
country to country. In addition, expenditures for the decedents aged 60 and above were 
only half of expenditure for the youngest age group (under 5 years). By gender, average 
expenditure for both genders was very similar in monetary terms, descriptive mean 
approximately 64,000 Baht, and the rate ratio from the model (4 percent higher in 
male). The expenditure across this factor was different in each country which might 
relate to other factors in the studies of each country (see Chapter Three, Table 3.2).  
Causes of death, another determinant of expenditure for the last year of life, was often 
evaluated. Owing to differences in disease categorization, only cancer was the group 
most studies explored. Spending for cancer was 1.3 times of the average but the 
reimbursement ratio of cancer in the US was in range of 4.3-7.7 for all decedents 
(Scitovsky 1994). Even though the ratio of spending on Thai cancer decedent was very 
low, compared to the US, but this study was limited to account for other patients like the 
US study did. In addition, this study found that 17.2 percent of cancer decedents 
accounted for 21.6 percent of expenditure meanwhile a study in the Netherlands found 
28 percent accounted for 35.3 percent which was quite similar (see Chapter Three, 
Table 3.2) (Polder, Barendregt et al. 2006). 
In addition to its objective, this study could not exactly indicate the magnitude of 
expenditure for the last year of life to the total health expenditure because of the time 
horizon of last year of life is not the fiscal year and the coverage of the decedents and 
their expenditure mentioned earlier. However, it might implicitly reveal that the total 
expenditure for acute care in last year of life in this study was 13,004 million Baht and 
the total health expenditure was 290,603 million Baht in 2006 (see Chapter Two, Table 
2.8)(Vasavid, Janyapong et al. 2009). That is, it might approximately be 4.5 percent of 
total health expenditure accounted for by decedents. This might be overestimated 
because the differences in defined year of the two figures; and underestimated because a 
lack of SHI decedent data and lack of expenditure for ambulatory care and household 
                                                 
42 Life expectancy of Thai population in both genders was 72 years and of the UK was 79 years in 2006 
World Health Organization (2008). World health statistics 2008. Geneva, World Health Organization.  
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expenditure. Another indicator, the per capita could not be directly compared due to this 
study could not obtained from the other part of expenditure from the SHI scheme.  
Apart from the inequality in expenditure across health insurance schemes, further 
disparity was found in places of death related to cause of death. In cancer decedents, it 
is clearly noticeable that while the CSMBS beneficiaries were likely to die in public 
hospitals, the UC beneficiaries died outside hospitals which were expected to be 
decedents’ homes. Further study on the background of these different groups might help 
in understanding their practices and in better guiding health services. 
Ill-defined causes of death remain the problem included in this study. It did not only 
indicate the poor quality of the data in mortality report, but it also affected the study on 
expenditure and others. Approximately, thirty percent of ill-defined cause of death 
including senility in this study weakened the validity and differentiated power 
expenditure by causes of death in some way. As a result, improving the defining causes 
of death was urgently needed. Study on specific causes of death, for instance, stroke, 
cardiovascular diseases could be conducted to reveal a specific pattern of expenditure 
and factors related and this might lead to better health service for this specific group. 
The causes of death classified with the trajectories of physical function indicated in 
Chapter One, section 1.4 might also provide clearer distinguished expenditure between 
groups (Lunney, Lynn et al. 2002; Murray, Kendall et al. 2005). 
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5.6 Conclusion 
Three issues this study could provide information on include: the hospitalisations and 
the per capita expenditure for last year of life for acute care in hospitals; the inequality 
in expenditures for different health insurance schemes and other factors influencing 
expenditures; and estimated per capita expenditure for individuals with specific 
characteristics.  
In 2006, the average per capita expenditure was 64,106 Baht in the last year of life with 
2.8 hospitalisations. It was estimated the CSMBS beneficiaries likely had an 
expenditure of 1.5 times greater than of the UC beneficiaries. Cancer patients had 
greatest hospitalisation compared to other diseases including other chronic diseases. 
Dying from cancer and communicable diseases caused the highest expenditure. It was 
also found that the CSMBS beneficiaries who died from cancer were likely to die in 
public hospitals, in contrast to the UC beneficiaries who were more likely to die outside 
hospitals. 
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CHAPTER SIX 
HOUSEHOLDS’ HEALTH EXPENDITURE FOR PATIENTS PRIOR TO 
DEATH BETWEEN 2005-2006 
 
6.1 Introduction 
The Universal Coverage health insurance scheme launched in 2002 aims to eliminate 
the financial barrier in accessing health care and to reduce the incidence of catastrophic 
illness among the Thai population, in particular the poor. In 2008, 97.8 percent of Thai 
citizens were enrolled in one of the 3 main health insurance schemes, i.e. UC, CSMBS 
and SHI (see Chapter Two, Table 2.7). However, the benefit package of each scheme is 
different and still has limitations such as not being able to provide free financing for all 
individual requirements of all members. That is additional ‘out of pocket’ payments for 
health services; both for health facilities and for complementary medicine remain.  
Spending on health care through the full extent of life including last period of life has 
been widely reported (Seshamani and Gray A. 2002; Shactman, Altman et al. 2003; 
Seshamani and Gray 2004b). It was found that for care during the last period of life, 
spending on massive resources of health care providers was taking place, incurring 
expenditure by health insurers, and requiring intensive inputs from households’ 
members and households’ incomes and assets (see Chapter One, subsection 1.4 and 
Chapter Two, subsection 3.2.1). 
Although literature and findings in Chapter Five illustrate the high expenditure on 
healthcare in this critical period of life, it is also believed that households still share a 
part of overall expenditure. Apart from the health care providers and insurers, such 
payment is likely to be an added burden to households, but no research on household 
expenditure during this specific period of life has been reported in Thailand thus far. To 
be consistent with Chapter Five, this chapter, therefore, mainly aims to investigate 
disparity (or inequality) in household expenditure during the last period of life among 
health insurance beneficiaries of UC, CSMBS, SHI including private health insurance 
and uninsured decedents. Further, the study specifically aims to: 
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? estimate the utlisation and household health expenditure (direct medical cost43) 
for the last 3 months for ambulatory care and for the last 6 months for acute care 
prior to death;  
? estimate the proportion of such expenditure to household income; and 
? investigate the health care seeking behaviour prior to death categorised by 
household income quintile 
Similar to Chapter Five, this chapter also reveals the factors influencing such disparity. 
Through the literature review in Chapter Three, subsection 3.1.2 and 3.2.1 accordingly, 
it was hypothesised that household expenditure in 2005-2006 was affected by individual 
demographic and geographic determinants including those that are health related, 
particularly in individual socioeconomics and health insurances. The unit of analysis 
was individual decedents. 
This chapter presents the cross-sectional secondary analysis of two linked datasets, 
methods, results, discussion and conclusion. Results are presented in two main sections 
of general findings which include population mortality and patterns of health seeking; 
and findings from multivariate regression which included factors affecting health care 
utilisation and expenditure.  
6.2 Methods 
Like the methods in Chapter Five, section 5.2, this section presents analytical methods, 
details of data sources including data retrieving and manipulation requirements in 
secondary analysis. All variables included in the multivariate analysis are also 
described. 
6.2.1 Overview of the study design and source of secondary data 
As described in Chapter Four, subsection 4.3.1, this part of the research uses the 
secondary data of the Survey on Healthcare Utilisations of and Household Health 
Expenditure for Decedents prior to Death between 2005 and 2006 (SHUE) which was 
linked to the 7th Survey of Population Change (SPC). The SPC was the backbone survey 
of the SHUE which used twelve variables and population weighting factors of the SPC. 
                                                 
43 includes expenditures for medical care from health facilities’ services and complimentary medicines. 
The indirect medical costs and indirect non-medical costs were excluded due to incomplete data. 
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Once death was indicated in the household of the SPC, household proxies were further 
surveyed with the SHUE questionnaire. Hence, subsection 6.2.3 presents details of the 
SPC sample design and sample size, population estimation, and survey data. Following 
this, details in subsection 6.2.4 are given of the SHUE coverage and identification of 
cause of death as well as variables of interest in subsection 6.2.5.  
Ethical consideration: Although the second dataset, the SHUE, had registered 
households and members records, the NSO abides by the Thai Statistics Act B.E.2550 
(2007)44. The data provided was limited to only the scope of the study. The researcher 
has not been able to map any variables of individual personal records beyond either 
these surveys or the first two datasets in Chapter Five of this thesis. The first names, 
family names, CID numbers, and addresses of the respondents were dropped and new 
study identification numbers (study IDs) were generated. In addition, all completed 
questionnaires were kept at the NSO and the researcher was restricted to the 
accessibility of these hard copies. 
6.2.2 Analytical methods 
Like Chapter Five, the analytical steps and methods employed in this chapter follow the 
method in Chapter Four, subsection 4.3.2.1. As a consequence that this study of the 
thesis had obtained the data from the SHUE which could provide information of 
decedents that did or did not have access to health services, the two-part model was 
employed in the multivariate regression and the step of analysis could be depicted as in 
the diagram in Figure 6.1 (see details of the two-part model in Chapter Four, subsection 
4.3.2.1 (4) c)). This model could distinguish the propensity and intensity of utilisations 
and expenditure and therefore, it provides a better understanding of factors determining 
accesses to and expenditure for health services of individual decedents with different 
characteristics. In Figure 6.1, the dashed line represents the analysis pathway of 
utilisations whereas the dotted line presents the route of expenditure which the two-part 
model for count data and for continuous data were employed, respectively. In addition, 
this study analyses the ambulatory care and acute care independently with the similar 
set of independent variables. This is due to differences in the time horizon designed for 
                                                 
44 Section 15 Personal information obtained under this act shall be strictly considered confidential… (2) 
Such disclosure is for the use of agencies in the preparation, analysis or research of statistics provided that 
such disclosure does not cause damage to the information owner and does not identify or disclose the data 
owner. 
 156
the survey as well as differences in types of healthcare services that decedents used 
prior to death, indicated in the literature (see Chapter Three, subsection 3.2.1.1). It 
should also be noted that expenditure in this chapter refers to out of pocket payment for 
direct medical cost including medicines, medical supplies, for instance. 
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Figure 6.1 Determinants and pathways of analysis of health care utilisations and expenditures of decedents 
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6.2.3 The Seventh Survey of Population Change (SPC) 
This survey was designed as a fully-structured questionnaire which was repeated five 
times at 3 month intervals with the first round providing an enumeration. The survey 
was conducted from July 2005 to August 2006 by the nationwide staff of the Provincial 
Statistical Office. The objectives of the survey were to estimate population indicators 
including birth rate, mortality rate, fertility rate, and population growth rate; and to 
provide current information for population projection including demographic 
characteristics, data on change in demographic characteristics in the mid-decade (inter-
census) period, as well as other socio-economic data. 
6.2.3.1 Survey design, sample size and population estimation 
It was a stratified two-stage sampling in which Bangkok and 4 regions (Central, North, 
North-East, and South), which included all 76 provinces were the strata. Blocks in 
municipal areas and villages in non-municipal areas were the primary sampling units, 
and private households and special households were the secondary sampling unit. 
Further details of the survey design and samplings are presented in Appendix 4, A4.1.  
Finally, 82,000 out of 354,678 households in 2,050 sample blocks/villages were 
included in the survey. All special households were also assigned to be samples. All 
household members were interviewed, however, in impractical cases; the heads of the 
households were allowed to respond as proxies.  
In inferences from individual samples to population, the weighting factor was applied 
(see details of its estimation in Appendix 4, A4.1). As a result of inferences, the 
estimated populations presented in each table might not be exactly the same because of 
the rounding up of the estimation into integer. 
6.2.3.2 Survey data of the SPC 
All questions and proposed answer choices are shown in a translated questionnaire 
indicated in Appendix 4, A4.2. Data employed in this study include information in 
households’ geographic data, Part 1 and Part 4. Details were mentioned simultaneously 
with data in the SHUE under the topic of variables in multivariate analysis, subsection 
6.2.5. 
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6.2.4 The Survey on Healthcare Utilisations of and Household Expenditures for 
Decedents prior to Death in 2005-2006 (SHUE) 
In every visit by the SPC data collectors to each household, once it was established that 
there were decedent(s) during the three-month period prior to each visit, the data 
collectors interviewed the decedent care giver(s) prior to death using an additional 
SHUE questionnaire for every decedents. This questionnaire mainly focused on 
utilisations of healthcare and household expenditure for the decedents before death. It 
retrieved information for ambulatory care (OP visit) during the last three months and for 
acute care (hospitalisation) during the last six months before death.   
6.2.4.1 Survey data of the SHUE 
All questions and proposed answer choices are shown in a translated questionnaire 
indicated in Appendix 4, A4.3. This survey data was the main information employed in 
the analysis. Details of the data were mentioned simultaneously with data from the SPC 
under the topic of variables in multivariate analysis, subsection 6.2.5. 
6.2.4.2 Identifying causes of death 
Causes of death of decendents were conveyed by the patient’s care giver or a household 
member and, if possible, the death certificate was shown to confirm the death to the data 
collectors45. The certificate included causes which had been indicated previously by the 
heads of villages or district officers, who officially provide the certificate for death at 
home, or causes which had been diagnosed by health personnel at a health facility. In 
addition to the death cases identified by non-health personnel, deaths at home or deaths 
with unknown causes were verified with Mahidol Verbal Autopsy System46 by data 
collectors. In the case that cause of death was identified differently, cause from verbal 
autopsy was indicated as cause of death of the decedents. Finally, all reported causes of 
death were categorized into 98 diseases in SPC as well as 6 major groups in the SHUE. 
                                                 
45 There were two objectives of clarification on death certification in the SPC, i.e. 1) to evaluate the death 
certification system and completeness of mortality data of Thailand; and 2) to confirm cause of death 
from interviewing 
46 Mahidol Verbal Autopsy System was developed by Institute for Population and Social Research, 
Mahidol University, Thailand. It was developed as a software on PDA as well as an algorithm manual and 
aims for cause of death investigation by non-medical personnel. 
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6.2.5 Variables in multivariate analysis 
While there was a lot of information in the questionnaires, this study took a selected set 
of data from the surveys to meet the aims of the study described in this thesis (see 
questionnaires in Appendix 4, A4.2 and A4.3). Table 6.1 summarises independent and 
dependent variables provided in the two surveys and new generated ones which were 
selected into the multivariate analysis in accordance with previous reviewed literature 
(Chapter One, section 1.3.2 and 1.4 and Chapter Three, subsection 3.2.1.1). Details of 
data manipulation are described as follows. 
6.2.5.1 Independent variables 
Independent variables include geographic data (region and municipality), demography 
(gender, and age at death), socioeconomics (income quintile and occupation), household 
relationships (being head of household), causes of death, places of death, health 
insurances and use of complementary medicine (in modelling utilisation of and 
expenditure for ambulatory care). Categorization of some independent variables 
provided by multiple choice questionnaires was revised to be consistent with the 
variables in Chapter Five, subsection 5.2.3. This revision also reduced the impact of 
differences in numbers of groups and samples in statistical analysis. The reference 
category of some variables was selected using the same reasons indicated in Chapter 
Five. 
(1) Region: In SPC Part 1, addresses of households were indicated. Of these, five 
regions of Thailand were classified as Bangkok Metropolitan (the capital), Central, 
North, North-east and South. Bangkok was indicated to be the reference category. For 
the reason that Bangkok had the best distribution of health facilities in particular 
advanced tertiary care, it was hypothesised that decedents living in Bangkok had the 
highest access to and expenditure for healthcare services. 
(2) Municipality: Urban and rural areas were separated by local governments as 
municipal and non-municipal areas from household addresses in SPC. All residences in 
Bangkok were indicated as a municipal area. To be consistent to region, urban areas 
were selected as a reference. Due to more convenience in travelling, it was expected that 
decedents living in urban areas had greater accesses to and expenditure for health 
services. 
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(3) Gender: This was coded as male and female in SPC Part 1. Female, a reference 
category, was expected to have greater access and expenditure. 
(4) Age at death: Age in years was calculated from the date of birth and date of death 
provided in the SPC Part 1 and Part 3. In the case of data loss of either date, age in the 
fifth round was employed. To be consistent to categorisation and its reason stated in 
Chapter Five, subsection 5.2.3.1 (2), eleven groups of age were defined. The under five 
year old group was the reference category. 
(5) Being head of the household: The SPC Part 1 provided 10 categories of household 
members’ relationship to the head of the household, however, only binary variable on 
whether or not the decedent was the head of household was employed in the 
multivariate analysis. This was in accordance with the discussion on the importance of 
the death of the head of the household to the households’ income and composition (see 
details in Chapter One, section 1.4). Being the head of the household might result in 
higher access to and higher expenditure for health services. 
(6) Education: Individual household members aged 6 years and above had the records 
of highest education in SPC Part 1. The 99 codes according to the standard code of 
education in the National Statistical Office were recategorised into three levels. Those 
included no education, primary level (1 to 6 years) and higher than primary level. To 
include children below 6 years old in the multivariate regression, their missing records 
of education was imputed to be no education. No education was selected to be a 
reference category and it was hypothesized that education had a positive relation with 
access to and expenditure for health services. 
(7) Occupation: Individual household members aged 15 years and above were asked 
about their occupations and income. From four digit codes in records of main 
occupation in SPC Part 1, three-level category of new occupation was generated. It 
comprises of economically inactive; professionals which also included senior officials, 
technical or administrative workers and armed forces; and other occupations. To include 
children below 15 years old in the regression, their occupation was imputed to be 
economically inactive. In addition, this group was set to be a reference category. The 
group of professionals was expected to have highest access to and expenditure for 
health services. 
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(8) Income quintile: From SPC Part 1 information on every household member average 
income both monthly and income received in-kind, the individuals income could be 
estimated through the methods described in Appendix 4, A4.4 accordingly. Individuals 
were equally categorised into 5 levels of incomes (quintile). The fifth quintile is the 
well-off group while the first quintile is the group of poorest households of this dataset 
and it was indicated as the referent category. So, it was hypothesised that access to and 
expenditure for health services increased as income increased. 
Note: Actually, this study had two living standard measures which included the incomes 
and incomes received in-kind in SPC Part 1, and household assets in the SPC Part 4. 
However, income and consumption were reported in its difficulty in developing 
countries because of less formal employment, reluctance to disclose information of 
income and quality of that information (O'Donnell, van Doorslaer et al. 2008d). As a 
result, this study also constructed the living standards by household asset index and 
found a significant positive correlation to income (see details in Appendix 4, A4.4). The 
measurement for living standards by income was selected to represent a socioeconomic 
factor due to less missing data than asset index in this data set (0.1 percent versus 4.1 
percent). 
 (9) Causes of death: Due to the fact that qualified causes of death requires well-trained 
personnel on ICD codes and causes of death identification, this study recategorised the 
ninety eight causes of death (SPC Part 3) into six causes. Similar to causes of death in 
Chapter Five, these causes were the categories through the Thai study of Burden of 
Diseases accordingly. A fewer groups of causes might lead to less errors in identifying 
the causes because of the broader scope of each cause. The six causes included 
communicable diseases; non-communicable diseases; injuries; senility; cancer; and ill-
defined causes. Ill-defined cause was a reference category and was expected to have 
least access to and expenditure for health services. 
Note: Communicable diseases also included maternal, perinatal and nutritional 
conditions. Injuries also included poisoning, certain other consequences of external 
causes, and external causes of morbidity and mortality.  
(10) Places of death: Eight places of death indicated in answer choices in SPC Part 3 
were re-categorized into 4 groups as public health facilities, private health facilities, 
home and others. Home was an additional group to places of death from that in Chapter 
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Five. It was selected to be the reference and was expected to be the place that results in 
least access and expenditure. 
 (11) Health insurance schemes: Seven health insurances were provided as answer 
choices in two questions, main and second health insurance schemes of decedents in the 
SHUE Part 1. The study included only the main insurance schemes because of rare 
response to the second health insurance scheme. The seven choices were recategorised 
into five groups used in the analysis, that is, uninsured group, CSMBS, UCE, UCP, and 
SPrEm (SHI, Private Health Insurance and Insurance provided by Employers). 
Following to Chapter Five, the CSMBS, a reference category, was expected to have 
highest access to and expenditure for health services. 
(12) Using complementary medicine: In ambulatory care, the SHUE provided records 
of using non-institutional health facilities including pharmacy, self medication, herbal 
medicines and alternative medicines. As of the survey period, complementary medicine 
had not been included in the benefit packages of all health insurance schemes including 
the newest health insurance, UC. However, after having health insurance allowing for 
health services from institutional health facilities which were mostly free of charge or 
30 Baht user fee, use of complementary medicines might fall. As a consequence, this 
binary variable hypothesized that using complementary medicine results in greater 
access to and expenditure for ambulatory care as a whole. 
6.2.6.2 Omitted independent variables 
A socio-economic factor commonly found in some studies, i.e. marital status was not 
included in multivariate analysis. This is due to no significant findings according to 
marital status in a study by Cartwright (1992). In addition, as a result that this study 
aims to reveal the effect in all different age groups, records of marital status which was 
hurdling at age 13 years and above were ignored. This could automatically keep 
additional 3.9 percent of samples in the multivariate analysis. 
6.2.6.3 Response variables 
Regarding the analysis pathways indicated in Figure 6.1, using health services consists 
of ambulatory care and hospitalisation, with different periods of recall for different care. 
In each care, it was set as two hurdles, that is, the first hurdle was using care and 
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amount of care and the second hurdle was having expenditure and value of expenditure 
among the respondents that reported using care. As a result, this study focuses on: 
(1) Using or seeking ambulatory care: All decedent care givers were asked to respond 
to this ‘yes-no’ binary choice. It was provided in the SHUE questionnaire. 
(2) Numbers of visits: This count data were specified to the respondents indicated ‘yes’ 
in using ambulatory care in (1). It was limited to 98 visits within the period of 3 months 
before death. In addition, all visits of all types of health facilities were summed into a 
variable. 
 (3) Having expenditure for ambulatory care: In decedents who reported using 
ambulatory care, respondents were asked about the total household direct medical 
expenditure for ambulatory care within the last three months of decedents’ lives. Of 
these, no payment or zero Baht was included. In analysis, as a result that there were 
nearly one-third of users for ambulatory care having zero payment, a binary variable of 
having expenditure was generated for the two-part model accordingly.  
(4) Expenditure for ambulatory care: Similar to numbers of visits, all expenditure 
through all types of health facilities was summed into a total expenditure per decedent 
during the last three months of life. This continuous data were limited to 99,998 Baht 
through the SHUE questionnaire design. 
(5) Using or seeking acute care: Similar to using ambulatory care, all decedent care 
givers were asked with a binary choice of using acute care as part I of the hurdle model. 
(6) Numbers of hospitalisations: Like numbers of visits, this count data were 
intensified to acute care users only. 
 (7) Having expenditure for hospitalisation: Like having expenditure for ambulatory 
care, this binary choice variable was generated to be a hurdle for having out of pocket 
expenditure for hospitalisation at all types of health facilities.  
(8) Expenditure for hospitalisations: This new continuous variable was generated by 
summing up all expenditure incurred by households for all types of health facilities 
providing acute care. 
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6.2.6.4 Handling missing data in multivariate analysis 
Missing data was manipulated using the method described in subsection 4.3.2.1 (3) in 
Chapter 4. The SPC lost some of the household members’ income data, 0.1 percent of 
income quintile was not available. As a result, the multivariate analysis included 2,170 
samples which represent 382,901 decedents. In other word, the analysis had 0.2 percent 
of missing data. 
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Table 6.1 Variables in multivariate data analysis 
Variable name Source of data Details of categorisation and reference category 
Independent variables 
Region SPC Part 1 
Five categorical data as: Bangkok; central; north; northeast; 
and south 
Reference category: Bangkok 
Urban (Municipality) SPC Part 1 Binary data as: urban area (municipal area) and rural area (non-municipal area, reference) 
Male (Gender) SPC Part 1 Binary data as: male and female (reference) 
Age at death SPC Part 1 and Part 3 
Eleven categorical data as: under 5 years; 5 to <10 years; 10 
to <20 years; 20 to <30 years; 30 to <40 years; 40 to <50 
years; 50 to <60 years; 60 to <70 years; 70 to <75 years; 75 
to <80 years; 80 years and above 
Reference category: under 5 years 
Head of household SPC Part 1 Binary data as: being head of household and none (reference) 
Education SPC Part 1 
Three categorical data as: no education; primary level; and 
higher level 
Reference category: no education 
Occupation SPC Part 1 
Three categorical data as: economically inactive; 
professionals; and others 
Reference category: economically inactive 
Income quintile SPC Part 1 
Five categorical data as: Q1; Q2; Q3; Q4; Q5 
Reference category: Q1 
Causes of death SPC Part 3 
Six categorical data as: ill-defined causes; communicable 
diseases; non-communicable diseases; injuries; senility; and 
cancer 
Reference category: ill-defined causes 
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Table 6.1 Variables in multivariate data analysis (cont.) 
Variable name Source of data Details of categorisation and reference category 
Places of death SPC Part 3 
Categorical data as: home; public health facilities; private 
health facilities; and others 
Reference category: home 
Health insurance 
schemes SHUE Part 1 
Five categorical data as: uninsured; CSMBS; SPrEm; UCE; 
and UCP 
Reference category: CSMBS 
Response variables 
Using ambulatory care SHUE Part 1 Binary data as: yes and no (reference) 
Numbers of visits New generated variable from data in SHUE Part 1 
Count data with defined range from 1 to 98 visits 
minimum = 1; maximum = 98 
Having expenditure for 
ambulatory care New generated variable from data in SHUE Part 1 Binary data as: yes and no (reference) 
Expenditure for 
ambulatory care SHUE Part 1 
Continuous data with defined range from 1 to 99,998 Baht 
minimum = 5; maximum = 99,998 
Using acute care SHUE Part 2 Binary data as: yes and no (reference) 
Numbers of 
hospitalisations New generated variable from data in SHUE Part 2 
Count data with defined range from 1 to 98 hospitalisations 
minimum = 1; maximum = 48 
Having expenditure for 
hospitalisations New generated variable from data in SHUE Part 2 Binary data as: yes and no (reference) 
Expenditure for 
hospitalisations New generated variable from data in SHUE Part 2 
Continuous data with defined range from 1 to 999,998 Baht 
minimum = 20; maximum = 999,998 
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6.3 Results 
Six main findings from this study are presented in this section. As a result that this study 
reveals findings from data in two linked surveys, samples and population inferred are 
firstly presented prior to the main findings. Thereafter, the first section presents the 
general findings of mortality and descriptive statistics focusing on the disparities from 
income and health insurance schemes including the proportion of expenditure to 
household income and health seeking behaviour; the second section reveals the results 
from multivariate analysis; the last section presents the implication of the models to 
reveal the inequality in cancer patients. 
Based on the fifth round of SPC, Figure 6.2 describes the flow of data collection, 
numbers of samples collected and the estimated number of population in both surveys. 
It was estimated that in 2005-2006 the Thai population was 64,675,145 (327,735 
samples) and the numbers of decedents was 387,970 (from 2,200 samples). That is, the 
mortality rate was 6.0 per 1,000 habitants. The response rate of the SHUE was 98.7 
percent of the death population, i.e. the study collected data on 2,173 (total N = 
382,933) decedents on health care utilisations and household expenditure.  
6.3.1 General findings 
As mentioned earlier, in subsection 6.2.5.1, twelve variables of interest were collected 
in either the SPC or the SHUE which is unable to reveal a comprehensive crossover of 
all variables, descriptive statistics by income quintile and health insurance schemes are 
focused on. Due to the designs of the two surveys, some variables could be described as 
estimated population ratios but some of them could not. However, these population 
ratios were also revealed by income quintile specifically to variables of interest which 
included age specific to gender, to regions, to education and to occupation. These 
variables are often studied in mortality and inequity in previous literature (Commission 
on Social Determinants of Health 2008). In such cases of health insurance schemes, 
descriptive statistics in estimated population across such variables are presented instead 
of the population ratios.  
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Figure 6.2 Diagram of collected samples and estimated population of both surveys 
 
 
 
 
 
 
 
 
 
 
 
Note: Sample and estimated population is based on the 5th round of the SPC. 
Source: summary from SPC’ s and SHUE’ s survey designs 
 
6.3.1.1 Lifespan and mortality rate  
The youngest decedent was an infant aged less than 1 year and the oldest died at 115 
years. Average lifespan was 62.7 years and women lived 10 years longer than men (68.5 
versus 58.0 years). By income quintile, the poorest decedents in the 1st and 2nd quintile 
had the longest lives, approximately 67 years, whereas decedents in the 3rd quintile had 
a lifespan of 56.2; in the 4th quintile 57.6; and the richest in the 5th quintile 60.7 years. 
Decedents in CSMBS scheme were the oldest with an average age of 70 and decedents 
in the SPrEm scheme were the youngest dying at 37.4 years. Meanwhile, on average, 
UCE died aged 68.5, the UCP died at age 20 years younger. Uninsured decedents died 
at 65.5 years (see details in Appendix 4, A4.5 Table A4.4). 
The crude mortality rate was 6.0 per 1,000 population. Table 6.2 shows the age specific 
mortality rate. No gradient of mortality rate from high to low in the poorest quintile 
(Q1) to the richest quintile (Q5) in all age groups. However, when comparing between 
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the poorest and the richest quintile, a disparity in age specific mortality rate, higher in 
the poorest and less in the richest group, was found in age groups below 50 years and in 
between 60 and 80 years. 
Table 6.2 Age specific mortality rates in overall population (per 100 population) 
Age group (yrs.) Q1 Q2 Q3 Q4 Q5 
<5 0.3 0.04 0.5 0.2 0.1 
5 to <10 0.01 0.02 0.1 0.1 - 
10 to <20 0.1 0.02 0.1 0.1 0.1 
20 to <30 0.3 0.3 0.1 0.1 0.1 
30 to <40 0.3 0.2 0.4 0.2 0.03 
40 to <50 0.6 0.3 0.4 0.2 0.3 
50 to <60 0.5 0.8 0.6 0.7 0.6 
60 to <70 1.5 1.4 2.0 1.5 1.0 
70 to <75 3.4 4.1 3.4 2.4 2.2 
75 to <80 4.7 5.1 6.0 2.6 3.2 
>=80 8.3 12.6 7.5 8.2 8.6 
Total 0.9 0.7 0.6 0.4 0.3 
 
Age specific mortality rates across quintile and some demographic, geographic and 
socioeconomic variables including gender, region, education, occupation were shown in 
Appendix A4.5, Table A4.5 to A4.8. No gradient of higher rate to lower rate across 
income quintile of individual age group from the poor (Q1) to the rich (Q5) was found. 
However, the total rates indicated that the poorer population had higher mortality rate 
across almost all levels of variables except population with professional occupation.  
6.3.1.2 Using care and paying out of pocket 
In general, 58.6 percent of decedents accessed ambulatory care services during the last 
three months and 57.0 percent accessed acute care during the last six months of life. In 
addition, 39.1 percent of decedents sought both types of care. Of these users, 65.6 
percent paid for ambulatory care and 42.2 percent paid for acute care. In total, the 
expenditure of 760 decedents seeking ambulatory care and paid out of pocket within the 
last three months was 4,691,515 Baht and of 526 decedents seeking acute care and paid 
within the last six months was 24,964,256 Baht. 
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Table A4.9 shows the percentage of decedents using care and the percentage of users 
paying out of pocket categorized by variables (Appendix A4.5). It was found that more 
than half of the UCP decedents accessed ambulatory care as well as acute care and 
almost all of the users (97.4 and 95 percent, respectively) paid out of pocket. This is due 
to the 30 Baht user fee of the UC scheme. Compared to other health insurance, 
uninsured decedents sought both types of care in the lowest percentage but more than 
four fifths of the users made payments. In contrast, two-thirds of the CSMBS decedents 
sought both types of care but only one-third of users paid out of pocket. Alternatively, 
nearly two-thirds of the SPrEm decedents accessed ambulatory care and four fifths of 
the users had payments whereas one forth decedents accessed acute care and more than 
two third had payments. Compared to other causes of death, decedents dying from 
injuries had the lowest percentage of access to ambulatory care (13.1 percent) but had 
the highest percentage of users paying for care (76.8 percent).  
6.3.1.3 Decedents and access to care across income quintile and across health 
insurance schemes 
Among decedents, the percentage of decedents distributed across income quintile and 
various variables, and across health insurance schemes and various variables are shown 
in Table A4.10 and Table A4.11 (Appendix A4.5). Such Tables also present the 
percentage of access to ambulatory care and acute care. Across quintiles, decedents 
aged 80 and above was the biggest group dying in the two poorest quintiles whereas the 
age between 50 and 60 of the two well-off groups was the group that had more deaths. 
In the 1st and 2nd quintile, decedents in the north-east and the north were the majority of 
decedents, but decedents in the north-east and Bangkok were the majority of the 5th 
quintile. In all but the 5th quintile, more than two-thirds of decedents resided in rural 
areas. More than half of decedents in all but the 1st quintile were not head of 
households. The biggest proportion of decedents in all quintiles was educated up to 
primary level and economically inactive. Nearly half to two-thirds of decedents in all 
except the well-off quintile died at home. In addition, the higher the quintile, the greater 
the proportion was of those dying in hospitals. In all except the 5th quintile, decedents 
being UCE beneficiary were the majority but CSMBS beneficiaries were the majority in 
the 5th quintile. Decedents in all quintiles had similar proportions in causes of death 
except the 1st and 2nd quintiles which had a higher proportion than other quintiles in 
dying from senility. In the percentage of access to ambulatory care, there was no clear 
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pattern of most of the variables across quintile. However, females had higher access 
than male decedents and more than four fifth of decedents dying from cancer in all 
quintiles accessed ambulatory care before dying. In addition, this access was the highest 
proportion, compared to other causes of death. Similarly, no pattern was found in access 
to acute care by most of the variables. It seems that decedents living in urban areas had 
higher access to the care than decedents living in rural areas except decedents in the 4th 
quintile and decedents who were head of household and had higher access than other 
members. Decedents actively working before death also accessed care more than 
decedents who were economically inactive. Decedents dying elsewhere were less likely 
to access care than those dying in hospitals and dying at home in all quintiles. 
Compared to other health insurance schemes, CSMBS beneficiaries in almost all 
quintiles had higher access to care. In uninsured groups, the well-off decedents accessed 
care more significantly than other quintiles. Decedents in all quintiles dying from 
communicable diseases and cancer accessed acute care at a greater number than 
decedents dying from other causes of death.  
Focusing on health insurance schemes independently, Table A4.11 in Appendix A4.5 
shows the distribution of decedents. Nearly one-third of uninsured decedents were aged 
80 and above; a quarter resided in Bangkok but more than half were in rural areas; 
nearly two-thirds were members of the households and nearly half were educated up to 
primary level. Approximately, four-fifths of decedents were economically inactive and 
nearly half were the poorest and 70 percent died at home with nearly one-third dying 
from senility. Nearly four-fifths of decedents did not use complementary medicines. 
The majority of the CSMBS decedents were similar to the uninsured group in age, 
gender, residing in rural areas, education, occupation, and using complementary 
medicine. However, nearly one-third of CSMBS decedents resided in the north-east and 
more than half were head of households. One-third of decedents were the poorest and 
another third was the well-off. Half of the beneficiaries died in public hospitals and 
nearly half died at home. More than one-third of the CSMBS decedents died from non-
communicable diseases. The SPrEm had differences in the majority of decedents by 
some variables, compared to the former groups. That is, nearly two-fifths of decedents 
aged 30 to 40 years. More than half resided in northern and central regions. Nearly four-
fifths were household members and had the highest education being higher than primary 
level. Nearly half of the decedents were in the third quintile and more than one-third of 
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SPrEm decedents accessed complementary medicines. Even though UCE and UCP 
decedents were beneficiaries of the UC scheme, both groups had differences in 
distribution by variables. The majority of the UCE decedents were aged 80 and above 
while the UCP were aged from 50 to 60 years. The UCE decedents were economically 
inactive but the UCP decedents had other occupations. More than one-third of the UCE 
decedents were the poorest meanwhile the UCP decedents were in 2nd and 3rd quintiles. 
Nearly two-thirds of the UCE beneficiaries died at home but those from UCP died at 
home equally to dying in public hospitals. While the UCE decedents died from senility, 
the UCP ones died from non-communicable diseases. 
In access to ambulatory care, the CSMBS and SPrEm decedents accessed care the 
greatest amount, i.e. 66.7 percent and 62.4 percent, respectively. Even though access to 
care by various variables were categorised, the CSMBS decedents still revealed greatest 
access in most of the variables. In addition, 67.7 percent of CSMBS decedents accessed 
acute care but 58.3 percent of the UCP and 56.5 percent of the UCE decedents were the 
second and third group which accessed care greatly. Across individual categories of 
variables, there was no clear pattern of access to care among health insurance schemes. 
6.3.1.4 Numbers of visits for ambulatory care and hospitalisations for acute care across 
income quintiles and across health insurance schemes 
On average, of all decedents, access to ambulatory care was 4.8 visits during the last 
three moths of life and access to acute care was 1.7 hospitalisations. Table A4.12 
revealed average visits and hospitalisation compared among income quintile by various 
variables (Appendix A4.5). In ambulatory care, it was found that no pattern in numbers 
of visits across most of the variables. However, decedents dying from cancer in every 
quintile but the 3rd quintile were likely to have a greater number of visits than decedents 
dying from other causes of death. It was also revealed that decedents in every quintile 
treated with complementary medicines had a greater number of visits than those with no 
treatments. Similarly to visits to ambulatory care, no pattern of hospitalisation among 
decedents in the different quintiles by various variables was seen. However, decedents 
dying from cancer had a higher number of hospitalisations than decedents dying from 
other causes in every quintile. Table A4.13 also shows no pattern observed of visits and 
of hospitalisations across health insurance schemes (Appendix A4.5). 
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6.3.1.5 Expenditure for ambulatory care and acute care across income quintiles and 
across health insurance schemes 
On average among users, households paid 3,763 Baht for ambulatory care within the 
three months before death and 15,767 Baht for acute care within the six months before 
death. Table A4.14 revealed household expenditure for both types of care by quintile 
and other variables (Appendix A4.5). No gradient between low to high expenditure 
from the poorest quintile to the richest quintile in all variables was found. However, the 
richest quintile paid 3 times more than the poorest quintile. Similar to ambulatory care, 
there was no gradient and pattern of expenditures paid for acute care across quintiles but 
on average, the richest quintile paid 6.3 times more than the poorest quintile. 
Compared among health insurance schemes, Table A4.15 shows the average 
expenditure by variables. It was clear that the uninsured decedents paid the greatest 
expenditure for ambulatory care (26,776 Baht), followed by the SPrEm decedents 
(6,530 Baht) and UCP decedents (4,988 Baht), respectively. There was no gradient and 
pattern of high to low expenditure across health insurance schemes and variables. 
However, female decedents as well as decedents educated higher than primary level 
were likely to have a greater expenditure than men and decedents educated at a lower 
level. Compared to other places of death, decedents dying in private hospitals had 
greatest out of pocket expenditure for beneficiaries of every health insurance scheme.  
6.3.2 Pattern of places of death 
Focusing on the pattern of places of death across income quintile, health insurance 
schemes and causes of death, Figure 6.3 shows such distributions of decedents. In total, 
half of all decedents died at home (53 percent), followed by approximately one-third in 
public hospitals (37 percent). The cause of death might have an influence to the places 
of death due to its relation to comorbidity prior to death. It is clear that death at public 
hospitals increased as the wealth by income quintile increased. In contrast, death at 
home decreased as the wealth increased (panel A). Approximately two-thirds of 
uninsured decedents as well as of UCE beneficiaries died at home whereas half of the 
CSMBS decedents died in public hospitals (panel B). By causes of death in panel C, the 
majority of decedents dying from ill-defined causes, senility and cancer died at home 
(75.7, 88.2 and 62.3 percent, respectively). On the other hand, nearly two-thirds of 
decedents dying from communicable diseases died in public hospitals (panel C). 
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Focusing on decedents dying from cancer, in addition, it was found that most of 
decedents residing in Bangkok (94.1 percent) died in either public or private hospitals, 
that is, only 5.9 percent died at home. In contrast, 79.1 percent of decedents resided in 
the north-east died at home whereas 20.9 percent died in hospital. 
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Figure 6.3 Distribution of places of death categorised by three variables 
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6.3.3 Pattern of health care use 
Figure 6.4 illustrates the utilisation pattern of access to ambulatory care and acute care 
by income quintile and health insurances. In seeking ambulatory care (panel A), 
generally community hospitals and general/regional hospitals were the major health 
facilities of decedents in all quintiles but the well-off quintile. Decedents in the richest 
quintile sought one-fifth of care at university hospitals while decedents in other quintile 
sought this care at these types of health facilities at less than 10 percent. In contrast, 
decedents in the richest quintile used complementary medicine at less than 15 percent 
while decedents in other quintile used 15 to 24 percent proportionate to all types of 
health facilities. This pattern was similar to the utilisation of private clinics in which 
there was a gradient of high to low utilisation proportion from the poorest to the well-
off quintile. In acute care, panel B shows a gradient of seeking care at different type of 
health facilities from the poorest to the well-off quintile. Access to community hospitals 
and general/regional hospitals was higher in the poorest quintile and declined in the 
better-off quintile (from 87.6 percent in the 1st quintile to 67 percent in the 5th quintile), 
particularly in the community hospitals (from 36.6 percent in the 1st quintile to 14.5 
percent in the 5th quintile). In contrast, access to university hospitals and private 
hospitals increased as the level of quintile increased, that is, from 6.6 percent and 5.8 
percent in the 1st quintile to 20.5 percent and 22.5 percent in the 5th quintile, 
respectively. 
By health insurance schemes, Figure 6.4, panel C shows the proportion of using 
ambulatory care at every health facility. Uninsured decedents accessed care at private 
hospitals at more than one-third of all types of health facilities and using 
complementary medicines was the second most popular. SPrEm decedents accessed 
care at private hospitals equally as to complementary medicines, that is, two-thirds of all 
access. With similar proportions, both UCE and UCP decedents accessed care at PCU, 
community hospitals, general and regional hospitals. In contrast, more than one third of 
CSMBS decedents accessed general and regional hospitals (38.2 percent). Meanwhile, 
university hospitals accounted for the second most popular health facility (16.2 percent) 
while the PCU as well as community hospitals ranked third (10.2 percent). In acute 
care, private hospitals were the most favourite health facility of the uninsured as well as 
SPrEm decedents, that is, 45.8 percent and 41.1 percent, respectively. CSMBS 
decedents accessed care at general and regional hospitals at more than half of the access 
 178
to other types of health facilities while the UCE and UCP used general and regional 
hospitals (49.3 percent and 43.2 percent, respectively) and community hospitals (37 
percent and 37.6 percent, respectively). 
Looking at geography and causes of death, the supply side and demand side factors in 
health services might influence the pattern of health seeking behaviour. Both factors 
were out of scope of this chapter’s objectives. However, the distribution pattern of both 
factors was depicted in Appendix A4.5, Figure A4.1. 
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Figure 6.4 Pattern of health care use at health facilities among different income quintiles and health insurance schemes 
A: Using ambulatory care categorised by income quintile 
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B: Using Acute care categorised by income quintile 
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C: Using ambulatory care categorised by health insurance schemes 
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D: Using acute care categorised by health insurance schemes 
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6.3.4 Multivariate analysis and the model selection 
It was shown in previous literature that there are many factors affecting health care use 
at end of life. This subsection, therefore, examines the impact and magnitude of some 
selected variables of the surveys on health service utilisation and household expenditure 
according to the analytical methods in Chapter Four, subsection 4.3.2.1 (4), and 
subsection 6.2.2. Ten to eleven categorical variables included in the analysis are 
detailed in subsection 6.2.5.1, that is age at death, gender, region, municipality, head of 
household status, education, occupation, income quintile, cause of death, place of death, 
health insurance scheme and use of complementary medicine (specifying to ambulatory 
care). Such analysis with the two-part model was specified to utilisation of and 
expenditure for ambulatory care within the last three months and acute care within the 
last half year prior to death. 
Utilisation of and expenditure for both types of care had non-normal distributions. The 
histograms of these utilisations and expenditure including the values of skewness and 
kurtosis are illustrated in Figure A4.2 and A4.3 (Appendix A4.6). The two-part model 
for utilisations employed the first part with logistic regression and the second part with 
the best fitted model, compared between zero-truncated Poisson model and zero-
truncated negative binomial model. The model for expenditure employed the first part 
with logistic regression and the second part with the best fitted model, compared 
between four based models. Such candidates included the OLS, the OLS of logarithmic 
term of expenditure with Duan’s smearing factor, the GLM with gamma distribution 
and log link, and the GLM with Poisson distribution and log link. The R2 from the OLS 
indicated that this set of variables could explain 35.9 and 28.7 percent of the linear 
relationship of the covariates over the expenditure for ambulatory care and acute care, 
respectively. Details of coefficients of all variables in all models and their significance 
as well as test results including overdispersion for Poisson in modelling utilisation, 
specification test for GLM, i.e. both families and link functions, and plots were shown 
in Appendix 4, A4.6 (Table A4.17 to Table A4.20 and Figure A4.4 to A4.5). 
In model selection for the utilisations between the zero-truncated Poisson and the zero-
truncated negative binomial, overdispersion indicated by the α value is the test 
employed. Such value in Table A4.17 indicates overdispersion of the zero-truncated 
Poisson model for ambulatory care utilisation but Table A4.18 revealed no 
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overdispersion of the model for utilisation of acute care. As a result, the zero-truncated 
negative binomial is more appropriate for utilisation of ambulatory care and the zero-
truncated Poisson model for utilisation of acute care.  
According to suggestions by Dodd et al (2006) described in Chapter Four, subsection 
4.3.2.1 (4) b), Table 6.3 and 6.4 summarises the test results (Root Mean Square Error: 
RMSE and Mean Absolute Error: MAE) and predicts the mean of the four candidates in 
modeling the expenditure for both types of care, compared to the observed ones. The 
lowest RMSE and the predicted means in both Tables indicated that the OLS was the 
best fitted model. However, the OLS might not be the appropriate model for 
expenditure due to the distribution profile, skewness and kurtosis of the data (shown in 
Appendix A4.6, Figure A4.2 and A4.3) could not meet the OLS assumption on the 
homoscedasticity of the variance. As a result, compared among the other three 
candidates in modeling the expenditures for both cares, the modified Park test in both 
GLM gamma-log and Poisson-log revealed that both families were suitable. Even 
though the predicted mean is approximately 50 percent over the observed mean, such 
model is the best fitted to this particular dataset in predicting expenditure for both types 
of care due to the lowest RMSE and MAE. In addition, the modified Park test in both 
GLM gamma-log and Poisson-log revealed that both families were suitable. The 
insignificance of Pregibon test for link function in modeling the expenditure for 
ambulatory care indicated; insignificance of Peason correlation test in GLM gamma-log 
and of Modified Hosmer and Lemeshow in modeling the expenditure for acute care, 
indicated that the log link could be employed (details in Appendix A4.6, Table A4.20 
and Table A4.21). In addition, Table 6.3 and Table 6.4 indicated that the GLM Poisson 
family with log link provided the lowest RMSE and MAE. Even though the predicted 
mean is approximately 50 percent over the observed mean of both expenditures, such 
model is the best fitted to this particular dataset in predicting expenditures for both types 
of care over the other three models.   
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Table 6.3 Diagnostic test results of the root mean square error (RMSE) and mean 
absolute error (MAE); and predicted means for ambulatory care 
Candidate model RMSE MAE mean S.E. lower bound 
upper 
bound 
observed  7187.5 1180.8 4828.6 9546.4
OLS 15826.8 9457.1 7602.8 998.9 5607.3 9598.4
LnOLS with Duan’s 
smearing factor 58837.8 19733.0 21593.3 4736.6 12130.9 31055.7
GLM gamma-log 100103.3 13035.0 14971.5 3597.1 7785.4 22157.6
GLM Poisson-log 28793.5 28793.5 10704.2 2410.0 5889.8 15518.7
 
Table 6.4 Diagnostic test results of the root mean square error (RMSE) and mean 
absolute error (MAE); and predicted means for acute care 
Candidate model RMSE MAE mean S.E. lower bound 
upper 
bound 
observed  39526.0 7228.4 25149.0 53902.9
OLS 132465.8 77890.5 57868.3 7258.1 43432.1 72304.5
LnOLS with 
Duan’s smearing 
factor 
833226.1 300077.0 313064.8 56533.1 200622.7 425506.8
GLM gamma-log 1250699.9 307199.8 312793.7 85572.1 142594.2 482993.1
GLM Poisson-log 187284.3 58094.85 60841.9 12338.3 36301.5 85382.3
 
6.3.5 The model and factors determining utilisation and expenditure 
This subsection specifies the factors determining utilisation of and expenditure for 
ambulatory care and acute care with the selected model indicated in the previous 
section. In addition to the odds ratio and rate ratio of all variables which were adjusted 
in such selected model, the unadjusted odds ratio and incident rate ratio of each variable 
were presented. For both types of care, the two-part model comprises of the first part 
which determines the probability of access to care or having expenditure and the part II 
which determines the positive value of access or the expenditure. 
6.3.5.1 Utilisation of ambulatory care 
Variables which played a significant role in determining the probability in utilisation of 
ambulatory care included age, cause of death, place of death and health insurance 
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scheme whereas determining numbers of visits included,  region, education, income 
quintile, cause of death, place of death, health insurance scheme and use of 
complementary medicine (Table A4.17 in Appendix A4.6). In the model for ambulatory 
care, Table 6.5 reveals odds ratio and the rate ratio of individual categorical level of a 
variable compared to its reference category when keeping other variables constant as 
well as unadjusting. Significantly when keeping other variables constant, decedents in 
all but the age group of 10 to <20 years had greater probability to use services for 
ambulatory care than decedents aged less than 5 years. Those aged between 20 to <30 
years had the greatest probability. Uninsured decedents also had a two-third less 
probability than the CSMBS group in accessing such care. Decedents dying from 
communicable diseases, non-communicable diseases, senility and cancer had a higher 
probability to access services for ambulatory care than decedents dying from ill-defined 
causes. Decedents dying elsewhere had 87 percent less probability to access health 
services for ambulatory care than dying at home.  
In determining the number of visits when keeping other variables constant, decedents 
living in the southern region accounted for nearly 50 percent less visits than those living 
in Bangkok. Higher educated decedents made three times more visits than uneducated 
decedents but the richest decedents in the fifth quintile represented nearly 50 percent 
less visits than the poorest decedents. SPrEm and UCP decedents had twice to thrice the 
number of visits of CSMBS decedents. Those dying from non-communicable diseases 
or cancer accounted for approximately 3 times more visits than those dying from ill-
defined causes of death. Dying in public hospitals caused less ambulatory visits than 
those dying at home. Decedents using complementary medicine had a greater number of 
visits than no use.  
 184
Table 6.5 The two-part model for the utilisation of ambulatory care 
 Part I: Logistic regression  Part II: Zero-truncated negative binomial 
 Adjusted model  Unadjustd model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Region, central  1.1293 0.5951  0.6519 0.2524  0.9229 0.2137  0.8655 0.3180 
Region, north  1.5807 0.6995  1.2786 0.4002  1.0660 0.2210  3.0021 1.7109 
Region, north-east  1.3039 0.5900  0.9561 0.3166  0.9135 0.2315  0.8126 0.2494 
Region, south  1.4882 0.6129  1.1127 0.5053  0.5755* 0.1397  1.4558 0.8273 
Urban  1.2584 0.2590  1.0763 0.1865  0.9842 0.1175  0.5204 0.2771 
Age 5 to <10  81.9315** 115.4153  1.5595 2.2600  0.5307 0.2541  0.7109 0.2875 
Age 10 to <20  4.9758 6.9749  0.5759 0.6013  1.0256 0.4719  2.3959 1.2930 
Age 20 to <30  315.3343** 477.0804  20.1062** 19.8005  0.7261 0.3272  11.2184** 6.7658 
Age 30 to <40  25.1074* 33.3640  23.1728** 23.9623  0.5291 0.2189  17.8832** 10.9019 
Age 40 to <50  22.7970* 31.5394  14.5269** 12.5342  0.5493 0.1930  2.1599 1.1470 
Age 50 to <60  10.5186* 12.5139  10.9924** 9.5016  0.5841 0.2251  3.4484* 2.0274 
Age 60 to <70  22.5107* 27.2747  22.2828** 19.7451  0.9280 0.2576  2.0411 0.9910 
Age 70 to <75  17.4583** 18.9500  16.9728** 12.5416  1.0954 0.3173  2.5055 1.3186 
Age 75 to <80  17.6623** 19.4905  17.3427** 13.6376  0.8886 0.3190  1.3986 0.6609 
Age >=80  18.5555** 18.8088  14.4826** 10.9269  1.1529 0.3612  1.5071 0.6567 
Male  0.8791 0.1373  0.6259* 0.1493  0.9009 0.1217  0.6294 0.4054 
Head of household  1.0703 0.2891  1.1692 0.2577  0.8396 0.1473  0.3081** 0.1267 
Education, primary  1.2520 0.4453  1.5387 0.5386  1.0713 0.1573  1.6766* 0.3621 
Education, higher  0.4451 0.2370  1.0247 0.5682  3.0389** 0.9305  11.7556** 6.0447 
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Table 6.5 The two-part model for the utilisation of ambulatory care (cont.) 
 Part I: Logistic regression  Part II: Zero-truncated negative binomial 
 Adjusted model  Unadjustd model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Occupation, professionals  0.5714 0.4054  0.3319* 0.1690  1.2394 0.4491  0.4916 0.3139 
Occupation, others  1.3053 0.5501  1.3861 0.4681  1.0828 0.1672  0.7036 0.3839 
Income, Q2  1.2439 0.4551  1.0430 0.2998  1.0031 0.1615  1.8436 0.8490 
Income, Q3  1.1928 0.3186  1.0090 0.4015  0.9120 0.1744  4.0320 2.8762 
Income, Q4  0.8694 0.2715  1.0226 0.4111  0.8103 0.1811  1.8170 0.8871 
Income, Q5  2.1674 0.8757  1.0409 0.2807  0.4607** 0.0824  0.6654 0.2149 
Communicable ds.  14.5721** 9.4453  6.5074** 4.0656  1.9172 0.8130  1.7292 0.7095 
Non-communicable ds.  6.7252** 3.7080  5.14756** 2.3650  2.8281* 1.1370  7.0085** 5.0110 
Injuries  0.3776 0.2850  0.3284 0.2439  5.3033 5.2382  13.4915** 10.2975 
Senility  5.0116* 3.7113  4.4367** 2.3439  1.1481 0.4757  1.2211 0.4767 
Cancer  13.0257** 8.2656  14.9803** 7.685272  3.4032** 1.2226  6.4350** 3.0365 
Place of death, public hosp.  0.6984 0.1538  0.6206* 0.1385  0.6562* 0.1252  0.5390* 0.1445 
Place of death, private hosp.  1.0769 0.7431  1.2729 1.2570  1.7012 0.6040  9.8664** 4.3772 
Place of death, others  0.1292* 0.1054  0.0547** 0.0278  1.2267 1.2120  0.3962 0.3201 
Uninsured  0.3357* 0.1525  0.4383* 0.1768  1.8244 0.6707  3.1919** 1.1586 
SPrEm  3.0608 2.1599  0.8614 0.6296  3.0419* 1.6500  29.0150** 9.1944 
UCE  0.6831 0.2165  0.9606 0.3153  1.1600 0.1756  2.0430** 0.5072 
UCP  0.7573 0.3172  0.5780 0.1633  2.0521** 0.4598  3.6845** 1.5182 
Complementary medicine        1.7915** 0.2476  4.1748** 2.2733 
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6.3.5.2 Utilisation of acute care 
Table 6.6 reveals all variables included in the two-part model for utilisation of acute 
care, both adjusted and unadjusted model. Keeping other factors constant, meanwhile 
age, occupation, cause of death, place of death and health insurance scheme were the 
factors determining the probability of hospitalisations, age and cause of death 
significantly determined the number of hospitalisations (Table A4.18, Appendix A4.6). 
For individual level of category compared to the reference category, for example, 
decedents aged 20 to <30, 30 to <40, 70 to < 75, 75 to <80 and 80 and over had a 
greater chance to be hospitalised than children aged less than 5 years. SPrEm 
beneficiaries had 95 percent less probability of hospitalisation than CSMBS 
beneficiaries during the last half year of life. Decedents dying from communicable 
diseases, non-communicable diseases, senility, and cancer had a greater probability to 
be hospitalised of 10 to 43 times more than dying from ill-defined causes. Meanwhile 
dying at public or private hospitals had 3 to 3.7 times greater probability of 
hospitalisation, dying elsewhere had 90 percent less probability than dying at home.  
In determining the number of hospitalisations, decedents aged 5 to <10 years had a 
much smaller number of hospitalisations than ones who were aged less than 5 years 
while decedents dying from injuries had nearly one-fifth less number of hospitalisations 
than decedents dying from ill-defined causes. 
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Table 6.6 The two-part model for utilisation of acute care 
 Part I: Logistic regression  Part II: Zero-truncated Poisson model 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Region, central  0.8422 0.3503  0.7317 0.1701  1.8480* 0.5418  1.5378 0.3690 
Region, north  1.0506 0.4826  0.8687 0.2947  1.2916 0.3042  1.3501 0.3920 
Region, north-east  0.8190 0.3442  0.6933 0.2470  1.6810* 0.4228  1.3983 0.3077 
Region, south  0.8623 0.4071  0.8298 0.3805  0.8302 0.2985  0.9507 0.2288 
Urban  1.1725 0.3364  1.1813 0.2679  0.9651 0.2301  0.9726 0.1861 
Age 5 to <10  9.3640 11.2594  0.2215 0.3661  4.7600E-09** 6.0100E-09  9.2900E-09** 9.4000E-09 
Age 10 to <20  0.9611 1.3084  0.1588 0.1828  1.0617 0.8626  1.0152 0.4735 
Age 20 to <30  38.7175** 52.7206  4.8011 5.5105  1.1743 0.4981  1.8016 1.0834 
Age 30 to <40  13.5036* 17.0202  2.8739 3.0331  0.8288 0.4331  0.8455 0.4282 
Age 40 to <50  7.3326 8.2854  5.1988 5.1933  0.4923 0.3712  0.5041 0.2612 
Age 50 to <60  6.6771 7.1468  6.5675 6.5887  1.1545 0.5989  0.8888 0.3571 
Age 60 to <70  7.0298 8.4718  4.5810 4.6223  0.8469 0.3748  0.8131 0.3484 
Age 70 to <75  19.2577* 22.3295  7.0453* 6.9763  0.7491 0.3679  0.7108 0.2869 
Age 75 to <80  19.8869** 22.2739  6.8887* 6.5321  0.5632 0.2621  0.5071 0.1870 
Age >=80  11.8942* 13.1683  2.4098 2.2370  0.6234 0.2702  0.5621 0.2189 
Male  1.2950 0.3631  1.3431 0.3291  1.1542 0.1817  1.36E+00 0.2428 
Head of household  1.1905 0.2651  2.0134** 0.3908  1.0293 0.1693  0.9947 0.2028 
Education, primary  1.0048 0.2065  1.9297* 0.5538  0.8623 0.2454  0.9473 0.2019 
Education, higher  0.6581 0.3759  1.1567 0.6605  1.6536* 0.3723  1.7017 0.5648 
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Table 6.6 The two-part model for utilisation of acute care (cont.) 
 Part I: Logistic regression  Part II: Zero-truncated Poisson model 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Occupation, professionals  2.6085 1.4819  1.9387 1.1342  0.3750** 0.1414  0.7451 0.1558 
Occupational, others  2.9831** 1.0620  2.5310** 0.8782  0.7901 0.1422  0.8962 0.1664 
Income, Q2  0.5583* 0.1563  0.6591 0.1978  1.0195 0.1436  1.3009 0.2898 
Income, Q3  0.7011 0.2570  0.7576 0.3001  0.9797 0.1834  0.8912 0.1087 
Income, Q4  0.5533 0.2395  1.0863 0.4687  0.8501 0.2017  0.9319 0.2042 
Income, Q5  0.3216** 0.1248  0.4289* 0.1403  0.6555 0.2491  0.7664 0.2031 
Communicable ds.  31.9585** 23.9480  28.0114** 17.8807  0.7372 0.2545  1.0461 0.2397 
Non-communicable ds.  19.2425** 15.2476  20.1191** 13.3828  0.7963 0.2857  0.9716 0.2075 
Injuries  4.5240 3.7030  2.5612 1.4439  0.1668** 0.0600  0.3768** 0.1233 
Senility  9.8317** 6.5781  7.5368** 4.2314  0.6954 0.2669  0.7735 0.1983 
Cancer  42.9494** 34.2598  45.7344** 28.3729  1.0979 0.4345  1.5037 0.3509 
Place of death, public hosp.  3.0349** 1.0642  2.2384** 0.6443  0.9635 0.1186  0.8343 0.1487 
Place of death, private hosp.  3.7585* 2.2600  0.8855 0.7628  1.0380 0.4763  0.8158 0.1971 
Place of death, others  0.0938** 0.0671  0.0423** 0.0226  1.8443 0.8453  0.9813 0.3442 
Uninsured  0.4467 0.2466  0.4329 0.2228  0.8855 0.2333  1.0551 0.3812 
SPrEm  0.0537* 0.0606  0.0847** 0.0528  0.3788 0.1904  0.5419* 0.1486 
UCE  0.6400 0.2814  0.7315 0.2368  0.7232 0.1527  0.8275 0.1383 
UCP  1.0278 0.4658  0.9323 0.2984  0.9148 0.2532  1.2064 0.3235 
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6.3.5.3 Expenditure for ambulatory care 
Table A4.19 and A4.20 show the logistic regression for the probability of having 
expenditure and the GLM (Poisson-log) for the values of expenditure for ambulatory 
care, respectively. It was indicated that after adjusting age, being head of household, 
occupation, cause of death, place of death and health insurance scheme determined the 
probability of having such expenditure while region, urban area, age, male, being head 
of household, occupation, cause of death, place of death, health insurance scheme  as 
well as using complementary medicine determined the values of expenditure. Table 6.7 
reveals the odds ratio and rate ratio of each factor in both parts of the model when 
keeping other factors constant as well as unadjusting. 
For instance, when keeping other factors constant, decedents accessing ambulatory care 
aged 20 to <30, 30 to <40 and 40 to <50 had 99 to 92 percent less probability of having 
expenditure than children dying aged less than 5 years. Heads of household had 65 
percent less likelihood of having expenditure than other members of the household. The 
uninsured as well as UCP decedents had approximately 300 to 500 times greater 
likelihood of having expenditure than CSMBS decedents. In determining the values of 
expenditure, decedents living in the central region had only one quarter of the 
expenditure of decedents living in Bangkok; decedents living in other regions had 
approximately one third or two fifths of the expenditure of decedents living in Bangkok. 
Heads of household paid 57 percent more than other household members. Decedents 
dying at private hospital had 4 times the expenditure of those dying at home. 
 190
Table 6.7 The two-part model of the expenditure for ambulatory care 
 Part I: Logistic regression  Part II: GLM (Poissopn-Log) 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Region, central  2.0114 2.4303  0.8234 0.5108  0.2630* 0.1375  0.1032** 0.0305 
Region, north  1.1872 1.2914  0.4487* 0.1747  0.3956* 0.1717  0.3599* 0.1617 
Region, north-east  2.7743 3.0755  0.7492 0.3301  0.3063* 0.1434  0.2045* 0.1303 
Region, south  2.4300 2.7482  0.7834 0.4885  0.3085** 0.1128  0.1284** 0.0571 
Urban  1.2095 0.3983  1.1692 0.2310  0.4394** 0.1338  1.5066 0.5817 
Age 5 to <10  0.2466 0.3007  0.6028 0.8757  1.7010 1.7891  1.5596 0.5325 
Age 10 to <20  (dropped)  (dropped)  1.9566 1.3834  12.1547** 10.0256 
Age 20 to <30  0.0129** 0.0205  2.2965 2.3338  6.2194 6.2509  8.8962** 6.0707 
Age 30 to <40  0.0400** 0.0483  3.2513 3.9856  0.5201 0.4482  2.3680 1.0394 
Age 40 to <50  0.0824* 0.0860  1.1257 1.0046  0.3118 0.2346  1.5122 0.8134 
Age 50 to <60  0.1904 0.3132  5.7791* 4.8967  1.0408 0.7827  2.9027 1.8022 
Age 60 to <70  0.2084 0.2284  0.5658 0.4770  0.8950 0.6331  3.5790* 2.0461 
Age 70 to <75  0.3471 0.4001  1.2661 0.9338  0.3462 0.2576  1.1798 0.5049 
Age 75 to <80  0.5319 0.6680  1.2600 1.0406  0.4834 0.3634  0.8666 0.4041 
Age >=80  0.4326 0.4838  1.1488 0.7809  0.8466 0.5870  1.8994 0.8993 
Male  0.8006 0.3315  1.0049 0.2613  1.8792** 0.3692  1.8368 0.6062 
Head of household  0.3515** 0.1411  0.5118* 0.1705  1.5693* 0.2873  0.9767 0.3615 
Education, primary  0.9943 0.4298  1.3435 0.5226  1.3311 0.3642  2.1861 0.9883 
Education, higher  0.8884 0.5434  1.3803 0.9944  1.7789 0.7231  7.3016** 3.5113 
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Table 6.7 The two-part model of the expenditure for ambulatory care (cont.) 
 Part I: Logistic regression  Part II: GLM (Poissopn-Log) 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Occupation, professionals  26.8158** 27.7575  2.6724 2.4060  0.5143 0.2076  2.0298 1.1696 
Occupational, others  1.3049 0.6427  1.6238 0.5768  2.0850 0.9048  0.8857 0.5365 
Income, Q2  1.3029 0.7520  2.1191 1.0420  1.0995 0.4697  0.8362 0.6395 
Income, Q3  0.5164 0.2004  1.6988 0.7073  2.0138 0.9690  0.9237 0.3123 
Income, Q4  0.6814 0.4156  1.7001 0.7379  1.1953 0.5200  0.3960 0.2165 
Income, Q5  0.8028 0.5816  1.0585 0.4313  1.2410 0.4455  2.5816 1.3559 
Communicable ds.  1.7016 2.6629  0.6062 0.5449  0.2533 0.2457  0.3129 0.2917 
Non-communicable ds.  1.6308 1.9698  0.9324 0.6858  0.5181 0.5054  0.6466 0.5715 
Injuries  10.3519 16.3078  2.7532 3.3116  0.1169 0.1340  0.1959 0.1851 
Senility  2.0837 2.6542  1.3177 0.7516  0.0901 0.1022  0.1374* 0.1240 
Cancer  5.0931 7.6936  2.4435 1.8313  0.2539 0.2675  0.8516 0.8155 
Place of death, public hosp.  0.2957** 0.1258  0.6300 0.2778  0.2054** 0.0736  0.2943** 0.1138 
Place of death, private hosp.  3.9772 3.8896  6.7311* 6.3285  4.1224** 1.2794  2.5950 1.2894 
Place of death, others  0.3828 0.5014  0.4081 0.3450  0.1965 0.2655  0.2635 0.3031 
Uninsured  317.4963** 451.5934  27.9108** 21.8341  2.2292* 0.7724  4.6829** 2.2250 
SPrEm  7.6145 9.2803  16.8194** 17.5586  0.1887* 0.1300  1.0924 0.3960 
UCE  0.8938 0.4089  2.1919* 0.7296  0.5376* 0.1662  0.3926* 0.1757 
UCP  485.4059** 491.1424  94.1623** 90.8702  0.2953* 0.1577  0.8074 0.4393 
Complementary med.  126.4473** 173.2768  48.2729** 49.7839  0.5664* 0.1376  0.3903* 0.1635 
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6.3.5.4 Expenditure for acute care 
The two-part model for expenditure for acute care is shown in Table A4.21 and A4.22 
in Appendix A4.6. Significantly, factors influencing the likelihood of having the 
expenditure included region, age, education, income quintile, occupation, cause of 
death, place of death and health insurance scheme. In addition, the factors adjusting in 
the model that significantly influenced the values of expenditure included region, age, 
male, cause of death, place of death and health insurance scheme. Table 6.8 illustrates 
the odds ratio of the part I and rate ratio in the part II of the two-part models, both 
adjusted and unadjusted. For instance, it was found that decedents living in central or 
north-eastern regions had four-fifths the likelihood of having expenditure for acute care 
compared to living in Bangkok. Decedents in the richest quintile had nearly 3 times 
greater likelihood of having expenditure than the poorest quintile. Part I of the model 
shows disparity in likelihood of having expenditure across different causes of death, 
compared to the ill-defined causes while dying from injuries had the greatest probability 
of having expenditure. In predicting values of expenditure for acute care, decedents in 
all regions had 16-34 percent the expenditure of decedents living in Bangkok. 
Expenditure for males was twice the expenditure of female decedents and the 
expenditure of the uninsured group was 5 times higher than that of CSMBS decedents. 
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Table 6.8 The two-part model of expenditure for acute care 
 Part I: Logistic regression  Part II: GLM (Poisson-Log) 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Region, central  0.1900** 0.1098  0.2603** 0.1233  0.3456* 0.1597  0.4436 0.3434 
Region, north  0.4073 0.2445  0.2117** 0.0840  0.2745** 0.1343  0.1398** 0.0583 
Region, north-east  0.2044* 0.1428  0.1192** 0.0493  0.1888** 0.0950  0.0749** 0.0515 
Region, south  0.5311 0.4611  0.0730** 0.0464  0.1571** 0.0878  0.1227** 0.0518 
Urban  0.8880 0.3380  1.9776** 0.4198  0.5763 0.2376  2.0567 1.3452 
Age 5 to <10  (dropped)  (dropped)  (dropped)  (dropped) 
Age 10 to <20  (dropped)  (dropped)  16.4851* 18.8293  17.7359** 15.0350 
Age 20 to <30  1.6388 1.9623  18.7982* 21.9914  64.9716** 63.2344  4.1643** 1.9151 
Age 30 to <40  0.2342 0.2831  4.0381 3.8226  7.3079 8.2365  0.7842 0.6128 
Age 40 to <50  0.2130 0.2903  7.01201* 6.8552  1.9493 1.9980  0.2460* 0.1391 
Age 50 to <60  3.2401 3.7654  6.2753 6.2802  36.1703** 25.9378  4.2968* 2.6468 
Age 60 to <70  0.7411 0.7107  1.9007 1.6561  15.9367** 13.5973  4.0686 2.9501 
Age 70 to <75  7.4745 7.6651  1.7096 1.4739  7.4428** 5.2979  3.3216* 1.6760 
Age 75 to <80  3.5940 3.9169  1.2902 1.0876  38.7833** 31.8770  27.0277** 20.5299 
Age >=80  4.2343 4.1933  2.0666 1.6281  12.6495** 10.1785  8.4372** 5.1924 
Male  0.8384 0.4036  1.0641 0.3043  2.1586** 0.6124  2.6278* 1.0950 
Head of household  1.2153 0.4716  0.8053 0.2240  0.8700 0.2296  1.3932 0.7959 
Education, primary  0.6517 0.2464  1.0201 0.3353  1.2406 0.3617  0.7911 0.4520 
Education, higher  2.7691 2.1313  3.8570* 2.5799  1.9283 0.7753  1.1750 0.6836 
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Table 6.8 The two-part model of expenditure for acute care (cont.) 
 Part I: Logistic regression  Part II: GLM (Poisson-Log) 
 Adjusted model  Unadjusted model  Adjusted model  Unadjusted model Variable 
 Odds Ratio Std. Err.  Odds Ratio Std. Err.  IRR Std. Err.  IRR Std. Err. 
Occupation, professionals  5.5934 4.9986  10.8693** 8.0619  0.5166 0.2863  0.3114 0.2070 
Occupation, others  0.4686 0.2630  1.7308 0.7548  0.3830 0.1879  0.0931** 0.0512 
Income, Q2  1.0539 0.5692  2.8416* 1.1622  0.5533 0.2824  0.3197 0.1612 
Income, Q3  2.9611 1.8057  2.9637* 1.5851  0.8225 0.4139  1.4425 1.1610 
Income, Q4  3.1616 1.9273  2.7408 1.6602  0.7583 0.4236  0.7080 0.5171 
Income, Q5  3.7797* 2.1069  4.5392** 2.3594  1.1790 0.5443  3.1422* 1.5861 
Communicable ds.  218.6065** 326.9798  2.6054 3.1329  8.1225 9.1728  4009.999** 2191.8310 
Non-communicable ds.  189.5587** 236.0907  3.4190 3.9944  3.6923 3.8096  789.4102** 358.1875 
Injuries  1203.995** 2306.0800  18.0214* 20.8545  2.9863 4.8813  1018.897** 472.1334 
Senility  336.6392** 422.2768  1.5973 1.8053  1.9156 1.9123  698.1312** 281.0954 
Cancer  1072.132** 1387.2520  3.8699 4.3801  2.0775 2.5539  1134.656** 348.5888 
Place of death, public hosp.  2.2503* 0.7762  1.9504* 0.6095  1.0630 0.3370  1.6350 1.1142 
Place of death, private hosp.  11.6738* 12.5103  16.8359** 12.7653  1.8474 0.7631  3.7888* 2.4149 
Place of death, others  1.2491 1.1010  0.7552 0.9346  0.1730* 0.1459  0.1055** 0.0477 
Uninsured  45.6689** 42.6860  7.7380* 6.4296  4.9680** 2.2266  3.6382* 2.2253 
SPrEm  2.1538 3.2045  3.3334 2.3182  0.3899 0.5664  1.2496 0.8108 
UCE  0.6689 0.1969  0.4740* 0.1550  2.3905 1.2149  1.9203 1.3444 
UCP  6478.04** 6380.6870  414.3686** 243.0202  0.2321 0.1873  0.1535** 0.0872 
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 6.3.6 Reasons underpinned for no use of acute care within the last six months of lives 
 Of all decedents, it was reported that 43 percent (N = 164,664) did not have any 
hospitalisation within the last six months prior to death. Of these non-seekers, the 
reason provided included sudden death (61.1 percent); decedents refused to be 
hospitalised (15.2 percent); decedents desired to die at home (14.2 percent); 
inconvenience in travelling (2.9 percent); inability to pay (0.4 percent); and other 
reasons which unable to identify (6.2 percent). 
6.4 Summary on research findings and study limitation 
6.4.1 Summary of research findings 
For the 2006 Thai fiscal year, the mortality rate reported in this study was 6.0 per 1,000 
population while the official mortality rate was 6.76, indicated in the Report on the 
2005-2006 Survey of Population Change which is a similar survey. It was found in this 
study that decedents died aged 62.7 in which males died at 58.0 and 68.5 for females, 
while male life expectancy was reported as 69.9 and 77.6 for females. This difference is 
due to the official calculation based on the de jure mid year population while this study 
calculation is based on the estimated population in the fifth round of the survey. In 
addition, numbers of decedents were adjusted with population factors and the factors 
resulted from the Post Enumeration Survey by the National Statistical Office (Economic 
and Social Statistics Bureau 2007). Focusing on the wealth status (income quintile) 
which was different from the report on such survey, the age specific mortality rate do 
not show any disparity pattern across income quintile by selected factors indicated as 
the social determinants of health, for example, geography (region), and socioeconomic 
status (education and occupation) (Commission on Social Determinants of Health 
2008). However, these age specific mortalities revealed the disparity between the 
poorest and the richest group in some regions, primary education, for instance. When 
comparing life span across health insurance schemes, decedents in CSMBS schemes 
were the oldest and SPrEm decedents were the youngest. This is due to each health 
insurance criteria for beneficiaries and benefit packages.  
Prior to death, nearly 60 percent of decedents sought either ambulatory care or acute 
care in the last quarter and the last half year of life, respectively, and nearly two-fifths 
sought both forms of care. Of these, nearly two-thirds and two-fifths paid out of pocket 
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for ambulatory care and acute care, respectively. On average, the access rate was 4.3 
visits per decedents within the last three months for ambulatory care and the household 
expenditure was 3,763 Baht per user. The access rate to acute care was 1.7 
hospitalisations per decedent within the last six months and households paid 15,767 
Baht per user.  
Place of death shows relation to wealth status, health insurance scheme and cause of 
death. It was found that death at public hospitals increased and death at home decreased 
as wealth increased. CSMBS beneficiaries were more likely to die in public hospitals 
than beneficiaries of other schemes but uninsured group and the UCE likely died at 
home. Nearly two-thirds of decedents dying from communicable diseases died in public 
hospitals and in contrast, a similar proportion of decedents dying from cancer died at 
home. In seeking ambulatory care, community hospitals and general/regional hospitals 
were the major health facility that all except the richest group accessed. Such decedents 
sought care at general/regional hospitals and university hospitals. Access to private 
clinics and complementary medicine decreased as income quintile increased. Of seeking 
acute care, the use of community hospitals and general/regional hospitals decreased as 
income quintile increased which is contradictory to the use of university hospitals. It is 
also clear that access to both types of cares at available health facilities was according to 
the health insurance scheme. However, while the CSMBS decedents were likely to 
access general/regional hospitals and university hospitals, both UCs accessed to PCU, 
community hospitals as well as general/regional hospitals for ambulatory care, which 
was equally distributed, and general/regional hospitals and community hospitals for 
acute care. 
In the two-part model, the based model was employed in multivariate regression in this 
study for both utilisations of and expenditure for ambulatory care and acute care. It 
provided the probability of using care or having expenditure in Part I and the positive 
values of the use and expenditure in Part II. Specifically to Part I and Part II, 
respectively, the best fitted model for utilisation of ambulatory care comprises of the 
logistic regression and the zero-truncated negative binomial model while the model for 
utilisation of acute care was the logistic regression and the zero-truncated Poisson 
model. In addition, the model for expenditure for both types of care was the logistic 
regression and the Poisson model.  
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A summary of the variables and the significant role of some variables for utilisations 
and expenditures of both types of care are shown in Table 6.9. It is clear that the four 
main predictors which played significant roles in seeking behaviour and payment for 
both types of care includes age, cause of death, place of death and health insurance 
scheme whereas the wealth status of the decedents which was one of two factors of 
interest stated in the objectives played a lesser role. Further, cause of death revealed its 
strong effect in determining all behaviour and payments but places of death and health 
insurance scheme had significant roles in all except in determining the number of 
hospitalisations. Age also affected all but the determining number of ambulatory visits 
and occupation was likely to determine the likelihood in seeking care and having 
expenditure. Region, a geographical factor, also determined the value of household 
payment for both types of care. 
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Table 6.9 Predictors of seeking health care and out of pocket payment for ambulatory care and acute care 
Ambulatory care Acute care 
Factor Predictor Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
Geography: Region  **  **   * * 
 Bangkok (ref.)         
 Central (+) (-) (+) (-)* (-)    (+)*    (-)** (-)* 
 North (+) (+) (+) (-)* (+) (+) (-)   (-)** 
 North-east (+) (-) (+) (-)* (-)   (+)*   (-)*   (-)** 
 South (+)   (-)* (+)   (-)** (-) (-) (-)   (-)** 
 Municipality    **     
 Rural (ref.)         
 Urban (+) (-) (+)   (-)** (+) (-) (-) (-) 
Demography: Age at death (yrs.) **  ** ** ** ** * ** 
 <5 (ref.)         
 5 to <10 (+)** (-) (-) (+) (+) (-)** (dropped) (dropped) 
 10 to <20 (+) (+) (dropped) (+) (-) (+) (dropped)  (+)* 
 20 to <30 (+)** (-) (-)** (+)    (+)** (+) (+)    (+)** 
 30 to <40 (+)* (-) (-)** (-)  (+)* (-) (-) (+) 
 40 to <50 (+)* (-) (-)* (-) (+) (-) (-) (+) 
 50 to <60 (+)* (-) (-) (+) (+) (+) (+)    (+)** 
 60 to <70 (+)* (-) (-) (-) (+) (-) (-)    (+)** 
 70 to <75 (+)** (+) (-) (-)    (+)** (-) (+)   (+)** 
 75 to <80 (+)** (-) (-) (-)    (+)** (-) (+)   (+)** 
 >=80 (+)** (+) (-) (-) (+)* (-) (+)   (+)** 
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Table 6.9 Predictors of seeking health care and out of pocket payment for ambulatory care and acute care (cont.) 
Ambulatory care Acute care 
Factor Predictor Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
 Gender    **    ** 
 Female (ref.)         
 Male (-) (-) (-)    (+)** (+) (+) (-)    (+)** 
Socioeconomics: Head of household   ** *     
 No (ref.)         
 Yes (+) (-)    (-)**   (+)* (+) (+) (+) (-) 
 Education  **     **  
 Uneducated (ref.)         
 Primary level (+) (+) (-) (+) (+) (-) (-) (+) 
 Higher (-)    (+)** (-) (+) (-)   (+)* (+) (+) 
 Occupation   ** ** **  *  
 Economically inactive (ref.)        
 Professionals (-) (+)    (+)** (-) (+)    (-)** (+) (-) 
 Others (+) (+) (+) (+)    (+)** (-) (-) (-) 
 Income quintile  **     *  
 1st (ref.)         
 2nd (+) (+) (+) (+)    (-)* (+) (+) (-) 
 3rd (+) (-) (-) (+) (-) (-) (+) (-) 
 4th (-) (-) (-) (+) (-) (-) (+) (-) 
 5th (+)    (-)** (-) (+)    (-)** (-) (+)* (+) 
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Table 6.9 Predictors of seeking health care and out of pocket payment for ambulatory care and acute care (cont.) 
Ambulatory care Acute care 
Factor Predictor Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
Seeking 
care 
Visit 
value 
Having 
payment 
Payment 
value 
Others: Causes of death ** ** * ** ** ** ** ** 
 Ill-defined (ref.)         
 Communicable ds.    (+)** (+) (+) (-)    (+)** (-)    (+)** (+) 
 Non-communicable ds.    (+)**   (+)* (+) (-)    (+)** (-)    (+)** (+) 
 Injuries (-) (+) (+) (-) (+)    (-)**    (+)** (+) 
 Senility  (+)* (+) (+)   (-)*    (+)** (-)    (+)** (+) 
 Cancer   (+)**    (+)** (+) (-)    (+)** (+)    (+)** (+) 
 Places of death ** * ** ** **  * ** 
 Home (ref.)         
 Public hosp. (-)    (-)*    (-)**    (-)**    (+)** (-)   (+)* (+) 
 Private hosp. (+) (+) (+)    (+)**   (+)* (+)   (+)* (+) 
 Others  (-)* (+) (-) (-)    (-)** (+)    (-)* 
 Health insurances * ** ** ** *  ** ** 
 CSMBS (ref.)         
 Uninsured   (-)* (+)    (+)**   (+)* (-) (-)    (+)**    (+)** 
 SPrEm (+)   (+)* (+)  (-)*   (-)* (-) (+) (-) 
 UCE (-) (+) (-)  (-)* (-) (-) (-) (+) 
 UCP (-)    (+)**    (+)**  (-)* (+) (-)    (+)** (-) 
 Complementary med. **       
 no (ref.)         
 yes     (+)**   (+)**  (-)*     
Source: Table A4.17 to Table A4.22,  Note: * p < 0.05; ** p < 0.01; 
Ref. = reference;  (+)  and (-) = direction of the coefficient of such independent variable relative to the its reference and dependent variable         
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6.4.2 Data and methodological limitations of the study 
 This study was limited from having a better analysis due to the issues including, first, 
the difference in duration of data, that is, within 3 months of ambulatory care and within 
6 months acute care. This mismatched duration made the analysis difficult in summing 
up the household expenditure of both types of care. As a result, the study had to reveal 
utilisation and expenditure for both types of services separately. Furthermore, for 
expenditure, in order to generalise such different periods into a year commonly used in 
health measures and financial terms, it required weighted factors for proportionate 
extrapolation. However, there was no factor available in the Thai setting, neither 
utilisation nor costs for ambulatory care nor acute care. Although Lubitz et al (1993) 
reported that the cost for hospitalisation during the last six months, last three months 
and last months of life accounted for 70-71, 51 and 30 percent of the cost for the whole 
last year of life in the US and Seshamani et al (2004a) predicted a significant increase in 
the rate of expenditure in the UK, as time gets closer to death, the model used in this 
study has not employed this fraction. This is for the reason that the different health 
systems in each country are likely to have different financing system and benefit 
packages which implicated different health care cost proportion. 
A suggestion for further research using this survey method could include reducing the 
duration of acute care to 3 months to be equal to the term of ambulatory care. In fact, 
the severity of illness prior to death may be in greater need of hospitalisation than other 
periods in life. Some studies support this assumption, for example, Seshamani et al 
(2004a) indicated that the probability of being hospitalised from the 2nd quarter  to  the 
last quarter of life had a  three fold increase (more details in Chapter Three, section 
3.2.1) (Feudtner, DiGiuseppe et al. 2003; Seshamani and Gray 2004a). This might also 
lead to a reduction in the recall bias of the interviewees and therefore an increase in the 
accuracy of the responses. 
Next, household expenditure on non-medical care cost might represent a great burden of 
cost incurred to households as well, particularly the travelling costs for households in 
remote rural areas. Although this travelling cost was included in the SHUE 
questionnaire, it was only for the last visit and last hospitalisation. A question about the 
average travelling expenditure households paid per visit or hospitalisation may be more 
useful. It would then not underestimate travel costs in the instance where the last visit or 
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hospitalisation was different from the usual health facility or free charge by the referral 
system. In contrast, the severity of illness in the last visit or hospitalisation might be 
greater than the visits or prior hospitalisations which the decedents required more 
comfortable and intensive care but expensive vehicles. That is, as a consequence, this 
last travel cost might be overestimated in representing the average cost of travelling 
during the last period of life. In addition, the question on reasons that underpinned no 
utilisation should not only be asked for non-hospitalised decedents but also the 
decedents who were non-users for ambulatory care services. This might fulfil the 
evidence for the non-seeking care decedents and monitoring the health system 
performance during the last period of life.  
Two important items of information are lacking from the surveys, i.e. the religious 
group and ethnicity of the decedents. Even though 94 percent of Thais are Buddhist, the 
rest of the country is Muslim and Christian (Ekachampaka, Taverat et al. 2008). 
Religion might have an influence on the concept of death, beliefs and decisions on 
dying. Ethnicity might also have role in accessibility to health care, especially the ethnic 
minorities or permanent residents without citizen ID. Those minority groups had not 
been enrolled in any three health insurance schemes due to lack of citizen ID. The 
implicaiton of these factors on health seeking behaviour was found in a study in 
Medicare beneficiaries dying between 1996 and 1999, where difference in expenditure 
between blacks and white was indicated (Shugarman, Campbell et al. 2004). An 
additional minor point was the information about health insurance schemes of all 
respondents in the main SPC questionnaire might shed more light, for example, on 
decedent to population ratio of each health insurance scheme. 
The analysis of health care utilisation and health expenditure employed the hurdle 
model or two-part model, in which the first stage or first part estimated the probability 
of using care and having expenditure by logistic regression. With regard to the 
modelling for probability, other models should be tested as well, for example, the probit 
model, clog-log model and log-log model for binary choice (Hardin and Hilbe 2007). 
The second part of the model for expenditure employed OLS, OLS on log expenditure 
with Duan’s smearing factor, and the two generalized linear models family including 
gamma-log and Poisson-log. Poisson and log link was the best model for expenditure 
for both types of care. However, two tests of goodness of fit for the log link were 
significant, that is, this link might not fit the data. This might be partly due to high 
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variations in data and in this circumstance more data may be required. Owing to 
unavailability of some commands in Stata, analysis on the survey using weighted factor 
had limitations, in particular, post-estimation tests. The predicted means of expenditure 
by the two GLM models were higher than the observed mean, in particular, the gamma-
log model. Thus, in addition to the based model, other one-part models might be more 
appropriate than this two-part model for both utilisation and expenditure. This one part 
for numbers of utilisation includes zero-inflated Poisson or zero-inflated negative 
binomial which takes the zero count into account of the regression (Hardin and Hilbe 
2007). There might be another model which is more appropriate to health care utlisation 
and expenditure. Similar to the issue discussed about the effect of length of 
hospitalisation on as an endogenous regressor in Chapter Five, subsection 5.4.2, 
modelling in this study might have such effect of three socioeconomic factors plus 
health insurance scheme. As a result, ensuring of neither collinearility nor association 
with the linear instrumental-variable regression which accounts for the endogenous 
regressors should be employed (Cameron and Trivedi 2009). Taking these education, 
occupation and wealth status plus health insurance scheme might lead to over-adjusted 
position of the socio-economic factor in the model. Further details discussing the 
association of such socioeconomic factors and the effect on health care utilisation and 
household expenditure are described in following section. 
6.5 Discussion 
This study was a survey from the household perspective whereas all the studies found in 
the literature reviewed in this thesis were studies on expenditure incurred by health 
insurers. Thus, to some extent, expenditure of both sides might be different in pattern of 
use and factors determining expenses. The analysis of the household survey in this 
chapter meets most of its aims as a means of: estimating utlisation and household 
expenditure for decedents prior to death; revealing the health seeking behaviour of such 
decedents; and revealing the multiple factors affected to those seeking and expenditure 
which probably leads to inequity of household payment. One objective that the analysis 
was unable to address is the proportion of health expenditure to household expenditure, 
due to disaggregation of questions on the types of service use and expenditure as 
previously mentioned in subsection 6.4.2.  
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Compared to the general population, the proportion of decedents by health insurance 
schemes in 2005-2006 was different in all schemes except the UC. That is, the enrollees 
in 2008 (indicated in Chapter Two, subsection 2.2.4.1) and decedents were 75.7 versus 
79.1 percent in the UC group; 8.1 versus 13.7 percent in CSMBS beneficiaries; 14.0 
versus 3.0 percent in SPrEm; and 2.2 versus 4.1 percent of uninsured group. It was for 
the reason that, for example, death actually occurs at older ages rather than childhood 
and younger ages. This old age is more likely distributed in UC and CSMBS schemes 
than the SPrEm which its target population includes working ages with a small 
mortality rate.  
Even though the seeking behaviour of the general population was reported in yearly 
durations and excluded decedents, comparison between both groups might provide 
some useful information. The general population revealed in 2003 Health and Welfare 
Survey47, the latest survey close to the survey period of this study, was reported that on 
average, the hospitalisation rate was 0.08 per person per year whereas the rate of the 
decedents in last six months of life was 1.7 hospitalisations per person (Vasavid, 
Tisayaticom et al. 2004). It should be noted that decedents were the population with 
high access. The utilisation of a decedent might share the health care resources more 
than double the general population. As a result, the report of illness, morbidity lacking 
of this decedent group might be underestimated. By health insurance schemes, it was 
reported in a different fashion in the HWS study and this study where the CSMBS 
beneficiaries were the group of highest hospitalisations in general population but the 
UCP decedents were the group with greatest hospitalisations, i.e. 0.10 versus 2.1. This 
might reflect the different patterns of health care use during the other periods and the 
terminally ill stage across different health insurance schemes.     
Even though first choice of health facilities between the UC and the CSMBS 
beneficiaries are different, no difference was found in ambulatory care seeking 
behaviour in both UC beneficiaries and CSMBS beneficiaries between the general 
population and the terminally ill group. That is, the UC group sought more service at 
PCUs and community hospitals and the CSMBS group sought more service at 
community hospitals and general/provincial hospitals. In seeking acute care, the 
                                                 
47 The Health and Welfare Survey is the regular survey on health conducted by the National Statistical 
Office. It explores illness episodes, health service utilisation and compliance rate of health insurances. 
Such illnesses are the episode in a month for ambulatory care and 12 months for acute care prior to 
interviewing date. The samples are the existing household members.  
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majority of hospitals which the general population and decedents accessed were not 
similar in the two groups. That is, in the general population, the group with CSMBS 
insurance sought general/regional hospitals (32.3 percent) as well as community 
hospitals (28.2 percent), and those covered by the UC accessed community hospitals 
(54.4 percent) and general/regional hospitals (27.0 percent).  In contrast, CSMBS 
decedents accessed general/regional hospital substantially (59.0 percent) and those from 
UC sought care at general/regional hospital (49.3 percent in UCE and 43.2 percent in 
UCP) and community hospitals (37.0 percent in UCE and 37.6 percent in UCP), 
respectively (Vasavid, Tisayaticom et al. 2004). It seems that the terminally ill 
population might seek more advanced care than the general population and patterns of 
using health facilities for acute care were also changed. However, these comparisons 
provide only a rough idea and interpretation should be done cautiously because of 
differences in time frame of both surveys and the survey design. Further research is 
needed for confirmation. 
By wealth status, Prakongsai (2008) reported that people in the poorer quintiles were 
more likely to seek ambulatory care at primary care health facilities than the better-off 
quintiles. In contrast, this study could not reveal different seeking patterns between the 
poor and the rich. It seems that community hospitals and general/regional hospitals were 
the popular health facilities for ambulatory care among decedents regardless of wealth 
status. In seeking acute care, the 2003 survey revealed that the poorest quintile had the 
lowest rate of hospitalisations while the richest had the highest rate (0.105 versus 0. 598 
hospitalisations per capita per year). In contrast, the poorer decedents in the 1st and 2nd 
quintile had the highest rate of hospitalisations (1.8 and 1.9 versus 1.3 hospitalisations 
per six months). Further, utilisation of community hospitals decreased as income 
quintiles increased in the general population which is similar to the decedent group. In 
addition to the decedent group, utlisation at university hospitals and private hospitals 
had a positive relation to the wealth status. 
Compared to other countries, Thai decedents are likely to have less access to formal 
health care than decedents in developed countries, i.e. 58.6 percent and 57 percent for 
ambulatory care within three months and acute care within six months, respectively 
while access to acute care in the US was 55-77 percent; 90 percent in access to GP and 
73.2 percent in access to acute care during the last year of life in the UK; and 79 percent 
in access to acute care and 60 percent to ambulatory care during the last three months in 
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Sweden (details show in Chapter Three, Table 3.2) (Emanuel, Ash et al. 2002; 
Seshamani and Gray 2004a; Jakobsson, Bergh et al. 2007).  
The findings of this study show there was disparity and inequality in utilisation and 
expenditure among decedents due to the effect of many factors revealed in the 
multivariate analysis. The main determinants of health care service utilisation and 
household expenditure include age at death, cause of death, place of death and health 
insurance scheme. In contrast, municipality, gender, being head of household, education 
and wealth status (income quintile) play a small role in utilisation and expenditure for 
both types of care. Geography (region) was likely to have no significant role in 
probability of payment but have a significant role in monetary terms of expenditure for 
both types of care. The differences revealed that when keeing other factors constant, 
decedents who sought care in the four regions had significantly less out of pocket 
payments than decedents living in Bangkok, implicating in inequality of payment across 
the geography. Cause of death revealed its different effects in all steps of determining 
utilisation and expenditure; however, it is difficult to conclude the inequality or the 
inequity. This is due to the fact that patients with different diseases may need different 
types of health care and services which is indicated as vertical equity, and it is difficult 
to measure such health needs (see Chapter Three, subsection 3.1.2.2). Compared to 
home death, dying at public hospitals was expected to have less chance and number of 
utilisation of, and less chance to incur and less amount of household expenditure for 
ambulatory care, but such place determined greater household expenditure for acute 
care. In other words, dying at home would lead decedents to have more utilisation of 
and expenditure for ambulatory care but would lead to less utilisation of and 
expenditure for acute care than dying in public hospitals. 
Focusing on wealth status, a main factor of interest, when holding other factors 
constant, it only had an effect on the amount of utilisation of ambulatory care and on 
payment for acute care.(Table 6.9). The richest decedents had significantly fewer visits 
for ambulatory care and a significantly less likelihood of hospitalisation than the 
poorest. Both adjusted and unadjusted models revealed a likely similar significant role 
of the wealth status for utilisation and household payment except the amount of 
payment for acute care (Table 6.8). After adjusting, the odds ratio and its standard error 
did not show great change. Considering with other socioeconomic factors (education 
and occupation) between adjusted and unadjusted models, these two factors also 
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revealed likely similar significant effect and small changes in odds ratio, rate ratio and 
standard error across each category (Table 6.5 to Table 6.8). Such change might support 
that there was no collinearity among the socioeconomic factors in the model but rather 
the association of such independent categorical variables. 
However, data quality of the wealth status which might influence the minimal effect to 
dependent variables should be taken into account. In this study, wealth status (or living 
standards) of individuals represented by household income quintile might have less 
accuracy than other methods. As indicated in Appendix 4, section A4.4, income quintile 
and quintile of household assests shows weak correlation possible leading to inaccuracy, 
that is, the quintile was scattering in distribution and less than half of population was 
classified in similar quintile. This might be in line with comment of O’Donnell et al 
(2008b) that generally, household income as well as consumption or expenditure itself 
has limitation leading to inaccuracy. This is due to reluctance of the survey respondents 
in disclosure of information. In developing countries including Thailand, the common 
employment is in the informal sector for which income is a multisource and continually 
changes, as a consequence collecting income is more difficult than comsumption 
(O'Donnell, van Doorslaer et al. 2008d).  
In contrast to the socio-economic factors, health insurance scheme, another main factor 
of interest, clearly shows their significant effect in all steps determining the utilisation 
and expenditure of decedents. With regard to collinearity among socio-economic factors 
and health insurance schemes and overadjusting of the model, Table 6.5 to Table 6.8 
show small change of odds ratio, rate ratio and standard error between adjusted and 
unadjusted models for use of both types of care. Dramatic change was observed in the 
likelihood of payment for both types. Even though health insurance schemes 
unavoidably relate to the socioeconomic status of their beneficiaries, the distribution of 
decedents in this study by health insurance schemes across education, occupation and 
wealth status shows unexpected relation as usual. That is, for example, the majority of 
CSMBS decedents had primary education and was economically inactive but was 
categorized in the 1st quintile as the same as the 5th quintile rather than the 2nd quintile 
(Appendix 4, Table A4.11) rather than higher education, having professional work and 
de facto being the well-off. As a result, such concerned problems might not be the case 
of the modelling in this study. In other words, those three socioeconomic factors 
including health insurance scheme were associated. This might be for the reason that the 
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study focusing on a special group of the whole population, the decedents which their 
wealth status represents the status of selected households rather than individual status of 
decedents (See details of method using for determining and categorising wealth status in 
Appendix 4, A4.4). The majority of the decedents was in old age, more than 60 years 
(subsection 6.3.1.1), hence, it was expected that they were not well-educated when they 
were young, at least 30 years ago. Even though they were CSMBS beneficiaries, they 
were economically inactive due to retiring before death. General CSMBS beneficiaries 
include people with the direction of higher education and being professional, compared 
to the UC. Specific to the propensity of having expenditure, it could additionally be 
explained by the fact that the health insurance schemes focus on different target 
population and provide different benefit packages (see Table 2.7). For example, 
compared to other schemes, the UCP shows greater probability of paying compared to 
the CSMBS because it was a compulsory of 30 Baht copayment of user fee as well as 
the uninsured decedents who were required all payment. 
Regardless of proving quality of the data, it should be concluded that there was 
nonsignificant inequality in access to ambulatory care between the rich and the poor 
when holding other factors constant (Table 6.5). However, significant inequity of access 
to acute care was found and the poor had greater access than the rich (Table 6.6). On 
payment, there was no significant inequality in the chance and value of expenditure 
incurred for ambulatory care except the chance of paying for acute care between the rich 
and the poor. That is, the rich had significantly greater chance of paying than the poor 
(Table 6.7 and Table 6.8).   
 Further indicating the progressiveness or regressiveness could be revealed by 
multiplying the predicted likelihood and the predicted value of utilisations and 
expenditure. However, this is out of the scope of this study.  
After holding other factors constant and compared to ill-defined causes, decedents dying 
from cancer would have the greatest chance in access to and number of utilisation of 
both types of care. However, such cancer decedents would have greater chance in 
paying and amount of expenditure for ambulatory care than dying from ill-defined 
causes and other non-communicable diseases but higher chance of paying but less value 
of payment than decedents dying from other non-communicalbe diseases. 
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6.6 Conclusion 
Access to ambulatory care and acute care during the last period of life was likely to be 
different from regular access by the general population including the utilisation pattern 
of health facilities. Decedents had greater access to both types of care and the utilisation 
during this period which shifted to health facilities with more advanced care. Vast 
differences were also found in utilisations of and household expenditure for ambulatory 
care within the last quarter of life as well as acute care within the last two quarters of 
decedents’ lives between 2005 and 2006. With multivariate regressions, it was 
confirmed that four factors including age at death, cause of death, place of death and 
health insurer had a significant effect on such utilisation and expenditure incurred to the 
decedents’ households. However, it could indicate the majority of horizontal equity in 
access and ability to pay or wealth status whereas the difference in health insurers 
benefit packages determined disparity in access to both types of care and expenditure 
incurred to households even in the last period of life.  
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CHAPTER SEVEN 
THE LAST PERIOD OF LIFE: TERMINALLY ILL CANCER PATIENTS AND 
THEIR CARE GIVERS PRACTICES AND PERSPECTIVES 
 
7.1 Introduction 
Unlike other diseases, cancer is a chronic disease that has a clear terminal stage. Up 
until now, patients with this chronic disease were likely to die within a certain period 
which depends on the disease staging after the first definite diagnosis. This period is 
shorter in the terminal stage, and has been estimated at less than three to six months 
(Thomas, Morris et al. 2004; National Cancer Institute 2006). The patients and their 
family might perceive disclosure of the diagnosis and prognosis, particularly in terminal 
illness, as bad news and thought that they were going to die. As a result, studying for 
example, their conceptualisation and experience of illness, their social culture, the level 
of economic development of the country, is needed to support the understanding of their 
preference, context and difficulties. These might lead to improvements in the services 
for health care for the terminal stage cancer patients and to have a good quality of life. 
For example, Murray et al (2003) indicated differences in needs and received health 
care between the 20 incurable cancer Scottish patients and 24 Kenyan patients, the 
background underpinning these differences included the health service system and 
available resources, disease patterns, religious beliefs and poverty level (Murray, Grant 
et al. 2003).  
Regarding the place of death which might be a factor determining the health services for 
the advanced stage cancer patients, Tang et al (2005) found that in a national survey 
taken during February 2003 to May 2004, 61 percent of terminally ill cancer patients 
and 56.9 percent of their family caregivers from a total of 617 dyads in Taiwan 
preferred death at home (Tang, Liu et al. 2005). Meanwhile, Thomas et al (2004) found 
in qualitative conversation style interviews with 41 cancer patients and 18 care givers 
that no patient expressed a wish to die in hospital.  Preferences were overwhelmingly in 
favour of either a home or hospice death. The study identified 13 factors as shaping the 
place of death preference (Thomas, Morris et al. 2004). In 2001-2002, Sepulveda et al 
(2003) found that preliminarily, the main needs of terminally ill HIV/AIDS and cancer 
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patients in 5 African countries seemed to be the relief of pain, accessible and affordable 
drugs and financial support.  Poverty and sickness combined to put families in a critical 
financial situation.  Other needs included the relief of symptoms other than pain and 
alleviation of social, emotional and spiritual problems (Sepulveda, Habiyambere et al. 
2003).  
Thus, this chapter focuses on the terminally ill cancer patients and care givers views. It 
was designed to seek an overview on their perspectives and preferences by employing 
the qualitative approach. The objectives of this study included: 
• To explore the current practice on the disclosure of diagnosis, preference for 
quality of life and care, place of dying in terminally ill patients and the patients 
relatives; and 
• To explore the multitude of factors considered important when people are dying. 
7.2 Methods 
Following the details given in Chapter Four, subsection 4.3.2.2, this study employed a 
qualitative approach, that is, the case study method in exploring and revealing some 
explanations supporting the findings from Chapter Five and Chapter Six. Terminal 
cancer was the disease of interest, as justified in the same section of Chapter Four.  
Ethical consideration: In addition to the ethics approval from the university, this part of 
the research was approved by the ethics committee of Sappasithiprasong Regional 
Hospital in 2007 and accepted by referring of other health institutes in Ubonratchathani 
province.  
The study encompassed end of life, dying and death. Thus, there might be unavoidable 
grief and bereavement of patients and their relatives during interviewing. Considering 
the sensitivity of the topic, the researcher aimed to avoid emotional disturbance and the 
interviews were conducted in a conversational style. The participants were given verbal 
information in illiterate cases or leaflet information (Appendix 5, A5.1) and details of 
the purposes of the study. There was no pressure on them to take part in the study. 
Verbal consent or/and informed consent (Appendix 5, A5.2) was gained and only 
competent adults were interviewed. Their permission to have their interviews tape 
recorded was requested and the cassettes will be kept confidentially for 5 years 
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according to the circumstances of the project48 and would be destroyed following that. 
They were guaranteed anonymity but were told that their information may be quoted 
without their names and family names in research findings. By observation or talking, 
whenever the interviewees begin to express their sorrow, e.g. crying, the interviewing 
was paused immediately. The researcher might change the conversation to other 
relaxing topics and continued the interview whenever the interviewee was willing. 
When the interviewee continued to be distressed, the attending physician or nurse was 
informed. According to their opinion, psychologists or counsellors may be requested to 
alleviate the interviewees’ distress.  The participants could withdraw his/her 
participation independently for whatever reason and whenever they wished. 
7.2.1 Research design and setting 
Research was carried out as in-depth interviewing conducted during March to August 
2007 in Ubonrachathani province as indicated in Chapter Four, subsection 4.3.2.2 (3). 
The researcher stayed for one to two months at each of three hospitals, i.e. 
Ubonratchthani Regional Hospital, Ubonratchathani Cancer Center, and KhuangNai. 
Figure 7.1 and 7.2 display the map of Thailand; the location of Bangkok and 
Ubonratchthani; and all 25 districts in the province and the three hospitals. Due to the 
distinctive referral system specific to health services for cancer patients, the patients 
who had definite diagnoses of cancer could have a short cut referral process, that is, 
patients could walk into the regional hospital or the cancer centre with one referral 
memo for an extensive period.  
                                                 
48  The University’s Guidelines on Good Practice in Research requirement 
 213
Figure 7.1 Map of Thailand, location of Bangkok, Ubonratchthani and other provinces 
in the regional referral systems of the regional hospital and the cancer centre 
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Figure 7.2 All 25 districts in Ubonratchthani including the districts the patient resided 
in (highlighted in grey) and the two districts where the three hospitals are located (the 
red-cross symbol) 
 
 
The study employed purposive sampling by starting with identifying the potential 
participants in accordance with the eligible criteria by physicians or nurses, followed by 
inviting the patients and their care givers to participate, asking for telephone numbers 
and making an appointment for conducting interviews at their most convenient time and 
place, all during the day and mostly at their home. In the case of those who were 
hospitalized, in which case most patients were either in severe conditions or unwilling 
to participate, interviewing their care givers was conducted in a private area in the 
hospital. In order to facilitate the convenience in travelling of the researcher and 
research assistant, all participants resided in Ubonratchathani. Details of identifying 
participants and their eligible criteria are described in the following section, 7.2.2. 
In addition to the patients and their caregiver perceptions on their illness, patients’ 
history of illness was confirmed by the patients’ medical record. This provides 
triangulation of the data collected in this study. Some participants might give more than 
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one interview depending on the completeness of their first interview. Later, they 
received a telephone call following up on their illness and mental health approximately 
within a week up to a month from the researcher. To be consistent across the researcher 
and research assistant, and individual to individual participant, the in-depth interview 
was constructed through the guided questions as described in Appendix 5, A5.3.  
7.2.2 Identifying participants 
Physicians and nurses who attend to the terminal stage cancer patients at surgical 
clinic/wards, obstetrics and gynaecology clinic/wards, pain clinics and general practice 
clinics were communicated with and asked to identify the cases. Then, the patients or 
their relatives (if any) were firstly approached by probing for the patients’ primary 
perception on their illnesses and diagnoses. Patients without the awareness of their 
diagnosis of cancer were dropped. All participants addressed were invited to be 
informants with verbal and leaflet information about the study (see details in Appendix 
5, A5.1), however interviews were not conducted unless the participants agreed by 
verbal consent and/or completing the consent form (Appendix5, A5.2). 
7.2.2.1 Cancer Patients 
Patients were recruited if they met the eligible criteria including patients who: 1) are age 
20 or above49; 2) have a disease at a terminal stage which continues to progress with 
distant metastases and is unresponsive to current curative cancer treatment or is given 
palliative treatment or has a prognosis of less than three months; 3) know their diagnosis 
of cancer50; 4) the physician consents for her/him to participate; 5) who are cognitively 
competent; 6) who have no psychological problem e.g. depression, psychiatric disorders 
(since (s)he cannot reflect on her/his real thoughts with the narrative); and 7) willing to 
participate in the study. 
7.2.2.2 Patients primary caregiver or decedents relatives 
Patients caregivers were included with criteria as those who: 1) are most involved in the 
patient care and health care decision making; 2) know that the patient is in the 
                                                 
49 Legal age at adult according to the Constitution of Thailand  
50 It was different from the proposal due to almost all of the patients in the fieldwork who met other 
criteria did not know their disease staging. 
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terminally ill stage of cancer; 3) are cognitively competent; and 4) willing to participate 
in the study. 
7.2.3 Data analysis 
The analysis was done using the method in Chapter Four, subsection 4.3.2.2 (5) 
accordingly. Due to the dialect specific to the Thais in the north-eastern region, the 
interviews were conducted in the official Thai and north-eastern dialect translated by the 
research assistant who is a local north-eastern Thai. The research assistant was a 
translator for the researcher and the patients as well as transcribing the conversation in 
the local dialect to official Thai.  
7.3 Findings 
This section revealed the findings from patients and caregivers experiences and views 
on cancer, making decisions regarding treatment, complementary medicines and 
supplement foods, preference for the place of care and place for dying, household 
expenditure, and perception on health insurance scheme and health services. On 
average, an interview took at least 2 hours per participant. Information was gathered 
from twelve patients and their caregivers while eight caregivers were interviewed alone, 
representing the patients.  
7.3.1 Characteristics of selected patients and their caregivers 
Forty-six cases were identified during the six months of standing by at three hospitals 
and twenty six were not recruited or dropped out. Reasons of such excluded cases 
include two patients dying prior to communication; eight residing in other provinces; 
eight unwilling to participate either since the beginning or during the second and third 
approach; three with unknown diagnosis; two unable to communicate or to follow up; 
and three unclear staging of cancer.  
Twenty terminal stage cancer cases participating in this study completed the interview. 
Mainly, patients as well as care givers were the key informants. However, seven 
patients were not in a good mood or condition for interviewing and their care giver did 
not agree, as well. Table 7.1 summarises the main characteristics of the patients and 
their care givers. Thirteen female and seven male patients participated in this study, 
ages ranging from thirty-six to sixty-three years with an average of fifty-two. Of these, 
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eight were diagnosed with cancer of the liver or bile duct; four with cervical cancer; two 
with ovarian cancer as well as colon; and one each of stomach, lung, nasal cavity and 
rectum cancer. All of the patients were educated at primary level except a patient who 
was a teacher graduated with bachelor degree. Half were farmers and a quarter was 
owners of small businesses, two were workers and one of each was a housewife, 
teacher, police and employee. All were Buddhists; fourteen were married and all but 
one lived with their spouse; and the others were single or divorced. Two were CSMBS 
beneficiaries, of which one was transferred from UC to CSMBS beneficiary; one was 
the SHI beneficiary; and the others were UC beneficiaries. 
Normally, there was more than one care giver taking care of a patient, particularly in 
older patients who were mothers. Next of kin and spouses were the primary care givers 
of patients with support from their families, of which three fourths were nucleus 
families. Ten of the care givers were the patient’s spouse; seven were daughters and one 
daughter in law, one elder sister and one sister-in-law. There were fourteen females and 
six males and aside from their spouses, all had higher education than the patients. Five 
were government employees or state enterprise employees, five farmers, five owners of 
small business, three workers, one teacher and one housewife.  
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Table 7.1 Main characteristics of cancer patients and their care givers 
Patient  Care giver 
Study 
no. 
Family 
type 
Gender Age 
Health 
insurance 
scheme 
Type of 
cancer 
Residential 
area 
 
Gender Relationship to patient 
Key 
informants 
1 E M 45 UC colon urban  F spouse CG 
2 N F 53 UC adv. hepatoma 
remote 
rural 
 M spouse P & CG 
3 N F 36 UC cervix remote rural 
 M spouse P & CG 
4 N F 48 UC liver urban  M spouse CG 
5 E M 39 SHI 
cholangioc
arcinoma 
to brain 
remote 
rural 
 
F sister P & CG 
6 N M 56 UC hepatoma urban  F spouse & daughter P & CG 
7 E F 55 UC adv. hepatoma rural 
 F daughter P & CG 
8 E F 62 UC ovary sub-urban  F sister in law P & CG 
9 N F 63 UC colon to liver 
remote 
rural 
 F daughter P & CG 
10 N F 56 CSMBS* ovary urban  F daughter P & CG 
11 N M 63 UC nasal cavity urban 
 F spouse CG 
12 N M 59 CSMBS hepatoma rural  F daughter CG 
13 N F 54 UC cholangiocarcinoma 
remote 
rural 
 F daughter P & CG 
14 N F 55 UC cervix rural  M spouse P & CG 
15 E F 48 UC lung rural  F daughter in law P & CG 
16 N F 40 UC stomach remote rural 
 M spouse P & CG 
17 N M 53 UC rectum sub-urban  F spouse CG 
18 E F 55 UC cervix urban  F spouse P & CG 
19 N F 36 UC cervix rural  M spouse CG 
20 N M 59 CSMBS liver sub-urban  F spouse CG 
Note: E = expanded family; N = nucleus family; P = patient; CG = primary care giver; 
          CSMBS* = transferred from UC 
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7.3.2 Telling the truth and the meaning of cancer 
Three approaches used in telling the diagnosis included physician to patient; physician 
to patient together with patient’s relatives; and physician to patient’s relatives, and later 
physician to patient or relative to patient. It seems that the last style was often used. 
However, most of the patients with cancer knew their diagnosis directly from their 
doctors. Patients sometimes proactively asked the physician rather than passively 
listening. This is due to their suspicion that they might have cancer. Some patients who 
did not know their diagnosis from the doctors but relatives knew due to the relatives’ 
fear of patients’ emotions which might lead to the deterioration of their illness. 
However, in fact, patients had always suspected their sickness themselves and they were 
likely aware of the cancer due to the disease progress as well as their awareness when 
they were referred from community hospital or regional/provincial hospital to the 
Regional Cancer Center. As a result, even though the patients received a shock at the 
first moment of knowing the diagnosis, they could gradually accept it. It was 
appropriate in telling the patients truthfully by doctors themselves. 
“In the first month (after knowing the diagnosis), I don’t wanna go 
anywhere…it was likely get stuck and obsessively think…like…I have 
cancer…I get it, the popular disease which the rich doesn’t want to...so how 
am I…so, I don’t wanna do anything…I don’t wanna go anywhere…I don’t 
feel enjoyable…During the first month I think what I should do…how long 
I’ll survive. I ask myself…if 1 year or 2 years, what I’m gonna do…if I’m 
strong…what I wanna do.” 
(Case no.5: patient) 
In the patients view, cancer can not be cured and means death whereas tumour is 
curable and does not lead to death. This thought was mostly perceived from their 
experiences with neighbours or relatives with cancer who finally died in a certain period 
and some had pain but the others did not. It was likely that they did not fear death, but 
the pain and suffering from cancer.  
“I don’t know…I asked doctor whether cancer has a mouth, like frogs…like 
ducks. The doctor told it doesn’t like that but it will eat our blood. It doesn’t 
have a mouth, otherwise cattle will eat us so.…I asked the doctor what 
cancer look like…catch for me and then chop it…chop like mince.”  
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(Case no.8: patient) 
“I routinely go to the hospital for drainage of ascitic fluid. It’s now not less 
than 50 times, 8-9 litre of each. I feel no pain. My doctor tells me every time 
to be restrained and I do (laughing). I told her that I didn’t fear for dying but 
I’m afraid of suffering…I’m really scare of such suffering.” 
(Case no.10: patient) 
“The doctor said that I should accept it, don’t be afraid of because doctor 
could also die. I told her I’m alright but I came to see you because I have 
pain. I wanna be treated to be free from pain…” 
(Case no.8: patient) 
In contrast to the patients, the care givers learned about cancer and steps for treatment 
from doctors and open source information, e.g. TV programmes and hospital 
information leaflets. Patients’ relatives played an important role in providing moral 
support to patients and knowledge transferring from doctors to patients. Patients and 
care givers expressed their vulnerability on knowing the prognosis, particularly in the 
terminal stage of the disease.   
“I wanna know so that I could control my mind…I think my dad (the patient) 
also wanna know…In fact, my dad always follow the doctor’s suggestion (he 
perceives only that he has liver mass). But in the second visit, the doctor said 
that whatever you (the patient) want to eat, you could eat. So, my dad was 
worried about this suggestion which seems that he gonna die. After that, he 
got worse.” 
(Case no.6: secondary care giver) 
 “…I don’t know how bad terminal stage is… I dare not to ask the doctor 
that how long my mom would be alive…coz…if I know that my mom is in the 
terminal stage of the disease, I couldn’t restrain myself…” (crying) 
…I wanna ask the doctor how the terminal stage would be (but she did not 
do). Others in terminal stage were live long…” 
(Case no.9: primary care giver) 
“CG: sometimes it isn’t just the patient but relatives that asked which stage 
and suggested we should ask the doctor. But I don’t…I think we’re 
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O.K….We’d better don’t know. It’s no need to ask which stage, how long 
will he alive. 
P: Yeah, I think so. If asked…then we know…it’ll…my feeling gets worse, 
I’ll get worse, so unknown (prognosis) is better” 
(Case no.5: patient and primary care giver) 
7.3.3 Decision making on treatments 
Thereafter visiting some health facilities and perceiving their disease as cancer, all 
patients were obedient and followed their doctors’ suggestions. They decided to get 
such suggested treatment by themselves and informed their primary care givers later, in 
the case that the patients are parents and primary care givers are offspring. In contrast, if 
the primary care givers were spouses, consultation between patients and care givers 
usually took place.  However, regardless of the decision made by the patient, it was 
supported by their care givers. For example, Miss P, a single woman, actually living 
alone but thereafter getting sick with cancer, moved to stay with her younger brother 
and sister in law. She immediately decided to follow the doctor’s suggestion on 
chemotherapy when the doctor explained the progress of her disease. 
“Yesterday, the doctor told me that the cancer spreads…could not remove 
but could ‘khao ya’ (intravenous chemotherapy) to suppress it. I said O.K. 
(for khao ya), so that it might be alleviated…I don’t know where it spreads 
to.”  
(Case no.8: patient) 
After realizing they had cancer, half of the cases had ideas to seek treatment at hospitals 
in other provinces, for example, advanced health facilities in Bangkok. However, they 
changed their minds due to suggestions by their neighbours who had experience that the 
services from hospitals in Ubonratchthani (Ubon) were similar to the advanced hospitals 
in other provinces. Seeking treatment in KhonKhan51 or Bangkok would require much 
more money for travelling, lodging for the care giver and treatment of which the UC 
scheme will not pay for except for official referrals. In addition, there was no difference 
of view or conflict between the patients and care givers. This was due to the fact that the 
                                                 
51 There is a KhonKhan University with Faculty of Medicine and the University hospital, the only one 
University hospital in the north-eastern part of Thailand. KhonKhan is located in the upper north-east. 
 222
care givers did not want to see the patients suffer from cancer and their utmost desire 
was to satisfy their loved ones.  
“…We don’t go to KhonKhan or Bangkok because we don’t have money. 
Even we have, we won’t go because we have seen from a patient who went to 
KhonKhan for treatment and they think that here is better. Another rich 
patient who went to Bangkok said that it’s similar to Ubon…similar 
medicines, similar radiation. So, why do we want to go to and I think it’s 
true…” 
(Case no.17: primary care giver) 
“Yes…we had an idea of going to KhonKhan. My neighbour was recovered 
with the treatment there because previously, there was no cancer centre 
here. Anyway, he suggested that now it’s the same, it’s no need to go 
there…wherever is similar. We won’t go to Bangkok coz…we don’t have 
enough money for travelling…” 
(Case no.16: patient and primary care giver) 
7.3.4 Complementary medicines and food supplement 
Almost all patients had experience in seeking complementary medicine or food 
supplements in addition to the Western treatments from hospitals. This was due to the 
attempt to fight cancer, to be healthy as well as to prolong their lives. Some expenditure 
for these additional treatments was incurred by the patients’ family and some might not 
have been as they were a gift from their relatives or neighbours. 
When the relatives or neighbours were informed of the patients’ illness, suggestions on 
complementary medicines and/or food supplement were introduced to the patients by 
word of mouth. In addition, the food supplements could be directly sold by the sale 
representatives from the direct sale products. These complementary medicines could 
range from holy water from temples to fresh herbal medicines and herbal decoction. 
One patient even reported that she took liquid plant fertilizer. It was usually a case of 
either medicines or supplements, but the patients sometimes used them together.  
“..The doctor told that my cancer could not be removed… I could be alive 
just one more week…he told my daughter. Later on, I stayed at home and I 
didn’t know what to do…so I test drinking the EM…a plant fertilizer. I 
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thought whatever will happen, it will happen…if it causes death…let it 
happen. If cancer is not killed, then it is myself that be killed (laughing)”  
(Case no.10: patient) 
In contrast, two patients adhered strictly to their doctor advice and Western medicines 
including vitamins and minerals prescribed. 
“…A salesman came to me at my house with a big file contains photos of a 
doctor, his clients who had cancer had paralysis…they eat this and 
that…and recover. My relatives also routinely bring me herbal medicines. I 
received but have never taken them…coz the doctor forbid eating them. It 
may counteract with the prescribed medicines.” 
(Case no.3: patient)  
Even if patients did not take complementary medicines, supplementary foods were very 
popular among patients. With the strong willpower to fight cancer and to survive longer, 
all patients had experiences of taking supplementary foods, even expensive ones, bird’s 
nest in syrup or expensive fruit juice, for instance. It was in order to supplement or to 
replace the main foods patients could not consume. Ms R (case no. 15) who worked in 
Sweden before and during her first diagnosis of and treatment for lung cancer. Finally, 
she decided to travel back and to die in her hometown. She talked about the 
supplementary foods that: 
“I eat everything saying ‘it’s good’…I paid 1,800 Baht per bottle even it was 
fruit juice but claimed to eliminate toxic substances. I wanna 
recover…wanna go back home to stay with my son. Whatever it is, I could 
eat…just do not trouble me with allergy (nausea and vomiting)…” 
(Case no.15: patient)  
7.3.5 Household expenditure  
Patients and their care givers detailed their expenditure in accordance with four main 
categories the researcher introduced and it was estimated that the household incurred 
from 50,000 up to 100,000 Baht since the first definite diagnosis. First, the additional 
payment for treatment included the investigation from private hospitals/clinics which 
provided quicker results than public hospitals; and some medical supplies and devices, 
for example, wound dressing set and rubber gloves, oxygen and refilled oxygen tank. 
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Second, travelling cost of both patients and care givers were estimated to account for a 
high proportion of household expenditure. This ranged from 40 Baht round-trip per 
person by bus to 1,200 Baht round-trip or per day by private van rental required in 
handicapped patients. This range included the estimated gasoline cost of household 
personal car. This household travelling cost was higher with an increasing of number of 
hospital visits, in particular in times close to death. It was highlighted by the patients 
and their care givers that this travelling cost markedly increased during the period of 
undergoing treatment courses of chemotherapy, radiation and pain control. 
Greater household expenditure was related to payments incurred from alternative 
medicines and food supplements. As mentioned in the previous subsection, almost all 
had experience on either or both types of care. It was reported from to cost 200 Baht per 
time to 6,000 Baht per month. Last, the care givers also incurred expenditure for food 
and lodging when visiting hospital with the patients and staying nearby if the patients 
were hospitalised.  
Indirectly, there must be reductions in household income due to the patients themselves 
and the care givers whom the advanced cancer patients depend on.  It was learned from 
such advanced cases that there must be a care giver who spent most of the time taking 
care of the patient. The care givers resigned from their permanent job and most of them 
migrated back from remote provinces. In addition, in the case that the patient was a 
head of household and breadwinner while his spouse was a housewife, household assets 
were gradually sold out. It seems that borrowing from the village fund and relatives was 
the source of income as well. 
“…At the time, I have worked nearby Bangkok. Our neighbour here rings 
me and tells that my mom is referred to Sappasit hospital. So, I quit my job 
immediately, come back home and haven’t got any job since then…” 
(Case no.13: primary care giver) 
“…My children living in Bangkok come back because mom (the patient) gets 
sick. Previously, we (the patient and primary care giver) live with my 
grandchild and my two children who are still studying here. Nowadays, mom 
can’t walk, my children must quit from their jobs because they couldn’t have 
long holiday…” 
(Case no.14: primary care giver) 
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“…We don’t have saving. I haven’t done any job but my husband did…a 
year now that he couldn’t work…so whatever we have, I sell them out. 
…borrow from village fund--60,000 Baht now and also from my 
relatives……Currently I did borrow again…borrowing and selling our 
assets…my golden necklace…our cattle. I don’t know how I can return 
them…but it’s just until my three children graduated, well…let see…” 
(Case no.17: primary care giver) 
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Table 7.2 Patients’ residential area and their expenditure estimated since diagnosis of cancer including terminal stage 
Expenditure since diagnosis (Baht) 
Study 
no. 
Health 
insurance 
scheme 
Type of 
cancer 
Residential 
area 
Estimated 
distance 
from home 
to hospital 
(km) 
Extra 
medical 
care 
Travelling 
(per round 
trip) 
Complementary 
med. & food 
supplement 
Travelling 
of care 
giver (per 
round trip) 
Estimate
d total 
1 UC colon Urban 15 5,708 400*, 20** 1,200 20 50,000 
2 UC adv. hepatoma Remote rural 50  600* 2,600   
3 UC cervix Remote rural 103   90 /day 200 100,000 
4 UC liver Urban 10   3,000   
5 SHI 
cholangio-
carcinoma to 
brain 
Rural 102 300  no use   
6 UC hepatoma Urban 4 6,000  5,400  10,000 
7 UC adv. hepatoma Rural 42 2,050  Free   
8 UC ovary Sub-urban 40  400*, 120** no use 120  
9 UC colon to liver Remote rural 105  170** 1,090 170  
10 CSMBS* ovary Urban 3  10** 47,500   
11 UC nasal cavity Urban 5 5,000     
12 CSMBS hepatoma Rural 108      
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Table 7.2 Patients’ residential area and their expenditure estimated since diagnosis of cancer including terminal stage (cont.) 
Expenditure since diagnosis (Baht) 
Study 
no. 
Health 
insurance 
scheme 
Type of 
cancer 
Residential 
area 
Estimated 
distance 
from home 
to hospital 
(km) 
Extra 
medical 
care 
Travelling 
(per round 
trip) 
Complementary 
med. & food 
supplement 
Travelling 
of care 
giver (per 
round trip) 
Estimate
d total 
13 UC cholangiocarcinoma Remote rural 120  1,200*  340  
14 UC cervix Rural 45  500* 90 Baht/ day  100,000 
15 UC lung Rural 48 6,500  4,100   
16 UC stomach Remote rural 100  1,000* 12,800 120  
17 UC rectum Sub-urban 35  300* Free (2,000)  100,000 
18 UC cervix Urban 7   10,000  20,000 / month 
19 UC cervix Rural 55  500* 200 80 70,000 
20 CSMBS liver Sub-urban 2 3,000  12,300   
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7.3.6 The place of care and the place of dying 
Both patients and care givers did not have any plan for the place of care and the place 
for dying, however, they had different expectations. There were debates between the 
choices of hospitals versus home. The care givers preferred hospitals to home because 
of their concerns over the patients’ symptoms and suffering in which they might not be 
able to help the patients and feel guilty, whereas doctors and nurses could help. 
However, patients favoured home over hospitals. It was due to the comfortable feeling 
and being familiar with the private area and personal belongings; and warm feeling of 
being among family members, relatives and close friends. Despite having a few private 
rooms, there is no comfortable private area in public hospitals for patients’ relatives and 
close friends similar to patients’ homes. In addition, it was inconvenient for travelling 
by the visitors to the hospitals. A few patients passed their decisions on to their next of 
kin and doctors. 
“Interviewer: It was that you’re concerning over patient’s suffering?  
CG: Yes…coz…I’d seen and I couldn’t help…I feel terrible…Due to pain, 
he’s groaning and ’s struggling…sweating through the whole body on the 
bed…like showering…I couldn’t tolerate. So, if anywhere could help him 
free from pain, I would select that place. In contrast, if there is no pain, I 
choose home.” 
(Case no.17: primary care giver) 
There might be a different view from primary care givers of urban patients that they 
preferred the patient to die in hospital because it was most convenient for the patient 
and family.   
In the Northeast, it was also a myth that souls of people dying at home would be able to 
visit to their home and village after death. In contrast, souls of those dying outside could 
not return home. In addition, the transportation costs of bodies are much more 
expensive than of live patients. There might be additional costs involved such as for the 
mortuary, cleaning, etc. As a result, at the end of life given a few hours or a few days 
before death, most patients were likely to be taken back home, particularly in the rural 
areas. 
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7.3.7 Perception on health insurance schemes and health services for cancer patients 
It was stated that the route of seeking health service of cancer patients usually started at 
private clinics and community hospitals like other common diseases. After finding signs 
and symptoms, and primary investigation of any cancer during the few visits, the 
patients were then referred to the regional hospital and cancer centre. Almost all cases 
of the UC, CSMBS and SHI had good perception on the process and standard benefit of 
the scheme in particular to cancer. One case seems to have less understanding and was 
underprivileged compared to the others due to the different subtype of the UC scheme 
(alien). The UC beneficiaries knew that the letter for referring to the regional hospital or 
cancer centre was valid for a certain period since cancer is a chronic disease and 
requires more visits to receive specialized care at such hospital and centre. If there was 
an emergency or uncomplicated condition of their illness, they should go to the 
community hospital where they registered at the secondary care unit. However, there 
were some cases who mentioned difficulty in and higher expenditure for routine 
travelling for pain control medicines. The care givers had to come to the pain clinic to 
get the medicines. In addition, the patients also had to come to the clinic frequently to 
get the medicines. For example, Mr. P had post-operation rectal cancer chemotherapy 
and radiation, four years later, his pain was increasing and as a result, he was referred to 
the pain clinic for pain control and supportive care. Mrs. P, the spouse and the care 
giver of Mr. P, said that the patient had been treated for pain control for a year and now 
Mr. P could not walk. Their house was approximately 30 km. away from the hospital. 
“During the past year, I did weekly visit to the clinic to get drugs, but 
recently, I come three times a week because it (the pain killer) isn’t 
enough…. 
…I do have to hire a van because my husband (the patient) couldn’t walk. If 
I don’t take my husband to the hospital, I’ll get drugs for one day only. I also 
could not leave him alone at home for long time. They (health staff) told that 
for an admission at least 6 hours, we can get one-week drugs. Previously, 
the doctor prescribed for two weeks but the pharmacy could not give us, due 
to the drugs are very expensive.… 
…The drug (morphine tablet) is 54 Baht per tablet; he takes 14 tablets per 
day. So, now 700 Baht per prescription is not enough for one day.…We 
know that he couldn’t recover and he’ll deteriorate but just doesn’t 
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suffer…just that…you know…it suffers… if we could not get the 
drug.…Whatever will be…but rather no suffering…if he passed away…just 
let him go without suffering because when he feels pain, I wanna die, too.” 
(Case no.17: primary care giver) 
“I heard from another case coming from Yasothorn (another province) 
talking about the expenditure. The relative took a patient who is unable to 
walk and so s/he requires a rental private van. The rental rate is 1,000 Baht 
per day and if the patient is admitted, so it’s two days…means 2,000 Baht 
and coming once a week…how much the expenditure is.  Moreover, it must 
have the food expense for the care giver. 
… Since policy change by the new director, the patient has to be admitted. 
Previously, I took care of my mom (the patient) at home and I just bring a 
booklet recorded the detail of drugs taken and pain score. It’s quite 
convenient but now my mom has to come and she complains because she 
feels pain when moving for travelling to the hospital.…” 
(Case no.18: primary care giver) 
Focusing on the sixteen UC beneficiaries, all of them expressed their satisfaction on this 
latest health insurance scheme. It helped in seeking care, gave a chance to survive and 
to prolong life.  
“Interviewer: The 30 Baht (the UC scheme) is good? 
A: Good, good, I acquiesce that the 30 Baht is good. If forgetting this health 
card, we have to pay more than 200 Baht even at the T hospital (a 
community hospital). Paying 30 Baht is simply. If there was no 30 Baht, 
we’ll pay a lot. Probably, the patient wouldn’t survive until now. If we don’t 
have money and it isn’t necessary, we won’t go (to the hospital).” 
(Case no.14: primary care giver) 
“If there was no the gold card (the UC scheme), we would not be able to get 
the treatment like this because just travelling to the hospital costs a lot…we 
now have nothing left to sell (to earn the money). If we have to pay…only the 
drug… it costs nearly 10,000 Baht…we wouldn’t have money for. If there is 
no card (no the UC scheme), we would let him die since the operation coz 
we don’t have income and my children are still school-age.…We wouldn’t 
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pay for the operation, would we? The operation cost is not cheap, and the 
drug cost taken after the operation, too. I’d seen the drug cost… it was 9,800 
Baht per month. Now the drug cost…just for a week…they give us 2 bottles 
of red syrup (Morphine syrup) which is 500 Baht each and 140 tablets and 
other drugs. It isn’t cheap. If there was no the card (the UC scheme), I 
wouldn’t have an ability to pay for the treatment and he would not survive til 
now… only his name would be left (laughing)” 
(Case no.17: primary care giver) 
The cases (patients and family members) seem to be satisfied with the services from the 
place they were receiving the treatment. However, in comparison among hospitals, that 
is community hospital, regional hospital and the cancer centre, according to those with 
experience in all three types of hospitals for current illness, they preferred the cancer 
centre. This is due to the more service minded and better attention from staff, less 
crowded, fewer queues and quiet. In addition, there were only cancer patients who could 
empathise with each other. Patients and care givers had more time to consult and to 
clarify the way they could receive care for the patients at the centre. Nonetheless, they 
realised that the regional hospital was most crowded with huge numbers of patients with 
variety of illnesses and diseases. The health personnel then have limited time to pay 
attention to the patients.  
Focusing on the pain control, there was limited medicine items for pain control in the 
community hospital. A care giver revealed her concerns on drug use and its benefits. 
Even though the hospital would have similar items of pain control substances as the 
centre had, she still had doubt in the expertise on such medicines because the hospital 
emphasized on general diseases. 
“Interviewer: Supposed that the K hospital (a community hospital) has all 
drug item for pain control, is it good? 
CG: It might be good. It’s nearer (the community hospital) but I’m not sure 
in their care and advice while I’m confident in the cancer centre even it’s 
farther….it’s good if the hospital could practice like the centre do. However, 
if the hospital just give the drugs (without advice and therapeutic 
monitoring), it’s useless because each tablet is valuable…” 
(Case no.17: primary care giver)   
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7.4 Summary of research findings and study limitations  
7.4.1 Summary of research findings 
Data was gathered from twenty cases of patients in advanced stages of cancer and/or 
their primary care givers. Of these, sixteen were UC beneficiaries, three CSMBS and 
one SHI. Nearly half the cases had liver cancer, including cholangiocarcinoma. Three 
styles of telling the truth or breaking bad news were identified.  Used most often was 
the doctor telling patients relatives and later either the doctor telling patients or relatives 
telling patients. It was the fear of relatives that resulted in some patients not perceiving 
the cancer at the time of definite diagnosis. The patient experiences reflected that cancer 
means being incurable. Knowing that they were going to die from cancer did not cause 
fear but suffering from cancer pain did. Two types of decision making on receiving 
treatments were found, that is consultation with spouse and deciding by oneself in the 
case that the patient was the mother or father. All cases followed the physicians’ 
recommendation and all cases adhered to hospitals in the province. This is due to the 
fact that crossing to health facilities out of the referral system required more financial 
resources for out of pocket and the inconveniences in travelling and the care givers 
lodging. 
Almost all of the cases had experience in seeking complementary medicines and/or food 
supplements while they followed the treatment at hospitals. This was the fight against 
cancer, keeping healthy as well as prolongation of life. In addition to the extra 
unclaimed medical care cost, travelling expense, and expense for care givers board and 
lodging, such seeking behaviour was a major cause of household expenditure. In order 
to take care of the patient, it was likely that an offspring had to quit from the current job 
in remote provinces. Therefore, this resulted in decreasing household income, 
particularly in the nucleus families. 
The patients and care givers had different expectations on the place for care and the 
place for dying. While patients preferred home, the care givers preferred the hospital. 
Home gives a comfortable feeling and environment, familiar private area and personal 
belongings. In contrast, hospitals were superior in ensuring the treatment to alleviate 
patients suffering by health professionals. However, the place of dying should be home 
due to the cultural belief in this north-eastern area as well as saving travelling 
expenditure from transporting the dead back home. 
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All cases, especially the UC beneficiaries, were satisfied with the health insurance and 
its benefits. It provided the opportunity to access the high cost care including medicines 
for pain control. However, some households had difficulty in earning for travelling 
expenditure and the extra unclaimed medical cost. It seems that the limitation on 
claimed expenditure of 700 Baht per visit increased the frequency of patients and care 
givers visits to get medicines for pain relief out of the schedule for routine following up. 
Inevitably, their travelling cost was also massively increased and there was also the 
effect of travelling on patients’ physical health. The cancer centre seems to be the 
preferred hospital for cancer care due to its specialty in services related to the disease, 
less crowding and providing more information and knowledge in caring for the patients 
accordingly.  
7.4.2 Data and methodological limitations of the study 
Due to the study tracking the cancer cases from hospitals, it was not possible to provide 
different views from cases without access to the institutional care. All cases were likely 
to have positive attitude to the health services. The study also lacked of the views of 
cases accessing private health facilities which were difficult to find due to their policy 
on patient privacy. Reaching such cases might require the comprehensive data in family 
folders and home-based care records at primary care units and health centres. Views of 
patients and their relatives residing in other provinces, for example, Srisakate and 
Nakornpanom under similar referral systems of the regional hospital and the cancer 
centre, respectively, might create better understanding of the services as well as the 
difficulties the patients and families confronted, for example, access to the care. In 
addition, an interesting inclusion criterion for patients and relatives should be the 
socioeconomics of the patients’ families or households. Child to adolescent cancer 
patients and their parents was a group of patients which might provide different views 
on such issues, and would be of interest of this study. Household expenditure during the 
terminal stage was the most difficult part of the interview and much time was spent on 
this during the interviews. This resulted in the incomplete data in Table 7.2. Most of the 
patients and relatives could not give the exact amount and value of their spending and 
thus strategies and interviewer skill to detail the expenditure was required.  
Talking about death with relatives and cancer patients who are close to death and dying 
during the period of recently perceiving the bad news were the difficulties the 
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researchers confronted with. It is quite difficult to get the fact and deep information 
from interviewing with such vulnerable relatives and patients as well as to limit and to 
protect them from some issues related to their sensitive points. That is, balancing 
between achieving the study objective and maintaining the ethical conduct was an issue. 
In addition, due to the vulnerable emotion and the sadness of the patients and relatives, 
continuation of many interviews could affect to the mood of the interviewers. As a 
result, the interviewers could have some mechanisms to protect their mental health from 
such sympathy to the cases.     
7.5 Discussion 
The process of telling the truth about the diagnosis and prognosis, particularly in the 
style comprising of two steps of physicians to relatives and then physicians to patients 
or relatives to patients was found to be different from the way in which it was 
mentioned in literature or textbooks. This implies that stressing the importance of the 
relatives’ involvement is likely not to be less important than the patients.  Even though 
the perception of the cancer patients in this study referred to death, it did not bring the 
patients feelings down much. Perceiving that the disease was in terminal stage might 
worsen patients feeling and willpower to fight against the disease. As a result, it seemed 
that most of the patients in this study did not know the prognosis from the physicians. 
The patients themselves realised the remaining time of life from the deterioration of 
their physical condition. Mystakidou et al (2004) reviewed that this disclosure style of 
giving the priority to relatives and undisclosed diagnosis on terminal stage of cancer 
was also probably accepted in other countries where there is no Anglo-Saxon 
background. This strong paternalistic approach was indicated in Japan, Turkey, Kuwait, 
Saudi Arabia, Greece, Italy and Spain (Mystakidou, Parpa et al. 2004). That is cultural 
issues as well as national legislation partially takes part in the approach of telling the 
truth. Compared to Japanese patients, the Thai patients might be able to make more 
decisions on treatment while the Japanese patients’ family makes decisions. However, 
telling the truth could not be justified as right or wrong due to the fact that telling the 
truth or breaking bad news regarding diagnosis and prognosis of cancer has pros and 
cons to the patients and the ethical dilemma remains (Kazdaglis, Arnaoutoglou et al. 
2010). In addition to the patients’ knowledge of their illness and prognosis, their 
perception on cancer seems likely to mean that they thought death was less serious than 
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pain and suffering from the disease. This might be a strong message about the health 
services provided to patients in the terminal phase of life. 
Two decades ago, a survey in Thailand revealed that 71 percent of the elderly ages 60 
years and above in Bangkok wished to die among their beloved, close relatives and only 
39 percent expected to die in hospitals. However, if they had chronic diseases, more 
than half wished to die at home with health care services provided by health 
professionals. In addition, the study indicated that differences in preferred place of death 
were determined by attitude, gender, ethnicity, religion, income, education level and age 
group (Silapasuwan and Tongvichien 1990).  
Improving health care services provided to patients at the terminal stage was the issue in 
line with place of care towards place of death at the end of life. Such place of care also 
was determined with several factors as well as being in the complexity of decision 
making. For example, different views between the patients and care givers on 
preference of the place of death were often reported.  
Preference on place of death for the patients in this study was similar to a survey in 
Taiwan during 2003-2004 and in the UK during 2000-2002. In Taiwan, home was the 
most preferable place of death for both patients and their care givers. However, a higher 
proportion of the family care givers indicated a preference for hospital death for 
patients.  Multiple reasons were provided including cultural concerns, quality of life, 
availability and ability of family caregivers, quality of health care, worries of being a 
burden to others, and concerns over the difficulty in managing the body if the patients 
died at home. This is due to the fact that the Taiwanese normally live in apartments 
(Tang, Liu et al. 2005). Even though the setting and culture were different, it was 
reported that nearly one-third of patients preferred to die at home as well as another 
one-third preferred hospice. No patients wished to die in hospitals. However, some 
patients wishing to die at home but actually died at hospice or hospitals. Factors which 
had an influence on place of death were categorised into four domains including the 
informal care resource, management of the body, experience of services and existential 
perspectives. It was also reviewed that clinical factors of the patients were associated 
with the ability in dying at home (Thomas, Morris et al. 2004; Cohen, Bilsen et al. 
2006). Thus far, preferences for place of care and place of death in all, including this 
study were similar in home death. However, the factors shaping the actual place of 
 236
death depended on the patients’ physical conditions and limitations, availability of the 
care givers as well as health care providers’ facilities. Local culture, in particular in 
Thailand, also played some role in place of death rather than the place for terminal care. 
That is, patients in last hours or last minutes to death were likely to be moved to die at 
home.  
Even though the household expenditure during the last period of life in this study could 
not reveal the exact total payment or average payment, it indicated the categories of 
household payment for caring for the terminally ill patients. Such payments included 
extramedical care and medical supply which the insurance benefit scheme did not 
include, for example, mobile oxygen, diaper; travelling cost for the patients which could 
range from 10 Baht for public transport to 1,200 Baht per day of a rental private van; 
complementary medicine and food supplements ranging from no payment to 47,500 
Baht a year; and travelling cost of a care giver. However, this expenditure excluded 
food and lodging during patients’ hospitalisation as well as the care givers income loss. 
The more visits the patient or the care giver made to the physicians, the expenditure for 
travelling cost increased. In addition, the care givers of the two patients detailed their 
coping mechanism to gain money for such payment by their personal assets sales, due to 
changing from the breadwinner to the full-time informal care giver. 
Complementary medicine and food supplements were popular among patients with 
chronic diseases including cancer and at the end of life. It seems to be another main 
treatment or care for the patients who were physically weak and wished to regain their 
healthy status. However, both medicine and food were the important factors of 
household expenditure as indicated in this study. All patients took either complementary 
medicine or food supplements or both concomitantly with the conventional therapy 
from Western medicine. This finding seems to show greater prevalence of using 
complementary and alternative medicines than in Australia. Correa-Velez et al (2003) 
found that 32 to 42 percent of the Australian in Brisbane used at least one type of 
complementary and alternative medicines at the end of life (Correa-Velez, Clavarino et 
al. 2003). However, findings from these studies were applicable to the patients using 
both complementary medicines and conventional therapy. This lacks the patients who 
were denied or were unable to access conventional therapy and might use only 
complementary medicines.  
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It might be due to differences in health systems of individual countries and difficulties 
in data collection on household expenditure, but no literature could be found that 
described household expenditure at the end of life, particularly none in developing 
countries was found that was comparable to the data reported in this study. 
The participants who were the UC beneficiaries in this study expressed their satisfaction 
in the UC scheme. Because of this, these cancer patients could access such high cost 
care without payments and be able to live longer. Prior to the UC, this access was 
impossible because cancer treatment was unaffordable. That is, it should be highlighted 
that the UC scheme achieved its goal on access to health care for all, in particular in the 
under privileged group (see Chapter Two, subsection 2.2.4.1). However, the complaint 
on limitations on the 700 Baht claim for pain control in palliative care per ambulatory 
visit which results in an increase in unnecessary additional visits for medication, 
resulting in increasing in travelling costs, was an issue requiring further exploration. 
Travelling costs might be another economic burden leading to impoverishment or 
catastrophic household expenditure instead of direct medical costs which were 
previously limited to access to health care. 
Further discussion in line with the health professionals’ current practice, preferences 
and health service for terminal stage cancer patients in Chapter Eight will be presented 
in Chapter Nine. 
7.6 Conclusion 
This chapter has shown  the views of patients with terminal stage cancer and their care 
givers on their attitudes and understanding about cancer; decision making regarding 
cancer treatments; using complementary medicines and food supplements; household 
expenditure; place for care and place for dying; and perception on their health insurance 
scheme and health service for cancer patients. The study employed the in-depth 
interview approach for individual patients and their primary care givers in 
Ubonratchthani province. The findings provided better understanding on the perception, 
coping mechanisms as well as constraints of the patients and their family during the 
terminal stage of life. 
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CHAPTER EIGHT 
THE LAST PERIOD OF LIFE: CURRENT PRACTICE AND HEALTH 
SERVICES FOR TERMINALLY ILL CANCER PATIENTS 
 
8.1 Introduction 
Regardless of patient demand, the health service is a system that is driven by health care 
providers as well as third party payers. That is, even though the third party payers or the 
health insurance payers determine the payment and benefit package for their 
beneficiaries, the quality and quantity of health service or health care provided to the 
beneficial patients also depends on the care providers. Consequently, their preferred 
practices are always of interest in understanding patterns of care. 
Health care for terminal illness, the final phase of human life, is possibly another issue 
which health care providers and patients, including their relatives had different views. 
These differences might include, beginning with the disclosure of the diagnosis, 
treatment, and until the patient's final period. Therefore, learning about the views and 
practices of health care providers might fulfill the comprehensive understanding of the 
health service provided to the terminal stage patients and the explanation for the factors 
which significantly determined the health insurance payers in Chapter Five.  
There are several studies in Thailand revealing knowledge, attitude, caring behaviour 
and truth revealed for end of life patients. However, those are surveys of nurses and/or 
nursing students (Vijitsukon 1975; Pratoomwon 1991; Daodee 1994; Wattanachote 
1997; Mahanupab, Leksawat et al. 1998; Pokpalagon 2005). Saruayiam (1998) 
identified ethical dilemmas in the case of terminally ill patients concerning veracity of 
general information e.g. patients illness and hospital rules, truth telling regarding 
diagnosis-treatment-prognosis, prolongation of life, euthanasia and hospice care 
according to the views of health professionals at two hospitals with advanced tertiary 
care and the National Cancer Institute in 1998. All are located in Bangkok (Saruayiam 
1998). However, due to the social change and advancement in medical technology, this 
study partially followed such study’s constructive qualitative approach but in a different 
setting.  
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Following the patients and care givers views on their preferences in Chapter Seven, this 
chapter, on the other hand, adds the health care provider’s views and practices on 
patients’ preference on the place of care and the place for dying. That is the study aims:  
• To explore the current practice on the disclosure of diagnosis, preference for 
quality of life and care, place of dying in terminally ill patients and the patient relatives 
• To describe the service and care pathways for terminally ill patients at several 
types of health facilities 
8.2 Methods 
This study employed a qualitative approach as indicated in Chapter Four, subsection 
4.3.2.2. It involved exploring and revealing explanations to support the findings from 
Chapter Five and Chapter Six and in particular, views of health professionals on the 
terminal stage of cancer. 
8.2.1 Research design and setting 
Similar to Chapter Seven, subsection 7.2.1, in-depth interviews during the same study 
period were employed.  Also similar was the study site which was located in two 
hospitals and a cancer centre to gather information on disclosure of diagnosis and health 
services for terminal stage of cancer. This study focuses on the information from and 
perspectives of health professionals taking care of cancer patients. To be consistent 
across the interviewees, the in-depth interview was conducted through the guide questions 
as described in Appendix 6. 
8.2.2 Health professionals 
The snowball method was employed for identifying the health professionals. They were 
recruited if they met the eligible criteria including physicians or nurses who 1) work at 
palliative care unit or medicine unit or surgical unit or obstetrics and gynaecology unit 
in the regional hospital or the cancer centre; 2) work at community hospitals; and  3) is 
willing to participate in the study. 
In order to obtain additional information on the service system for medicines provided 
to terminally ill patients, particularly the pain relief group, the heads of pharmacy unit at 
the regional hospital and the cancer centre were also interviewed. 
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8.2.3 Data analysis 
The analysis was done using the method described in Chapter Four, subsection 4.3.2.2 (5). 
8.3 Findings 
This section revealed the findings from health professional experience and views on 
current practice of disclosure of diagnosis, place of care and place for dying, perception 
on health insurance scheme and health services. On average, an interview took 30 
minutes to one hour per participant. Information was gathered from eighteen health 
professionals in three hospitals. 
8.3.1 Characteristics of health professionals 
Ten physicians, six nurses and two pharmacists participated in this study. Of the 
physicians, two had expertise in general surgery, three in general practice, two in 
radiation therapy, one in obstetric-gynecology, one in haematology and one in family 
medicine. Of these nurses, two had expertise in general nursing care, one in oncology, 
one in anaesthesiology, one in psychology, and one in cancer care. On average, these 
twelve female and six male health professionals had 16.3 years of experience in their 
careers and 11.1 years in the health services for cancer patients. Eight were working in 
the regional hospital, six in the cancer centre and four in the community hospital. 
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Table 8.1 Characteristics of participating health professionals  
No. Professional Hospital Gender Professional experience (yrs.) 
Experience on 
cancer (yrs.) 
1 Physician RH F 18 11 
2 Physician CC M 12 9 
3 Physician CH F 8 8 
4 Physician CC F 10 5 
5 Physician CC M 17 10 
6 Physician RH M 31 25 
7 Physician RH M 22 16 
8 Physician CH M 6 6 
9 Physician CC F 18 14 
10 Physician RH F 9 6 
11 Nurse CH F 23 10 
12 Nurse RH F 20 20 
13 Nurse CC F 12 10 
14 Nurse RH F 24 15 
15 Nurse CH F 20 13 
16 Nurse CC F 8 8 
17 Pharmacist RH F 26 3 
18 Pharmacist CC M 10 10 
Note: RH = regional hospital; CH = community hospital; CC = cancer centre 
 
8.3.2 Disclosures of diagnosis and prognosis 
Identifying the diagnosis can be classified into two types, that is, at the primary or 
secondary care level where the definite diagnosis could not be made and at the advanced 
or specialised hospitals; and at the early and the late stage of the disease.  
Prior to disclosure of the definite diagnosis, physicians at primary care or secondary 
care level gave the general diagnosis of tumour or mass and referred the patients to the 
tertiary care, through the referral system accordingly.  
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“Interviewer: Could you do definite diagnosis here? 
P: Even we could do, we won’t tell the case. We must refer to the regional 
hospital...” 
KI no.3 
At such hospitals, the biopsy, other investigations and staging of cancer was 
determined for definite diagnosis. In order to treat the patients as soon as possible, 
and to obtain the patients’ adherence to the treatment, the patients were informed 
about their disease followed by the details of the course of treatment. 
“…if the patients understand, it would follow with the good cooperation for 
following up the treatment. I think that prior to treatment, the diagnosis must 
be clarified.…” 
KI no.9 
In patients with late stage cancer, specifically advanced stages (III and IV) including 
last to the end of life, all physicians had a similar principle in disclosure of the diagnosis 
or communicating bad news.  Due to the reason that the patients' next of kin were the 
potential care givers throughout the patient’s survival period and were often the decision 
maker for treatment and care management, such next of kin were the first to know the 
diagnosis including prognosis. They would then better prepare themselves, including 
their availability as care givers. Nonetheless, identifying the next of kin as well as the 
patient’s decision makers was the first step prior to the disclosure. These next of kin had 
best knowledge of patient’s characteristics, behaviour as well as other illnesses or 
conditions which might affect the patient’s mental health and will power if they 
perceived the truth as bad news. Concomitantly, physicians also evaluated the patient’s 
condition in accordance with accommodating the patient’s rights and decision of their 
next of kin. 
“In our country, it is the relatives who don’t want (us to tell the patients). In 
fact, we must tell the patients. But in Thailand, if we had conflict to the 
relatives, we would get into trouble, sometimes. Good compliance to the 
treatment is due to the relatives who are really important.” 
KI no.5 
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“I’ll firstly invite the patients’ relatives. Mostly, I haven’t directly talked to 
the patients. Mostly, I have talked to the relatives who are offspring, wife, or 
husband of the patients…I tell them the disease, staging of the cancer, and 
ask them about the readiness of the patient in perceiving the disease. I think 
that our culture is probably different from the western countries…” 
KI no.2 
“In fact, telling (the diagnosis) is better. First, the patients will know their 
disease, second, when perceiving, good practice will follow if they have will 
power.…If we don’t tell them, sometimes the patients will resist.…” 
KI no.11 
This experience-based evaluation included physical and mental health status of the 
patients; underlying or other diseases, for instance, chronic heart failure, which might 
have been a contraindication to breaking bad news; patient’s age; residential area; the 
care givers characteristics; and the patient's health insurance scheme which often 
implied to their care givers something about education level and their knowledge in 
health and medical science. This practice on disclosure also prevented themselves from 
future difficulties and suing after the patient’s death. 
“I’m personally not undisclosed to the patients if there is no any prohibiting 
condition to listen bad news. Contradict condition is that the relatives tell 
that the patient has heart disease, their GP said that the patient’s feeling 
shouldn’t be hurt.…” 
KI no.4 
“Partially, if it is the CSMBS beneficiaries, their children will perceive well, 
in general. Because usually, their children are teachers, officers who are 
better educated…but it’s just partly…” 
“…Sometimes I will evaluate that where are their house, near to or far from 
the hospital, then I will make 2 to 3 following up appointments to seeing how 
the illness progresses (including the patient)…” 
KI no.1 
“…it could evaluate from patients’ gesture…” 
KI no.5 
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“…Actually, I evaluate the patients’ age—age interval, gender…for old age 
group, it must take some time…Basically, there is no difference between 
male and female but age does. Old age need more time for understanding.” 
KI no.9 
Due to the recognition of their illness, some patients might want to know the diagnosis 
themselves, and as a result, physicians inform them directly. However, some patients 
know their diagnosis from their next of kin or indirectly by perceiving their disease 
from being referred to the “cancer” centre. In the case that the care givers did not agree 
to tell the truth, the patients were informed that it was “tumour”. Otherwise, it might 
require a few visits for evaluation of patient’s mental health and perception to ensure the 
ability to accept this bad news. 
“I tell them “cancer” but in the case that the relatives don’t want to tell the 
patients, I’ll say “tumour”. And I refer them to the cancer centre because 
I’m not sure whether you have cancer or not. It must require additional 
investigation, I tell them…I think that finally, the patient must know because 
our treatment process will let patients know that they have cancer. But 
today, they might not need to know that they have cancer. Going to cancer 
centre…finally they must ask that I do have cancer.” 
KI no.6 
“…that is, I try to tell…you have “tumour”. Otherwise, sometimes I tell the 
patients the expected symptoms…itching, loss appetite, flatulence…”  
KI no.1 
In contrast to the diagnosis, even though the staging and prognosis were a popular 
concern of the patients and their care givers, physicians informed the care giver and 
they sometimes tried to put this issue less priority to the patients. Rather, the supportive 
treatment, including palliative care and quality of life of the patients were the main 
focus where information and knowledge were provided. 
“Could they live long, this is mostly the relatives ask, the patients themselves 
never ask “Whether I could live long?” If it is the advance stage, I’ll tell the 
relatives…something like …on average one month or one year.” 
KI no.6 
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“Yes, I’ll tell the patients intermittently. Even it is the terminal stage, I won’t 
say terminal stage but I’ll say you have breast cancer, something like that. 
To the relatives, I tell them all…” 
KI no.2 
In addition to disclosure of the diagnosis, nurses and other health professionals played 
an important role in further explaining the disease stage and treatment plan, particularly 
in the case that the physicians are busy with other patients. This knowledge also 
included the preparation for treatment, the health care and hygiene, wound dressing, 
nutrition and medicines.  
 “Sometimes, I continue the explanation to the patients and their relatives 
from the physician, in particular in the cases having doubt…” 
KI no.13 
“…We’ll tell the patients after the physicians told the case. We won’t be the 
first who tell the patients…we’ll help in preparation for the case nearly 
dying and the relatives don’t want to bring the dead body back home, it is 
the cultural belief….” 
KI no.16 
8.3.3 Route of health care and treatments for cancer patients 
The route of health care might be identified into two processes of access to care, that is, 
for the initial diagnosis of cancer and the recurrence into late stage of cancer. In the first 
diagnosis, thereafter recognising their illness, the patients visited the hospitals for which 
they had registered, which were community hospitals for those in the districts as well as 
provincial/regional hospitals in provincial city areas. The patients residing in 
Ubonratchathani with suspected diagnosis of cancer were further referred to the regional 
hospital. While the patients residing in the district areas of three other neighbouring 
provinces had one in-between step, i.e. referring from community hospital to the 
provincial hospital. 
“…If it is the first stage or first diagnosis here or we suspect, we’ll send 
them (the patients) to other hospitals. We don’t provide care for them and 
we send them to the cancer centre and the regional hospital. We won’t see 
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them for 5-7 years until the end stage which the centre and the regional 
hospital send them back with recommendation on palliative care.…” 
KI no.3 
At the regional hospital including the cancer centre, the patients were investigated for 
definite diagnosis of cancer and for plan of treatment, particularly treatment with 
surgery and chemotherapy. The patients requiring radiotherapy, for instance, were sent 
to the cancer centre. Once the diagnosis was definite, further visits and follow up could 
be by passed to the advanced care level. In the case of early stage cancer, the patients 
adhered to treatment by following up with the same physician at the hospital or the 
cancer centre which was the last health facility that provided the treatment until the 
disease was recurrent into the advanced stage.  
When focusing on the chemotherapy, it was indicated that according to the policy on 
excellent centres, and the disease management programme of the UC scheme (see 
details in Chapter Two, subsection 2.3.3), the chemotherapy ward and the cancer 
coordination centre at the regional hospital, as well as the systematic collaboration 
between the regional hospital and the cancer centre were established in August 2006 
and were strengthened. This resource management, in particular the chemotherapy 
ward, had an advantage over the previous care management which was distributed by 
ward specialty. It pooled together the cancer patients requiring similar treatment, 
environment and care, as well as the care providers specialised in nursing care and 
pharmaceutical care. Such chemotherapy ward also reduced the crowding of patients in 
general wards. However, there was still a limitation on the Rule of Government 
Procurement on medicines which was constrained to the purchasing of expensive 
medicines. 
8.3.4 Palliative care and pain control for, prolong life versus prolong death in the 
advance stage of cancer 
When the cancer deteriorated to the advanced stage in patients with prior early stage 
diagnosis or with the first diagnosis at the advanced stage, patients might be referred 
back to the primary hospital, particularly the patients residing in the rural areas, for 
supportive treatment and palliative care. Some patients might be treated at the regional 
hospital or referred to the cancer centre for further therapy which alleviated the patients 
suffering, for example radiation for pain control until the end of life.  
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“…I’ll refer (the patients) to the regional hospital for the definite diagnosis, 
then the regional hospital refers back with the suggestion on supportive 
treatment at community hospital…” 
KI no.3 
Prolonging life versus prolonging death was the issue discussed in the interviews. 
Palliative care is a tool to maintain patients’ quality of life and diminishing their 
suffering and it might prolong life a few months beyond the estimated prognosis. While 
palliative care for “prolonging life” means an increase in survival period and includes 
chemotherapy, radiation therapy, pain control and supportive care, “prolonging death” 
implies intubations in the patients who were undergoing cardiopulmonary resuscitation 
(CPR) and were unconsciousness after cardiac arrest. Prolonging death was an issue 
discussed with the patient’s next of kin when the physician had seen the deterioration of 
the patients. It was suggested to not do CPR and no intubation, however, some cases 
asked for this practice due to their families’ concerns. Following intubation, it would 
not be allowed to withdraw the tube and, as a consequence, patients who were still 
conscious and/or their next of kin would have to make in advance a decision. 
“As I said…it depends on whether or not such cancer has any evidences. In 
my opinion, prolong life means increasing in life time. But it doesn’t mean 
intubation in the ICU, it’s different…umm…and this means “prolong death” 
which helps nothing. It doesn’t make any usefulness. A patient in this 
condition…umm…like that…With the nature of that cancer, he/she couldn’t 
alive…it (prolong death) seems useless for everyone.” 
KI no. 2 
“…But we have to talk (with the patients relatives)…that if they want 
intubation and dripping Dopamine (inotropic agent), I don’t agree. It is 
prolonging death.…” 
KI no.1 
Focusing on palliative care and pain control, there was the programme/unit in the 
regional hospital and the cancer center. At the regional hospital, almost all physicians 
specialized in cancer normally took care of their terminally ill cancer patients until 
death with supportive care. However, a palliative care programme was commenced a 
few years ago and integrated in the family medicines unit. The main responsibility of 
 248
this unit was the primary care of the primary care units (PCU) within its catchment area. 
Apart from hospitalisation in the wards according to specialised departments, e.g. 
gynecology and surgery, patients with late stage cancer could end up at the family 
medicines ward. Recently, the pain control unit was created and functioned under the 
anaesthiology department.  
Similar to the regional hospital, the cancer centre established a palliative care unit and 
pain control clinic since 2002. Due to rare cases with long hospitalisation and dying at 
the centre, nowadays, the specialised palliative care unit has reserved only a few single 
private rooms for terminal stage patients expecting to end up at the centre. These rooms 
were also called the hospice unit, providing hospice care. The pain control clinic 
provided only the medicines for pain relief. Previously, acupuncture was a health 
service provided by a trained physician but it was stopped because of moving to other 
hospitals by the physician. There were concerns over the claimed expenditures for the 
pain control under the UC scheme. It was limited at the highest amount of 700 Baht per 
visit, whereas the expenditure for a patient with advanced pain was mostly over this 
ceiling amount. As a result, the patients or the care givers had to frequently visit the 
hospital for the medicines even when patients were not due for following up. The extra 
unclaimed expenditure was absorbed by the referred hospital and the increasing travel 
expenditure of these unnecessary visits incurred by the patient’s household. 
“The duration for following up is a week after the problem of the budget and 
payment.…Previously, if there is no problem, the uncomplicated or stable 
case, they get the drugs (for pain control) no longer than a month…Up to 
date, there is no problem with the restriction of this narcotic drug 
(morphine) but I don’t know the future.…” 
“Nowadays, asking about the quality of the service, it would decrease.  
Patients evaluated that it is inconvenient and complicated. Relatives said 
that it is a difficulty, they don’t know where they could get the money for the 
travel cost…But today, we do have to follow the policy. 
KI no.13 
In the community hospital, there was pain control with analgesic drugs and acupuncture 
by a trained physician. Compared to other diseases and other medicines, it was 
commented that there were few patients. Pain control does not include only a group of 
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medicines but requires various medicines and their several strengths and formulation to 
overcome several types of pain. Focusing on the opioid analgesics, it requires minimum 
specialized knowledge but close monitoring for pain control and serious adverse 
reactions. As a result, it might not be efficient to stock the medicines at every hospital, 
in particular the PCUs and community hospitals. The regional hospitals and provincial 
hospitals, as well as the cancer centre specialising in cancer should be the management 
centre of medicines for pain control. The suggestion also included prescribing a large 
amount of the medicines from the regional hospital or the cancer centre and establishing 
a monitoring system by the responsible PCU or hospital. 
“Actually, we have a campaign on the top five diseases including 
hypertension and DM (diabetes mellitus). The highest incidence is 
diarrhea…but CA (cancer) is rare, it is around the last rank.…  
During the period that I’m a chief ward for 2-3 years, there are 5-6 cases of 
terminal stage cancer.” 
KI no.11  
“We don’t have these pain control medicines at the unit (PCU) because even 
in the regional hospital, the use rate is small. If we have in the PCU, it’ll be 
rarely used.…” 
KI no.10 
 “…I don’t think that all hospitals should stock this drug group because not 
all hospitals that have cases.…Like this cancer centre which is the tertiary 
care specialised in cancer might have these drugs and setting up a system 
that the hospitals could buy the drugs from the cancer centre.…” 
KI no.13 
8.3.5 The places for care and the places for dying  
The physicians and nurses suggested that the patient’s homes were the main suitable 
place for terminal care and dying. Thai culture in expanded families is that the younger 
generation would take care of the older generation. The next of kin or relatives should 
take care of the patients and this responsibility should not be totally transferred to others 
or even health personnel. It was the shared responsibility between the relatives and 
health professionals. That is, home is the place in which this cultural structure, 
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particularly in the north-eastern region, would be better retained than in the health 
facilities. However, it required well prepared supportive care at the patient’s home, for 
example, pain control management, mobile oxygen support for patients with difficulty 
in breathing from lung cancer. This should also be a compromising consideration which 
accommodated patients’ and their care givers’ requirements and household context as 
well as the availability of the health resources, for example, bed occupancy at that 
moment. In addition, the scarce hospital beds should be allocated to the patients in need 
with good prognosis.  Also, it is inconvenient to the patient’s relatives if the dying 
patients remain hospitalised. During the period of deterioration, the nearest hospital 
could be the place for the palliative care and end of life care which does not require any 
advanced expertise. Referring to the cancer centre, where the patients must go to, 
results in difficulties in travelling.  
“I think home is…because of the familialisation, feeling of relaxation. But it 
is also that they (the patients) were able to stay without too much 
suffering…they should have medicines…umm…there should be a unit taking 
this special care in order to bring  them (the patients’) into calmness…for 
being alive or supporting the oxygen (mask or cannula) at their home and 
don’t let them having much pain.” 
KI no.2 
“When the patients wanna stay in the ward, the doctor said O.K. as she 
wants because she couldn’t accept anything right now. She couldn’t accept 
in going back home. Another case is that the patients do not have relative at 
all. A patient with end stage cervical cancer was left…the relatives left her 
being alone in our hospital….We had to contact her relatives after her death 
but no one came…” 
KI no.12 
In the cultural context, some health professionals mentioned that the north-eastern 
people had a belief in dying at home. This supports the concept that patients 
would prefer dying at home than other places, particularly in people living in rural 
areas. It was also a supportive care for patients’ relatives. 
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“Mostly, relatives will take them (the patients) home because here, there is a 
faith that if a patient died, they couldn’t bring back to the village. So they do 
have to carry alive patients.… 
Even if the patient was dead, they want us to prepare the patient pretended 
as alive in carrying back home…Even we already issued the death certificate 
but we do have supportive care to the relatives….There are a lot of cases 
like this.” 
KI no.3 
8.3.6 Differences in services by health insurance schemes and suggestion on 
improving the health systems for cancer patients 
The perception about the differences in health services provided to beneficiaries of the 
three health insurance schemes emerged in the discussion with a few health 
professionals. One key informant did not agree to record and to note his/her opinion. 
However, the views of these health professionals were in the same direction, that is, in 
general, the CSMBS provided the best benefits to their beneficiaries. There was not 
much difference between the SHI and the UC in the case of cancer. In contrast, it might 
have no difference between the UC and the CSMBS for pain control. 
 “Yeah…different…a lot…coz…who said money couldn’t buy life…there are 
some medicines that limited to UC. The CSMBS beneficiaries’ survival rate 
is higher…The CSMBS is the best, isn’t it? Next is the SHI but the SHI for 
cancer is not different from the UC, except the referral case which the 
primary hospital could be fully charged so that it wouldn’t refer…” 
KI no.1 
“We must control the expenditure through the budget limited…that is we 
must accept that benefit of each scheme isn’t equal. We couldn’t say equality 
because the background of each scheme is not equal.” 
KI no.2 
“It’s good in terms that everyone gets the services, that is, patients without 
money also get the services…before the UC, patients who have no money, 
first, be unable to come and, second, pay out of pocket which most of them 
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are unable…The referral system is improved. The referred cases are the 
case that really required our specialised care which in contrast to before the 
UC which the patients came by themselves… 
At pain clinic, there is no difference because for whichever your card 
(scheme) is I treat like this…I guarantee that we have no difference, 
whatever you are, the UC, CSMBS I didn’t treat the CSMBS first…” 
KI no.13 
A few health professionals also suggested improving the health systems which includes 
both the financing and services for patients for all stages of cancer. This could be 
categorised in three issues, namely the referral system; care for patients at advanced 
stage; and financing and payment mechanism of the UC.  
In the referral system, improvements in two-way communications between the primary 
referring hospital and the referred hospital in the referral system, particularly the plan of 
palliative care were suggested. 
“We are trying to do a two-way communication, that is, at least we’ll 
describe the treatment plan in the referral form to the primary hospitals 
(community hospitals) including drugs…When referring, at least, they 
should ring us that what we could do for the patients because 
sometimes…it’s a pity that they come here but we could help similar to the 
primary hospitals.” 
KI no.4 
“…In fact, it was set up, the centre for referring, so, there should be a phone 
call in all cases referred for coordination…it might include a fax of 
investigation as well as the communication between physicians at both 
hospitals about the suggestion (on the case management or treatment), for 
example…” 
KI no.14 
Another idea regarding health services for all stages of cancer patients included 
additional cancer centres in some areas of the country, that is the upper and the lower 
part of the north-eastern region. This is due to the difficulties in travelling by patients 
residing in the provinces far from the existing cancer centres. These specialised health 
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facilities had advantages of expertise on the disease over other tertiary care hospitals 
which had responsibility to all diseases. This might be an extended unit from the tertiary 
hospitals like the Ubonratchthani model. That is, the cancer centre had collaboration and 
coordination with the regional hospital for sharing the resources. 
“…Umm…I think…first, we should have a new centre. I think there are less 
numbers of centre…In the lower north-eastern region, there might be a 
centre at Surin (a province) including new radiation equipment. There are 
also not enough centre in the upper north-eastern region…it might be at 
Mukdaharn (a province)…if there are not enough, the centre here has been 
so crowded and the patients get difficulties in travelling. It should have more 
health professionals, place and equipments…umm…what else…those for 
operating….” 
KI no.2 
“…Cancer centre in Thailand?...I think, there might be another centre in E-
sarn (North-eastern region)…in my opinion, it should be NakornPhanom 
(province) but it might have insufficient capability…the distance between 
NakornPhanom and here is 300 km. and Surin (province) might be another 
place (for a new centre) because of the distance, both are nearly 300 km.… 
Only at UdonThani, KhonKhan and Korat (provinces in the north-eastern 
region) where (the health facilities) could provide comprehensive treatments 
for cancer.” 
 “…The importance is that the mental support which takes time. And 
actually, it must be home visit because the patients are not able to travel. 
Even in the areas nearby Ubon, it must be home visit. If they communicate to 
us, the nearest hospital should take the action. It depends on the technique 
(technical approach). If it is implemented, nurses probably are the key 
service providers….” 
KI no.5 
A key informant would prefer co-payment for both the UC and the CSMBS. It might 
help the beneficiaries in realising the monetary value of health services and saving the 
government budget. 
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“…I would desire that this system (the UC scheme) was cancelled 
because…at least the patients should have co-payment so that they could 
help in saving (the budget) because all investigations have cost and 
expenditure.” 
KI no.4 
Due to the increasing trend in migration of working adults from rural areas to cities, the 
elders stayed at home with young children as nucleus families. As a result, the concept 
of hospice care was agreed upon in principle by most of the key informants. This might 
also diminish the overload on the scarce health resources shared with other diseases, e.g. 
bed occupancy, and stress of the care giver as well as interruption in earning of the next 
of kin. That is, if there were health facilities and health professionals taking specific 
care of the patients during their late stage and end of life period, it might be an option 
for improving health service, particularly in big cities. However, there should also be a 
specific or additional budget for this new service (of hospice care). There was also a 
disadvantage of this specific facility that the terminally ill patients would see death 
more frequently and this would decrease their willpower and might increase their fear of 
death. This also supports the idea that home is the best place for dying. In contrast, a 
key informant would prefer that hospice care be incorporated into the current in-hospital 
service. It was emphasised that the concept of palliative care should be encompassed 
into health-service provision by health personnel. This hospice would not only be 
specifically for the cancer patients but also other chronic diseases. This is due to the 
experience on refusal for long hospitalisation from all levels of care. It might be a 
private room that the patients are allowed to stay in with their relatives and engage in 
any activities they require, for instance, religious activities. Thus, the patients close to 
death were separatedand they would not scare other patients in general ward.  
For the hospice care at home, it might be possible to strengthen volunteers in the village 
or the community to help health personnel in providing care. This home hospice might 
require a 24-hour consultative phone line for the relatives of the patients approaching 
death. 
“For now it is not, it is too quick but it might be good in the future because 
nowadays offspring haven’t stayed in the village. The one who should take 
care of their mom and dad haven’t stayed, so if there is a unit supporting 
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this social condition, I personally agree. Actually, it should start now 
because if the problem arises, it might be too late....” 
KI no.9 
“Hospice?…Cancer is increasing…in particular the end stage so there is 
health needs…regional hospitals and cancer centres must have…provincial 
hospitals should also have but the district hospitals (community hospitals) 
might be a network for referring but the problem is who will do these.…I 
think provincial hospitals and regional hospitals should have this care. The 
cancer centres must provide this care if they want to.” 
KI no.5 
“…It’s very good, in fact it should have one hospice per province because 
there are always these patients but not much…It could be in hospitals, that 
is, an independent unit supported with an Act…or what it should be?...It 
should have physicians, nurses…it might be a part…a small ward in 
provincial hospitals…Otherwise, 4-5 beds would be reserved for this group 
of patients who could go nowhere or who are afraid of dying at home.…” 
KI no.4 
“…It might not good because the patients have frequently seen dying…death 
of friends, so if patients at the terminal stage stay together, they might see 
their friends pass away and fear for.” 
KI no.12 
“…Yes, it should incorporate in the existing health facilities. It could set up 
as a ward but isn’t necessary to be a separated facilities…It’s necessary for 
temporary stay of the chronic cases which the care givers feel 
burden…like…“if I continue in taking care, I will burn out…please let me 
take a break…let me sleep like a log and then I’ll get back”…It should be 
like that.…” 
KI no.10 
“…Actually, hospitals always have limited numbers of bed, so I will count 
the patients’ homes as hospice. I’ll allow the relatives of the nearly dying 
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patients to ring me when required. It also needs 24-hour phone because it 
wouldn’t happen during the office hour….” 
KI no.13 
8.4 Summary of research findings and study limitations 
8.4.1 Summary of research findings 
This study summarized viewpoints on health care provided for cancer, especially at the 
terminal stage, provided by 18 key informants in the regional and community hospitals 
and the cancer centre in Ubonratchathani province. On average, the key informants had 
11.1 years of experience in health services for cancer patients. Some issues according to 
the study’s objectives and new issues emerging during data analysis included disclosure 
or telling the truth regarding diagnosis and prognosis; route of health care and 
treatment; palliative care and pain control for prolonging life versus prolonging death in 
the advanced stage of cancer; the place for care and the place for dying; and difference 
in services by health insurance schemes and suggestions on improving the health 
systems for cancer patients. 
Disclosure of definite diagnosis and prognosis of cancer was mostly carried out by 
physicians at the regional hospital or the cancer centre despite the patients having 
started their access to treatment at a community hospital. It was the patient’s relatives or 
next of kin to whom physicians disclosed both diagnosis and prognosis including 
treatment while the patients were usually informed only of the diagnosis and treatment. 
Often was the case that the relatives did not agree on disclosure of the diagnosis, as a 
result the patients might be informed of the disease as tumour. However, due to the 
deterioration of the disease, especially in advanced stage, patients themselves probably 
perceived the cancer. The demand on, and details of disclosure also depended on the 
compromise of different demands and the assessment of the patients and relatives 
characteristics, age, medical condition, residential area and education level as well as 
health insurance scheme. 
Like other diseases, the route of health care and treatment for cancer patients usually 
starts at a primary care unit including private clinic and community hospitals, in 
accordance with the programmatic registration of their health insurance scheme. The 
referral system was the key bridging structure of the health services classified into three 
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levels of care including advanced tertiary care; however, it should be strengthened. 
Once the patients had a definite diagnosis of cancer at the tertiary care level, they could 
continue their treatment at the tertiary care health facilities until either ending up at such 
facilities, or being referred back to the community hospital for palliative or supportive 
treatment during the terminal stage. Recently, both the regional hospital and cancer 
centre set up the palliative care unit and pain control clinic. This palliative care also 
included chemotherapy and radiation therapy while the pain clinic provided medicines 
for pain relief. The community hospital also provided pain control with some medicines 
for pain relief and acupuncture. It was commented that the claimed expenditure limited 
at the maximum of 700 Baht per out-patient visit was not adequate for the actual 
expense of pain relief medicines due to the expensive and increasing prescription and 
the amount of opioid analgesics.  
In accordance with health care at the terminal stage, physicians also gave their views on 
the concepts of prolonging life versus prolonging death. The former is determined with 
palliative care in maintaining the quality of life of patients, which might result in 
prolonging life for a few months while the latter refers to cardiopulmonary resuscitation 
with medical and mechanical support or ‘intubation’.  
The patient’s relatives took part of the responsibility in addition to the health personnel 
in caring for patients in the terminal stage. This was related to the Thai culture in the 
issues of expanded family and younger generation which should take care of the older 
generation. Home was the best place for health care at the terminal stage as well as the 
place for dying. The reason for this is that patients would feel relaxed and familiarised 
with. This is different from hospitals, as it was the place that patients could stay without 
limitation of numbers of visitors, time, as well as travel limitations.  However, selecting 
the places was a compromised decision between preferences, conditions and family 
context of patients and their relatives.  
It was mentioned that health services under the health insurance schemes and benefit 
packages were different in the views of health care providers. The health service 
package for cancer according to CSMBS scheme was the best, whereas the UC and SHI 
schemes were likely equal. However, there might not be differences between the 
CSMBS and the UC in medicine items for pain control, but there were differences in the 
amount prescribed. It was also suggested that there should be one or two new cancer 
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centres in the north-eastern region to reduce the geographical imbalances. The palliative 
care concept should be introduced to all health personnel, particularly in the PCUs as 
well as the home-based hospice care. The hospice facilities would be a new requirement 
in the near future because of the changing Thai lifestyle, and family or household 
structure, especially in the city areas. 
8.4.2 Data and methodological limitations of the study 
The difficulties in conducting the interviews for the study were found to be the time 
constraint in interviewing, particularly of interviewees who were physicians. This 
constraint also resulted in losing an interview with a head of pharmacy unit at the 
community hospital. Even though it was out of the scope of this study, opinions of the 
executive members of the hospitals should also be sought out. It would help in 
providing further suggestions on the health service system in relation with the financing 
system.   
8.5 Discussion 
This subsection describes the discussion mainly on the professionals' views on current 
practice, place of care and place of death. The discussion on the health care service for 
terminally ill patients and the previously mentioned issues as a whole is deferred to 
Chapter Nine. 
No terminology of bad news in medicine was found, but it was determined around the 
information of diagnosis of incurable cancer; diagnosis of cancer; prognosis in dying 
patients; diagnosis and prognosis in terminally ill; incurability in undisclosed cancer; 
diagnosis of incurable diseases including, for instance, AIDS. Breaking the bad news or 
telling the truth was a concern regarding moral dilemmas due to its perspectives on 
patients rights as well as its consequence for the patients as the recipients of such bad 
news (Donovan 1993; Wattanachote 1997). 
Telling the truth in this study was consistent with Sengprasert (2003) who found that 
most of key informants, physicians at the National Cancer Institute in Bangkok, always 
told the truth to the patients relatives prior to the patients. However, it was the patients 
right to know and to make co-decisions on treatment with the physicians. Disclosure of 
the diagnosis made no concern on further discussion of treatment and care with the 
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patients. In the case that the relatives asked the doctor to conceal the information, such 
request including the usefulness of disclosure should be clarified with and indicated to 
the relatives. However, it was revealed that in the case of terminal stage, a physician 
accommodated the relative’s request where no specific treatment was available or the 
patients were in poor mental health (Sengprasert 2003). 
In consideration of the moral judgment in line with ethical theories, Saruayiam (1998) 
reported that the Thai moral judgment is similar to the western culture but it also takes 
into account the Buddhist ethics. This study employed an in-depth interview of 7 
physicians and 7 nurses working at 2 advanced tertiary care hospitals and the National 
Cancer Institute located in Bangkok. Two concepts in telling the truth were summarised 
as telling all truth to patients and telling as seen appropriate based on individual cases. 
This latter concept not only included telling partial truth, but also telling everything to 
the patients or telling the truth to relatives (Saruayiam 1998). 
The practice in disclosure of the diagnosis-treatment-prognosis by the physicians in this 
study fell into the model 3, individualised disclosure categorised by Donovan (1993). 
The first two models were non-disclosure and full-disclosure. Table 8.2 shows three 
such models compared in terms of doctor-patient relationship; management decision 
making style; doctor-patient communication; underlying assumption; disadvantages; 
advantage; and summing up (Donovan 1993). This individualised disclosure had taken 
into account the individual patient’s requirements on the amount of information 
disclosed and the times of disclosure as indicated in subsection 8.3.1.  
There was an issue revealed in this study and other studies in Thailand that even though 
patients were told about the information of their diseases, health professionals gave the 
precedence of telling the truth to the patient’s relatives rather than to the patients. It was 
the relatives of the patients that played an important role in decision making about this 
truth that was told. So far, this finding was not found or mentioned in any western 
guidelines or references (Lederberg and Joshi 2005; Sadock and Sadock 2007; Tulsky 
and Arnold 2007). 
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Table 8.2 Comparison between three disclosure models 
 Non-disclosure Full disclosure Individualized disclosure 
Doctor-patient relationship Paternalistic Paternalistic Partnership 
Management decision 
making style Physician only Patient only Joint 
Doctor-patient 
communication Poor Fair Good 
Underlying assumptions 1. appropriate for doctor to decide what is 
best for patient 
2. patients do not want to hear bad news 
about themselves 
3. patients need to be protected from bad 
news 
1. patient has right to full information about 
self and doctor had obligation to give it 
2. all patients want to know bad news about 
themselves 
3. patients should decide what treatment is 
best for them 
1. people are different 
2. it takes time to absorb and 
adjust to bad news 
3. partnership relationship as 
basis for decision making is in 
patient’s best interests 
Disadvantages 1. opportunity to adjust denied 
2. trust in doctor undermined 
3. opportunities for helpful interventions lost 
4. patient compliance less likely 
5. barriers between partners 
6. may acquire wrong information 
7. leads to avoidance, isolation and 
perception of rejection 
8. patient sense of control lost 
1. discussion of options in detail frighten 
and confuse some 
2. insisting on informing may undermine 
defences e.g. denial 
3. full information may have negative 
emotional consequences for some 
1. it is a very time consuming 
process 
2. it drains caregivers’ emotional 
resources 
Advantages 1. easier and less time consuming for doctor 
2. suits those people who prefer not to know 
their condition 
1. promotes doctor-patient trust 
2. promotes family support and allows time 
to put affairs in order 
3. helps those who cope by finding out 
maximum information 
1. amount of information given 
and rate of disclosure tailored to 
needs of the individual 
2. supportive relationship with 
doctor is developed 
Summing up 1. assumptions cannot be supported from 
literature 
2. negative impact on lives of most patients 
1. assumptions are no valid for a significant 
group 
2. could be harmful to some especially if 
done abruptly 
3. ethical problems in medicines 
1. appears to be the ideal model 
Source: Table 1 and Table 4 in (Donovan 1993) 
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Health professionals preferred home as the place of care and the place of death for 
patients with terminal cancer. This preference took into account the patient’s quality of 
life, patients and their family contexts and the social and cultural norm as well as the 
scarce resources of health care providers. However, they also agreed and suggested to 
have new interventions such as hospice health facility to accommodate the social 
structure and population changes in the near future, and one to two new cancer centres 
in the north-eastern region.  
In using home as the place of care and place of death for terminally ill patients, 
particularly the cancer patients, strengthening health care services was suggested. This 
included particularly the concept of palliative care, pain control and hospice care in 
health professionals at the primary care level. However, it was commented that in the 
management for pain relief medicines, there might not be a need to stock all medicines 
at the PCU or community hospitals. Not only the pain relief medicines, but also the 
medical supplies and devices should be available to reduce patient suffering and to 
maintain patient’s quality of life. Therefore, there should be a better mechanism to 
support the palliative care and pain control at home. Further discussion will be 
presented in the next chapter. 
8.6 Conclusion 
This chapter revealed the health services for cancer patients provided by the three levels 
of health care in Ubonrachthani province. The study employed a qualitative approach to 
address the service system including the referral system among such levels of care for 
cancer patients at both the early stage and late stage. It revealed the current practice of 
health professionals, particularly physicians, on the disclosure of diagnosis-treatment-
prognosis, suggestions on place of care and place of death as well as improving health 
services on palliative care for terminally ill cancer patients.  
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CHAPTER NINE 
DISCUSSION AND CONCLUSION 
 
This last chapter comprises of two main sections of discussion and conclusion. The 
former presents the final discussion on the overall research integrating four studies 
including hospitalisation and claimed expenditure in the last year of life; utilisation of 
and household expenditure for ambulatory care and acute care; current practice and 
preferences of patients with advanced cancer and their care givers; and current practice 
and views of health professionals on health services for terminally ill patients. The 
discussion is focused on two main issues including the study design, methodology and 
data of the research, and the key findings of the four studies. The last section is the 
conclusion of the findings, policy implication and research questions for further studies. 
9.1 Discussion 
The research was set up to respond to the research questions (Chapter Three, section 
3.5) including: 
1). Is there any inequity among Thai people in health care during the end of life period? 
2) What are the factors influencing that inequity? 
3) How do terminally ill cancer patients and their families cope with financing and their 
preferences for healthcare during that period? 
4) What new policy directions need to be developed or changes made in the current 
policy and practices in Thailand? 
This research then has specific objectives to prove the research questions on equity in 
health in three aspects, including payment, access to services and services provided, 
during the last period of life (see Chapter Three, subsection 3.1.4). Such equity was 
revealed by estimating the estimated utilisations and expenditure as well as the 
influencing factors, which were conceptualized on the basis of tripartite stakeholders 
including households, health care providers and third party payers in health care 
financing systems (Morris, Devlin et al. 2007). The research employed quantitative 
methods to reveal those estimated utilisations, expenditure and factors, details shown in 
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Chapter Five and Chapter Six. Using the qualitative approach, the coping mechanism 
with financial barriers and the preferences of terminally ill cancer (as the 'tracer 
disease') patients and their families were explored and described in Chapter Seven. In 
addition, the research sought views of the health professionals as the health care 
providers on services for such group of paitents. Beyond informing the quantitative 
evidence on equity, the findings from the two qualitative studies could also suggest the 
policy implications for health service provided to terminally ill cancer patients in 
Ubonratchathani province, where the research took place.  
9.1.1 Research design, methodological issues and data  
9.1.1.1 Research design 
The research was designed to employ the mixed method of quantitative study and 
qualitative approach. These methods each have limitations of the nature and 
appropriateness to each type of research questions of each approach. The former 
provides the reality but the later addresses the ontological perspective (Mason 2002). 
Meanwhile the quantitative method is mainly used to quantify the magnitude of a 
phenomenon of interest, for example, determining the proportion of event, the 
qualitative approach can provide details of and reasons for positive and negative 
response to such event (Jones 1995). As a result, this mixed method of quantitative and 
qualitative approaches are widely used in many areas of research, currently in medical 
science and social science.  
9.1.1.2 Methodological issues of the quantitative methods 
Focusing on the two quantitative studies of the research, the first study intended to 
explore the data of the third party payers and the second study focused on the household 
payment. The strength of the research is on making use of datasets which could be 
nationally representative and it was designed to retrieve the national data from the 
health insurers and households which represent the third party side and the patient side. 
The national representative has an advantage in evidence-based policy recommendation 
at the national level. In other words, such representation already accounted for 
individuals distributed throughout the country. The data collection period of both 
studies inclusively covered the episodes occurring within a year, and thus, the seasonal 
effect did not need to be considered as a confounding factor. However, a weakness of 
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the research is on both datasets which referred to different time periods of health 
experience before death, as well as their inconsistency. That is, the duration of the 
health insurance claim dataset was one year whereas the recall period of the household 
survey was three months for ambulatory care and six months for acute care. The claims 
dataset also could not link the registered records of every beneficiary of all health 
insurance schemes; as a result, the propensity of using the health services and having 
expenditure could not be estimated.   
Two of the research studies, claimed data and household survey, were designed as a 
retrospective cross-sectional study for a year during 2005-2006. As a result, it was not 
possible to explore any time trend in or variation across time of hospitalisation and 
expenditure. Under this circumstance, a time-series study, that is, including a few years 
of retrospective data, could fix the effect of over-time change by including the year as 
an additional independent variable (Zweifel, Felder et al. 1999; Seshamani and Gray 
2004b). This analysis could portray the retrospective trend and better forecast the future 
estimation. 
In particular in the insurance claims dataset on hospitalisation and expenditure, this 
research was able to analyse data from only the two out of three health insurance 
schemes, the UC and CSMBS (details in Chapter Two, subsection 2.2.4.1 2) and 
Chapter Five, section 5.1). It would have been better to have the SHI dataset in a 
comparable manner to the other two. This health insurance scheme which benefits the 
working-age population might reveal differences in mortality pattern, utilisation of and 
expenditure for health resources. 
The household dataset was specifically designed as an addition to the Survey of 
Population Change which is a ten-year routine survey. This useful survey did not 
include only patients’ utilisation of health services and households expenditure on direct 
medical cost, but also travelling cost and lodging for the care givers for the last visit for 
ambulatory care and last hospitalisation. It might detect changes in such patterns of use 
and expenditure and respond to the health service policy in time. This is necessary 
research for health policy makers, due to the fact that the utilisation and expenditure of 
this group of dying patients, an average of 0.6 percent of the annual population in 
Thailand, have been shown in many countries to require greater health resources than 
survival patients (Calfo, Smith et al.; Riley and Lubitz 1989; Lubitz and Riley 1993; 
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Garber, MaCurdy et al. 1998; Hogan, Lunney et al. 2001; Hoover, Crytal et al. 2002; 
Lunney, Lynn et al. 2002; Seshamani and Gray 2004c). In order to have such dataset as 
a time series, this survey should be repeated in greater frequency. Another option is for 
collecting this informaion is the Health and Welfare Survey (HWS) which is a biennial 
household survey of sickness, health care utilisation and health insurance could include 
a question regarding to the decedents of the households as a unit of survey or household 
member. 
To have comparable data of health care utilisation and expenditure of a decedent 
supported from both sides, the third party payers and the households, a new research 
design and research methods might be necessary. For example, it might be a specific 
mapping of data using the citizen identification numbers (CID) as common reference 
between the household dataset and the health insurance datasets. However, this 
individual data mapping requires ethics approval. The research might be conducted 
prospectively or retrospectively with different pros and cons. The prospective or 
longitudinal or cohort design should encounter problems about unreliable memories of 
the informants. As a result, all episodes of health care utilisation and expenditure 
occurring during the study period will be accurate. However, difficulties include 
seeking the patients who are dying, which should be the main inclusion criteria of the 
study. In contrast, the retrospective research will have limitations on poor reliable 
memories recalled for all episodes, particularly the informants from the household side. 
Identifying the decedents and tracing back their utilisations and expenditure are easier 
compared to the prospective method. Nonetheless, it should be taken into consideration 
that retrospective study might have a systematic recall bias, which occurs when one 
group has better memory than the other groups due to having more experience (Bland 
2000). This would be the case in particular in the case-control study which might apply 
to the decedents and the survivors in the area of this study. 
9.1.1.3 Methodological issues of the qualitative approach 
The two studies employing a qualitative approach focused on advanced stage cancer 
patients, their care givers, and health professionals in a province. These studies helped 
in exploring the health services from the views of households, patients and their 
informal care givers (demand side). In order to have a broader view of the Thai health 
service systems for terminally ill cancer patients, other research sites, e.g. other 
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provinces with similar referral systems of the regional hospital and the cancer centre; 
provinces in other regions of the country should be included in the research. However, 
the number of participants, in particular the patients and their care givers in each setting 
might be adjusted according to the principle of validity and reliability in qualitative 
method. 
Regardless of the study time frame, the research design of both studies was limited with 
a few issues. Even though the study employed purposive sampling in the attempt to 
recruit patients with some different characteristics, i.e. socioeconomic status as the poor 
and the rich; geography as urban and rural areas; and the three health insurance 
schemes, UC, CSMBS and SHI, the study could not seek out patients with these 
completely mixed characteristics, accordingly. Such characteristics were the factors 
partly influencing the expenditure for the end of life which might be underpinned by the 
different view and practice of patients and their care givers (see Chapter Three, section 
3.2.1). For example, the recruitment was limited to only one SHI for those residing in 
urban area but could not have the SHI in the rural area. In addition, the study could not 
differentiate between the rich and the poor among patients. A few criteria for identifying 
patients’ wealth status should be developed in further research. The research also did 
not include terminally ill patients with other diseases, for example, the end stage of 
organ failure. Compared to cancer, these groups of patients might require different 
health care, for example, they would rather need end of life care or palliative care 
without pain control. Hence, having views of dying from other diseases might lead to 
more comprehensive recommendation for national policy on health services than from a 
single disease. 
 9.1.1.4 Secondary data of the claimed dataset and household survey 
The research actually made use of three datasets in which two of the datasets, the death 
certified record of decedents and the hospitalisation data were combined as one—the 
claimed dataset (Chapter Five). The other dataset was the household survey, analysed as 
described in Chapter Six.  
In the combined dataset of the study in Chapter Five, there were some limitations. First, 
the dataset could not include those decedents who had not sought any in-hospital acute 
care as well as all zero claims during the last year of life. This additional data would 
provide the propensity of utilisation and expenditure incurred to the health insurance 
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schemes. This would also be consistent with the data of the household survey. Next, 
compared to the household survey, there were much fewer variables of individual data. 
The dataset should include, for example, the residential area of the decedents as well as 
the geographical data of their place of death, and the socioeconomic status of residential 
area. The appropriate unit of such area might be available as province or district. In 
addition, when the place of death is a hospital, further categorization should be made 
into different level of care available, for example, the advanced or specialised hospitals, 
tertiary care hospitals and secondary care hospitals. Such groups of care level might 
better reflect the hospital capacity in relation to the expenditure at each level of care. It 
has been reported by others in other countries that this variation had an effect on the 
health service systems including expenditure for decedents (Hogan, Lunney et al. 2001; 
Shugarman, Campbell et al. 2004; Wennberg, Fisher et al. 2004). However, the 
insurance claims dataset itself may be limited to only the data which is necessary to the 
reimbursement system. Perhaps, individual record mapping on this information to other 
datasets should be considered simultaneously with the possibility of ethical approval.  
The household survey dataset in the study of Chapter Six had a greater number of 
variables than the combined dataset of the hospitalisations and claimed expenditure. 
However, the geographical data could be categorised into only 5 regions. The 
categorisation into provincial levels was not recommended due to the sample size 
estimation of the survey which was based on regions. Further estimation, taking into 
account the provincial level, was likely to reduce the limitations on explanation of the 
factors which determined the health care utilisations and household expenditure.  
The quality of identifying cause of death indicated in both datasets seems to be poor. 
Nearly one-third of all causes in the combined dataset and one-fourth in the household 
survey dataset were reported as ill-defined causes including senility. These high 
proportions of ill-defined causes reflect the poor performance of and quality of 
identifying the cause of death in the country. This identification requires further 
exploration, explanation and improvement because it is an important indicator of the 
health system (Commission on Social Determinants of Health 2008; World Health 
Organization 2008). 
Causes of death in this research could not be compared to the causes of death from other 
studies in the country due to the methods of defining the causes. This study employed 
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broader categories, such as communicable diseases and non-communicable diseases, 
due to the fact that the retrospective interview was conducted and responded by lay 
people, i.e. non-health personnel and the decedents’ caregiver or household member, 
respectively. This differed from other specific studies on causes of death which 
identifying causes of death classified by health professionals (details in Chapter One, 
section 1.3.2) (Chooprapawan, Porapakkham et al. 2000; Thai working Group on 
Burden of Disease and Injuries 2007; Project on Setting Priorities Using Information on 
Cost-Effectiveness (SPICE 2004-2009) 2009). However, the causes of death recorded 
by the ICD10 in the insurance claimed dataset linked to the death certification dataset 
were likely to be much more accurate (Chapter Five). This death certification or the 
citizen identification number dataset should be useful to the household survey and it 
could provide the details of diseases as well as the different patterns in utilisation and 
expenditure among causes of death as such. This methodology on the linkage by death 
certification and the identification number requires another study for which ethics 
approval would need to be taken into consideration. 
The economic status of households is a crucial variable in monitoring equity. The 
household survey dataset provides the income, in kind contributions and assets which 
are a set of data in measuring the household living standards. Even though the survey 
collected assets and analysed with principal component analysis, the study in Chapter 
Six selected the sum of income and in kind contributions as a measure for household 
living standards. This is the reason for less percentage of data loss. The sum of income 
and in kind contributions, and the asset index score were ranked and categorised into 
quintiles and both measures of living standards showed a weak positive relationship  
(Spearman correlation was 0.4, details in Appendix 4, section A4.4 c)). This weak 
relationship might reflect less reliability of both measures in this dataset. Employing the 
principal components analysis technique, the asset index selected the first principal 
component. As a result, several assets which have high monetary value but a few 
household have and indicated wealthy status, for example, monetary value of the land, 
might not be taken into account. Apart from the countable assets, this technique also 
requires an appropriate intermediate variables transferring from some original variables. 
However, the asset index quintile is suggested to be used in measuring living standards 
of households instead of the sum of income and in kind if there are difficulties in data 
collecting. Further, the monetary terms of income and in kind contributions as a 
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continuous variable was another choice of the direct measure of the household 
economic status. The income measure was criticised that it, likes the consumption or 
expenditure data, is difficult to collect. The informal sector in developing countries is 
more common, and as a result many households have multiple and continually changing 
sources of income and home production is widespread. Even in the developed countries, 
income data collection often has to deal with the problems of self-employment, informal 
economic activities and widespread reluctance to disclose information on income 
(O'Donnell, van Doorslaer et al. 2008d). 
9.1.1.5 Primary data from the patients, primary care givers and health professionals 
Difficulties were found during the study in terms of interviewing the patients and the 
care givers including finding patients who were CSMBS or SHI beneficiaries. In this 
study, there were sixteen UC, three CSMBS and one SHI beneficiaries. Perhaps, there 
were two reasons that both health insurance schemes have much fewer enrollees than 
the UC scheme; therefore, there was less chance of finding them as well (see Chapter 
Two, Table 2.7). Specific to the SHI scheme which recruits only the working age group, 
the mortality rate as well as rate of illness from cancer of such young group is rare 
compared to the UC and the CSMBS beneficiaries who are older (see Appendix A4.5, 
Table A4.4). 
The study on the patients and the care givers was limited in recruitment of the variation 
of patients’ characteristics, for example, residing in the rural areas, especially the poor, 
as partly indicated in subsection 9.1.1.3. In terms of the deviant cases which will 
express their opposite view to the others, the study could recruit only a minority ethnic 
patient who is the UC beneficiary subtype alien but was unable to confirm with the 
others on the constraints the case had confronted. Other ethnic minority groups and the 
patients from other religions which are not Buddhism also had not been found. The 
ethnic minority groups were the people who are prone to be underprivileged in access to 
public services, even in health care which is essential. In addition, this group may have 
differences of thought and experience which affects health care utilisation. For example, 
Bruera E, et al found that the African-American patients were 1.9 times more likely to 
die in hospitals than at home and some other researchers suggested that this preference 
might be due to them being less likely to accept physicians advice and preferred to 
select aggressive intervention as well as they were less likely to choose  hospice 
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enrollment (Bruera, Russell et al. 2002); Eleazer GP, et al cited in (Bruera, Russell et al. 
2002); Christakis NA and Escarce JJ cited in (Bruera, Russell et al. 2002). Meanwhile 
religions which usually have a complex but causal link with culture and folklore also 
play an important role in the management of the body after death which in turn 
determines the last period of human life, preferred place for dying and the health care 
provided (see Chapter Seven, subsection 7.4.3). 
9.1.2 Discussion on the research main findings 
In addition to the specific discussions in Chapter Five to Chapter Eight, this subsection 
focuses on the in-between research findings of such four chapters through the reseach 
questions mentioned in section 9.1, accordingly. There were mainly two topics 
including the findings of terminally ill patients as a whole and the findings focusing on 
terminally ill cancer patients.  
9.1.2.1 Health care utilisation of and expenditure for terminally ill patients 
Despite some limitations on comparison across studies were found, the two studies of 
the 2005-2006 claims dataset and household survey were able to reveal an overview of 
utilisation and expenditure of the health insurance schemes and the households for 
decedents over the period of the last year and the last six months of life.  
(1) Factors determining hospitalisation and expenditure during the last year and last six 
months of life 
Like other periods of life, it was clear that during the last six months of life, none of all 
decedents sought health care as well as experienced expenditures on health care. 
Consequently, the study has shown the propensity and intensity of using acute care and 
having expenditure of the decedents. In addition to the decedent or household side, the 
research could reveal the intensity of using acute care and the expenditure for the last 
year of life incurred the health insurance schemes, the third party payers.  
In accordance with the factors influencing health which were mentioned in the research 
conceptual framework, Table 9.1 shows all factors explored in this research in Chapter 
Five and Chapter Six. The common factors that determined the intensity of using acute 
care reported both by households and health insurers in the last year or the last six 
months included age and cause of death, whereas the factors in propensity to use health 
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care included age, occupation, place of death and health insurance scheme. Other 
factors found from the health insurance data analysis, determining intensity, included 
gender and comorbidity. These factors, particularly age and gender in the health 
insurance side, were also found in previous studies employing descriptive statistics or 
regressions (Roos, Montgomery et al. 1987; Shugarman, Campbell et al. 2004; 
Hanratty, Jacoby et al. 2008; Payne, Laporte et al. 2009) (see also Chapter Three, 
section 3.2.1). Further research on the propensity of hospitalisation including factors on 
geography, demography and socioeconomics of the individuals and health care 
providers; and the comorbidity of the decedents might confirm whether the findings 
reported in this thesis are confounded and/or further explained by the additional factors. 
These proposed research areas might support the evidence on variation across areas of 
the country. Hence, this fact finding could guide tailor-made policy and interventions 
for specific problems of such area, for instance. 
Table 9.1 Factors included both in the insurance claims dataset and household survey 
tested as significant determinants of propensity and intensity of hospitalisation 
Health insurance 
scheme (last year) 
 Decedents and households 
(last six months) Factors 
Intensity  Propensity Intensity 
Geography Region -  ? ? 
 Municipality -  ? ? 
Demography Age at death ?  ? ? 
 Gender ?  ? ? 
Socioeconomics Head of household - 
 ? ? 
 Education -  ? ? 
 Occupation -  ? ? 
 Wealth status -  ? ? 
Others Comorbidity ?  - - 
 Cause of death ?  ? ? 
 Place of death ?  ? ? 
 Health insurance scheme 
? 
(CSMBS and UC) 
 ? ? 
? = yes; ? = no; - = not available 
 
Table 9.2 indicates the determinants of the propensity and intensity of expenditure for 
hospitalisation, both claimed and out of pocket. Age, gender, cause of death, place of 
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death and health insurance scheme were the main determinants of expenditure while 
region, age and three socioeconomic factors, place of death and health insurance had an 
influence on the propensity of paying out of pocket. Similar to the discussion on the 
propensity and intensity of hospitalisation, such factors determined expenditure in other 
developed countries.  
Table 9.2 Factors included in both claimed dataset and household survey tested as 
significant determinants of expenditure for hospitalisation 
Health insurance 
scheme (last year) 
 Decedents and households 
(last six months) Factors 
Intensity  Propensity Intensity 
Geography Region -  ? ? 
 Municipality -  ? ? 
Demography Age at death ?  ? ? 
 Gender ?  ? ? 
Socioeconomics Head of household - 
 ? ? 
 Education -  ? ? 
 Occupation -  ? ? 
 Wealth status -  ? ? 
Others Comorbidity ?  - - 
 Cause of death ?  ? ? 
 Place of death ?  ? ? 
 Health insurance scheme 
? 
(CSMBS and UC) 
 ? ? 
? = yes; ? = no; - = not available 
 
(2) Factors determining visiting ambulatory care and expenditure during the last three 
months of life 
Many studies have not reported evidence on costs and use of services beyond the 
hospitalisation and its expenditure; this research, specifically Chapter Six explored the 
propensity and intensity of ambulatory care visits during the last three months of life. 
According to Table 6.13 in Chapter Six, the main determinants of the propensity and 
intensity of visiting ambulatory care included cause of death, place of death and health 
insurance scheme. Meanwhile, the factors determining household expenditure for 
ambulatory care included age, being head of household, occupation, cause of death, 
place of death, and health insurance scheme. Other determinants affecting such visit and 
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expenditure included municipality, gender, education, living standards and using 
complementary medicines.  
Using complementary medicine was a determining factor for the total number of visits 
because essentially, this type of care requires more frequent visits than the institutional 
health facilities which mostly have fewer follow up appointments. The care providers of 
complementary medicines mostly reside in the village, thus, it is much easier to travel to 
clinics/shops for complementary medicines than the health facilities in the municipality. 
This also determined the out of pocket payment because it is unlikely to provide some 
services, for example, some types of alternative medicines, in health facilities as well as 
the others might not be adopted in the health facilities even it is the policy. For example, 
some herbal medicines are included in the list of national essential medicines for which 
is referrably covered by the benefit package of all health insurance schemes (see Table 
2.7, Chapter Two). However, if the herbal medicines are not included in the hospital 
formulary list, there is still no medicine available in the health facilities. Thus patients 
have to buy from the drug stores, if needed. 
(3) Seeking acute care and expenditure during the last year and the last six months of life 
Among the CSMBS and the UCE and the UCP beneficiaries who sought in-hospital 
acute care during the last year and the last six months of life, Table 9.3 summarises the 
average hospitalisations and rate per month of such decedents. Even though this average 
hospitalisation was not directly comparable because of the overlapping of periods and 
different variables in the datasets, to some extent the rate per month could implicitly 
reflect that the closer to time of death, the greater the seeking or hospitalisation was. It 
was indicated that the hospitalisation rate per month during the last year was 0.23 and 
increasing to 0.49 during the last six months. This might be due to the fact that closer to 
dying, the severity of diseases usually increased and, as a result, much more health care 
was needed. This finding was in line with other predictions of likelihood of 
hospitalisation during the four quarters of the year of death, in which the quarter 
including the date of death had positive effect. That is, the decedents in the last quarter 
of life had more than fifty percent chance for hospitalisation while it was eleven to 
seventeen percent during the second to the fourth quarters (Seshamani and Gray 2004a). 
This finding of the greater average hospitalisation during the last six months than the 
last year also similarly presents across most of the age groups at death, both types of the 
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UC beneficiaries, place of death, and some cause of death. However, this finding could 
only be confirmed by a study designed to reveal numbers of hospitalisation along a 
certain period of time up to death, which was not possible in this research. 
Table 9.3 Mean hospitalisations (95% confidence interval) of decedents seeking care 
during the last year (claimed dataset) and the last six months of life by factors 
(household survey) 
 Last year 
Rate per 
month  Last six months 
Rate per 
month 
Average 2.8 (2.8, 2.8) 0.23  3.0 (2.7, 3.3) 0.49 
Gender      
Male 2.7 (2.7, 2.7) 0.22  3.2 (2.7, 3.8) 0.54 
Female 2.9 (2.9, 2.9) 0.24  2.6 (2.4, 2.8) 0.43 
Age group (yrs.)      
< 5 3.2 (3.1, 3.3) 0.27  3.7 (1.1, 6.2) 0.61 
5 to <10 3.4 (3.1, 3.6) 0.28  3.9 (-0.3, 8.1) 0.65 
10 to <20 2.7 (2.6, 2.8) 0.22  1.7 (0.7, 2.6) 0.28 
20 to <30 2.8 (2.7, 2.9) 0.23  6.6 (-0.2, 13.4) 1.10 
30 to <40 2.8 (2.7, 2.8) 0.23  3.4 (1.5, 5.3) 0.57 
40 to <50 2.9 (2.9, 3.0) 0.25  2.3 (1.5, 3.1) 0.39 
50 to <60 3.1 (3.0, 3.1) 0.26  2.9 (2.3, 3.5) 0.49 
60 to <70 3.0 (3.0, 3.0) 0.25  3.5 (2.7, 4.4) 0.59 
70 to <75 2.8 (2.8, 2.9) 0.24  3.1 (2.3, 4.0) 0.52 
75 to <80 2.6 (2.5, 2.6) 0.21  2.4 (2.0, 2.8) 0.40 
>=80 2.2 (2.2, 2.2) 0.18  2.5 (2.0, 3.1) 0.42 
Health insurance scheme      
CSMBS 2.8 (2.8, 2.8) 0.23  2.6 (2.1, 3.1) 0.43 
UCE 2.7 (2.7, 2.7) 0.23  2.8 (2.5, 3.0) 0.46 
UEP 2.9 (2.8, 2.9) 0.24  3.6 (2.7, 4.6) 0.60 
Place of death      
Public hospitals 2.8 (2.8, 2.8) 0.23  2.6 (2.2, 3.0) 0.43 
Private hospitals 2.5 (2.4, 2.6) 0.21  3.0 (2.1, 3.8) 0.50 
Home  3.4 (2.8, 3.9) 0.56 
Others 
2.7 (2.7, 2.8) 0.23 
 3.1 (2.0, 4.2) 0.52 
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Table 9.3 Mean hospitalisations (95% confidence interval) of decedents seeking care 
during the last year (claimed dataset) and the last six months of life by factors 
(household survey) (cont.) 
 Last year 
Rate per 
month  Last six months 
Rate per 
month 
Cause of death      
Ill-defined 2.7 (2.6, 2.7) 0.22  2.1 (1.2, 3.1) 0.36 
Communicable ds. 2.7 (2.7, 2.7) 0.22  3.0 (2.3, 3.6) 0.49 
Non-communicable ds. 2.9 (2.9, 2.9) 0.24  2.9 (2.5, 3.2) 0.48 
Injuries 1.6 (1.5, 1.6) 0.13  1.4 (1.1, 1.7) 0.24 
Senility 2.1 (2.1, 2.1) 0.18  2.4 (2.0, 2.7) 0.39 
Cancer 3.5 (3.5, 3.6) 0.30  3.8 (2.6, 4.9) 0.63 
 
In addition to hospitalisation, Table 9.4 shows the expenditure of decedents seeking 
care incurred by health insurance schemes and households and the payment 
proportionate to the reference category. Due to the different period of the expenditure, 
the research could not reveal the average total proportionate expenditure incurred by 
both payers. However, it is likely that the health insurance schemes paid more for 
younger decedents than the older ones whereas the household paid increasingly more 
when age increased, compared to the decedents at age less than five years. Health 
insurers and households paid for the UC beneficiaries less than the CSMBS 
beneficiaries. In other words, the payments for the CSMBS from the health insurance 
scheme and the household were highest, compared to the UCE and the UCP. It is 
interesting that dying at home seems to be associated with reduced expenditure not only 
of health insurers but also households, compared to dying in hospitals. This finding 
might partly support the concept of good death at home and saving the cost for both the 
health insurers and out of pocket (Clark 2003). Apart from ill-defined cause of death, 
the health insurers as well as household spent the least amount of expenditure for 
senility death. 
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Table 9.4 Mean expenditure (95% confidence interval) of decedents seeking care 
during the last year (by health insurers) and the last six months of life (by household) by 
factors 
 Last year Ratio Last six months Ratio 
Average 64107 (63564, 64649)  11596 (4455, 18737)  
Gender     
Male* 64025 (63292, 64759) 1 16082 (3939, 28224) 1 
Female 64205 (63398, 65011) 1.0 5712 (3571, 7853) 0.4 
Age group (yrs.)     
<5* 130189 (119962, 140417) 1 886 (-440, 2212) 1 
5 to <10 104849 (93004, 116695) 0.8 0 0.0 
10 to <20 94157 (86367 101947) 0.7 23318 (-24571, 71207) 26.3 
20 to <30 61085 (57295, 64874) 0.5 21822 (6513, 37130) 24.6 
30 to <40 51251 (49531, 52971) 0.4 5370 (1218, 9522) 6.1 
40 to <50 62296 (60715, 63877) 0.5 2289 (-377, 4956) 2.6 
50 to <60 65798 (64475, 67120) 0.5 11061 (-301, 22423) 12.5 
60 to <70 66903 (65704, 68102) 0.5 6611 (-1089, 14310) 7.5 
70 to <75 66604 (65034, 68174) 0.5 4593 (2289, 6896) 5.2 
75 to <80 62368 (60927, 63808) 0.5 31311 (-14008, 76631) 35.3 
>=80 57587 (56344, 58829) 0.4 12807 (5886, 19728) 14.5 
Health insurance scheme     
CSMBS* 119995 (117925, 122064) 1 15185 (5360, 25010) 1 
UCE 50439 (49891, 50987) 0.4 12496 (1049, 23943) 0.8 
UCP 56788 (55875, 57703) 0.5 7422 (3851, 10992) 0.5 
Place of death     
Public hospitals* 84481 (83492, 85469) 1 14976 (482, 29470) 1 
Private hospitals 110973 (105896, 116049) 1.3 79292 (21514, 137071) 5.3 
Home 4192 (1735, 6650) 0.3 
Others 
43699 (43210, 44188) 0.5 
634 (-449, 1717) 0.0 
Cause of death     
Ill-defined* 50918 (49928, 51908) 1 64 (-43, 172) 1 
Communicable diseases 85620 (84000, 87240) 1.7 31508 (-4721, 67737) 490.6 
Non-communicable disease 65350 (64334, 66365) 1.3 6630 (3325, 9934) 103.2 
Injuries 46687 (44652, 48721) 0.9 9884 (-959, 20728) 153.9 
Senility 32381 (31528, 33233) 0.6 5397 (1280, 9514) 84.0 
Cancer 80780 (79345, 82215) 1.6 8159 (4200, 12118) 127.0 
*Reference for ratio 
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(4) Inequality in access to and expenditure for services provided during the last period of 
life 
In addition to the factors determining utilisation and expenditure of health insurers and 
household that the thesis revealed, the consequence of the differences the factors 
determined probably means inequality in terms of access to care and finance of health 
care. With the multivariate regression technique and various factors indicated in Table 
9.1 and Table 9.2, however, the health insurance schemes and wealth status were the 
main focus in this research. Keeping other factors constant, the health insurance 
schemes determined significantly variations in all propensity and intensity of the 
utilisation and household expenditure for ambulatory care and acute care and intensity 
of hospitalisation. That is, the CSMBS beneficiaries, compared to the UCE and the UCP 
beneficiaries, were likely to have greater chance in access to ambulatory care but less 
frequency in numbers of visits; less chance of paying but paying greater amount for 
such visits; non-significant difference in access hospitalisation and numbers of 
hospitalisation; and less chance in paying but non-significant difference in amount paid 
for such hospitalisations (Table 6.9, Chapter Six). On the other hand, Table 9.5 shows 
expenditure and the ratio of the CSMBS to the UC for hospitalisations per capita per 
year for beneficiaries who accessed care in 2001, 2003 by Prakongsai (2008), compared 
to dying beneficiaries who accessed care between 2005 and 2006. The ratios indicated 
that the public resource spending via the Comptroller General’s Department (CGD) for 
the CSMBS beneficiaries was double of such spending via the National Health Security 
Office for the UC beneficiaries including even the dying beneficiaries found in this 
research. The author reported the mean unit costs per ambulatory visit and per 
hospitalisation per capita per year in 2001 and in 2003 which revealed the inequality of 
such public subsidy. In addition, the review on the government budget spending for the 
least number of beneficiaries also supported this finding on the public resource subsidy 
for the CSMBS beneficiaries (see Table 2.7, Chapter Two). In contrast to expenditure, 
this research found small difference in numbers of hospitalisation under the CSMBS 
versus the UCP and the UCE while the study on the 2005 Health and Welfare Survey in 
general population found that the CSMBS beneficiaries were likely to have greater 
numbers of hospitalisation than the UC beneficiaries (Thammatacharee 2009). 
In conclusion, the thesis revealed that the factors which determined the differences of 
utilisation and expenditure during the last period of life as indicated in Table 9.1 and 
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Table 9.2. The four main determinants included age at death, cause of death, place of 
death and health insurance scheme. In light of equity or equality, this thesis aims to 
reveal a few issues which should be concomitantly considered including health is the 
basic right of all ordinary Thai people as stated in the latest 2007 Constitution; health 
care financing; and seven categories of avoidable and unavoidable factors suggested by 
Whitehead (2000). Age at death seems to fall in the category of natural, biological 
variation as well as casue of death which is likely an original ill health in the category of 
natural selection, regardless of health-damaging behaviour. Both unavoidable categories 
would not normally be indicated as inequities. Place of death was a complexation of 
patients and care givers preference, family context, health professionals’ suggestions, 
and service system provided to the patient. As a consequence, these were avoidable as 
well as unavoidable health and social features. It is difficult to decide whether or not the 
differences in utilisation and expenditure by different places of death were fair. Health 
insurance scheme which represent different financing systems including tax and 
government budget subsidising for health care is an avoidable issue. The significant 
determination on such utlisation and expenditure of the health insurance scheme might 
be due to the inequality of the concept and mandate of each scheme and the system 
superior the healt service system rather than the service system or healt care provided 
itself. 
Table 9.5 Expenditure and ratio of the CSMBS to the UC for hospitalisations per capita 
per year  
 2001*  2003*  2005-2006** 
 Expenditure Ratio  Expenditure Ratio  Expenditure Ratio 
CSMBS 11,939 - 22,166 3.25  10,078 - 28,221 2.03  119,995 2.11 - 
2.38 
UC 3,669 - 6,812   4,960 – 13,889   50,439 - 56,788  
Note: * per beneficiaries accessing care; ** per dying beneficiaries accessing care 
Sources: Table 6.2 and Table 6.3 in Prakongsai (2008); Table 2.7 in Chapter Two; and Table 5.2 in Chapter 
Five 
 
(5) Place of death 
Discussion of the place of death related to the terminal stage of life or at the end of life 
in the research could not be ignored. Even though the place of death might not be the 
place of care, it can partly determine the place of care during the terminally ill period 
through the care plan or the service system design. Some places of death which are 
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usually compared included home and dwelling room (e.g. apartment), hospital, nursing 
home, hospice and others. Among other factors affecting place of death, dying at home 
was mentioned as a desire of the terminally ill or elderly patients. Consequently, it has 
been seen as a key issue indicating quality of care at the end of life or patient centred 
death as well as a determinant of good death (Pierson, Curtis et al. 2002; Kikule 2003; 
Editorial 2008). 
In general, this research found that approximately 54 percent of decedents in 2005-2006 
died at home. This percentage gradually declined from 59 percent over nearly the past 
two decades. On the contrary, however, dying in hospital had been rising from 28 
percent to 39 percent over such period (Figure 1.3, Chapter One). This majority of 
deaths at home was similar to the findings from other developing countries but was 
opposite to that of the developed countries. For example, 50 percent to 71.2 percent of 
terminally ill patients in rural Tanzania in 1994 died at home (Ngalula, Urassa et al. 
2002) and deaths in 2003 of six European countries ranged from 33.9 percent in the 
Netherlands to 62.8 percent in Wales. However, the trend over time of dying at home in 
Thailand was decreasing but was increasing in developed countries. That included 
Canada having a declining trend in hospitalised death which was the majority from 77.7 
percent in 1994 to 60.6 percent in 2004 while non-institutional places like private 
residences rose from 19.3 percent to 29.4 percent (Wilson, Truman et al. 2009); home 
deaths in Japan fell from approximately 82 percent in 1951 to 13 percent in 2002 and 
death in hospital correspondingly increased over such period (Yang, Sakamoto et al. 
2006); and between 1990 and 1998, home deaths in the US rose from 17 percent to 22 
percent and hospital deaths declined from 54 percent to 41 percent (Flory, Young-Xu et 
al. 2004). 
However, several publications criticised the differences found in preference of dying at 
home versus the actual place of death, and variation from country to country. This is 
due to the influence of multiple factors including the different preference between 
patients and care givers; the health services provided or ability to provide care at home; 
nature of illness and treatment required; patient family support and social support; and 
health policy which affected care for terminally ill patients e.g. financing policy which 
allows home based care (Fukui, Kawagoe et al. 2003; Thomas, Morris et al. 2004; Tang, 
Liu et al. 2005). In addition, some studies employing multivariate analysis confirmed 
the correlation of characteristics of patients and of health facilities against place of 
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death. For example, decreasing in home deaths is related to increasing in numbers of 
beds in hospitals and the utilisation of hospitals; higher probability of home death is 
found when age increased; patients with cardiovascular diseases, cancer and lower 
respiratory diseases had higher probability of dying at home (Cohen, Bilsen et al. 2006; 
Yang, Sakamoto et al. 2006; Cohen, Bilsen et al. 2008). The contradictory trend over 
time of the place of death between developed and developing countries might partly 
depend on the advancement of system design for and the scarcity on infrastructure of 
health services. In countries, mostly developed, there are home-based health services 
with professional and/or well-trained care givers whereas patients in developing 
countries do have to seek professional care at health facilities. 
Like this research, there was interesting evidence about the influence of health 
insurance schemes and wealth status on place of death which had not been found in 
other studies. It was reported that a smaller percentage of the CSMBS beneficiaries who 
were the oldest decedents and of the UCP who were in working age died at home, at 
42.3 percent and 41.5 percent, respectively. Meanwhile 69 percent of uninsured and 63 
percent of the UCE decedents died at home (Figure 6.4 panel B, Chapter Six). On 
wealth status, death at public hospitals increased as income quintile increased. Thirty 
percent of the richest group which was the least proportion compared to others died at 
home while 61 percent died in hospital (subsection 6.3.2 and Figure 6.3 panel A, 
Chapter Six). Perhaps this disparity indicated differences in accessibility to care and 
expenditure incurred by households in relation to cause of death.. On the one hand, 
these diseases allow some time for preparing care at terminal stage as well as requiring 
care givers, compared to other causes of death. On the other hand patients in Q5, the 
well-off group was expected to have the least financial hurdle, compared to others. 
Further details provided (Table A4.10, Appendix 4) that nearly half of decedents (43.8 
percent) categorised in Q5 were CSMBS beneficiaries and more than half of decedents 
in Q5 died from non-communicable disease including cancer (31.9 percent and 22.2 
percent). These quantitative findings were confirmed by the views of patients with 
terminal stage cancer (section 7.5, Chapter Seven) and the health professionals (section 
8.5, Chapter Eight) that CSMBS payment mechanism as fee for service and its benefit 
package allows privileged treatment over the other health insurance schemes. This 
means that the CSMBS beneficiaries would have least financial constraint and have 
greatest chance in access to health care, compared to the others. In addition, care givers 
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view which was accounted as an important decision by health professionals also played 
significant role in determining the place for care and place for dying. Although selecting 
the places was a compromised decision between preferences, conditions and family 
context of patients, their relatives and health professionals, it could not denied that the 
availability of informal care givers and family context were outweighed, particularly in 
patients with chronic diseases requiring long term professional care.  
Further research specifically designed to place of care and place of death in relation to 
the health insurance schemes, wealth status and cause of death including other factors 
might support this hypothesis in the setting of Thailand. 
This research has shown that the place of death was a determinant strongly related to 
access to care and expenditure for both ambulatory care and acute care, and for the 
health insurers side and the household side, as mentioned earlier (see Table 9.3 and 
Table 9.4; Table 5.5 and Table 5.6 in Chapter Five; and Table 6.5 to Table 6.8 in 
Chapter Six). Table 9.6 summarises the effects of places of death on access and 
expenditure for hospitalisations and ambulatory visits from both the supply and demand 
sides. On the health insurer side, it was predicted that dying at home including 
elsewhere likely had equal numbers of hospitalisations, with nearly equal payment to 
dying at private hospitals but less payment than to public hospitals. On the household 
side, dying at home resulted in fewer of ambulatory visits than private hospitals and 
other places but greater numbers than public hospitals; greater chance in paying out of 
pocket for ambulatory care than public hospitals; less chance of hospitalisation but non 
significant difference in numbers of hospitalisation; and less chance in paying out of 
pocket than both types of hospitals but non-significant difference in payment value. 
Focusing on acute care which requires greater resources than ambulatory care as 
reported in some studies (Lubitz and Riley 1993; Stooker, van Acht et al. 2001; Hoover, 
Crytal et al. 2002), dying at home might be able to save costs to the health care 
providers resulting in savings for third party payers as well as households. In addition to 
the direct medical cost, other direct and indirect cost incurred by households might 
reduce, for instance, travelling cost of decedents and care givers, cost of lodging and 
foods for care givers while caring for in-hospital decedents. However, it might not be 
that all decedents are able to die at home. Other factors also affect determination of the 
place of death, for example, physical condition of decedents themselves; family and 
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household context; the cause of death and comorbidity; and the availability of home-
based health service. 
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Table 9.6 The effect of place of death on utilisation and expenditure by health insurance side and household side 
Health insurances  Households 
 Ambulatory care (last 3 months)  Acute care (last 6 months) Acute care  
(last year)  Utilisation  Expenditure  Utilisation  Expenditure 
 
Hospitalisation Expenditure  Prob. Value  Prob. Value  Prob. Value  Prob. Value
Home (ref.)              
Public 
hospitals (-) (+)** 
 (-) (-)*  (-)** (-)**  (+)** (-)  (+)* (+) 
Private 
hospitals (-)** (-)** 
 (+) (+)  (+) (+)**  (+)** (+)  (+)* (+) 
Others Including in home  (-)* (+)  (-) (-)  (-)** (+)  (+) (-)* 
Note: * p < 0.05; ** p < 0.01; Ref. = reference;  
          (+)  and (-) = direction of the coefficient of such independent variable relative to the its reference and dependent variable 
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9.1.2.2 Health service for terminally ill cancer patients, the case of Ubonratchthani 
province 
Cancer is a disease which has a more clearly defiined terminal phase than other diseases 
(see Figure 1.4, Chapter One). Therefore, improving health service or health care for the 
terminal patients, it is usual to select cancer as a starting point. The evidence also 
revealed that incidence of cancer is increasing worldwide including Thailand, and that 
the metastasis of cancer leads to suffering from chronic pain (World Health 
Organization 2004; World Health Organization 2008). However, it was commented that 
terminal care could be expanded to patients with other chronic diseases including organ 
failure such as chronic renal failure, and HIV/AIDS, for instance, when it becomes clear 
that health care is needed, but can no longer provide a cure (Franks, Salisbury et al. 
2000; Kikule 2003; Zallman, Sanchez et al. 2003). Nonetheless, for the reason 
mentioned, cancer was selected to be the tracer disease in this research and as a starting 
point for improving health services. This research further explored details of terminally 
ill cancer patients by applying the multivariate regressions in Chapter Five and Chapter 
Six to predict the expenditure during the last period of life. In addition, the findings 
from Chapter Seven and Chapter Eight provided explanations on and understanding of 
the perception and family and household context of the patients in Ubonratchthani.  
With triangulation technique among patients, care givers, provided in Chapter Seven, 
and the health professionals, in Chapter Eight, the following issues are the key findings 
concomitantly presented with discussion. 
(1) Telling the truth and decision making for treatments 
Giving the diagnosis of cancer, particularly advanced stage of cancer and its prognosis 
is addressed as bad news because the word 'cancer' seems to be the disease that 
threatens life with the meaning of death, compared to the term 'tumour'. The way in 
which the physicians give diagnosis and prognosis, in principle, was to first tell patients 
relatives who knew the details of the disease progress. Patients know the diagnosis later 
on, either from the physicians or their relatives or even from their own perception of 
deterioration of the illness and confirmation by physicians. So far, this style of breaking 
bad news has not been reported in any publications written by western authors (Downie 
and Randall 2004). In contrast, it was mentioned in the publication reviewed in eastern 
countries, e.g. Japan in the Far East and the eastern Mediterranean countries (Kazdaglis, 
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Arnaoutoglou et al. 2010). It implied that health professionals give patients relatives 
priority in breaking bad news as well as keeping awareness and modifying the ‘how 
much of the bad news’ towards the concept of individualized disclosure to the patients 
(Donovan 1993). However, the Thai patients still have their own right, with the support 
from their close relatives, in making a decision for treatments which often follow the 
physicians’ suggestion, compared to patients in some eastern Mediterranean countries. 
This difference in style was indicated to be due to the difference in cultures and 
religious backgrounds, as well as the view from political science, for example, of the 
paternalism in many eastern countries including some countries in Western Europe 
(Kazdaglis, Arnaoutoglou et al. 2010).   
(2) Route of health service for treatments of cancer and the referral system 
It would help with further interpretation to describe the health service system for cancer 
patients in the province. Figure 9.1 depicts such health service and referral system in 
Ubonratchthani province. Both the regional hospital and cancer centre are excellent 
centres working together by the coordination office. Focusing on the advanced stage of 
cancer, the patients could be referred up to either regional hospital or cancer centre or 
the patient could be referred down to their primary health facilities at either regional 
hospital or district hospitals or ending up at the cancer centre with the supply of 
radiation therapy, pain clinic, palliative care and hospice care. This is because care for 
cancer patients requires expertise, but not at the terminal stage which needs only the 
trained health personnel in the area of palliative care including pain control medication. 
The route of health service for cancer was likely flexible for the patients with short cuts 
compared to other diseases. Patients with other diseases from a remote and small 
community hospital were referred to the bigger advanced community hospital which 
acted as a hub of the zone. However, some details of the referral system should be 
improved as mentioned by the key informants in Chapter Eight.  
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Figure 9.1 Diagram of health service system and referral system for cancer care in Ubonratchthani province 
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(3) Preference of place of death 
Focusing on cancer, the patients in the terminal stage of the disease received no curative 
treatments but only palliative care (see Chapter Three, subsection 3.3.1). The palliative 
care service was conceptualised for the sake of improving on quality of life of patients 
and their families. As a result, place of care and place of death were unavoidably part of 
the discussion for this chronic disease with a clear terminal phase.  
This research revealed that 37.5 percent of cancer patients died in hospitals and 62.3 
percent died at home (Figure 6.4 C, Chapter Six) but 39.9 percent of the patients who 
sought acute care during their last year of life died in hospitals and 60.1 percent died 
elsewhere including home (Figure 5.2, Chapter Five). Moreover, compared to other 
regions, the greatest proportion of cancer patients resided in the north-east died at home, 
that is, 79.1 percent.  This markedly higher proportion than average for Thailand was 
supported by the findings from patients and care giver interviewing in Chapter Seven. It 
indicated that even though there was different view on place of death between the 
patients and their care givers, the patients’ desire was the priority. The cultural issues in 
the Northeast also supported death at home:  even if the patients had nearly died in 
hospital, they were transported back home. However, this cultural facet was not a 
concern of patients and their care givers residing in the city.  
Compared to other countries, such proportion of hospital death in this research differed 
from the 2003 death certificate records in the Flanders, Belgium (59.5 percent); Sweden 
(85.1 percent); Scotland (57.4 percent); England (49.5 percent); and Wales (59.8 
percent) while in-hospital death in the Netherlands was 30.8 percent. However, the 
remainder of these proportions could not be directly interpreted as death at home 
because there were other types of institutional places which the study could not 
distinguish from homes or private residences, for example, nursing home, care home 
and hospice (Cohen, Bilsen et al. 2008).  
Changes in place of death over time were also an issue often analysed. The declining 
trend in hospital death of cancer patients in developed countries was reported, for 
example Nova Scotia, Canada from 1992 to 1997 (80.2 percent to 69.8 percent) (Burge, 
Lawson et al. 2003); Canada between 1994 and 2004 (85 percent to 68.5 percent) 
(Wilson, Truman et al. 2009); The US between 1980 and 1998 (70 percent to 37 
percent) (Flory, Young-Xu et al. 2004); However, death in hospitals and other 
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institutional places in England between 1985 and 1994 was reported in slightly 
increased trend from 70.4 percent to 72 percent (Higginson, Astin et al. 1998).  
As with deaths from all causes, factors determining the place of death for cancer 
patients were of interest among health service providers. Many factors which showed 
the impact on the place of death included age, sex, primary care workload and pressure 
on the services of GPs, head of household in social class IV or V, ethnic minorities, 
high-dependence households, cancer site, region, admission to a palliative care 
programme, receiving palliative radiation, length of survival from initial diagnosis and 
living situation (living alone or living together with someone) (Higginson, Jarman et al. 
1999; Burge, Lawson et al. 2003; Ahlner-Elmqvist, Jordhoy et al. 2004). 
(4) Utilisations and expenditure during terminal stage of life in patients who sought health 
care 
Utilisation and expenditure during the terminal illness for cancer patients were the 
facets considered together with place of death. Although the thesis could not reveal the 
use of and expenditure for both types of care of the specific case of terminally ill cancer 
patients in Ubonrachthani province, the econometric modellings in Table 5.5 and Table 
5.6 (Chapter 5) and Table 6.5 to Table 6.8 (Chapter 6) could partly show some related 
finding. Decedents dying from cancer had greatest chance in seeking care among other 
causes of death, compared to ill-defined cause. In seeking ambulatory care, the 
decedents had significantly greater chance and numbers of use and nonsignifcant chance 
of out of pocket and the payment value than the decedents with ill-defined cause during 
the last quarter of life. For hospitalisation, cancer decedents had significantly greatest 
numbers of hospitalisation and expenditure incurred health insurers during the last year. 
The decedents also had significantly the greatest chance in access but numbers of 
hospitalisation. Households also had the greatest chance of paying but with 
nonsignificant value of expenditure during the last two quarters of life.   
 (5) Financial constraint to the health service provided and inequality in access to and 
expenditure for pain relief medicines and financial burden to households 
Compared to the era prior to UC in 2001, it was revealed that access to care of the Thai 
people in 2003, particularly the beneficiaries of the MWS and the HCS which are likely 
equal to the UC beneficiaries and the majority is the poor had increased. In addition, the 
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financial constraint of household in access to health services reduced. However, some 
barriers to access to care by geography remained, specifically for the poor in rural areas 
(Vasavid, Tisayaticom et al. 2004; Prakongsai 2008).  
Similar to previous study findings mentioned earlier, it was reported that the terminally 
ill cancer patients and their care givers addressed the advantage of the UC. They 
realized that the UC removes their financial barrier in access to treatment and health 
care since any stage of cancer until the palliative care in the late stage of cancer, and the 
patients could live longer. This reflected the equitable access to health care, compared 
to the CSMBS and the SHI which were more advance in development than the UC. 
However, some financial constraint of the UC beneficiaries remains as indicated in 
qualitative findings from terminally ill cancer patients in Chapter Seven and Chapter 
Eight.  
With triangulation technique, this thesis provided the useful evidence on the financial 
constraint of the patient and the health facility for pain relief medicines. It was indicated 
that the UC beneficiaries had a limit of 700 Baht per prescription per day while 
advanced cancer patients with pain required increasing pain relief medicines from time 
to time. In addition, such medicines particularly the morphine derivatives were 
expensive and were available in all strengths and dosage forms at tertiary care level. 
This limitation led to more frequently unnecessary visits of the patients or the care 
givers to the hospitals. That means an increase in household expenditure for travelling 
by the patients and the care givers. This phenomenon was primarily explored and it was 
found that this limitation on claimed expenditure from health insurance scheme had 
been specified to the referral system between the community/general/provincial/regional 
hospitals under the Office of the Permanent Secretary and hospitals and specialised 
institutes under other Departments of the MoPH. In addition, it was also limited to the 
referral systems of the hospitals under the Office of the Permanent Secretary in different 
provinces, that is, the provincial hospitals to the regional hospitals, for instance. This 
MoPH guideline could not applicable to the health facilities out side the MoPH as well 
as it had been apply to not only the cancer but also all other diseases (Ministry of Public 
Health 2007 (2550 B.E.)). Comprehensive study on pain control in advanced stage 
cancer including cost per prescription or visit of other diseases, the unmet needs and the 
magnitude of the costs incur to referring hospitals, the referred hospitals and the 
household might better guide policy recommendation.  
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Even though the palliative care could not be exactly determined by time close to death, 
the last six months and the last three months of life should cover the period of palliative 
care to the end of life, especially the cancer patients. Thus, findings of seeking care and 
household expenditure from household survey in Chapter Six as well as the perception 
of the patients, their care givers and health professionals in Chapter Seven and Chapter 
Eight could imply to palliative care. That is, it could be concluded that there was likely 
equitable access to the palliative care during the last period of life among the poorest to 
the wealthiest Thai. Rather, some inequitable access and incurring expenditure were due 
to the health insurance schemes. 
(6) Importance of the informal care givers for the terminally ill cancer patients 
It was indicated that demand for care was increasing as the chronic diseases and aging 
population increased. Individual demand also increased at time close to deah. Apart 
from professional care or institutional care, normal care at health facilities, various types 
of care were addressed including services from social workers and home-care worker, 
home-care poroviders, complementary health care providers, chaplaincy terams and 
support groups as well as patient families and friends. These care providers might be 
different according to health service systems of an individual country. In Thailand, these 
care providers except the latter group were not popular in the past decades, but therafter 
increasing as volunteers in the communities, villages or health facilities. During the 
illness period, patients’ families, household employees through housemaids are the 
primary care givers for daily activities of the patients. The care from this group of care 
givers, so-called ‘informal care’, plays a vital role in health care for terminally ill 
patients, however, they also have cost of care (McCrone 2009). The finding from this 
thesis was that, for example, a familiy member quit a job in a remote province in order 
to take care of a member who was ill was similar to some findings of previous studies. 
Grunfeld et al (2004) found that 69 percent of employed care givers had an adverse 
impact on work and 77 percent lost their work due to care giving responsibilities during 
the terminal stage of breast cancer patients (Grunfeld, Coyle et al. 2004). It was also 
indicated in this thesis that the informal care giver being the breadwinner was likely to 
turn to the full-time care giver when the patients’ disease developed into the advanced 
stage of cancer. This informal care cost may well be greater in the social perspective if 
the care giver was a breadwinner as same as the case of the patient as a breadwinner. A 
family falling in this situation would be prone to being a catastrophic household. 
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However, time spending and trend of this cost towards time close to death likely varied 
for such incurable diseases and the level of patients’ physical function, for example, 
duration requires informal care in patients with dementia or Alzheimer’s might be 
longer than patients with advance stage cancer (Zarit 2004; McCrone 2009).  
Quantifying such burden of care givers, time spent, informal care cost and economic 
evaluation, this informal care should be further explored in order to design the 
appropriate health service delivery including palliative care for the patients during 
terminal stage.   
(7) Services for the terminally ill cancer patients 
As mentioned earlier in Chapter Three, subsection 3.3.1, there are many terms used for 
the care for the terminally ill patients including palliative care, end of life care, hospice 
care, etc. However, such terms have the same main concept of holistic care and the 
quality of life of the patients and their families. This research, therefore, selected the 
term 'palliative care' to represent of all those forms of care because of its worldwide 
definition through the World Health Organization. This term seems to be the umbrella 
term for other forms of care which are likely specific to narrower period of life, to 
diseases, to country or to old age group. Due to its broader term, the discussion on 
palliative care focuses on the relief of suffering which was mentioned in the patients’ 
perspective stated in Chapter Seven as well as the suggestion on strengthening the 
health care service for terminal cancer patients by the health professionals in Chapter 
Eight. In addition, those issues are unavoidably linked to the setting or the place of care 
and place of death associated with the service provided.  
Cancer in Thailand is still in the top rank of causes of death and has an upward trend on 
incidence in the future (see Chapter One, subsetion 1.3.2 and Chapter Two, subsection 
2.3.1). In addition, this research revealed that terminally ill cancer patients were 
expected to use health services nearly equally to other non-communicable diseases but 
markedly greater than ill-defined causes of death (that is, 13 times and 43 times higher 
chance of ambulatory care and acute care utilisation, respectively—Table 6.5 and Table 
6.6 in Chapter Six). That is, the health care and service including palliative care for 
terminally ill patients needs to be well prepared to cope with this increasing group of 
patients in terms of both numbers of patients and frequency of the utilisation. 
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In the concept of palliative care, the research revealed that the regional hospital and the 
cancer centre had set up a palliative care programme for their cancer patients, 
developing a more advance pain clinic and palliative care service. As the cancer centre 
had high cost radiation technology providing radiation therapy and the specialty to 
cancer, this comprehensive pain management during the terminal stage was superior in 
palliative care compared to the regional hospital. The programme in the regional 
hospital was newer starting with the pain clinic and the palliative care ward in the 
responsibility of the family medicine physician. However, the service seems less 
comprehensively available to other causes of suffering, for example, the mobile oxygen 
due to the shortness of breath in patients with lung cancer, while the community 
hospital is unlikely to have full palliative care but rather supportive care with some pain 
relief medicines. It was argued by the health care providers in the community hospital 
(see Chapter Eight, section 8.3.4) that cancer was not the priority of the endemic 
diseases in the district like hypertension and diabetes were. Thus, many of resources 
were firstly allocated on such preventable prioritised diseases. Although cancer patients 
were a smaller group in community hospitals, the broad concept of palliative care was 
applicable to various chronic diseases which show the terminal phase towards the end of 
life. As a result, strengthening palliative care would be useful to the health services of 
community hospitals to some degree. 
Apart from pain, palliative care itself also includes overcoming the suffering from 
emotional and distress symptom (e.g. fear from no hope of cure), other physical 
symptoms and weakness, social problem including financial constraints (Sepulveda, 
Habiyambere et al. 2003; Larsson and Wijk 2007). In addition, it addressed not only the 
care for suffering of patients but also their care givers and families (World Health 
Organization 2009). That is, these issues are also the palliative care in which health 
personnel should not omit. 
Chronic pain is a physically and psychologically hazardous symptom. It is the major 
symptom that terminal stage cancer patients suffer and complain about (Singer, Martin 
et al. 1999; Kikule 2003; Sepulveda, Habiyambere et al. 2003). Although the patients 
received pain control treatment, its effectiveness should be monitored. For example, it 
was also found in Botswana that even if patients got treatment, pain persisted because of 
use of only mild analgesics (Sepulveda, Habiyambere et al. 2003). That is, above the 
availability of the care, quality and sufficiency of pain control and the pain relief 
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medicines, as well as the unmet needs which were out of the scope of this research, 
must be evaluated in order to better policy development. Policies for palliative care, 
including the national drug control policy for the pain relief medicines, particularly the 
opioids which might be restrictively regulated, would be the constraint in access to 
medicines as indicated in Romania (Mosoiu, Ryan et al. 2006). It should be a further 
research area for the terminally ill patients in Thailand. 
Palliative care services must be provided with a coordination of the care settings, both 
institutions and non-institutions including home, hospital, hospice, nursing home and 
other institutions (Davies and Higginson 2004). In fact, patients during the terminal 
stage in which illness is deteriorating until death need supportive and frequent care by 
care givers and professional health carers. As stated, even though the reasons 
underpinning death at home were different in developing and developed countries, 
several studies concluded that home is the best place of care for the terminal stage in 
relation to the place of death (Davies and Higginson 2004; Editorial 2008). In the Thai 
setting which has only one hospice in the country and some nursing homes within the 
city areas, this research suggested that home should be the main place of palliative care 
with support and guidance from health care providers including occasional institutional 
care. This home care was also in line with the views of patients, their care givers and 
health professionals indicated in this research (Chapter Seven and Chapter Eight). Home 
care needs well-informed and trained care givers who are willing to take care of the 
patients at all times, in particular in times close to death. Additionally, supervision from 
health personnel, e.g. nurses, is also required along with the care at home because of the 
development of the worse symptoms as well as analgesic dose adjustment. Telephone-
based nursing intervention were recommended to be an efficient tool for early problem 
detection before the patients developing to the advanced symptom or crisis as well as 
the care givers being in panic as indicated in the findings of Chapter Seven. This 
intervention would further reduce unnecessary numbers of ambulatory visits and 
readmission in hospitals (Cox & Wilson (2003) cited in (Larsson and Wijk 2007).  
Focusing on care at home and pain management, pain relief medicines are the key tool 
of pain control. Given that there were no constraints on prescribing under the national 
drug policy for narcotic substances as well as financial constraint policy for ambulatory 
visit reimbursement in the UC was removed, the drug delivery as well as the policy for 
other pain relief medicines in the province should be redesigned to correspond to such 
 294
place of care. This is also another research area to explore. Cost saving from the home 
care compared to the existing conventional care spending, the quality of life and the 
effectiveness, and efficiency might be the goal of this home care programme. 
Monitoring the expenditure incurred by the system including health insurers, health care 
providers and households that shift from current hospital care to home care can possibly 
be another research area which would support the idea for home care. However, 
findings might not always prove the concept, for example in the US, evaluation on the 
expenditure for hospice service and the effect of hospice on other services show that 
hospice was cost-neutral or cost-saving to significant saving for the last year of life 
among the enrollees with cancer but it was additional cost among other enrollees 
without cancer to the Medicare when compared to non-enrollee to the hospice 
(Emanuel, Ash et al. 2002; Campbell, Lynn et al. 2004).  
It is a fact that care at home needs the support from families and availability of care 
givers. One patient also probably needs more than one care giver. Many patients in 
Thailand could not meet such criteria, and so other optional care and the places of care 
might be the alternative, for example, the conventional hospital, nursing home as well as 
hospice mentioned in advanced developing countries and developed countries. This 
concept of places of care was likely to be supported by the social and economic change 
included change in population structure into old age society; the nucleus family in 
particular the people living in city and urban areas; and the migration of the working 
age population from rural to urban areas, as a result there were only the old age group 
and the children in the rural areas. However, culture also plays some role in preference 
to the place of care as indicated in a study in Taiwan that in-patient hospice had the 
negative image of a death ward (Tang, Liu et al. 2005). In addition, such care should not 
be designed for not only the cancer case but also terminal stage patients with other 
chronic diseases. Further research on the magnitude and trend of such change might 
make clearer the demand for such service system. Community care by the volunteers in 
the patients’ community was another suggestion which should be explored. 
9.2 Conclusion 
The last period of life has explicitly been shown to use a high level of health resources 
in many developed countries. It shows higher proportion of spending and greater 
frequency in utilisation than other period of life up to the time closest to death. The 
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pattern and spending at the beginning of this research in Thailand were not known.   In 
order to partly respond to this question, research questions were developed based on the 
available information in the country. The research was designed to employ mixed 
methods comprised of cross-sectional quantitative analysis during 2005-2006 national 
data and the qualitative approach among key stakeholders during 2007 in a Thai 
province. 
The research met its objectives in estimation of nationwide per capita expenditure for 
treatment in the last period of life incurred by health insurers and households. The 
health insurers in this research included the CSMBS for civil servant and government 
employee beneficiaries, the SHI for the employees in formal sector, the UCE for the UC 
beneficiaries who were neither CSMBS nor the SHI, and the UCP beneficiaries who had 
to pay 30 Baht for user fee. Disparity of the expenditure by household income as well as 
the health seeking behaviour was also revealed. In addition, the research estimated the 
utilisation of the ambulatory care and acute care. To understand the current practice 
among health professionals, patients and their relatives, the research focused on the 
terminally ill cancer patients in a province. As a result, it recommends further 
improvement of the health care provided to this group of patients. 
Regarding the conceptual framework which focused on the tripartite players (health 
insurers, health providers, and patients and households) in health financing and health 
services and the factors affecting those, the research has indicated the factors 
determining the expenditure of the health insurers and the households in Thailand. 
However, this research could identify only the demand side factors, that is, of patients 
and households which were included in the datasets analysed. Those factors including 
geography, demography, socioeconomics and other conditions significantly played a 
different role in determining propensity and intensity, utilisation and expenditure, and 
ambulatory care and acute care. However, the main determinants were age at death, 
health insurance scheme, cause of death and place of death. The cause of death and 
comorbidity were the factors that markedly affected the variation of demand on 
hospitalisation whereas age at death and health insurance scheme in addition to the two 
former factors determined disparity in spending of public resources among decedents 
who sought care. Age at death and cause of death determined the disparity in propensity 
of seeking ambulatory care whereas cause of death, health insurance scheme and using 
complementary medicine determined the different of numbers of cares during the last 
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quarter of life. In seeking acute care, age at death, cause of death and place of death 
affected the propensity of hospitalisation but age and cause clearly showed the effect 
during the last half year of life. The propensity of household payment for ambulatory 
care was determined by age, being head of household, occupation, cause, place and 
health insurance scheme whereas the intensity was determined by many factors 
including region, urban area, age, gender, being head of household, occupation, cause, 
place and health insurance. In household payment for acute care, many factors included 
region, age, education, income quintile, occupation, cause, place, and health insurance 
scheme had an effect on the propensity of such payment while region, age, gender, 
cause, place and health insurance scheme determined the intensity of out of pocket.  
Even though data on factors on the health care provider side was unavailable, the in-
depth interview study disclosed that the differences in benefit package and payment of 
health insurance scheme drove the different treatment the patients received. That is, the 
research confirmed the strong effect of the health insurance scheme in determining 
households and patients, third party payers, and health care providers in health service 
and financing via use and expenditure, respectively. 
In addition, the research also indicated the inequality in access to ambulatory care and 
acute care, and public subsidy through the health insurance schemes. The CSMBS 
beneficiaries who sought care were expected to spend double that of the UC 
beneficiaries in public money for acute care during the last year of life. Focusing on the 
wealth status, there was likely an insignificant regressive utilisation of but 
progressiveness in ability to pay out of pocket for both type of care. 
In exploring the practice of health professionals, terminal stage cancer patients and their 
relatives as well as the health service in Ubonratchthani. Similar to other countries in 
Asia and some European countries, the patients’ relative was indicated as a priority in 
telling the diagnosis and prognosis as well as in decision making for the treatment of the 
patients with advanced stage of cancer. This practice was different from the case of the 
patients with early stage.  Cultural issues, (which may differ in other Thai provinces), 
also played significant role, particularly in time close to death or at the end of life 
period. That is, hospitalised patients were likely to travel back to die at home. In 
addition, home was the place of preference to die. It was also recommended by most of 
the patients and their care givers, and health professionals to be the place for care at the 
 297
terminal stage. At present, the cancer centre was addressed to be the most favoured 
place for care and it had the most advanced and comprehensive palliative care and pain 
control management for terminally ill patients. 
All UC beneficiaries interveiwed seemed satisfied with this newest health insurance in 
the circumstance that it provided the opportunity in access to institutional health service 
as well as the chance to live longer. However, the research found that there was a 
financial constraint in the UC beneficiaries who were treated with morphine. This 
expensive medicine was limited in prescribing with the limited maximum at 700 Baht 
per ambulatory visit. As a result, the patients with advanced chronic pain who required 
more and more morphine got insufficient morphine in one visit. The problem was 
alleviated with an increase in the frequency of visits but resulting in increased travelling 
cost of the care givers as well as the patients.  
9.3 Policy implication on health services for terminally ill patients 
The findings of the research provided some evidence for recommendations to Thai 
policy makers. 
The UC scheme which is achieving its goal in ensuring access to health care for all 
should be sustainable with strong support from government. It was proved that the 
insurance provided the opportunity in access to care of the worse-off households. 
Health insurance schemes played a significant role in determining access and 
expenditure incurred to public spending and private households. It was not surprising 
that there was an inequality in public spending, out of pocket payment and access to 
care across the health insurance schemes, that is, the CSMBS and the UC. It was due to 
the difference in payment mechanism, fee for service versus capitation, as well as the 
benefit packages that determined the access and expenditure and the population who are 
eligible. This greater payment and access might be overused or the less payment might 
be underused. As a result, the standard practice and medication guideline should be 
available nationwide as a benchmark for the palliative care. To achieve the equity in 
public spending, such determinants should be similar or harmonised. It would also, in 
line with the practice guidelines, help in protection of the moral hazard, that is, the 
excess use of services. 
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Pain control was an important treatment of the palliative care with which a proportion of 
cancer patients were likely to be confronted. Policy on the narcotic drugs should support 
and facilitate this group of patients who suffer the most from the disease. Specifically to 
the UC scheme, it was indicated that only the health facilities in different contracting 
units under the MoPH were affected by the reimbursement ceiling of 700 Baht per 
ambulatory visit. This matter requires further exploration. However, there was another 
policy option that this pain control treatment might be integrated into the benefit 
package for high cost care for cancer patients. This will remove the barrier of ceiling of 
700 Baht per ambulatory visit.  
Controlling pain was one of the aims of achieving good quality of life of such health 
care and patients. In addition, policy to improve or to strengthen better management and 
service for pain control, concomitant with the patients’ preference in dying at home, 
could facilitate such patients centre of care. The appropriate home care might mitigate 
numbers of visits and hospitalisation of this group of patients; however, it might be a 
shifting of the workload of the specialists in conventional care to health professionals in 
family medicine or primary care units or the palliative home care team. This is due to 
the fact that the health care must be continued even though place of care was changed. 
In addition, the conventional care in hospitals must remain because not all patients 
could be cared for at home. Care at home also still requires some professional services 
and hospital resources for the advanced symptoms. To provide seamless care for 
patients, some contents of referral systems should be improved. 
9.4 Recommendation for further research 
So far this research was a first study which explored the nationwide access to and 
expenditure for care during the last period of life. Many previous studies aim to reveal 
the attitudes or preferences of health professionals, patients and care givers towards the 
end of life. Thus, many further questions remain. Apart from remaining reseach topics 
suggested simutaneously with discussion in section 9.1.2, the following topics were also 
areas for further researches. 
In quantitative research, many topics include the relation and pattern of utilisation and 
expenditure and the proximity to death, the survival to decedent ratio of expenditure. 
These might help in the projection of the future expenditure required for the patients as 
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indicated that the estimation of the health expenditure should include time to death 
(Stearns and Norton 2004; Seshamani and Gray 2004c).  
The study on the proportion between the health insurance or public spending and the 
household payment for patients during the last period of life might help to understand 
the role of public resource and households towards different health insurance schemes, 
resulting in revealing the efficiency of the spending. 
The study on direct and indirect cost incurred by households was also an interesting 
area. This is due to the fact that the more visits to health facilities, the higher 
expenditure the households needs to pay. This could increase the trouble for a 
'catastrophic' household as well as the direct medical cost, so that relief of the latter 
through insurance may be only part of the solution for the poorest households.  In 
addition, since the terminal illness threatens life, almost all patients, particularly who 
are young perceiving this fact were likely to stay longer. This is due to the fact that 
people wish to live with their beloved ones. They usually seek other service and care 
which might help, that is, the food supplement or complimentary medicine. These 
products might not really benefit the consumers’ health. They are usually expensive and 
thus might trouble the household. Even though health insurances ensure the access to 
health service and reduce expenditure that burdens the households. Such households 
have more income for other essentials. Thus, further study on the expenditures the 
households pay for these products is also interesting. 
With qualitative approach, a study on the perspectives of the policy makers who are 
another key stakeholder should be further explored. This group plays a significant role 
in policy implementation including the improvement of health services for terminally ill 
patients as recommeneded in this research. 
 
 300
REFERENCES 
 
(1997). Constitution of the Kingdom of Thailand, B.E.2540 (1997). Thailand. 
(2005). Constitution of the World Health Organization: 1. 
(2007). Constitution of the Kingdom of Thailand, B.E.2550 (2007). Thailand: 22. 
(2007). National Health Act B.E. 2550 (2007). The Kingdom of Thailand. 
Acock, A. C. (2006). A gentle introduction to Stata. Texas, Stata press. 
Ahlner-Elmqvist, M., M. S. Jordhoy, et al. (2004). "Place of death: hospital-based 
advanced home care versus conventional care, a prospective study in palliative 
cancer care." Palliative Medicine 18: 585-593. 
Anand, S., F. Diderichsen, et al. (2001). Measuring disparities in health: methods and 
indicators. Challenging inequities in health: from ethics to action. T. Evans, M. 
Whitehead, F. Diderichsen, A. Bhuiya and M. Wirth. New York, Oxford 
University Press. 
Anonymous (2005). Chapter 3: National health development plan under the 9th 
National Economic and Social Development Plan (2002-2006). Thailand Health 
Profile 2001-2004. Wibulpolprasert S., Siasiriwattana S., Ekchampaka P., 
Wattanamano S. and T. R. Bangkok, Printing Press, Express Transportation 
Organization: 21-40. 
Anonymous (2005). Chapter 6: Health service systems in Thailand. Thailand Health 
Profile 2001-2004. S. Wibulpolprasert, S. Siasiriwattana, P. Ekachampaka and 
N. Wattanamano. Bangkok, Printing Press, Express Transportation 
Organization: 241-354. 
Bambas, A. and J. A. Casas (2001). Assessing equity in health: conceptual criteria. 
Equity and health: views from the Pan American Sanitary Bureau. The Pan 
American Health Organization. Washington, DC, Pan American Health 
Organization: 12-21. 
Barnato, A. E., M. B. McClellan, et al. (2004). "Trends in inpatient treatment intensity 
among Medicare beneficiaries at the end of life." Health Services Research 
39(2): 363-75. 
Batljan, I. and M. Lagergren (2004). "Inpatient/outpatient health care costs and 
remaining years of life--effect of decreasing mortality on future acute health care 
demand." Social Science & Medicine 59: 2459-66. 
 301
Bland, M. (2000). Sampling and observational studies. An introduction to medical 
statistics. M. Bland. Oxford, Oxford University Press: 26-46. 
Braun, V. and V. Clarke (2006). "Using thematic analysis in psychology." Qualitative 
Research in Psychology 3: 77-101. 
Braveman, P. and S. Gruskin (2003). "Defining equity in health." Journal of 
Epidemiological and Community Health 57: 254-8. 
Brockmann, H. (2002). "Why is less money spent on health care for the elderly than for 
the rest of the population?: health care rationing in German hospitals." Social 
Science & Medicine 55: 593-608. 
Bruera, E., N. Russell, et al. (2002). "Place of death and its predictors for local patients 
registered at a comprehensive cancer center." Journal of Clinical Oncology 
20(8): 2127-33. 
Buam, C. F. (2006). An introduction to modern econometrics using Stata. Texas. 
Buntin, M. B. and A. M. Zaslavsky (2004). "Too much ado about two-part models and 
transformation? Comparing methods of modeling Medicare expenditure." 
Journal of Health Economics 23: 525-42. 
Bureau of Health Policy and Planning (1998). International Classification of Diseases 
10th Revision (English-Thai). Nonthaburi, Bureau of Health Policy and 
Planning. 
Bureau of Health Policy and Strategy (2007). Health resource survey. 
Bureau of Health Policy and Strategy (2007). Minutes of the Ministry of Public Health 
meeting 7/2550. M. o. P. H. Bureau of Health Policy and Strategy. 
Bureau of Health Policy and Strategy (2009). Health Policy in Thailand 2009, Ministry 
of Public Health, Thailand. 
Burge, F., B. Lawson, et al. (2003). "Trends in the place of death of cancer patients, 
1992-1997." Canadian Medical Association Journal 163(3): 265-70. 
Byock, I. R. (2001). "End-of-life care: A public health crisis and an opportunity for 
managed care." The American Journal of Managed Care 7(12): 1123-32. 
Calfo, S., J. Smith, et al. Last year of life study, Centers for Medicare & Medicaid 
Services, Office of the Actuary. 
Cameron, A. C. and P. K. Trivedi (2009). Count-data model. Microeconometrics using 
Stata. A. C. Cameron and P. K. Trivedi. Texas, Stata Press: 553-99. 
 302
Cameron, A. C. and P. K. Trivedi (2009). Linear instrumental-variables regression. 
Microeconometrics using Stata. A. C. Cameron and P. K. Trivedi. Texas, Stata 
Press: 171-86. 
Cameron, A. C. and P. K. Trivedi (2009). Linear regression basics. Microeconometrics 
using Stata. A. C. Cameron and P. K. Trivedi. Texas, Stata Press: 71-112. 
Campbell, D. E., J. Lynn, et al. (2004). "Medicare programme expenditures associated 
with hospice use." Annals of Internal Medicine 140: 269-77. 
Carlson, M. D. A., R. S. Morrison, et al. (2007). "Hospice care: What services do 
patients and their families receive?" Health Services Research 42(4): 1672-90. 
Cartwright, A. (1992). "Social class differences in health and care in the year before 
death." Journal of Epidemiological and Community Health 46: 54-7. 
Charlson, M. E., P. Pompei, et al. (1987). "A new method of classifying prognostic 
comorbidity in longitudinal studies: development and validation." Journal of 
Chronic Diseases 40: 373-83. 
Chooprapawan, C., Y. Porapakkham, et al. (2000). Report on Cause of Death Study in 
Thailand phase I in 5 provinces. Nonthaburi, Health Systems Research Institute 
and Bureau of Health Policy and Planning. 
Clark, J. (2003). "Patient centred death: We need better, more innovative research on 
patients' views on dying." British Medical Journal 327: 174-75. 
Clarke, P., A. Gray, et al. (2003). "The impact of diabetes-related complications on 
healthcare cost: results from the United Kingdom Prospective Diabetes Study 
(UKPDS Study No.65)." Diabetic Medicine 20(6): 442-50. 
Cohen, J., J. Bilsen, et al. (2008). "Population-based study of dying in hospital in six 
European countries." Palliative Medicine 22: 702-10. 
Cohen, J., J. Bilsen, et al. (2006). "Dying at home or in an institution using death 
certificates to explore the factors associated with place of death." Health Policy 
78: 319-29. 
Collaborative Project to Increase Production of Rural Doctor. "Background."   
Retrieved 20 October, 2009. 
Commission on Social Determinants of Health (2008). Closing the gap in a generation: 
health equity through action on the social determinants of health. Geneva, World 
Health Organization. 
 303
Cooper, N. (2000). The economic impact of rheumatoid arthritis in the first five years. 
School of Health Policy and Practice. Norwich, University of East Anglia. PhD: 
349. 
Correa-Velez, I., A. Clavarino, et al. (2003). "Use of complementary and alternative 
medicine and quality of life: changes at the end of life." Palliative Medicine 17: 
695-703. 
Creswell, J. W. (2007). Writing a qualitative study. Qualitative inquiry & research 
design: Choosing among five approaches. J. W. Creswell. California, Sage 
Publications: 177-99. 
Culyer, A. J. (1993). Health, health expenditures, and equity. Equity in the finance and 
delivery of health care, an international perspective. E. van Doorslaer, A. 
Wagstaff and F. Rutten. New York, Oxford University Press: 299-319. 
Daodee, S. (1994). Self perception of nurses and their caring behaviour for end of life 
patients. Master of Science. 
Davies, E. and I. J. Higginson, Eds. (2004). Better palliative care for older people. 
Copenhagen, WHO Regional Office for Europe. 
Davies, E. and I. J. Higginson, Eds. (2004). The solid fact, palliative care. Copenhagen, 
WHO Regional Office for Europe. 
Deaton, A. (1997). The analysis of household surveys: a microeconomics approach to 
development policy. Massachusette, John Hopkins University Press. 
Department of Health (2008). End of life care strategy: Promoting high quality care for 
all adults at the end of life, equality impact assessment. London, DH 
Publications Orderline. 
Diehr, P., D. Yanez, et al. (1999). "Methods for analyzing health care utilization and 
costs." Annual Review of Public Health 20: 125-44. 
Dodd, S., A. Bassi, et al. (2006). "A comparison of multivariable regression models to 
analyse cost data." Journal of Evaluation on Clinical Practice 12(1): 76-86. 
Donovan, K. (1993). Breaking bad news (I). Communicating bad news: Behavioural 
science learning modules. W. H. O. Division of Mental Health. Geneva, World 
Health Organization: 1-14. 
Dougherty, C. (2002). Introduction to econometrics. Oxford, Oxford University Press. 
Downie, R. and F. Randall (2004). 3.3 Truth-telling and consent. Oxford textbook of 
palliative medicine. D. Doyle OBE, G. Hanks, N. I. Cherny and K. Calman. 
New York, Oxford University Press: 61-5. 
 304
Duan, N. (1983). "Smearing estimates: a nonparametric retransformation method." 
Journal of the American Statistical Association 78(383): 605-10. 
Dupont, W. D. (2002). Statistical modeling for biomedical researchers: a simple 
introduction to the analysis of complex data. New York, Cambridge University 
Press. 
Economic and Social Statistics Bureau (2007). Report on the 2005-2006 Survey of 
Population Change. Bangkok, National Statistical Office, Ministry of 
Information and Communication Technology. 
Editorial (2008). "A good death." The Lancet 372: 264. 
Ekachampaka, P. and R. Taverat (2008). Chapter 2: Thailand country profile. Thailand 
health profile 2005-2007. S. Wibulpolprasert, S. Sirilak, P. Ekachampaka, N. 
Wattanamano and R. Taverat. Bangkok, Printing Pres, The War Veterans 
Organization of Thailand: 15-21. 
Ekachampaka, P. and R. Taverat (2008). Chapter 3: Health policy and strategy in 
Thailand. Thailand Health Profile 2005-2007. S. Wibulpolprasert, S. Sirilak, P. 
Ekachampaka, N. Wattanamano and R. Taverat. Bangkok, Printing Press, The 
War Veterans Organization of Thailand: 23-37. 
Ekachampaka, P., R. Taverat, et al. (2008). Chapter 1: Chakri dynasty and Thai public 
health. Thailand health profile 2005-2007. Wibulpolprasert S., S. Sirilak, P. 
Ekachampaka, Wattanamano N. and R. Taverat. Bangkok, Printing Press, The 
War Veterans Organization of Thailand: 1-13. 
Ekachampaka, P. and N. Wattanamano (2008). Chapter 4: Situation and trends of health 
determinants. Thailand health profile 2005-2007. Wibulpolprasert S., S. Sirilak, 
P. Ekachampaka, Wattanamano N. and R. Taverat. Bangkok, Printing Press, The 
War Veterans Organization of Thailand: 39-160. 
Emanuel, E. J., A. Ash, et al. (2002). "Managed care, hospice use, site of death, and 
medical expenditures in the last year of life." Archives of Internal Medicine 162: 
1722-8. 
Emanuel, E. J. and L. L. Emanuel (1994). "The economics of dying-the illusion of cost 
saving at the end of life." The New England Journal of Medicine 330: 540-4. 
Faramnuayphol, P., P. Ekachampaka, et al. (2008). Chapter 6: Health service system in 
Thailand. Thailand health profile 2005-2007. Wibulpolprasert S., S. Sirilak, P. 
Ekachampaka, N. Wattanamano and R. Taverat. Bangkok, Printing Press, The 
War Veterans Organization of Thailand: 257-339. 
 305
Faramnuayphol, P. and P. Vapattanawong (n.d.a). Disparity of mortality by Thailand 
geography. Nonthaburi, Health Information System Development Office. 
Faramnuayphol, P. and P. Vapattanawong (n.d.b). Disparity of mortality among 
geographical socio-economics in Thailand. Nonthaburi, Health Information 
System Development Office. 
Felder, S., M. Meier, et al. (2000). "Health care expenditure in the last months of life." 
Journal of Health Economics 19: 679-95. 
Feudtner, C., D. L. DiGiuseppe, et al. (2003). "Hospital care for children and young 
adults in the last year of life: a population-based study." BMC Medicine 1(3). 
Finlay, I. (2001). "UK strategies for palliative care." Journal of the Royal Society of 
Medicine 94: 437-41. 
Flory, J., Y. Young-Xu, et al. (2004). "Place of death: U.S. trends since 1980." Health 
Affairs 23(3): 194-200. 
Ford, K., P. Rakumnuaykit, et al. (2006). Death and household income. Mortality...the 
reflection of population security. K. Archavanitkul and V. Thongthai. Bangkok, 
Plan Printing. 
Fox, J. (2008). Applied regression analysis and generalized linear models. California, 
Sage Publications, Inc. 
Franks, P. J., C. Salisbury, et al. (2000). "The level of need for palliative care: a 
systematic review of the literature." Palliative Medicine 14: 93-104. 
Fukui, S., H. Kawagoe, et al. (2003). "Determinants of the place of death among 
terminally ill cancer patients under home hospice care in Japan." Palliative 
Medicine 17: 445-53. 
Garber, A. M., T. E. MaCurdy, et al. (1998). Medical care at the end of life: diseases, 
treatment patterns, and costs. NBER working paper series. Massachusetts, 
National Institute of Aging/Commonwealth Fund/Robert Wood Johnson 
Foundation. 
Gaumer, G. L. and J. Stavins (1992). "Medicare use in the last ninety days of life." 
Health Service Research 26(6): 725-42. 
Glick, H. (2008). Methods for cost estimation in CEA: the GLM approach. Academy 
Health, issues in Cost-Effectiveness Analysis. Washington, DC. 
Greene, W. H. (2008). Econometric analysis. New Jersey, Pearson Prentice Hall. 
 306
Grunfeld, E., D. Coyle, et al. (2004). "Family caregiver burden: results of a longitudinal 
study of breast cancer patients and their principal caregivers." Canadian Medical 
Association Journal 170(12): 1795-1801. 
Gruskin, S. and P. Braveman (2003). "Defining equity in health." Journal of 
Epidemiological and Community Health 57: 254-8. 
Gujarati, D. N. (2003). Basic econometrics. Singapore, McGraw-Hill Higher Education. 
Gwatkin, D. R. (2000). "Health inequalities and the health of the poor: What do we 
know? What can we do?" Bulletin of the World Health Organization 78(1): 3-
18. 
Hanratty, B., A. Jacoby, et al. (2008). "Socioeconomic differences in service use, 
payment and receipt of illness-related benefits in the last year of life: findings 
from the British household panel survey." Palliative Medicine 22. 
Hardin, J. W. and J. M. Hilbe (2007). Generalized linear models and extensions. Texas, 
Stata Press. 
Higginson, I. J., P. Astin, et al. (1998). "Where do cancer patients die?: ten-year trends 
in the place of death of cancer patients in England." Palliative Medicine 12: 353-
63. 
Higginson, I. J., B. Jarman, et al. (1999). "Do social factors affect where patients die: an 
analysis of 10 years of cancer deaths in England." Journal of Public Health 
Medicine 21(1): 22-8. 
Himsworth, R. L. and M. J. Goldacre (1999). "Does time spent in hospital in the final 
15 years of life increase with age at death? A population based study." British 
Medical Journal 319: 1338-9. 
Hogan, C., J. Lunney, et al. (2001). "Medicare beneficiaries' cost of care in the last year 
of life." Health Affair 20: 188-95. 
Hoover, D. R., S. Crytal, et al. (2002). "Medical expenditure during the last year of life: 
findings from the 1992-1996 Medicare current beneficiary survey." Health 
Services Research 37(6): 1625-42. 
Hudelson, P. M. (1996). Qualitative research for health programmes. W. H. O. Division 
of Mental Health and Prevention of Substance Abuse, World Health 
Organization. 
International Health Policy Program-Thailand (2007). Interim report on the 2004 burden 
of diseases and injuries of the Thai population. Nonthaburi, International Health 
Policy Program-Thailand, Ministry of Public Health. 
 307
Itivaleekul, S. (2002). Chapter 4: Social Security Scheme: experiences of capitation 
payment system. Health insurance systems in Thailand. P. Pramualratana and S. 
Wilbulpolprasert. Bangkok, Desire. 
Jakobsson, E., I. Bergh, et al. (2007). "Utilization of health-care services at the end-of-
life." Health Policy 82: 276-87. 
Jones, A. (2008). Applied econometrics for health economists, a practical guide. Oxon, 
Radcliffe Publishing. 
Jones, R. (1995). "Why do qualitative research?" British Medical Journal 311(6996): 2. 
Kazdaglis, G. A., C. Arnaoutoglou, et al. (2010). "Disclosing the truth to terminal 
cancer patients: a discussion of ethical and cultural issues." Eastern 
Mediterranean Health Journal 16(4): 442-7. 
Keating, N. L., L. J. Herrinton, et al. (2006). "Variations in hospice use among cancer 
patients." Journal of the National Cancer Institute 98(15): 1053-9. 
Kennedy, P. (1998). A guide to econometrics. Massachusetts, MIT Press. 
Kikule, E. (2003). "A good death in Uganda: survey of needs for palliative care for 
terminal ill people in urban areas." British Medical Journal 327: 192-4. 
Koroukian, S., H. Beaird, et al. (2006-2007). "End-of-life expenditures by Ohio 
Medicaid beneficiaries dying of cancer." Health Care Financing Review 28(2): 
65-80. 
Larsson, A. and H. Wijk (2007). "Patient experience of pain and pain management at 
the end of life: a pilot study." Pain Management Nursing 8(1): 12-6. 
Lederberg, M. S. and N. Joshi (2005). 28.4 End-of-life and palliative care. Kaplan & 
Sadock's comprehensive textbook of psychiatry. B. J. Sadock and V. A. Sadock. 
Philadelphia, Lippincott Williams & Wilkins. II: 2336-66. 
Levinsky, N. G., W. Yu, et al. (2001). "Influence of age on Medicare expenditures and 
medical care in the last year of life." Journal of American Medical Association 
286(11): 1349-55. 
Limwattananon, C., S. Limwattananon, et al. (2009). Analyzing and forecasting drug 
expenditure for outpatients in provincial hospitals under Civil Servant Benefit 
Scheme and Universal Health Coverage Scheme. Bangkok, Health Systems 
Research Institute. 
Limwattanon, S., C. Limwattananon, et al. (2004). Cost and utilization of drugs 
prescribed for hospital-visited patients: impact of universal health care coverage 
 308
policy. Nonthaburi, Health Systems Research Institute; and Centre for Health 
Equity Monitoring, Faculty of Medicines, Naresuan University. 
Long, J. S. and J. Freese (2006). Regression models for categorical dependent variables 
using Stata. Texas, Stata Press. 
Lubitz, J., J. Beebe, et al. (1995). "Longevity and Medicare expenditures." The New 
England Journal of Medicine 332(15): 999-1003. 
Lubitz, J. D. and G. F. Riley (1993). "Trends in Medicare payments in the last year of 
life." The New England Journal of Medicine 328(15): 1092-6. 
Lunney, J. R., J. Lynn, et al. (2003). "Patterns of functional decline at the end of life." 
Journal of the American Medical Association 289(18). 
Lunney, J. R., J. Lynn, et al. (2002). "Profiles of older Medicare decedents." Journal of 
the American Geriatrics Society 50: 1108-12. 
Mahanupab, T., N. Leksawat, et al. (1998). Professional nurses' attitude on death of 
patients and dying patients at Maharat Nakorn ChiangMai Hospital. 
Makinen, M., H. Waters, et al. (2000). "Inequalities in health care use and expenditures: 
empirical data from eight developing countries and countries in transition." 
Bulletin of the World Health Organization 78(1): 55-65. 
Manning, W. G. (1998). "The logged dependent variable, heteroscedasticity, and the 
retransformation problem." Journal of Health Economics 17: 283-95. 
Manning, W. G. and J. Mullahy (2001). "Estimating log models: to transform or not to 
transform?" Journal of Health Economics 20: 461-94. 
Martin, N. and N. Patel (2007). Chapter II: Cancer incidence and leading sites. Cancer 
in Thailand, Vol. IV, 1998-2000. T. Khuhaprema, P. Srivatanakul, H. Sriplunget 
al. Bangkok, Bangkok Medical Publisher. 4. 
Mason, J. (2002). Finding a focus and knowing where you stand. Qualitative 
researching. J. Mason. London, Sage Publication: 13-23. 
Mason, J. (2002). Organizing and indexing qualitative data. Qualitative researching. J. 
Mason. London, SAGE Publications: 147-72. 
McCarthy, E. P., R. B. Burns, et al. (2003). "Barriers to hospice care among older 
patients dying with lung and colorectal cancer." Journal of Clinical Oncology 
21(4): 728-35. 
McCrone, P. (2009). "Capturing the costs of end-of-life care: comparisons of multiple 
sclerosis, Parkinson's disease, and dementia." Journal of Pain and Symptom 
Management 38(1): 62-67. 
 309
Meekrut, S. (2009). Social Security Fund. Health budget management for the fiscal year 
B.E.2551. Nonthaburi. 
Miles, M. B. and A. M. Hubeman (1994). Introduction. An expanded sourcebook: 
Qualitative data analysis. Thousand Oaks, CA, Sage Publication, Inc.: 1-15. 
Ministry of Public Health (2007 (2550 B.E.)). Payment guideline on referral of the 
health facilities under the Ministry of Public Health. Office of the Permanent 
Secretary. MOPH 0209.02/36. 
Mooney, G. (1987). "What does equity in health mean?" World Health Statistics 
Quarterly 40: 296-303. 
Morris, S., N. Devlin, et al. (2007). Chapter 6: Health insurance and health care 
financing. Economic analysis in health care. S. Morris, N. Devlin and D. Parkin. 
West Sussex, John Wiley & Sons: 149-81. 
Morris, S., N. Devlin, et al. (2007). Chapter 7: Equity in health care. Economic analysis 
in health care. West Sussex, John Wiley & Sons, Ltd: 183-205. 
Mosoiu, D., K. M. Ryan, et al. (2006). "Reform of drug control policy for palliative care 
in Romania." Lancet 367: 2110-7. 
Murray, S. A., A. Grant, et al. (2003). "Dying from cancer in developed and developing 
countries: lessons from two qualitative interview studies of patients and their 
carers." British Medical Journal 326: 368-73. 
Murray, S. A., M. Kendall, et al. (2005). "Illness trajectories and palliative care." British 
Medical Journal 330: 1007-11. 
Mystakidou, K., E. Parpa, et al. (2004). "Cancer information disclosure in different 
cultural contexts." Support Care Cancer 12: 147-54. 
National Cancer Institute (2006). Hospice. U.S.Department of Health and Human 
Services, National Institutes of Health,. 
National Economic and Social Development Board (2009). National Economic and 
Social Development Plan, 1st - 10th Plans. Bangkok, Office of the National 
Economic and Social Development Board,. 
National Statistical Office (2002). The 2000 population and housing census. Bangkok, 
National Statistical Office, Office of the Prime Minister. 
Ngalula, J., M. Urassa, et al. (2002). "Health service use and household expenditure 
during terminal illness due to AIDS in rural Tanzania." Tropical Medicine and 
International Health 7(10): 873-7. 
 310
Nimmannitya, S. (2007). Understanding when death approaches End of life care: 
Improving care of the dying. P. Lertsagnuansinchai, I. Nuchprayul, P. Chatkaew 
and C. Sitthipun. Bangkok, Aksornsampun (1987): 24-32. 
O'Donnell, O., E. van Doorslaer, et al. (2008a). Chapter 1: Introduction. Analyzing 
health equity using household survey data: a guide to techniques and their 
implementation. O. O'Donnell, E. van Doorslaer, A. Wagstaff and M. Lindelow. 
Washington, DC, The World Bank: 1-10. 
O'Donnell, O., E. van Doorslaer, et al. (2008b). Chapter 2: Data for health equity 
analysis: requirements, sources, and sample design. Analyzing health equity 
using household survey data: a guide to techniques and their implementation. O. 
O'Donnell, E. van Doorslaer, A. Wagstaff and M. Lindelow. Washington, DC, 
The World Bank: 13-27. 
O'Donnell, O., E. van Doorslaer, et al. (2008c). Chapter 7: Concentration curves. 
Analyzing health equity using household survey data: A guide to techniques and 
their implementation. O. O'Donnell, E. van Doorslaer, A. Wagstaff and M. 
Lindelow. Washington, DC, The World Bank: 83-93. 
O'Donnell, O., E. van Doorslaer, et al. (2008d). Chapter 6: Measurement of Living 
Standards. Analyzing health equity using household survey data: a guide to 
techniques and their implementation. O. O'Donnell, E. van Doorslaer, A. 
Wagstaff and M. Lindelow. Washington, D.C., The World Bank. 
O'Donnell, O., E. van Doorslaer, et al. (2008e). Chapter 8: The concentration index. 
Analyzing health equity using household survey data: A guide to techniques and 
their implementation. O. O'Donnell, E. van Doorslaer, A. Wagstaff and M. 
Lindelow. Washington, DC, The World Bank: 95-108. 
O'Donnell, O., E. van Doorslaer, et al. (2008f). Chapter 10: Multivariate analysis of 
health survey data. Analyzing health equity using household survey data: A 
guide to techniques and their implementation. O. O'Donnell, E. van Doorslaer, 
A. Wagstaff and M. Lindelow. Washington, DC, The World Bank: 115-29. 
Office of the Permanent Secretary (2006). Transferred position of technical nurses to 
professional nurses. Ministry of Public Health. 
Oxford University (2000). hospice, hospitality, hospital and host. Concise Oxford 
Dicitionary-Tenth Edition. Oxford, Oxford University Press. 
Pannarunothai, S. (2000). Equity in health system. Nonthaburi, Desire. 
 311
Pannarunothai, S. (2002). Chapter 5: Medical welfare scheme: financing and targeting 
the poor. Health insurance systems in Thailand. P. Pramualratana and S. 
Wibulpolprasert. Bangkok, Desire: 62-78. 
Pannarunothai, S., D. Patmasiriwat, et al. (2004). Health equity at household level: the 
second wave of household survey and first health examination survey. 
Pisanulok, Centre for Health Equity Monitoring, Faculty of Medicine, Naresuan 
University. 
Pannarunothai, S. and C. Rehnberg (1998). Equity in the delivery of health care in 
Thailand, Health Systems Research Institute, Thailand. 
Panpiemras, J., K. Sampuntharak, et al. (2007). Evaluating and analyzing impacts of the 
universal health care coverage. Bangkok, Thailand Development Research 
Institute. 
Patel, N., N. Martin, et al. (2007). Chapter I: Registry procedure and statistical methods. 
Cancer in Thailand, Vol. IV, 1998-2000. T. Khuhaprema, P. Srivatanakul, H. 
Sriplunget al. Bangkok, Bangkok Medical Publisher. 4. 
Pattaravanich, U. and S. Jarassit (2006). Cause of external death by age groups. 
Mortality... the reflection of population security. K. Archavanitkul and V. 
Thongthai. Bangkok, Plan Printing: 62-71. 
Patton, G. C., C. Coffey, et al. (2009). "Global patterns of mortality in young people: a 
systematic analysis of population health data." Lancet 374: 881-92. 
Payne, G., A. Laporte, et al. (2009). "Temporal trends in the relative cost of dying: 
evidence from Canada." Health Policy 90: 270-6. 
Pelaseyed, S. and E. Jakubowski (2007). Tenth futures forum on steering towards equity 
in health. Copenhagen, WHO Regional Office for Europe: 6. 
Peter, F. and T. Evans (2001). Ethical dimensions of health equity. Challenging 
inequities in health: from ethics to action. T. Evans, M. Whitehead, F. 
Diderichsen, A. Bhuiya and M. Wirth. New York, Oxford University Press, Inc.: 
25-33. 
Phongphit, S. (2002). Chapter 9: Community saving and health welfare scheme. Health 
insurance systems in Thailand. P. Pramualratana and S. Wibulpolprasert. 
Bangkok, Desire. 
Pierson, C. M., J. R. Curtis, et al. (2002). "A good death: a qualitative study of patients 
with advanced AIDS." AIDS Care 14(5): 587-98. 
 312
Pimsab, M. (2002). Accuracy of the Causes of Death Reported on Death Certificates by 
International Classification of Diseases and Related Health Problem Tenth 
Revision, Amnat Charoen Provinces. The Graduate School. Chiang Mai, Chiang 
Mai University. Master of Public Health: 127. 
Pitayarangsarit, S. (2004). The introduction of the Universal Coverage of health care 
policy in Thailand: policy response. Health Policy Unit. London, London School 
of Health and Tropical Medicine. Doctor of Philosophy: 251. 
Podhisita, C. (2006). Art and science in qualitative research. Bangkok, Amarin Printing 
and Publishing. 
Pokpalagon, P. (2005). Knowledge, attitude, and caring behaviour for end of life 
patients among professional nurses in governmental hospitals. Bangkok. 
M.N.S.(adult nursing). 
Polder, J. J., J. J. Barendregt, et al. (2006). "Health care costs in the last year of life-the 
Dutch experience." Social Science & Medicine 63: 1720-31. 
Population Survey Division (1966). Report on the Survey of Population Change 1964-
1965. Bangkok, National Statistical Office, Office of the Prime Minister. 
Population Survey Division (1977). Report on the Survey of Population Change 1974 - 
1976. Bangkok, National Statistical Office, Office of the Prime Minister. 
Population Survey Division (1987). Report on the Survey of Population Change 1985 - 
1986. Bangkok, National Statistical Office, Office of the Prime Minister. 
Population Survey Division (1990). Report on the Survey of Population Change 1989. 
Bangkok, National Statistical Office. 
Prakongsai, P. (2008). The impact of the universal coverage policy on equity of the Thai 
health care system. Health Policy Unit, Department of Public Health and Policy. 
London, London School of Hygiene and Tropical Medicine. Doctor of 
Philosophy: 386. 
Prakongsai, P., S. Limwattananon, et al. (2009). The equity impact of the universal 
coverage policy: lessons from Thailand. Innovations in health system finance in 
developing and transitional economies. D. Chernichovsky and K. Hanson. 
Bingley, JAI Press. 21: 57-81. 
Pratoomwon, R. (1991). Relationship between selected factors and professional nurses' 
capacity on nursing care of dying patients in public hospitals in Bangkok. M.S. 
Project on Setting Priorities Using Information on Cost-Effectiveness (SPICE 2004-
2009) (2009). SPICE-COD: Improving causes of death in Thailand 2005-2008. 
 313
Y. Porapakkham, W. Polprasert, J. Pattara-Achachaiet al. Bangkok, The 
Ministry of Public Health and The University of Queensland School of 
Population Health. 
Puengrasamee, T. (2007). End of life care. End of life care: Improving care of the dying. 
P. Lertsagnuansinchai, I. Nuchprayul, P. Chatkaew and C. Sitthipun. Bangkok, 
Aksornsampun (1987): 15-23. 
Puttasri, W. (2008). Evaluation on the Project for development of excellent cancer 
center. Evaluation on the Project for development of excellent center under 
Universal Health Coverage System. S. Srithamrongsawat. Nonthaburi, Health 
Insurance System Research Office. 
Research and Development Division (2009). Social Security Office: annual report 2008. 
Nonthaburi, The Social Security Office. 
Riley, G. (2007). "Long-term trends in the concentration of Medicare spending." Health 
Affairs 26(3): 808-816. 
Riley, G. F. and J. D. Lubitz (1989). "Longitudinal patterns of Medicare use by cause of 
death." Health Care Financing Review 11(2): 1-12. 
Roos, N. P., P. Montgomery, et al. (1987). "Health care utilization in the years prior to 
death." Milbank Memorial Fund Quarterly/Health and Society 65(2): 231-54. 
Rungkijkarnwattana, Y. and P. Yamprom (2007). Appendix 1.2: Guideline for leukemia 
and lymphoma service management. Disease management: a system approach to 
improve health outcomes. C. Sornchomeni and S. Bhakeecheep. Bangkok, Sor. 
Pichit publisher. 
Sadock, B. J. and V. A. Sadock (2007). End of life care and palliative medicine. Kaplan 
& Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry. B. J. 
Sadock and V. A. Sadock. Philadelphia, Lippincott Williams & Wilkins, a 
Wolters Kluwer Business: 1359-70. 
Saruayiam, R. (1998). Ethics and ethical dilemmas in terminally ill patients. Bangkok, 
Mahidol University. M.A.(Ethical studies). 
Saunders, C. (2001). "The evolution of palliative care." Journal of the Royal Society of 
Medicine 94: 430-2. 
Scitovsky, A. (1984). "The high cost of dying: what do the data show?" Milbank 
Memorial Fund Quarterly 62(4): 591-608. 
 314
Scitovsky, A. (1988). "Medical care in the last twelve months of life: the relation 
between age, functional status, and medical care expenditures." Milbank Q 
66(4): 640-60. 
Scitovsky, A. (1994). "The high cost of dying, revisited." Milbank Q 72(4): 561-91. 
Sen, A. (2001). Health equity: perspectives, measurability, and criteria. Challenging 
inequities in health: from ethics to action. T. Evans, M. Whitehead, F. 
Diderichsen, A. Bhuiya and M. Wirth. New York, Oxford University Press, Inc.: 
69-75. 
Sen, A. (2002). "Why health equity?" Health Economics 11: 659-66. 
Sengprasert, W. (2003). The right in advance directive for terminal stage cancer patient. 
Bangkok, Mahidol University. M.Sc.(Public Health). 
Sepulveda, C., V. Habiyambere, et al. (2003). "Quality care at the end of life in Africa." 
British Medical Journal 327: 209-13. 
Seshamani, M. (2004d). The impact of aging on health care expenditures: impending 
crisis, or misguided concerns? London, Office of Health Economics. 
Seshamani, M. and A. Gray (2004a). "Ageing and health-care expenditure: the red 
herring argument revisited." Health Economics 13: 303-14. 
Seshamani, M. and A. Gray (2004c). "Time to death and health expenditure: an 
improved model for the impact of demographic change on health care costs." 
Age and Ageing 33: 556-61. 
Seshamani, M. and Gray A. (2002). "The impact of ageing on expenditures in the 
National Health Service." Age and Ageing 31: 287-94. 
Seshamani, M. and A. M. Gray (2004b). "A longitudinal study of the effects of age and 
time to death on hospital costs." Journal of Health Economics 23: 217-35. 
Seymour, J., R. Witherspoon, et al. (2005). End-of-life care: Promoting comfort, choice 
and well-being for older people. Bristol, The Policy Press in association with 
Help the Aged. 
Shactman, D., S. Altman, et al. (2003). "The outlook for hospital spending." Health 
Affairs 22(6): 12-26. 
Shugarman, L., D. Campbell, et al. (2004). "Differences in Medicare expenditures 
during the last 3 years of life." Journal of General Internal Medicine 19. 
Silapasuwan, P. and S. Tongvichien (1990). "Attitudes of old ages living in Bangkok on 
death and selection on place of death." Journal of Demography 6(1): 65-71. 
 315
Singer, P. A. and K. B. Bowman (2002). "Quality care at the end of life." British 
Medical Journal 324: 1291-2. 
Singer, P. A., D. K. Martin, et al. (1999). "Quality end-of-life care, patients' 
perspectives." Journal of American Medical Association 281(2): 163-8. 
Social Statistics Division (1997). Report on the 1995-1996 Survey of Population 
Change. Bangkok, National Statistical Office, Office of the Prime Minister. 
Soranastaporn, S. (2009). Reimbursement system of the Civil Servant Medical Benefit 
Scheme (presentation). Bangkok, Central Office for Healthcare Information. 
Sornchumni, C., K. Kiatthanaphun, et al. (2009). 2008 Annual report on universal 
coverage. Bangkok, National Health Security Office. 
Sriplung, H. (2007). Chapter IV: Projection of cancer problems. Cancer in Thailand, 
Vol. IV, 1998-2000. T. Khuhaprema, P. Srivatanakul, H. Sriplunget al. 
Bangkok, Bangkok Medical Publisher. 4. 
Sriratanaban, J. (2002). Chapter 3: Civil Servant Medical Benefit Scheme: Unregulated 
fee-for-service and cost escalation. Health insurance system in Thailand. P. 
Pramualratana and S. Wibulpolprasert. Bangkok, Desire: 43-51. 
Srithamrongsawat, S. (2002). Chapter 6: The Health Card Scheme: a subsidized 
voluntary health insurance scheme. Health insurance systems in Thailand. P. 
Pramualratana and S. Wibulpolprasert. Bangkok, Desire: 79-93. 
Stearns, S. and E. C. Norton (2002). Time to include time to death?: the future of health 
care expenditure predictions, The Triangle Health Economics Working Paper 
Series. 
Stearns, S. and E. C. Norton (2004). "Time to include time to death? The future of 
health care expenditure prediction." Health Economics 13: 315-27. 
Stooker, T., J. W. van Acht, et al. (2001). "Cost in the last year of life in the 
Netherlands." Inquiry 38: 73-80. 
Sublon, A., N. Chaithum, et al. (2007). Public health statistics A.D.2006. Nonthaburi, 
Bureau of Health Policy and Strategy, Ministry of Public Health. 
Suraratdecha, C., S. Saithanu, et al. (2005). "Is universal coverage a solution for 
disparities in health care? Finding from three low-income provinces of 
Thailand." Health Policy 73: 272-84. 
Swanson, J. and A. Cooper (2005). Treatment options. A physician's guide to coping 
with death and dying. J. Swanson and A. Cooper. Quebec, McGill-Queen's 
University Press 2005. 
 316
Tang, S. T., T. Liu, et al. (2005). "Discrepancy in the preferences of place of death 
between terminally ill cancer patients and their primary family caregivers in 
Taiwan." Social Science & Medicine 61: 1560-6. 
Tangcharoensathien, V., P. Prakongsai, et al. (2009). From targeting to universality: 
lessons from the health system in Thailand. Building decent societies: rethinking 
the role of social security in development. P. Townsend. Hampshire, Palgrave 
Macmillan: 310-22. 
Tangcharoensathien, V., S. Srithamrongsawat, et al. (2002). Chapter 2: Overview of 
health insurance systems. Health insurance systems in Thailand. P. 
Pramualratana and S. Wibulpolprasert. Bangkok, Desire: 28-39. 
Tangcharoensathien, V., C. Vasavid, et al. (2004). National health account in Thailand 
1994-2001. Nonthaburi, International Health Policy Program, Ministry of Public 
Health. 
Thai working Group on Burden of Disease and Injuries (2002). Priority setting for 
Policy: burden of disease and injuries in Thailand. K. Bundhamcharoen, Y. 
Teerawatananon, T. Vos and S. Begg. Nonthaburi, Bureau of Health Policy and 
Planning, Ministry of Public Health. 
Thai working Group on Burden of Disease and Injuries (2007). The interim report on 
Burden of disease and Injuries in Thailand 2004. K. Bundhamcharoen and P. 
Odton. Nonthaburi, International Health Policy Program, Bureau of Health 
Policy and Strategy, Ministry of Public Health. 
Thailand Nursing and Midwifery Council (2009). The second national plan for nursing 
and midwifery development B.E. 2550-2559 (2007-2015). R. Srida. Bangkok, 
Thailand Nursing and Midwifery Council,. 
Thammatacharee, J. (2009). Variations in the performance of three public insurance 
schemes in Thailand. Health Policy Unit. London, London School of Hygiene 
and Tropical Medicine. PhD: 373. 
The Comptroller General's Department (2006). Payment system for CSMBS under the 
project on direct reimbursement for cancer patients. Ministry of Finance. 
The Comptroller General's Department (2007). Payment for inpatient care at public 
hospitals with DRG. Ministry of Finance. 
The Health Committee (2004). Palliative care: fourth report of session 2003-04, volume 
1. London, The House of Commons. 
 317
The Henry J. Kaiser Family Foundation (2007). Fact sheet on Medicare spending and 
financing, the Kaiser Family Foundation's website. 
The National Hospice and Palliative Care Organization. (2009). "History of hospice 
care."   Retrieved December 25th, 2009, from http://www.nhpco.org. 
The National Hospice and Palliative Care Organization. (2009). "What is hospice and 
palliative care?"   Retrieved December 25th, 2009, from http://www.nhpco.org. 
The United Nations. (1948). "The Universal Declaration of Human Rights." from 
www.un.org/en/documents/udhr. 
The World Bank (2006). Chapter 4: Equity and well-being. World development report 
2006: equity and development. The World Bank. New York, Oxford University 
Press: 76-88. 
Thomas, C., S. M. Morris, et al. (2004). "Place of death: preferences among cancer 
patients and their carers." Social Science & Medicine 58: 2431-44. 
Tulsky, J. A. and R. M. Arnold (2007). Communication during transitions of care. 
Principles and practice of palliative care and supportive oncology. A. M. Berger, 
J. L. J. Shuster and J. H. Von Roenn. Philadelphia, Lippincott Williams & 
Wilkins, a Wolters Kluwer bussiness: 527-36. 
United Nations (2000). Resolution adopted by the General Assembly, 55/2. United 
Nations Millennium Declaration. A/RES/55/2. 
Urassa, M., T. Boerma, et al. (2001). "The impact of HIV/AIDS on mortality and 
household morbidity in rural Tanzania." AIDS 15(15): 2017-23. 
van Vliet, R. C. J. A. and L. M. Lamers (1998). "The high costs of death: should health 
plans get higher payments when members die?" Medical care 36(10): 1451-60. 
Vapattanawong, P. and P. Prasartkul (2006a). Mortality and longevity of Thai 
population. Mortality... the reflection of population security. K. Archavanitkul 
and V. Thongthai. Bangkok, Plan Printing. 
Vapattanawong, P. and P. Prasartkul (2006b). Thai population in the future. Mortality... 
the reflection of population security. K. Archavanitkul and V. Thongthai. 
Bangkok, Plan Printing: 34-41. 
Vasavid, C., S. Janyapong, et al. (2009). Thai national health accounts: sustainable 
updates of 2006 and 2007 and diversification. Nonthaburi, International Health 
Policy Program, Ministry of Public Health. 
 318
Vasavid, C., K. Tisayaticom, et al. (2004). "Health and welfare of Thai population after 
universal health care coverage (UC)-Part I: Illness, utilisation compliance of 
health care services of UC members." Journal of Health Science 14: 428-39. 
Vijitsukon, K. (1975). Perception of nursing students on dying patients. M.A. 
Wagstaff, A. and E. van Doorslaer (1993). Equity in the finance and delivery of health 
care: concepts and definitions. Equity in the finance and delivery of health care, 
an international perspective. E. van Doorslaer, A. Wagstaff and F. Rutten. New 
York, Oxford University Press: 7-19. 
Wattanachote, W. (1997). Perception and practice of ICU nurses on truth telling about 
dying. M.S. 
Wennberg, J., E. Fisher, et al. (2004). "Use of hospitals, physician visits, and hospice 
care during last six months of life among cohorts loyal to highly respected 
hospitals in the United States." British Medical Journal 328. 
Werblow, A., S. Felder, et al. (2007). "Population ageing and health care expenditure: a 
school of 'red herrings'?" Health Economics 16: 1109-26. 
Whitehead, M. (2000). The concepts and principles of equity and health. European 
health for all series no. 1. Copenhagen, WHO Regional Office for Europe. 
Whitehead, M. and G. Dahlgren (2007). Concept and principles for tackling social 
inequities in health: Leveling up part 1. Copenhagen, WHO Regional Office for 
Europe. 
Williams, A. (1993). Chapter 16: Equity in health care: the role of ideology. Equity in 
the finance and delivery of health care, an international perspective. E. van 
Doorslaer, A. Wagstaff and F. Rutten. New York, Oxford University Press: 287-
98. 
Wilson, D., C. Truman, et al. (2009). "The rapidly changing location of death in 
Canada, 1994-2004." Social Science & Medicine 68: 1752-8. 
World Health Organization (2004). Health in the Millennium Development Goals: 
millennium development goals, targets and indicators related to health. 
www.who.int/mdg. Geneva, World Health Organization. 
World Health Organization. (2004). "World Health Organization supports global effort 
to relieve chronic pain."   Retrieved 29 June 2010, 2010. 
World Health Organization. (2008). "Are the number of cancer cases increasing or 
decreasing in the world?"   Retrieved 29 June 2010, 2010. 
 319
World Health Organization (2008). Part 2: Causes of death. The global burden of 
disease: 2004 update. Switzerland, World Health Organization. 
World Health Organization (2008). World health statistics 2008. Geneva, World Health 
Organization. 
World Health Organization. (2009). "Palliative care."   Retrieved December 25th, 2009, 
from http://www.who.int/cancer/palliative/en/. 
World Health Organization (2009). World health statistics 2009. France, World Health 
Organization. 
World Health Organization. (2010). "Key components of a well functioning health 
system."   Retrieved 1st June 2010, from 
http://www.who.int/healthsystems/topics/en/index.html. 
Yamano, T. and T. S. Jayne (2004). "Measuring the impacts of working-age adult 
mortality on small-scale farm households in Kenya." World Development 32(1): 
91-119. 
Yang, L., N. Sakamoto, et al. (2006). "A study of home death in Japan from 1951 to 
2002." BMC Palliative Care 5(2). 
Zallman, L., J. Sanchez, et al. (2003). "Unmet need for chronic disease and end-of-life 
care at urban family health centers in the Bronx, NY." Family Medicine 35(8): 
637-42. 
Zarit, S. H. (2004). "Family care and burden at the end of life: commentary." Canadian 
Medical Association Journal 170(12): 1811. 
Zweifel, P., S. Felder, et al. (1999). "Aging of population and health care expenditure: a 
red herring?" Health Economics 8: 485-96. 
 
 320
APPENDIX 1 
GLOSSARY 
A1 Terms Defined 
Following terms are those used interchangeably in the thesis. 
Communicable 
diseases 
means infectious diseases including maternal, perinatal and 
nutrition conditions 
Complementary 
medicines 
includes pharmacy, self medication, herbal medicines, 
traditional medicines and alternative medicines 
Decedents or deceased including dying person and patients before 
death, terminally ill patients  
Dependent variable or explained variable, outcome variable, regressand, 
response variable 
Expenditures means costs, charges, expenses 
Head of household 
Means a person who is the head in social meaning whether 
or not he/she is a breadwinner 
Health expenditure or health care cost 
Health facilities includes private clinic and polyclinic, health center, primary 
care unit (PCU), community or district hospital, general or 
provincial hospital, regional hospital, specialized hospital, 
university hospital 
Household Means a group of people who live in the same house, 
regularly eat together from the same cooking (whether or not 
they are in the same family) 
Independent variable or explanatory variable, regressor, covariate 
Injuries includes poisoning and other external causes of morbidity 
and mortality 
Inpatient service means acute care, hospitalisation, admission at available 
health facility 
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Medical cost is expenditures or cost paid for medical treatment including 
medicine, x-ray, laboratory investigation, surgery, medical 
supplies, for instances 
Non-communicable 
disease 
means chronic non-communicable illnesses 
Out-patient care means ambulatory care, both in health facilities or 
complementary medicine 
Utilisation means visiting for ambulatory care and hospitalisation for 
acute care at any health facility and complementary medicine 
by decedents  
Exchange rate in 2006a 1 USD =  34.5182 Baht 
1GBP = 69.0678 Baht 
1 International dollar = 12.12 (in 2005)  
 
                                                 
a www.bot.or.th (accessed date: 31 March 2010) 
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APPENDIX 2 
REGRESSION 
 
A2.1 Ordinary least square 
Ordinary least square (OLS) is based on the minimization of the sum of squared 
residuals between the estimated value and the actual value of the outcome variable.  
Since this method is under the assumption of normal distribution, the hypothesis tests 
are F statistic for all coefficients of the model and t statistic for individual coefficient of 
each variable. The former is ‘the ratio of two independent chi-squares, each divided by 
its degree of freedom’ (Kennedy 1998). The null hypothesis is that the coefficient 
parameters are zero, βi = … = βk = 0, and the alternative hypothesis is that at least one 
of the βi ≠ 0. The latter is ‘the distance between regression estimate and hypothetical 
value divided by standard deviation of the regression estimate’ (Dougherty 2002). The 
null hypothesis is the mean of estimator β ( βˆ ) is equal to its true β and its alternative 
hypothesis is βˆ  is not equal to true β (or hypothetical β). In other words, the null 
hypothesis by t tests is βi = 0, or βk = 0, individually.  
A2.2 Maximum likelihood (ML) 
An alternative method to OLS, based on the maximum likelihood approach, relaxes the 
assumption of the OLS of normal distribution of all variables, mean of residual equals 
to zero and homoscedasticity (more detail is indicated in the section of multiple linear 
regression). Generally, it is called a large-sample method. In principle, the maximum 
likelihood estimates the value of unknown parameters in which the probability of 
observing the given y’s as maximum as possible (Dupont 2002; Gujarati 2003). The 
hypothesis testing for the explanatory power of the model uses the likelihood ratio test 
in which distributed as chi-square statistic. The null hypothesis is that all joint 
coefficients are equal to zero. The test for an individual coefficient is t statistic 
(Dougherty 2002) and the null hypothesis is the same as t statistic in OLS. 
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A2.3 Multiple linear regression 
The relationship between a dependent variable and independent variables of the 
model is generated by the OLS. The general equation of the linear regression is  
y = f(x1, x2, …, xi) + ε 
y = β1 + β2x1 + … + βkxi + ε. 
Where y denotes a dependent variable as continuous data and x1, …, xi are independent 
variables. β coefficients are fixed quantities as parameters of the equation. β1 is constant 
and ε is defined as disturbance or residual term. 
The assumptions about the best predicted result of coefficient of general linear 
regression are (Kennedy 1998; Dougherty 2002; Greene 2008) 
• A linear relationship exists between a dependent variable and independent 
variables 
• The residual of one observation is distributed independently from residuals of 
other observations 
• There is no relationship between residuals and independent variables 
• Residuals are normally distributed 
• The mean of the residuals of all observations equals zero 
• The variance of the residuals is same for all observations so called 
homoscedasticity 
• The observations on the independent variable can be considered fixed in 
repeated samples 
• The number of observations is greater than the number of independent 
variables 
• There is no exact relationship between the independent variables 
Diagnostics of the model 
The goodness of fit of the model is specified by test of F statistic and t statistic as 
mentioned in OLS. In addition, R2 is informative measure for the relationship of 
explanatory variables and an outcome variable, reported in proportion of the explanation 
of a set of x on y. The higher the R2 the better explain of such set of x on y. Another 
indicator, adjusted R2 in which the R2 is adjusted by the degree of freedom when 
another explanatory variable is added into the model (Kennedy 1998; Dougherty 2002; 
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Greene 2008). However, since sometimes a rise in adjusted R2 does not follow as it was 
suggested, the adjusted R2 has lost preference as a diagnostic test (Dougherty 2002).  
In the following,  each regression model for specific type of data and model selection 
criteria or goodness of fit are described under individual models. 
A2.4 Generalized linear model (GLM)  
This general model was developed by restructuring the relationship between the linear 
predictor which is seemingly non-linear and the response. The assumption about 
normality of general linear model is relaxed and each GLM family member is linearized 
by link function and variance function. Both functions would be mapped to a probability 
distribution which is a member of the exponential family (Acock 2006; Hardin and 
Hilbe 2007). Put simply, the GLM consists of  
1) a random component for the response variable, y which its distribution is a 
member of exponential family;  
2) a linear predictor that is a linear function of regressors, 
ηi = α + β1xi1 + β2xi2 + … + βkxik; 
3) a smooth and inverse linearizing link function g(·) which transforms the 
expectation of the response variable, μ = E(yi) to the linear predictor, 
g(μi) = ηi = α + β1xi1 + β2xi2 + … + βkxik . 
The exponential family provides modeling for continuous, discrete, proportional, count 
and binary outcomes. Such models include the Gaussian or normal, binomial, Poisson, 
gamma, inverse Gaussian, geometric, and negative binomial family. By maximum 
likelihood method, the estimation of y in the standard form of log likelihood is 
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θ denotes the canonical (natural) parameter which simplify the GLM, φ  is the 
scale or ancillary parameter required to produce standard error. The a(φ ) is a scale 
factor (Hardin and Hilbe 2007; Fox 2008). This section, mentioned models for 
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continuous data, i.e. Gaussian distribution and log like and Gamma distribution and 
models for count data, i.e. Poisson and negative binomial.  
A2.4.1 Model for continuous data 
a) Gaussian distribution 
It was usually referred to as the normal density with symmetric bell shape. Its normal 
cumulative distribution function is a member of the exponential family and is a basis for 
GLM. The μ is the same as xβ as identity link. That is, there is a straightforward 
identity between the fitted value and the linear predictor. The form of log likelihood 
function of the model in terms of linear predictor (xβ) is  
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b) Gamma distribution and log link 
This GLM model, so-called log-gamma model is used for continuous data for which its 
value is greater than or equal 0, e.g. healthcare cost. Even though length of stay (LOS), 
health data is discrete data and generally modeled by Poisson or negative binomial, the 
log-gamma model is acceptable when there are many LOS values. Presently, this log-
gamma model is preferred to the Gaussian regression with log transformation since it 
needs not to have any external transformation. The form of log likelihood function of 
this model in term of linear predictor is 
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c) Poisson distribution and log link 
The Poisson distribution is one of the exponential family in GLM and it could be 
employed to the expenditure data (see details of the model in the next subsection) 
(Manning and Mullahy 2001).   
A2.4.2 Models for count data (Poisson family) 
a) Poisson model 
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Poisson is a model for count or rate data, length of stay is an example for health data. 
The canonical link of the model is log, so the inverse link is exp(η) in which the linear 
predictor. The mean and variance function are equal. If the variance is more than mean, 
that is overdispersed, more details are described later. The model in log likelihood 
function is formed as 
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where Γ  is a gamma distribution. The model is popular in epidemiological 
studies like rate of morbidity, it includes zero count in the model and allows offset as an 
exposure (in epidemiological term). Thus, it can not directly model other types of count 
data, for example number of admission and length of stay which are of interest. In this 
case, the zero-truncated Poisson model is suggested and its reshaped log likelihood is 
( ) ( ) ( ) ( ) ( ){ }[ ]( )∑
=
−−−+Γ−−=>
n
i
iiii xyxxyiyyxLR
1
expexp1ln1lnexp0|: ββββ  
That is the probability of a Poisson 0 count is subtracted from 1. 
Overdispersion is a problem of discrete outcome models because continuous models fit 
the scale (or dispersion) parameter φ  while none of this scale is in discrete model. That 
is, in this research, the model probable to have this problem is the Poisson family in 
which variance is equal to mean. If the variance is larger than mean that is 
overdispersion which rather occurs than underdispersion, vise versa. There are two 
types of overdispersion, i.e. apparent and true overdispersion. The former may be 
caused by omitting crucial explanatory variables; data contain outlier; failure to include 
enough interaction term; a predictor needs to be transformed; and assumption of linear 
relationship in which the actual one is quadratic. Overdispersion can be easily 
investigated through the value of deviance or Pearson chi-square divided by degree of 
freedom. The value of more than 1 indicates overdispersion but smaller amounts are of 
little concern. However, if the real dispersion value is larger than 2.0, an adjusted 
standard errors is required. Otherwise, it is suggested turning to negative binomial 
model or quasi-Poisson (Hardin and Hilbe 2007; Fox 2008). However, the latter is 
based on non-exponential family which is beyond the scope of this research. Therefore, 
the negative binomial is mentioned next. 
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b) Negative binomial 
By maximum likelihood method, the negative binomial is a Poisson-gamma mixture 
model in which accommodating overdispersed Poisson data. That is, the model is rather 
log link than canonical and identity link. It has an ancillary parameter and its value (α) 
which solves the overdispersion through. In addition, the variance function is adjusted 
in term of the mean by two methods, i.e. constant mean (NB-1: constant overdispersion) 
and mean square (NB-2: variable overdispersion). This research would apply only the 
NB-2 which is used more often in applied research and it accommodates within the 
GLM framework (Long and Freese 2006; Hardin and Hilbe 2007). 
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Like Poisson regression, the zero-truncated negative binomial model was suggested to 
be more appropriate for non-zero count data. Also, the concept is the same that 
subtraction probability of a 0 count from 1, as indicated in the rescaled equation as 
follows: 
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Table A2.1 summarises variance, scale parameter, the link functions and its inverse in 
which are appropriate to probability distributions of GLM. Thus the model selected and 
tested would be within the scope of these link functions. 
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Table A2.1 Variance, scale parameter, link function and inverse link of each 
distribution in this research 
Distribution Variance V(μ) Link η = g(μ) Inverse link 
Poisson μ Log: ln(μ) exp(η) 
Negative binomial μ + αμ2 negative binomial: ln{αμ/(1+αμ)} e
η/{α(1-eη)} 
Gaussian 1 identity: μ log: ln(μ) 
η 
exp(η) 
Inverse Gaussian μ3 
canonical: -1/(2 μ2) 
identity: μ 
log: ln(μ) 
(-2 η)-1/2 
η 
exp(η) 
Gamma μ2 Log: ln(μ) exp(η) 
Source: Summarized from Hardin et al (2007) 
 
Diagnostics of the model 
Firstly, goodness of fit of the GLM is measured by deviance, a chi-square statistic. It is 
twice that of the difference between the log likelihood of the model of interest and the 
saturated (or full parameters) model  
S = -2ln(Lm/Lf) 
given S = scale deviance; 
         Lm = likelihood of the model with full parameters; 
         Lf = likelihood of the fitted model. 
The values of parameters which minimize the deviance are the values that fit the model. 
These values of the parameters are the same values that maximize the likelihood. Link 
function, the fit of appropriate link function of each distribution has to be assessed by 
changes in the deviance value as well. The wrong link function is a systematic 
misspecification of the model. However, there is no single point that identifies the 
appropriate line. For example, this assessment is to compare between the usual log-link 
and identity link for Poisson regression. Tests for link function include Pearson 
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correlation test checking for systematic bias in fit on raw scale; and Pregibon link test 
and Modified Hosmer & Lemeshow test checking linearity of response on scale of 
estimation. Ideally, these tests should indicate insignificant p-values (Glick 2008). Test 
for the appropriate family for the data is required and Modified Park Test is 
recommended. It tests a family given a specific link function. The test predicts the 
square of residual as a function of the log of the predictions. As a result, the value of 
coefficient of the log of the prediction recommends family. If the coefficient is 
approximately equal 0, the recommended family is Gaussian; if the coefficient is around 
1, the family is Poisson; if the coefficient is around 2, the family is gamma; and if the 
coefficient is around 3, the family is inverse Gaussian (Glick 2008).   
Next is the residual analysis which tests that the residual distribution is normal, 
approximately. There are many formulas for residual analysis e.g. Anscombe residuals, 
variance-stabilizing residuals, and Pearson residuals, however, this research used the 
Pearson residual which is equal to Pearson chi-square statistic. Dependencies of 
variance could be revealed by the standard plot between the Pearson residuals and 
individual predictor or the outcome value. 
Hardin et al (2007) suggested that in addition, the best fit of the competing model (or 
non-nested model) could be detected by the Akaike Information Criterion (AIC) and 
Bayesian Informaiton Criterion (BIC). The AIC comparison is that the lower the value, 
the better fitting the model and a difference which is over 2 suggested that models with 
smaller values is preferable. Like AIC, the model with lower BIC value is better fit. 
There is also a level of preference for BIC by determining the difference of its absolute 
value. Degree of 0-2, 2-6, 6-10 or more than 10 differences indicated weak, positive, 
strong and very strong preferences, respectively (Hardin and Hilbe 2007; Glick 2008). 
A2.5 Simple logistic regression 
In this section, only the binary outcome variable is mentioned. The logistic regression is 
a member of exponential family of distribution in generalized linear regression model 
(GLM). There are only two discrete values of outcome, i.e. 0 and 1, so the OLS cannot 
be used. This binary outcome is unable to meet the assumption of general linear model, 
i.e. normal distribution of residuals, homoscedasticity and residual mean equals zero. 
Thus, fitting the model, the maximum likelihood technique, described in section 
‘hypothesis testing for coefficient’ is used instead. By log transformation, the outcome 
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variable, y, is estimated in the form of log odds ratio (p/1-p), probability of an event lies 
between 0 and 1: 
ln(y) = ln(p/1-p) = Z = β1 + β2xi  
p = eZ/(1 + eZ) 
where y denotes a binary outcome variable, that is 1 as an interested event and 0 
otherwise; xi represents the independent variable and P is a probability of an interested 
event (Gujarati 2003). 
Diagnostics of the model 
R2 is not appropriate in maximum likelihood technique and this dichotomous outcome 
variable in which the value would limit from 0 to 1. However, the pseudo R2 could be 
presented in the analysis output. By comparison, the ratio between log likelihood of all 
joint coefficients and log likelihood of the intercept only, and subtract to 1, the value of 
pseudo R2 would be very small. In addition, there is no natural interpretation 
(Dougherty 2002). Apart from hypothesis testing by likelihood ratio and t statistic 
which are the main diagnostic tools of the model, goodness of fit could be tested by 
Wald’s test and Lagrange multiplier or score test (Kennedy 1998). Both statistics are 
also to some extent of chi-square statistics. Given a sufficiently large sample size of all 
three tests, i.e. likelihood ratio, score test and Wald’s are equal. It was, nonetheless, 
suggested, when available, that the likelihood ratio is most preferred since there is no 
effect of parameter transformation. The Wald’s test is easiest in calculation but should 
be used when it is only an available one (Dupont 2002). 
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APPENDIX 3 
CLAIMED EXPENDITURE 
 
Table A3.1 List of causes of death by diseases and injuries classification and its ICD-10 
code 
 Disease group ICD-10 Codes 
     
I Communicable, maternal, perinatal and nutrition conditions 
A00-B99, D50-D539, E00-
E02, E031, E40-E649, 
G00-G058, H65-H669, 
J00-J22, N70-N739, O00-
O99, P00-P969 
   
A Infectious and parasitic diseases A00-B99, G00-G058, N70-N739, P370                            
B Respiratory infections J00-J22, H65-H66 
C Maternal conditions O00-O998                              
D Conditions arising during the perinatal P00-P37, P371-P969            
E Nutritional deficiencies D50-D539, E00-E02, E031, E40-E46, E50-E649    
   
   
II Non-communicable diseases 
C00-C97,D00-D489,D55-
D899,E030,E032-E079, 
E10-E169, E20-E349, 
E65-E899, F00-F99, G06-
G99, H00-H619, H68-
H959, I00-I99, J30-J989,  
K00-K929, L00-L989, 
M00-M999, N00-N64, 
N75-N999, Q00-Q999 
     
F Malignant neoplasms C00-C97 
G Benign neoplasms D00-D48 
H Diabetes mellitus E10-E149 
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Table A3.1 List of causes of death by diseases and injuries classification and its ICD-10 
code (cont.) 
 Disease group ICD-10 Codes 
I Endocrine and metabolic disorders 
D55-D899, E030, 
E032-E079, E15-E169, 
E20-E349, E65-E899      
J Mental disorders F04-F050, F058-F69, F80-F998 
K Neurological disorders F00-F03,F70-F79,G06-G98, F051                        
L Sense organ diseases H00-H619, H68-H959 
M Cardiovascular diseases I00-I99 
N Respiratory diseases J30-J989 
O Digestive diseases K20-K938 
P Genito-urinary diseases N00-N649, N75-N999     
Q Skin diseases L00-L998                        
R Musculoskeletal diseases M00-M999 
S Congenital anomalies Q00-Q999                        
T Oral conditions K00-K149                        
   
III Injuries 
V01-X58, X60-Y09, 
Y35-Y871, Y88-Y891, 
Y90-Y98                          
    
A Unintentional injuries V01-X58, Y40-Y86, Y88-Y891, Y90-Y98       
B Intentional injuries X60-Y09, Y35-Y369, Y870-Y871                      
 Redistribution categories X59, Y10-Y34, Y872, Y899 
   
IV N-code injuries S00-S999, T00-T999 
 Ill-defined non-injury conditions R00-R99 except R54 
   
V Senility R54 
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Table A3.2 Correlation matrix of all variables of interest 
 
 Expenditure Length of stay 
Numbers of 
admission Gender 
Death age 
group 
Places of 
death 
Causes of 
death Comorbidity
Charlson 
index 
Expenditure 1         
Length of stay 0.7035** 1        
Numbers of 
admission 0.2868** 0.4935** 1       
Gender 0.0008 0.0129** 0.0360** 1      
Death age group -0.0322** -0.0506** -0.0872** 0.1008** 1     
Places of death 0.1633** 0.0774** -0.0021 -0.0196** -0.1123** 1    
Causes of death 0.0120** 0.0494** 0.0594** -0.0115** 0.0602** -0.1266** 1   
Comorbidity 0.2673** 0.1934** 0.0564** 0.0348** -0.0260** 0.1811** -0.0978** 1  
Charlson index 0.1640** 0.2608** 0.3719** 0.0200** -0.1127** 0.0414** 0.0997** 0.2549** 1 
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Table A3.3 Descriptive statistics of some variables by health insurance groups 
  Mean S.E. S.D. Minimum Maximum 50Ptile 75Ptile 90Ptile 
Claimed expenditure All 64,106.5 276.8 124,658.0 10 6,741,127 25,437 64,289 152,976 
 CSMBS 119,994.5 1,056.0 198,682.2 200 6,741,127 52,098 136,889 301,449 
 UCE 50,438.9 279.7 96,303.2 10 2,990,939 21,032.7 51,268.9 117,857 
 UCP 56,788.7 466.4 103,142.0 10 2,979,576 25,463.5 60,103 130,816 
Length of stay All 20.8 0.06 29.2 1 365 11 26 51 
 CSMBS 30.9 0.21 39.7 1 365 17 40 75 
 UCE 18.1 0.07 25.4 1 363 10 22 44 
 UCP 20.1 0.12 27.1 1 364 11 25 50 
Numbers of admission All 2.8 0.005 2.5 1 50 2 3 6 
 CSMBS 2.8 0.013 2.5 1 47 2 4 6 
 UCE 2.7 0.007 2.4 1 50 2 3 5 
 UCP 2.9 0.012 2.6 1 39 2 4 6 
Numbers of comorbidities 
in last admission All 2.5 0.005 2.2 0 12 2 4 6 
 CSMBS 2.9 0.012 2.3 0 12 2 4 6 
 UCE 2.5 0.006 2.2 0 12 2 3 5 
 UCP 2.5 0.010 2.2 0 12 2 4 5 
Charlson comorbidity index All 1.7 0.005 2.2 0 16 1 2 6 
 CSMBS 1.9 0.012 2.3 0 16 1 3 6 
 UCE 1.4 0.006 1.9 0 16 1 2 4 
 UCP 2.1 0.012 2.6 0 16 1 3 6 
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Table A3.4 Descriptive statistics of claimed expenditures by Charlson comorbidity index 
Percentage of decedents and mean claimed expenditures 
Variables 
All CSMBS UCE UCP 
Numbers of 
decedents (n) 202,858 35,396 118,548 48,914 
 % n Baht % n Baht % n Baht % n Baht 
Charlson 
comorbidity index         
0 42.0 40,820.0 34.3 72,683.3 43.6 33,770.5 43.5 39,761.9
1 20.0 66,678.6 22.1 105,874.7 21.2 56,052.8 15.4 61,558.6
2 14.5 78,941.1 16.5 135,794.2 15.4 60,975.9 11.0 78,213.8
>=3 23.5 94,272.3 27.1 181,656.4 19.8 72,960.1 30.1 71,172.0
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Table A3.5 Statistical tests and values of zero-truncated Poisson model versus zero-truncated negative binomial model for hospitalisations 
Model: Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err. 
Age 5_10 0.0258 0.0616  -0.0379 0.0739 
Age 10_20 -0.0615 0.0471  -0.1528** 0.0567 
Age 20_30 -0.0510 0.0368  -0.0765 0.0446 
Age 30_40 -0.1310** 0.0329  -0.1611** 0.0396 
Age 40_50 -0.1248** 0.0315  -0.1448** 0.0379 
Age 50_60 -0.1170** 0.0312  -0.1272** 0.0375 
Age 60_70 -0.1842** 0.0301  -0.1956** 0.0360 
Age 70_75 -0.2343** 0.0307  -0.2539** 0.0368 
Age 75_80 -0.3126** 0.0310  -0.3467** 0.0372 
Age >=80 -0.5015** 0.0310  -0.5810** 0.0372 
Male -0.0846** 0.0070  -0.0920** 0.0087 
Communicable ds. -0.0265* 0.0121  -0.0151 0.0148 
Non-communicable ds. 0.0729** 0.0106  0.0932** 0.0131 
Injuries -0.9145** 0.0313  -1.0601** 0.0359 
Senility -0.1358** 0.0163  -0.1772** 0.0200 
Cancer 0.3247** 0.0107  0.4093** 0.0134 
Place of death, public hosp. -0.0065 0.0082  -0.0159 0.0101 
Place of death, private hosp. -0.0459** 0.0102  -0.0531** 0.0125 
UCE -0.0287** 0.0096  -0.0318** 0.0120 
UCP -0.1031** 0.0131  -0.1230** 0.0165 
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Table A3.5 Statistical tests and values of zero-truncated Poisson model versus zero-truncated negative binomial model for hospitalisations (cont.) 
Model: Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err. 
1 comorbidity 0.0981** 0.0122  0.1170** 0.0152 
2 comorbidity 0.1515** 0.0123  0.1889** 0.0153 
3 comorbidity 0.1997** 0.0128  0.2523** 0.0159 
4 comorbidity 0.2136** 0.0146  0.2647** 0.0180 
>=5 comorbidity 0.2313** 0.0126  0.2880** 0.0156 
Constant 1.0674** 0.0328  0.6586** 0.0405 
Test for overdispersion (α = 0)  0.4391**    
Pseudo R2  0.04    
Number of observations  101513   101513 
Wald χ2  5188.39**   5372.71** 
ll(null)  -212119.5   -184145.2 
ll(model)  -203632.5   -180880.9 
AIC  407317   361815.8 
BIC  407564.7   362073 
Wald test for group variables (χ2)     
Age  925.99**   809.54** 
Causes of death  2677.51**   2815.91** 
Places of death  45.11**   51.95** 
Health insurances  64.2**   58.66** 
Comorbidities  443.83**   458.33** 
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Figure A3.1 Histogram of independent variable (expenditure) in raw scale and log scale 
A: Raw scale 
 
Skewness = 7.549921; Kurtosis = 142.6821 
B: Log scale 
 
Skewness = -0.04958; Kurtosis = 3.04466 
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Table A3.6 Statistical tests and values of models for claimed expenditure 
Model: OLS  LnOLS with Duan’s smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Age 5-10 -23411.03* 11870.1  -0.1918* 0.0788  -0.3645** 0.0861  -0.1689 0.0956 
Age 10-20 -33870.65** 10214.3  -0.3413** 0.0572  -0.4162** 0.0750  -0.2607** 0.0856 
Age 20-30 -58528.98** 8790.1  -0.4527** 0.0500  -0.6704** 0.0685  -0.5477** 0.0768 
Age 30-40 -75716.32** 8351.9  -0.5937** 0.0462  -0.9015** 0.0587  -0.8473** 0.0658 
Age 40-50 -71014.51** 8378.5  -0.5051** 0.0451  -0.8043** 0.0567  -0.7499** 0.0641 
Age 50-60 -69133.06** 8385.4  -0.4783** 0.0446  -0.7720** 0.0558  -0.7244** 0.0635 
Age 60-70 -67683.23** 8338.0  -0.4322** 0.0436  -0.7388** 0.0544  -0.6950** 0.0623 
Age 70-75 -67245.06** 8394.6  -0.4501** 0.0441  -0.7481** 0.0553  -0.6964** 0.0634 
Age 75-80 -72230.25** 8411.7  -0.4995** 0.0443  -0.8105** 0.0553  -0.7667** 0.0637 
Age >= 80 -75356.94** 8440.9  -0.6231** 0.0442  -0.9168** 0.0553  -0.8180** 0.0640 
Male 398.69 749.5  -0.0135 0.0078  0.0181 0.0107  0.0056 0.0115 
Communicable ds. 13254.34** 1454.2  0.2488** 0.0134  0.1870** 0.0178  0.2020** 0.0205 
Non-communicable ds. 4187.82** 1017.8  0.1786** 0.0116  0.1267** 0.0157  0.0962** 0.0176 
Injuries -18147.91** 1802.8  -0.3480** 0.0217  -0.2693** 0.0321  -0.2998** 0.0356 
Senility -2127.11 1171.3  -0.0847** 0.0165  -0.1488** 0.0243  -0.1639** 0.0250 
Cancer 29117.24** 1195.9  0.5627** 0.0129  0.4403** 0.0168  0.4365** 0.0181 
Place of death, public hosp. 20993.47** 786.1  0.3256** 0.0090  0.3171** 0.0120  0.3298** 0.0125 
Place of death, private hosp. -5124.48** 1298.6  -0.1400** 0.0114  -0.0931** 0.0143  -0.1150** 0.0144 
UCE -61893.99** 1517.6  -0.7226** 0.0110  -0.7679** 0.0137  -0.7439** 0.0149 
UCP -60381.60** 1910.3  -0.6520** 0.0153  -0.6963** 0.0201  -0.6869** 0.0217 
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Table A3.6 Statistical tests and values of models for claimed expenditure (cont.) 
Model: OLS  LnOLS with Duan’s smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
1 comorbidity 5956.11** 809.5  0.1862** 0.0131  0.1558** 0.0186  0.1514** 0.0204 
2 comorbidities 13009.18** 896.6  0.4045** 0.0133  0.3359** 0.0193  0.3149** 0.0204 
3 comorbidities 24444.16** 1070.4  0.6461** 0.0139  0.5183** 0.0190  0.5115** 0.0207 
4 comorbidities 31595.27** 1375.0  0.7942** 0.0157  0.6495** 0.0221  0.6119** 0.0232 
>=5 comorbidities 77755.55** 1559.5  1.2436** 0.0139  1.0944** 0.0188  1.0541** 0.0200 
Constant 141930.40** 8807.9  10.3963** 0.0465  11.5665** 0.0590  11.5210** 0.0704 
Duan’s smearing factor: LnOLS    2.0812       
Number of observations  101513   101513   101513   101513 
R2  0.122   0.2146       
F statistic  266.08**   1110.33**       
Residual df        101487   101487 
Deviance        148023.573   8.73E+09 
Pearson        286067.5105   1.6E+10 
Log likelihood (null)  -1335237   -176690.7   .   . 
Log likelihood (model)  -1328631   -164432.7   -1205523   -4.36E+09 
AIC  2657314   328917.4   2411098   8.73E+09 
BIC  2657562   329165.2   2411346   8.73E+09 
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Table A3.6 Statistical tests and values of models for claimed expenditure (cont.) 
Model: OLS  LnOLS with Duan’s smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Modified Park Test for GLM family (χ2)          
Coefficient        1.6362   1.6548 
Family:        Chi2   Chi2 
Gamma        32.27**   30.09** 
Poisson        98.69**   108.08** 
Inverse Gaussian or Wald        453.54**   456.15** 
Gaussian NLLS        652.79**   690.28** 
Results of tests for GLM Log  link       p-value   p-value 
Pearson Correlation test        0.000   0.067 
Pregibon Link Test       0.035   0.038 
Modified Hosmer and Lemeshow       0.145   0.249 
Root Mean Square Error 117028.8   116896.5   116602.9   116456.4 
Mean Absolute Error 57960.8   57737.3   57176.7   57063.6 
Wald test for group variables (χ2)           
Age  21.02**   41.31**   434.79**   329.92** 
Causes of death  202.71**   642.97**   1183.10**   1139.51** 
Places of death  437.99**   744.81**   921.40**   903.79** 
Health insurances  832.53**   2174.43**   3183.65**   2518.96** 
Comorbidities  622.91**   2144.86**   4776.57**   4090.59** 
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Figure A3.2 Scatter plot of estimated mean (fitted values) versus residual of four models 
A: OLS 
 
B: OLS of log transformed data with Duan’s smearing factor 
 
C: GLM gamma log link 
 
D: GLM Poisson log link 
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Figure A3.3 Plots of predicted value versus residual of the two GLM models (scatter plot and standardized normal probability plot) 
 
A: Gamma log link (scatter plot) 
 
B: Poisson log link (scatter plot) 
 
C: Gamma log link (standardized normal probability plot) 
 
D: Poisson log link (standardized normal probability plot) 
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Table A3.7 Descriptive statistics of length of stay and numbers of admission by various variables 
Length of stay Numbers of  admissions 
Characteristics 
All CSMBS UCE UCP All CSMBS UCE UCP 
N 202,858 35,396 118,548 48,914 202,858 35,396 118,584 48,914 
Average 20.8 30.9 18.1 20.1 2.77 2.81 2.72 2.85 
Gender         
Male 20.5 30.0 18.3 18.7 2.69 2.77 2.70 2.62 
Female 21.2 31.9 18.0 22.2 2.87 2.86 2.75 3.21 
Death age groups (yrs.)         
< 5 38.7 30.3 39.8 24.4 3.18 1.96 3.29 2.98 
5 to <10 31.5 53.8 30.4 34.4 3.38 4.95 3.32 2.00 
10 to <20 22.5 25.3 23.0 21.4 2.69 2.53 2.71 2.67 
20 to <30 20.5 35.4 19.7 20.4 2.78 2.86 2.70 2.80 
30 to <40 19.7 28.7 20.4 19.0 2.79 3.07 2.99 2.71 
40 to <50 21.0 32.9 19.4 20.0 2.94 3.33 3.04 2.85 
50 to <60 21.8 33.2 19.4 20.5 3.08 3.36 3.14 2.99 
60 to <70 21.6 32.3 19.4 21.3 3.00 3.16 2.99 2.76 
70 to <75 21.1 31.7 18.2 16.1 2.82 2.90 2.81 2.07 
75 to <80 19.9 30.4 16.4 20.9 2.58 2.69 2.54 2.27 
>=80 18.3 28.6 14.2 13.2 2.19 2.30 2.14 1.92 
Causes of death         
Ill-defined causes 18.5 27.1 16.5 17.9 2.67 2.66 2.69 2.62 
Communicable ds. 24.7 37.6 23.1 20.2 2.68 2.64 2.70 2.67 
Non-communicable ds. 19.5 27.6 18.0 17.7 2.89 2.70 2.93 2.93 
Injuries 10.8 17.1 10.4 9.3 1.58 1.81 1.61 1.47 
Senility 13.4 21.0 11.8 10.4 2.10 2.19 2.09 1.85 
Cancer 29.2 40.8 24.5 29.0 3.55 3.79 3.37 3.68 
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Table A3.7 Descriptive statistics of length of stay and numbers of admission by various variables (cont.) 
Length of stay Numbers of  admissions 
Characteristics 
All CSMBS UCE UCP All CSMBS UCE UCP 
Places of death         
Elsewhere 18.2 25.5 16.0 20.7 2.75 2.75 2.67 3.02 
Public hospitals 23.7 34.4 21.1 19.5 2.81 2.86 2.83 2.72 
Private hospitals 22.1 25.5 22.3 20.4 2.51 2.52 2.44 2.59 
Comorbidities in last admission        
None 15.6 23.6 13.3 16.4 2.50 2.73 2.41 2.60 
1 16.8 24.6 14.8 17.0 2.66 2.76 2.60 2.75 
2 19.0 27.0 16.8 18.7 2.76 2.78 2.72 2.87 
3 22.2 32.8 18.9 20.4 2.87 2.86 2.85 2.94 
4 23.1 31.5 20.9 22.3 2.96 2.85 2.95 3.06 
>=5 31.1 42.9 27.6 28.3 2.97 2.87 2.99 3.01 
Charlson comorbidity index        
0 13.2 12.0 12.0 12.7 1.84 1.83 1.85 1.82 
1 20.0 18.4 18.4 17.7 2.59 2.35 2.66 2.58 
2 25.6 22.2 22.2 27.0 3.39 3.21 3.33 3.77 
>=3 32.0 28.2 28.2 29.4 4.20 4.18 4.24 4.14 
Numbers of admission         
1 8.7 14.5 7.7 7.3     
2 16.2 25.6 14.0 15.0     
3 24.0 35.8 20.7 23.0     
4 31.0 45.1 27.2 29.5     
>=5 48.5 63.4 43.9 47.9     
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APPENDIX 4 
HOUSEHOLD EXPENDITURE 
 
A4.1 Sample selection, and sample and population estimations (Economic and 
Social Statistics Bureau 2007) 
Regarding the survey design as a stratified two-stage sampling indicated in Chapter Six, 
subsection 6.2.2, the 2,050 samples from 109,966 blocks and villages in Bangkok and 4 
regions over the country were independently selected. As a result that there was no 
exact information regarding which areas and households were expected to have 
decedents or newborn babies during the survey period, a new listing of private 
households in the enumeration was made for every block/village selected to serve as the 
sampling frame for the remaining parts of the survey. Owing to the need for a sufficient 
sample covering births and deaths, the private households in the sampling frame were 
classified in the second stage of sampling in accordance with the high to low 
probabilities of births and deaths of household members. Below are such three groups of 
households: 
? Group one: households with infants (age less than one year), or elderly (aged 80 
or above), or pregnant women; 
? Group two: households with children aged - 5 years, or younger elderly (aged 
60-79); and 
? Group three: households with older children and adults aged 6-59 years or 
unable to enumerate households, or vacant houses. 
Next, sequential selection was conditionally applied to households from group one to 
group three. That is group one was the main selection, followed by group two and three 
until there was a sufficient number of 30-50 households per block/village. 
Consequently, eighty two thousand out of the 354,678 households in 2,050 sample 
blocks/villages were included in the survey. All special households were also assigned 
to be samples. 
The samples of the survey could be inferential to the population by employing 
weighting factors. Two weighting factors were generated for inferences from individual 
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samples to population and from household samples to household population. Details of 
estimation for the weighting factor for individuals which were employed in the study 
are presented below. The weighting factor for households was used in the measuring of 
household living standards which was out of the scope of this study. 
Given that 
h = 1, 2, 3, 4, 5 (region) 
i = 1, 2 (area of municipality) 
j = 1, 2, 3,…, mhi  (block/village) 
k = 1, 2, 3 (household group), 
estimation of the total numbers of individuals with X characteristic of the ith area, hth 
region is: 
Y
y
x
X hi
hi
hi
hi 1
1
1
1ˆ ′
′= , 
where  
xxx hihihi ′′′ += 12111 ;  
yyy hihihi ′′′ += 12111 ; and 
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hijk
hi
m Nhi
11
1
3
1 1
1
11 ∑∑′ = ==  and yn
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1
3
1 1
1
11 ∑∑′ = ==  for private household 
xn
Nx hij
j hij
hij
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12
1 2
2
12 ∑′ ==   and ynNy hijj hijhijhi
m hi
12
1 2
2
12 ∑′ ==  for special household 
x hijk11  is total numbers of enumerated population with X characteristic in a private 
household of kth household group, jth block/village, ith area and hth region. 
x hij12  is total numbers of enumerated population with X characteristic in a special 
household of kth household group, jth block/village, ith area and hth region. 
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N hijk1  is total numbers of listing private households in kth household group, jth 
block/village, ith area and hth region. 
N hij2  is total numbers of listing members in special households in jth block/village, ith 
area and hth region. 
n hijk1  is total numbers of sample private households in kth household group, jth 
block/village, ith area and hth region. 
n hij2  is total numbers of sample members of special households in jth block/village, ith 
area and hth region. 
mhi  is numbers of sample blocks/villages in ith area and hth region.  
y hijk11  is total numbers of enumerated population from samples of private households in 
kth household group, jth block/village, ith area and hth region. 
y hij12  is total numbers of enumerated population from special households in j
th 
block/village, ith area and hth region. 
Y hi1  is total numbers of population estimated from Thai population in ith area and hth 
region. 
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A4.2 Summary of translated questionnaire in the 7th Survey of Population Change 
 
 
 
 
 
Confidential 
Logo of National Statistical Office 
The survey of Population change B.E.2548-2549 (A.D.2005-2006) 
 
Topics of the question in the questionnaire 
1. Geographic area of household and survey record, household type (private or 
special)  
2. Date of interview 
3. Interview summary table 
4. Part 1: General information of members of the household (order in rank starting 
with head of household) 
4.1. For all members: Title, name-surname, identify number from Identification 
Card, registered status in registration booklet, date of birth (date, month, 
year), age, gender, relationship to head of household (head, spouse, 
unmarried child, married child, child in law, grandchild, parent or parent in 
law, other relative, resident or servant, member in special household), 
residency status (permanent resident, temporary leave, temporary resident, 
temporary resident and leave, out migrant, death) 
4.2. For private household and persons age of 0 to 18 years old: parents’ 
residency status (absence, death, vanishing, unknown parents) 
4.3. For persons age of 6 years and over: education (highest year completed, 
none), period of educational or vocational study, literacy (able/unable, Thai, 
English, Chinese, Japanese, Malaysian-Yawi, others (identify)…) 
4.4. For persons age of 15 years and over (working during 12 months prior to 
date of interview): main occupation, type of the job, working status 
(employer, own account worker, unpaid family worker, government 
employee, state enterprise employee, private employee, cooperative group), 
income, i.e. net monetary income on monthly average and monetary value 
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A4.2 Summary of translated questionnaire in the 7th Survey of Population Change (cont.) 
 
 
4.5 For persons aged 13 and over:  
4.5.1 marital status (single, married or unmarried, widowed, divorced, 
separated, married with unknown status, priest 
4.5.2 For females:  
4.5.2.1   children (excluding adoption): total number, number of living, 
number of deceased 
4.5.2.2  For persons aged below 50: contraception (none, pills, 
emergency pills, injection, implantation, intrauterine device, 
condom, female sterilization, male sterilization, safe period, 
others (identify)…, not known) 
4.5.2.3  Pregnancy: no, yes (number of months, delivered, miscarriage) 
5. Part 2: Birth (2nd to 5th round), for newborn baby 
5.1 Residency: birth and living in household, birth but deceased, birth and 
migration/temporary resident and leave 
5.2 Place of delivery: public hospital, private hospital, health centre/ primary 
care unit, maternal and child health centre, midwifery centre /clinic, house, 
car/boat/ship, others (identify)… 
5.3 Birth certificate: received, have not received, have not registered 
5.4 Name-surname of father and mother of new born baby in the registration 
booklet: yes, no 
6. Part 3: Death (2nd to 5th round) 
6.1 Date of death 
6.2 Place of death: public hospital, private hospital, health centre/primary care 
unit, clinic, house, on the way, drowning, others (identify) 
6.3 Cause of death 
6.4 Death certification: received, have not received, have not registered 
6.5 Number of death certification 
6.6 Migration in-out 
7. Respondent: his/herself, proxy 
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A4.2 Summary of translated questionnaire in the 7th Survey of Population Change (cont.) 
 8. Part 4: Dwelling place and living condition and asset of private household (1st 
round) 
8.1 Materials used of dwelling unit: cement, wood, wood and cement/brick, 
non-permanent local materials, reused materials e.g. box, crate 
8.2 Tenure: land and house owner, house owner on rental land, house owner 
on public land, leasing, rent, paying rent by other, rent free 
8.3 Number of rooms: total rooms (except bathroom/shower room/rest 
room/toilet), bedrooms 
8.4 Electricity (including battery origin and other generators): have, no have 
8.5 Fuel for cooking: no cooking, charcoal, firewood, kerosene, gas, electrics, 
others (identify)… 
8.6 Toilet: flushing, latrine, flushing and latrine, pit/adapted bucket or others, 
no have 
8.7 Drinking water: bottled water, in-let piped water, in house well, external 
piped water, public well, river/stream/canal, rain, others (identify)… 
8.8 Water supply: bottled water, in-let piped water, in house well, external 
piped water, public well, river/stream/canal, rain, others (identify)… 
8.9 Waste elimination: rubbish service, burning, landfill, animal feeds, 
composting, disposing into river/canal, disposing on vacant/public land, others 
(identify)… 
8.10 Asset of household member (identify number of each ownership): 
wooden or metallic bed, gas cooker, electric cooker, microwave oven, electric 
kettle, refrigerator, electric iron, electric rice cooker, electric fan, radio, 
television, video/CD player, washing machine, air conditioner, bath water 
heater, computer, telephone (including PCT), mobile phone, facsimile, car, 
small truck/pickup truck/van, agricultural truck/machine, motorboat, 
motorcycle, bicycle 
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A4.3 Summary questions of the Survey on Healthcare Utilisation of and Household 
Expenditure for Decedents prior to Death in 2005-2006 
 
 
Confidential  
Logo of National Statistical Office, International Health Policy Program-
Thailand, and National Health Security Office 
Survey on Healthcare Utilisation of and Household Expenditure for Decedents 
Prior to Death between 2548-2549 B.E. (2005-2006 A.D.) 
Question topics  
1. Geographic information of household and survey record, household type (private 
or special) 
2. Demographic information of respondents and decedents referred to the SPC Part 1 
3. Interview date 
4. Interview summary table 
5. Cause of death (choices copied from SPC) 
6. Grouping cause of death (communicable, non-communicable, accident, suicide, 
homicide, others (please specify)…) 
7. Health insurance of the decedents, main and second (none, Civil Servant Medical 
Benefit Scheme, Social Security Scheme, Universal Coverage Scheme with 30 
Baht exemption, Universal Coverage Scheme 30 Baht co-payment, private, 
employer, others (please specify)…) 
8. Care (care giver in everyday life prior to death, excluded during illness: none, 
relative, maid, nurse/nurse assistant, neighbour, others (please specify)…) 
9. Part 1: Ambulatory care use during the three months prior to death 
a. Usage of ambulatory care (use or no use) 
b. Total amount of ambulatory care use and  health care costs incurred 
each health facility (traditional/herbal medicine, alternative medicine, self 
medication, health centre/primary care unit (PCU), district hospital, 
regional/general hospital, university hospital, other special hospital, private 
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A4.3 Summary questions of the Survey on Healthcare Utilisation of and Household 
Expenditure for Decedents prior to Death in 2005-2006 (cont.) 
 
 
 
c. Type of last ambulatory service used (traditional/herbal medicine, 
alternative medicine, self medication, health centre/primary care unit, district 
hospital, regional/general hospital, university hospital, other special hospital, 
private polyclinic/clinic, private hospital, others (please specify)…) 
d. Expenditure of last visit (household health care cost, travelling cost, 
other relevance cost e.g. lodging, unavailable drugs or medical supplies in the 
benefit packages) 
e. Utilisation of health insurance in last visit (none, CSMBS, SSS, UC, 
private, employer, no use) 
10. Part 2: Hospitalisation during six months prior to death 
a. having hospitalisation (use/no use) 
b. Total numbers of hospitalisations, total numbers of referral 
c. Numbers of hospitalisations and its expenditure for each type of 
health facility (district hospital, regional/general hospital, university hospital, 
other special care hospital, private polyclinic/clinic, private hospital, others 
(please specify)…) 
d. Type of last hospitalisation (district hospital, regional/general 
hospital, university hospital, other special hospital, private polyclinic/clinic, 
private hospital, others (please specify)…) 
e. Length of stay for last hospitalisation 
f. Household expenditure for last hospitalisation (health care cost, 
travelling costs, other relevance costs e.g. lodging, unavailable drugs or 
medical supplies in the benefit packages) 
g. Utilisation of health insurance in last hospitalisation (none, CSMBS, 
SSS, UC, private, employer, no use) 
h. Reasons for not using health facilities (monetary constraint, 
inconvenience of travelling, sudden death, patient’s preference, end stage of 
illness and preference of death at home, others (please specify)…) 
11. Respondents: care givers, other household members, non-household members 
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A4.4 2005-6 population living standards 
a) Measuring living standards by income 
In the SPC Part 1, all household members aged at least 15 reported their working status 
and were asked about their average monthly income and income received in in-kind for 
both working and/or investment during the past 12 months. By summing up all income 
for all members, the household income was generated. As a result of Deaton’s 
suggestion, household incomes were adjusted. After such adjustment, per capita 
monthly income was reallocated to household individual member and was ranked into 
quintiles. 
Notes: In Deaton’s recommendation, adults and children unequally demanded and 
shared household resources. In addition, economies of scale of households are affected 
by household consumptions/expenditure/income (Deaton 1997), that is, household size 
could be adjusted into adult equivalents (AE) by a formula: 
AE = (A + αK)θ 
where  
A is a number of adult;  
K is a number of child;  
α is the cost of children and  
θ reflects the degree of economies of scale 
Deaton A suggested that half of the cost of an adult is the cost of a child (Deaton 1997). 
The EQUITAP working group recommended setting the θ equals to 0.75 estimating 
from Indian and Pakistani data, that is, 0.72 and 0.87, respectivelybbb. 
                                                 
bbb The Indian and Pakistani data are estimated in Deaton Angus (1997). The analysis of household 
surveys, a microeconometric approach to development policy. Page 264. In addition, ‘Deaton and Zaidi 
(2002) propose values in the region of 0.3 to 0.5 for α and 0.75 to 1.0 for θ, given that food accounts for a 
large proportion of total consumption, and economies of scale are relatively limited.’ (O'Donnell, O., E. 
van Doorslaer, et al. (2008d). Chapter 6: Measurement of Living Standards. Analyzing health equity 
using household survey data: a guide to techniques and their implementation. O. O'Donnell, E. van 
Doorslaer, A. Wagstaff and M. Lindelow. Washington, D.C., The World Bank. 
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.  
b) Measuring living standards by household assets and characteristics 
Regarding the data in Part 4 of the SPC, the head of the household was interviewed 
about household housing and assets (details described in Part 4 of the SPC 
questionnaire, Appendix 4, A4.2). There were 7 questions with 43 choices in qualitative 
and 27 questions in quantitative indicators. To construct the asset index, the study 
applied Principal Component Analysis (PCA) technique (O'Donnell, van Doorslaer et 
al. 2008d) by SPSS15. Household characteristics were mostly in type of qualitative 
indicators, for example, the tenure of dwelling which has seven types, i.e. house and 
land ownership, house owner on rental land, house owner on public land, house and 
land leasing, house and land renting, renting paid by others, rent free. Such indicators 
were, therefore, re-categorized into simply binomial variables. For instance, tenure of 
dwelling was modified into dwelling ownership, i.e. the score was either 1 is ‘yes’ or 0 
is ‘no’. As a result, the variables were reduced from 72 to 35 variables, and PCA 
extracted such 35 variables into 8 components/factors and the first factor selected 
represents the highest linear combination of 27 variables. Those variables include 
number of televisions, mobile phones, electric fans, beds, telephones, washing 
machines, air conditioners, computers, refrigerators, bedrooms, water heaters, video 
players, microwaves, cars, rooms, electric irons, gas stoves, electric kettles, radios, 
electric pots, motorcycles, electronic stoves, small trucks and fax machines; 
accessibility to government available cooking fuel, rubbish elimination, accessibility to 
sanitized and in-house water supply. 
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Table A4.1 Example for the modification of qualitative asset indicators into binary 
dummy variable for PCA  
 Set of questions Modified binary dummy variables 
1st example Tenure of dwelling Household ownership 
 • House and land ownership 1 
 • House owner on rental land 0 
 • House owner on public land 0 
 • House and land leasing 0 
 • House and land renting 0 
 • Renting paying by sponsor 0 
 • Rent free 0 
2nd example Drinking water Accessibility to sanitary  and convenient drinking water 
 • Bottled water 1 
 • In house tap water 1 
 • In house well 1 
 • Village tap water  0 
 • Village well 0 
 • Stream/river 0 
 • Rain 0 
 
c) Correlation of the 2 measurements 
The population 64,633,529 (99.9 percent) and 62,000,045 (95.9 percent) out of 
64,675,145 provided data on income and household assets, respectively. That is, the 
study has 0.1 percent and 4.1 percent missing data. Table A4.2 shows the range of 
monthly income and factor score of asset index, numbers and percentages of population 
in each level of quintile. The Spearman correlation coefficient between both living 
standards was 0.40 with the significance level at p less than 0.01 percent (Table A4.3). 
It was indicated as a weak relationship in accordance with the findings in the correlation 
between living standards indices based on principal component analysis and 
consumption comment by O'Donnell et al (2008d). 
 357
Table A4.2 Population quintile classified by income per capita and household assets per 
capita 
Quintile Income Population % Factor scorea Population % 
1 0.0 to 1,294.1 12,890,894 19.9 -3.64 to -0.78 12,400,924 20.0 
2 1,294.6 to 2,473.5 12,961,581 20.1 -0.78 to -0.13 12,398,224 20.0 
3 2,473.6 to 3,983.8 12,928,100 20.0 -0.13 to 0.29 12,399,059 20.0 
4 3,984.1 to 6,848.7 12,935,880 20.0 0.29 to 0.73 12,401,763 20.0 
5 6,849.6 to 118,918.3 12,917,074 20.0 0.73 to 9.76 12,400,455 20.0 
Total  64,633,529 100.0  62,000,425 100.0 
a: the same figure showed in consecutive interval are different at more than 4 digits. 
 
Table A4.3 Correlation between population quintile by income and by household assets 
 Household asset index quintile Total 
Income 
quintile  1 2 3 4 5  
population 5,182,422.0 3,152,398.0 1,893,187.0 1,256,791.0 670,966.0 12,155,764.0 
1 
% 41.8 25.4 15.3 10.1 5.4 19.6 
population 3,655,654.0 2,935,414.0 2,485,149.0 1,950,025.0 1,570,368.0 12,596,610.0 
2 
% 29.5 23.7 20.1 15.7 12.7 20.3 
population 1,806,397.0 2,473,218.0 2,783,259.0 2,872,954.0 2,552,845.0 12,488,673.0 
3 
% 14.6 20.0 22.5 23.2 20.6 20.2 
population 1,029,104.0 1,921,041.0 2,627,967.0 3,254,558.0 3,600,268.0 12,432,938.0 
4 
% 8.3 15.5 21.2 26.3 29.0 20.1 
population 714,965.0 1,905,572.0 2,605,035.0 3,058,027.0 4,000,029.0 12,283,628.0 
5 
% 5.8 15.4 21.0 24.7 32.3 19.8 
population 12,388,542.0 12,387,643.0 12,394,597.0 12,392,355.0 12,394,476.0 61,957,613.0 
Total 
% 100.0 100.0 100.0 100.0 100.0 100.0 
 
Symmetric Measures 
  Value Asymp. Std. Error(a) Approx. T(b) Approx. Sig. 
Interval by Interval Pearson's R 0.40 0.00 3,400.2 0.000c 
Ordinal by Ordinal Spearman Correlation 0.40 0.00 3,401.5 0.000
c 
N of Valid Cases  61,957,613.0    
a Not assuming the null hypothesis. 
b Using the asymptotic standard error assuming the null hypothesis. 
c Based on normal approximation. 
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A4.5 Descriptive statistics 
Table A4.4 Mean (confident interval) lifespan of decedents categorised by gender, income 
quintile and health insurances 
Lifespan (yrs.) Mean (CI) 
All 62.7 (60.8, 64.6) 
Gender  
Male 58.0 (55.0, 60.9) 
Female 68.5 (66.5, 70.6) 
Income quintile  
Q1 66.9 (63.8, 69.9) 
Q2 66.8 (63.1, 70.5) 
Q3 56.2 (49.8, 62.7) 
Q4 57.6 (54.7, 60.6) 
Q5 60.7 (57.6, 63.8) 
Health insurances  
Uninsured 65.5 (59.9, 71.1) 
CSMBS 70.1 (67.9, 72.2) 
SPrEm 37.4 (32.4, 42.4) 
UCE 68.5 (65.0, 72.0) 
UCP 48.6 (46.3, 50.8) 
 
Table A4.5 Male and female age specific mortality rate 
Male  Female 
Age group 
Q1 Q2 Q3 Q4 Q5  Q1 Q2 Q3 Q4 Q5 
<5 0.49 0.04 0.95 0.36 0.16  0.07 0.05 0.04 0.06 0.07 
5 to <10 0.01 0.04 0.22 0.00 -  0.00 0.00 0.00 0.15 - 
10 to <20 0.22 0.04 0.21 0.18 0.10  0.01 0.00 0.01 0.00 0.01 
20 to <30 0.55 0.37 0.15 0.09 0.14  0.09 0.17 0.03 0.04 0.06 
30 to <40 0.43 0.31 0.31 0.31 0.05  0.17 0.15 0.56 0.08 0.01 
40 to <50 1.02 0.25 0.50 0.33 0.34  0.20 0.29 0.39 0.13 0.17 
50 to <60 0.64 1.14 1.09 1.39 0.54  0.46 0.42 0.17 0.10 0.73 
60 to <70 1.58 1.42 2.78 1.37 0.75  1.38 1.42 1.25 1.65 1.16 
70 to <75 2.93 6.64 4.71 3.04 2.30  3.67 1.91 2.28 1.95 2.13 
75 to <80 6.29 5.72 6.95 2.71 3.85  3.63 4.68 5.31 2.44 2.67 
>=80 8.45 14.54 6.73 6.97 11.66  8.26 11.58 7.98 8.89 7.20 
Total 1.06 0.76 0.79 0.51 0.34  0.85 0.60 0.50 0.29 0.34 
 359
 
Table A4.6 Age specific mortality rate by regions 
Bangkok: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 - - 0.1 0.2 0.3 
5 to <10 - - - - - 
10 to <20 - - 0.05 - 0.04 
20 to <30 - - 0.2 - 0.1 
30 to <40 - 0.9 0.3 0.1 0.05 
40 to <50 0.3 0.1 0.3 0.2 0.2 
50 to <60 0.5 0.7 1.5 0.3 0.7 
60 to <70 0.6 0.7 2.2 1.4 1.0 
70 to <75 1.2 1.8 5.5 3.1 1.3 
75 to <80 2.5 4.1 1.1 2.8 2.1 
>=80 6.2 8.1 4.9 5.4 7.2 
Total 0.6 0.5 0.6 0.3 0.3 
Central region: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.2 - 0.03 0.2 0.04 
5 to <10 0.1 - 0.03 0.2 - 
10 to <20 0.2 - 0.03 0.2 0.1 
20 to <30 0.1 0.3 0.1 0.1 0.1 
30 to <40 1.3 0.3 0.2 0.1 0.0 
40 to <50 0.3 0.2 0.2 0.1 0.3 
50 to <60 0.2 2.3 0.5 0.8 0.4 
60 to <70 2.3 3.0 1.1 1.0 0.5 
70 to <75 2.9 5.5 4.7 0.6 0.9 
75 to <80 3.2 4.9 4.5 3.5 3.7 
>=80 8.4 12.3 6.9 6.7 7.8 
Total 1.3 1.1 0.4 0.3 0.2 
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Table A4.6 Age specific mortality rate by regions (cont.) 
North: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.05 0.05 0.1 0.05 - 
5 to <10 - - - 0.1 - 
10 to <20 0.3 - 0.5 - 0.02 
20 to <30 0.5 0.7 0.1 - - 
30 to <40 0.3 0.1 1.2 0.6 0.04 
40 to <50 1.5 0.4 0.8 0.4 0.05 
50 to <60 0.8 0.9 1.0 0.4 0.4 
60 to <70 1.7 1.2 1.4 4.3 1.2 
70 to <75 5.3 1.0 3.0 3.5 0.6 
75 to <80 5.6 5.5 8.7 3.3 1.2 
>=80 10.0 14.7 8.9 9.2 7.2 
Total 1.6 0.8 1.0 0.6 0.2 
 
North-east 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.4 0.05 1.6 0.6 0.1 
5 to <10 - 0.03 0.3 - - 
10 to <20 0.1 0.1 0.02 0.01 0.02 
20 to <30 0.1 0.2 0.04 0.03 0.3 
30 to <40 0.2 0.2 0.3 0.3 0.03 
40 to <50 0.3 0.2 0.5 0.0 0.4 
50 to <60 0.3 0.4 0.5 0.1 1.1 
60 to <70 1.3 1.2 3.1 0.9 2.1 
70 to <75 2.7 6.8 2.9 5.2 7.1 
75 to <80 5.0 5.8 7.4 0.3 6.7 
>=80 7.2 13.7 7.7 15.6 6.9 
Total 0.6 0.6 0.8 0.3 0.6 
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Table A4.6 Age specific mortality rate by regions (cont.) 
South: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.1 0.1 0.1 0.03 0.1 
5 to <10 - 0.1 - - - 
10 to <20 - - - 0.1 - 
20 to <30 3.0 - 0.1 0.2 - 
30 to <40 0.1 0.2 0.3 0.1 0.0 
40 to <50 0.2 0.3 0.2 0.5 0.3 
50 to <60 2.3 0.2 0.1 2.2 0.5 
60 to <70 0.4 0.8 2.1 1.1 0.3 
70 to <75 2.6 1.4 2.0 0.8 2.9 
75 to <80 4.4 2.9 4.4 2.0 2.5 
>=80 9.3 7.5 7.5 5.8 18.3 
Total 1.5 0.4 0.4 0.5 0.3 
 
Table A4.7 Age specific mortality rate across income quintile by education levels 
No education: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.3 0.04 0.5 0.2 0.1 
5 to <10 - 0.1 - - - 
10 to <20 - - - - - 
20 to <30 0.6 - - - - 
30 to <40 0.8 0.1 0.1 1.1 - 
40 to <50 0.4 0.2 - - - 
50 to <60 0.3 1.1 0.7 0.3 0.5 
60 to <70 1.5 1.1 2.6 1.4 2.0 
70 to <75 3.4 3.0 3.6 3.5 1.1 
75 to <80 6.8 6.2 7.2 3.5 2.8 
>=80 9.0 14.4 7.9 8.2 14.2 
Total 1.6 1.2 1.1 0.7 0.8 
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Table A4.7 Age specific mortality rate across income quintile by education levels (cont.) 
Primary level: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 - - - - - 
5 to <10 0.01 0.02 0.2 0.1 - 
10 to <20 0.1 0.02 0.1 0.1 0.1 
20 to <30 0.7 - 0.1 0.1 0.3 
30 to <40 0.2 0.2 0.3 0.1 0.04 
40 to <50 0.5 0.3 0.5 0.2 0.1 
50 to <60 0.6 0.7 0.6 0.9 0.5 
60 to <70 1.6 1.2 2.0 1.6 1.0 
70 to <75 3.5 4.5 3.3 2.3 1.9 
75 to <80 4.1 4.8 5.8 2.3 3.4 
>=80 7.9 10.7 7.2 8.2 6.2 
Total 0.9 0.6 0.7 0.5 0.4 
 
Higher education: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 - - - - - 
5 to <10 - - - - - 
10 to <20 0.2 0.03 0.1 0.1 0.02 
20 to <30 0.1 0.4 0.1 0.1 0.1 
30 to <40 0.4 0.3 0.7 0.2 0.03 
40 to <50 1.1 0.2 0.2 0.3 0.3 
50 to <60 0.3 0.9 0.4 0.0 0.7 
60 to <70 0.6 5.0 0.8 0.7 0.7 
70 to <75 1.2 - 4.2 0.7 3.9 
75 to <80 5.2 - 2.1 1.0 2.4 
>=80 6.4 19.0 8.7 8.4 6.6 
Total 0.3 0.4 0.3 0.1 0.2 
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Table A4.8 Age specific mortality rate across income quintile categorised by 
occupation 
Economically inactive: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 0.3 0.04 0.5 0.2 0.1 
5 to <10 0.01 0.02 0.1 0.1 - 
10 to <20 0.1 0.01 0.1 0.1 0.1 
20 to <30 0.7 0.6 0.1 0.0 0.1 
30 to <40 1.2 0.9 2.2 0.2 - 
40 to <50 1.7 1.0 0.4 0.2 0.2 
50 to <60 1.3 1.4 0.6 0.5 1.9 
60 to <70 1.9 2.1 2.6 2.0 1.5 
70 to <75 3.5 5.6 5.0 2.5 2.8 
75 to <80 5.4 6.1 5.6 2.3 3.5 
>=80 8.7 13.3 7.8 8.5 8.7 
Total 1.4 1.0 0.9 0.5 0.6 
 
Professional: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 - - - - - 
5 to <10 - - - - - 
10 to <20 - - - - - 
20 to <30 - - 0.1 - - 
30 to <40 - - 0.1 0.1 - 
40 to <50 0.2 1.0 - 0.4 0.2 
50 to <60 0.1 0.1 1.1 1.3 0.5 
60 to <70 - 3.8 2.4 1.5 0.3 
70 to <75 - - 1.2 6.9 - 
75 to <80 - - 2.2 2.6 0.6 
>=80 2.1 3.3 2.3 2.8 9.3 
Total 0.1 0.9 0.6 0.5 0.2 
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Table A4.8 Age specific mortality rate across income quintile categorised by 
occupation (cont.) 
Others: 
Age group Q1 Q2 Q3 Q4 Q5 
<5 - - - - - 
5 to <10 - - - - - 
10 to <20 0.1 0.1 - - - 
20 to <30 0.04 0.1 0.1 0.1 0.1 
30 to <40 0.1 0.1 0.3 0.2 0.05 
40 to <50 0.4 0.2 0.5 0.2 0.3 
50 to <60 0.3 0.7 0.5 0.7 0.3 
60 to <70 1.0 0.8 1.6 1.2 0.5 
70 to <75 3.0 2.3 1.3 1.2 - 
75 to <80 0.1 1.2 7.8 4.1 0.9 
>=80 3.7 2.1 4.7 4.7 5.9 
Total 0.4 0.4 0.5 0.3 0.2 
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Table A4.9 Number of decedents and percentage of using care and of paying out of 
pocket categorised by various variables 
Ambulatory care Acute care 
Variables 
Decedents 
N (%) % users % payers* % users % payers* 
Total 382,933 58.6 65.6 57.0 42.2 
Death age (yrs.)      
<5 9,618 (2.5) 10.8 54.5 33.9 25.4 
5 to <10 2,004 (0.5) 13.1 33.8 8.7 0.0 
10 to <20 8,388 (2.2) 8.5 89.7 22.6 40.0 
20 to <30 11,614 (3.0) 49.2 81.4 49.7 83.0 
30 to <40 22,631 (5.9) 60.2 82.1 44.8 60.7 
40 to <50 36,952 (9.6) 58.5 74.4 57.3 67.0 
50 to <60 51,386 (13.4) 56.9 77.0 72.2 61.9 
60 to <70 59,112 (15.4) 68.4 54.5 62.6 40.4 
70 to <75 49,112 (12.8) 64.7 67.7 67.2 22.5 
75 to <80 45,589 (11.9) 67.7 61.7 64.8 24.4 
>=80 86,527 (22.6) 56.8 59.0 45.3 32.7 
Gender      
Male 211,904 (55.3) 54.6 66.0 58.4 43.8 
Female 171,030 (44.7) 63.5 65.3 55.2 40.1 
Region      
Bangkok 23,367 (6.1) 60.9 70.9 62.5 83.3 
Central 75,734 (19.8) 52.9 69.9 54.0 48.9 
North 106,448 (27.8) 62.1 55.3 59.9 43.2 
North-east 134,239 (35.1) 58.4 69.9 56.6 32.6 
South 43,145 (11.3) 59.3 69.8 53.4 33.0 
Municipality      
Urban 84,915 (22.2) 60.1 66.7 60.8 55.2 
Rural 298,018 (77.8) 58.2 65.4 55.9 38.2 
Head of household      
No 204,782 (53.5) 57.1 69.4 51.8 44.9 
Yes 178,151 (46.5) 60.4 61.6 63.0 39.6 
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Table A4.9 Number of decedents and percentage of using care and of paying out of 
pocket categorised by various variables (cont.) 
Ambulatory care Acute care 
Variables 
Decedents 
N (%) % users % payers* % users % payers* 
Education      
Uneducated 83,796 (21.9) 53.8 62.5 45.1 40.0 
Primary level 251,125 (65.6) 60.3 66.8 60.3 38.7 
Higher level 48,012 (12.5) 57.9 64.3 60.3 63.0 
Occupation      
Economically 
inactive 254,597 (66.5) 58.1 60.9 51.5 32.6 
Professionals 18,955 (4.9) 42.5 74.1 72.5 75.2 
Others 109,381 (28.6) 62.6 74.9 67.2 53.0 
Income quintile      
Q1 121,012 (31.7) 56.8 58.9 58.8 28.9 
Q2 86,549 (22.7) 61.5 74.6 56.4 45.4 
Q3 81,622 (21.4) 54.7 67.3 53.0 49.5 
Q4 51,186 (13.4) 58.5 72.3 62.0 48.5 
Q5 41,723 (10.9) 64.5 54.5 54.3 52.4 
Health insurances      
Uninsured 15,740 (4.1) 44.0 91.5 40.3 83.0 
CSMBS 52,582 (13.7) 66.7 36.3 67.7 30.8 
SPrEm 11,679 (3.0) 62.4 80.0 28.5 70.8 
UCE 207,180 (54.1) 60.1 58.7 56.5 17.4 
UCP 95,753 (25.0) 52.8 97.4 58.3 95.0 
Places of death      
Public hospitals 135,875 (36.9) 56.2 57.0 76.3 45.8 
Private hospitals 15,238 (4.1) 68.1 88.8 58.7 91.1 
Home 197,266 (53.6) 64.6 67.4 49.9 36.0 
Others 19,858 (5.4) 12.7 65.9 4.0 61.5 
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Table A4.9 Number of decedents and percentage of using care and of paying out of 
pocket categorised by various variables (cont.) 
Ambulatory care Acute care 
Variables 
Decedents 
N (%) % users %payers* %users %payers 
Causes of death      
Ill-defined 7,693 (2.0) 17.0 71.3 11.2 37.2 
Communicable ds. 56,071 (14.6) 66.9 58.4 75.9 43.2 
Non-communicable 
ds. 125,232 (32.7) 61.3 63.1 64.9 46.5 
Injuries 40,387 (10.5) 13.1 76.8 21.5 45.5 
Senility 89,641 (23.4) 56.4 64.8 36.3 23.8 
Cancer 63,909 (16.7) 82.7 74.1 82.0 45.6 
* As a percentage of users 
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Table A4.10 Distribution in percentage of decedents across income quintile by various variables 
 
Decedents 
(N = 387,128) 
Ambulatory care 
(N = 223,591; 57.8%) 
Acute care 
(N = 217,628; 56.2%) 
 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Total 121,865 87,489 82,780 51,670 43,324 68,792 53,234 44,673 29,964 26,929 71,158 48,799 43,279 31,731 22,662 
% Access      56.4 60.8 54.0 58.0 62.2 58.4 55.8 52.3 61.4 52.3 
Death age (yrs.)                
<5 2.0 0.5 5.5 3.4 1.5 12.5 21.0 4.2 23.7 6.2 58.5 9.8 13.6 35.2 88.0 
5 to <10 0.1 0.3 1.4 1.2  100.0 0.0 7.9 14.1  100.0 0.0 7.9 0.0  
10 to <20 2.4 0.7 2.9 3.2 2.1 2.6 0.0 2.8 22.4 21.5 39.7 0.0 6.4 24.4 21.5 
20 to <30 2.8 3.8 1.8 2.7 4.9 26.7 81.6 37.7 35.1 48.9 32.4 81.6 38.8 70.1 18.7 
30 to <40 3.6 4.7 10.8 8.5 1.9 79.9 57.3 60.4 50.3 19.2 62.5 48.3 19.0 77.8 37.0 
40 to <50 7.9 6.7 11.9 9.4 14.4 42.7 77.5 45.6 79.6 63.3 46.6 73.0 51.3 60.0 60.3 
50 to <60 6.5 13.7 11.2 23.0 26.1 44.3 57.4 55.0 60.3 58.7 86.5 79.8 63.0 75.8 52.0 
60 to <70 15.1 13.6 18.1 17.8 11.7 61.2 60.2 76.1 74.7 73.9 61.4 60.0 73.6 49.8 59.0 
70 to <75 16.2 15.6 10.4 8.5 7.8 58.8 68.0 67.0 63.2 65.1 71.1 58.7 72.7 68.0 51.6 
75 to <80 16.9 12.0 12.4 5.3 7.2 66.6 55.6 67.3 62.7 85.5 62.7 52.3 63.8 92.7 66.2 
>=80 26.7 28.5 13.7 16.9 22.5 60.8 57.7 41.7 45.7 64.8 46.6 38.3 48.1 48.8 49.0 
Gender                
male 51.9 54.4 59.8 62.8 48.9 53.0 56.9 53.5 55.5 50.0 55.4 63.1 53.3 67.8 48.7 
female 48.1 45.6 40.2 37.2 51.1 60.2 65.5 54.7 62.2 73.8 61.6 47.0 50.8 50.6 55.7 
Region                
Bangkok 1.8 1.5 5.5 8.8 25.3 39.9 50.7 64.9 62.9 62.6 64.4 87.6 56.4 63.6 59.8 
Central 13.7 23.5 17.7 27.6 25.1 54.1 53.6 60.3 38.9 52.4 45.1 56.5 71.0 46.4 44.0 
North 35.2 25.9 31.2 23.3 8.4 64.0 55.5 61.0 68.2 57.7 63.9 63.1 47.6 63.1 58.5 
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Table A4.10 Distribution in percentage of decedents across income quintile by various variables (cont.) 
 
Decedents 
(N = 387,128) 
Ambulatory care 
(N = 223,591; 57.8%) 
Acute care 
(N = 217,628; 56.2%) 
 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Region                
North-east 40.1 41.7 34.3 16.9 29.0 53.1 70.8 44.3 43.3 77.3 60.3 52.3 47.2 71.2 57.1 
South 9.3 7.5 11.3 23.4 12.2 49.3 48.6 48.8 79.1 48.3 47.3 40.9 49.4 69.4 38.0 
Municipality                
Urban 14.5 15.4 21.2 30.7 50.6 54.4 64.2 67.0 56.5 55.0 60.2 62.1 61.1 56.6 58.7 
Rural 85.5 84.6 78.8 69.3 49.4 56.8 60.2 50.5 58.6 69.5 58.1 54.6 49.9 63.5 45.8 
Head of 
household                
No 43.0 53.7 57.6 66.0 57.7 50.5 69.2 43.9 59.6 63.3 56.1 46.5 44.4 60.0 50.3 
Yes 57.0 46.4 42.4 34.0 42.3 61.0 51.2 67.6 54.9 60.6 60.1 66.5 63.0 64.2 55.1 
Education                
Uneducated 26.0 24.7 20.7 16.0 16.0 57.6 61.9 33.4 39.5 64.1 46.9 41.5 37.7 51.0 47.6 
Primary level 67.8 65.1 68.7 70.7 43.8 56.6 62.0 57.3 64.3 66.1 62.8 58.3 60.2 62.2 46.2 
Higher 6.2 10.2 10.7 13.3 40.2 49.5 50.7 72.4 46.7 57.1 58.2 74.2 29.3 69.7 60.8 
Occupation                
Economically 
inactive 82.5 68.6 56.1 46.7 63.3 54.4 62.4 53.3 51.7 67.4 56.8 46.4 43.2 48.0 52.9 
Professionals 0.2 4.1 4.1 10.6 14.3 100.0 25.1 66.8 16.9 59.3 62.4 74.6 66.5 76.5 71.6 
Others 17.3 27.3 39.8 42.8 22.4 65.7 62.3 53.5 75.0 49.1 66.1 76.4 63.6 72.3 38.4 
Places of death                
Public hospitals 31.9 30.6 40.0 45.8 50.2 52.1 56.6 50.2 56.0 66.0 80.0 81.7 70.4 72.0 68.0 
Private hospitals 1.2 3.3 6.1 3.3 11.0 36.7 12.4 92.9 73.1 82.7 46.2 80.0 13.1 91.0 87.1 
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Table A4.10 Distribution in percentage of decedents across income quintile by various variables (cont.) 
 
Decedents 
(N = 387,128) 
Ambulatory care 
(N = 223,591; 57.8%) 
Acute care 
(N = 217,628; 56.2%) 
 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Home 63.2 63.4 46.6 43.2 30.4 64.3 68.4 60.9 51.1 67.4 53.3 46.2 50.1 52.6 29.9 
Others 3.7 2.7 7.4 7.7 8.4 3.0 16.0 5.3 40.3 7.8 6.6 0.0 5.8 0.0 4.3 
Health 
insurances                
Uninsured 5.9 2.0 1.6 4.1 8.3 37.8 52.3 50.0 25.8 61.6 38.7 11.1 23.2 34.0 68.5 
CSMBS 14.6 5.5 5.9 13.6 43.8 66.2 71.3 55.6 51.2 74.9 67.7 54.2 73.7 68.8 69.3 
SPrEm 0.6 0.5 6.6 4.9 6.5 57.8 100.0 86.4 33.4 37.4 57.8 71.1 16.6 41.8 26.0 
UCE 64.6 62.0 53.2 44.5 21.6 55.5 63.7 57.1 70.9 64.7 60.5 50.0 58.8 63.5 34.3 
UCP 14.3 30.1 32.7 33.0 19.8 61.1 55.2 44.5 52.6 51.6 50.5 72.7 48.7 63.6 46.4 
Causes of death                
Ill-defined 1.6 3.1 3.0 1.8 4.7 26.2 7.7 14.5 12.8 4.9 17.9 6.6 10.9 0.0 2.6 
Communicable 
ds. 11.6 13.3 21.2 15.9 10.9 63.2 78.7 57.1 72.9 73.3 83.5 77.2 65.8 74.6 88.2 
Non-
communicable 
ds. 
34.6 31.5 31.4 33.7 31.9 56.7 57.5 68.1 56.4 69.5 66.2 69.8 59.1 65.9 52.5 
Injuries 8.5 7.5 13.6 12.1 13.7 0.2 40.5 3.5 19.2 14.3 26.9 31.3 15.3 12.5 22.2 
Senility 29.1 31.5 14.9 13.9 16.6 57.8 57.7 43.7 50.0 72.9 35.5 35.6 33.8 38.9 43.8 
Cancer 14.6 13.1 16.0 22.6 22.2 84.3 82.7 81.8 79.1 79.8 88.5 74.7 77.1 90.1 69.9 
Complementary 
med.                
No 73.7 72.8 63.5 63.3 80.8           
Yes 26.3 27.2 36.5 36.7 19.2           
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Table A4.11 Distribution in percentage of decedents and percentage of decedents accessing care across health insurances by various 
variables 
Decedents (N = 382,993) 
Ambulatory care 
(N = 224,389; 58.6%) 
Acute care 
(N = 218,269; 57.0%) Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
N 15,740 52,582 11,679 207,180 95,753 6,930 35,069 7,289 124,505 50,596 6,349 35,592 3,329 117,155 55,843 
% Access      44.0 66.7 62.4 60.1 52.8 40.3 67.7 28.5 56.5 58.3 
Death age 
(yrs.)                
<5 6.4 0.5  3.2 1.7 15.3 79.9  9.2 3.6 61.2 100.0  32.1 14.6 
5 to <10    1.0     13.1     8.7  
10 to <20 0.4 1.4 11.3 0.7 5.1 100.0  7.2 12.7 7.7  100.0 7.2 39.5 10.8 
20 to <30 1.4 0.1 13.8 1.5 6.9   52.8 27.0 60.8   45.4 22.5 65.8 
30 to <40 6.5 0.2 38.2 2.3 12.7 6.0  91.3 69.4 50.2 73.6 28.3 7.4 66.9 47.4 
40 to <50 9.0 8.8 23.8 3.7 21.3 55.3 86.8 40.5 56.2 55.7 33.5 88.6 34.0 46.2 59.2 
50 to <60 5.8 16.0 6.8 6.6 28.9 71.0 64.6 79.3 63.6 50.2 92.5 65.2 84.7 77.2 70.9 
60 to <70 16.5 13.6 5.7 16.8 14.5 38.5 43.4 76.8 76.9 65.2 39.4 64.6 82.6 62.1 66.4 
70 to <75 11.3 9.8  19.4 2.1 57.5 74.7  62.4 90.8 49.2 62.0  68.9 62.7 
75 to <80 12.4 17.2  15.5 2.6 63.7 74.1  66.1 67.6 26.4 75.2  66.7 32.9 
>=80 30.4 32.5 0.4 29.3 4.1 40.7 69.1  54.7 56.0 26.3 60.9  42.1 49.4 
Gender                
Male 51.3 55.5 50.8 49.5 69.1 47.3 66.1 32.8 59.1 45.3 42.4 67.4 34.6 60.2 55.9 
Female 48.7 44.5 49.2 50.5 30.9 40.6 67.4 93.0 61.0 69.6 38.2 68.1 22.2 53.0 63.6 
Region                
Bangkok 25.3 9.3 13.1 2.4 8.3 57.8 67.9 58.7 47.0 67.3 68.6 61.4 58.4 63.3 60.4 
Central 18.4 20.7 33.5 16.7 24.4 39.6 57.9 40.1 61.9 41.1 26.5 57.8 33.8 54.4 58.5 
North 23.8 24.2 42.3 28.2 27.8 45.2 69.8 88.5 64.0 51.6 48.3 83.6 10.3 59.8 59.6 
North-east 23.0 31.3 2.8 40.7 30.9 39.7 74.0 89.1 57.2 55.3 27.4 67.1 89.1 54.2 60.8 
South 9.6 14.5 8.3 12.0 8.6 23.6 57.5 16.4 61.0 67.2 3.7 60.7 32.6 58.6 42.5 
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Table A4.11 Distribution in percentage of decedents and percentage of decedents accessing care across health insurances by various 
variables (cont.) 
Decedents (N = 382,993) 
Ambulatory care 
(N = 224,389; 58.6%) 
Acute care 
(N = 218,269; 57.0%) Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SprEm UCE UCP Uninsured CSMBS SprEm UCE UCP 
Municipality                
Urban 45.1 35.3 37.3 14.8 25.3 54.0 62.4 35.8 60.9 63.6 57.9 69.4 40.7 61.0 58.2 
Rural 54.9 64.7 62.7 85.2 74.7 35.8 69.1 78.2 60.0 49.2 25.9 66.8 21.2 55.8 58.4 
Head of 
household                
No 64.2 45.4 75.6 51.6 57.5 37.8 62.9 68.8 59.1 52.2 36.0 68.1 23.4 49.0 57.5 
Yes 35.8 54.6 24.4 48.4 42.5 55.2 69.8 42.7 61.2 53.7 48.1 67.3 44.3 64.6 59.4 
Education                
uneducated 39.9 11.7 0.7 28.8 12.1 31.8 79.0 100.0 52.6 58.1 41.6 56.2 100.0 44.0 46.5 
Primary level 47.1 60.5 28.6 68.4 69.9 53.3 62.6 43.3 63.6 54.0 33.6 64.7 44.8 62.1 58.4 
Higher 13.0 27.7 70.7 2.8 18.1 48.1 70.3 69.8 52.7 44.7 61.0 79.1 21.3 51.4 66.0 
Occupation                
Economically 
inactive 78.2 80.9 53.5 77.8 33.7 42.3 66.8 78.3 56.2 57.9 37.8 66.4 18.0 50.9 46.3 
Professionals 6.9 8.0 9.2 2.0 8.8 71.8 71.0 11.1 44.7 27.6 87.3 76.7 25.2 59.0 81.2 
Others 14.9 11.1 37.3 20.2 57.5 40.2 62.7 52.3 76.6 53.8 32.1 70.7 44.4 78.0 61.9 
Income 
quintile                
Q1 45.5 33.7 5.9 37.8 18.2 37.8 66.2 57.8 55.5 61.1 38.7 67.7 57.8 60.5 50.5 
Q2 10.8 9.1 3.5 25.9 27.4 52.3 71.3 100.0 63.7 55.2 11.1 54.2 71.1 50.0 72.7 
Q3 8.5 9.2 45.9 21.0 28.0 50.0 55.6 86.4 57.1 44.5 23.2 73.7 16.6 58.8 48.7 
Q4 13.3 13.2 21.4 11.0 17.8 25.8 51.2 33.4 70.9 52.6 34.0 68.8 41.8 63.5 63.6 
Q5 22.0 34.8 23.4 4.3 8.7 61.6 74.9 37.4 64.7 51.6 68.5 69.3 26.0 34.3 46.4 
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Table A4.11 Distribution in percentage of decedents and percentage of decedents accessing care across health insurances by various 
variables (cont.) 
Decedents (N = 382,993) 
Ambulatory care 
(N = 224,389; 58.6%) 
Acute care 
(N = 218,269; 57.0%) Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
Places of death                
Public hospitals 16.0 51.0 25.5 32.6 43.0 43.6 67.0 35.2 55.2 52.7 49.5 80.9 38.4 75.6 78.5 
Private 
hospitals 14.1 3.1 43.3 1.2 4.8 58.3 72.0 93.6 53.0 51.8 81.8 59.3 16.7 70.6 86.5 
Home 69.0 42.3 15.3 63.0 41.5 42.8 69.8 89.1 65.0 65.3 31.1 57.3 72.6 48.5 54.5 
Others 0.9 3.6 16.0 3.2 10.7  24.8 18.2 3.2 15.7  6.1 13.9 4.8 1.3 
Causes of death                
Ill-defined 4.7 1.9 0.4 0.9 4.2 19.7 19.1  39.4 5.8  21.4  17.3 8.0 
Communicable 
ds. 20.2 12.0 7.2 15.5 14.2 47.5 84.7 93.4 65.7 64.5 79.8 90.6 80.8 69.4 83.4 
Non-
communicable 
ds. 
22.9 35.3 47.1 29.1 38.9 54.1 74.0 93.2 60.0 53.2 44.5 76.1 13.9 65.3 68.1 
Injuries 8.9 9.7 28.3 5.9 19.2 58.4 1.5  14.7 14.1 21.7 28.1 7.6 32.4 14.9 
Senility 33.9 21.7 0.4 33.1 4.5 24.0 73.7  55.3 68.9 9.8 54.1  35.4 36.5 
Cancer 9.4 19.3 16.6 15.5 19.0 83.1 71.9 71.0 83.2 89.2 93.6 78.0 84.1 83.9 79.7 
Complementary 
med.                
No 79.8 86.4 27.9 66.6 74.9           
Yes 20.2 13.6 72.2 33.4 25.1           
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Table A4.12 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across income quintile by various variables 
Ambulatory care (N = 387,128) Acute care (N = 387,128) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Average 3.5 4.6 7.6 4.6 3.8 1.8 1.9 1.6 1.7 1.3 
Death age (yrs.)           
<5 0.4 0.7 0.2 1.0 0.2 3.1 0.3 0.3 0.4 1.2 
5 to <10 4.0  0.2 0.4  7.0  0.1   
10 to <20 0.1  0.1 1.0 2.2 0.4  0.1 0.5 1.3 
20 to <30 0.7 34.4 5.0 1.3 3.6 0.8 0.0 0.8 1.6 0.6 
30 to <40 5.3 2.5 43.2 3.1 0.6 1.1 0.0 0.5 3.5 0.7 
40 to <50 1.4 4.9 3.9 4.2 2.1 1.8 8.6 0.7 2.0 1.1 
50 to <60 2.3 3.3 2.3 10.6 4.6 2.6 1.7 1.4 2.2 1.0 
60 to <70 4.2 3.3 5.9 2.7 3.9 2.8 1.5 3.2 1.0 2.2 
70 to <75 5.3 5.8 3.8 3.7 6.3 2.2 3.5 3.0 1.7 2.1 
75 to <80 4.1 2.2 3.0 2.7 4.7 1.4 1.2 1.6 2.2 1.2 
>=80 3.3 2.7 1.7 2.9 3.5 1.3 1.6 1.0 1.1 1.3 
Gender           
male 2.8 5.7 2.9 5.5 3.3 1.7 2.6 1.7 2.0 1.4 
female 4.3 3.3 14.9 3.0 4.2 1.9 1.0 1.4 1.1 1.2 
Region           
Bangkok 2.2 3.5 3.6 3.2 5.1 2.1 1.8 1.1 1.3 1.7 
Central 4.3 3.6 3.4 2.5 3.3 1.9 2.3 2.3 1.4 1.1 
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Table A4.12 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across income quintile by various variables (cont.) 
Ambulatory care (N = 387,128) Acute care (N = 387,128) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
North 3.3 6.6 17.9 3.9 2.3 1.6 2.8 1.3 1.6 1.9 
North-east 3.4 4.5 2.4 2.6 3.8 2.2 1.3 1.4 2.7 1.1 
South 4.3 1.9 3.3 9.5 2.8 0.7 0.9 1.9 1.7 0.8 
Municipality           
Urban 3.0 6.9 2.9 3.0 4.1 1.9 2.5 1.5 1.3 1.8 
Rural 3.6 4.2 8.9 5.3 3.4 1.8 1.8 1.6 1.9 0.8 
Head of household           
No 3.4 6.3 10.5 5.2 3.3 1.7 1.5 1.1 1.7 1.3 
Yes 3.6 2.7 3.8 3.4 4.4 1.8 2.3 2.2 1.6 1.2 
Education           
Uneducated 3.5 2.6 2.5 2.4 2.2 1.1 1.3 1.2 0.9 1.0 
Primary level 3.5 3.8 3.3 5.2 3.8 2.0 1.7 1.8 1.6 1.4 
Higher 3.4 14.7 44.6 3.7 4.4 2.9 4.6 0.5 3.2 1.2 
Occupation           
Economically 
inactive 3.3 5.1 11.0 2.7 3.9 1.5 1.8 1.6 1.2 1.4 
Professionals 2.6 1.4 2.9 1.1 4.7 3.3 2.2 1.6 1.8 1.3 
Others 4.5 3.8 3.5 7.6 2.7 3.1 2.0 1.5 2.3 0.8 
Places of death           
Public hospitals 2.3 3.3 2.4 2.2 3.5 2.2 2.6 1.8 1.6 1.4 
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Table A4.12 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across income quintile by various variables (cont.) 
Ambulatory care (N = 387,128) Acute care (N = 387,128) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Private hospitals 2.9 0.7 77.6 4.7 7.5 1.2 2.4 0.4 2.0 2.3 
Home 4.5 5.8 4.2 3.5 3.5 1.8 1.7 1.8 1.9 1.1 
Others 0.1 0.2 0.4 0.7 0.2 0.2  0.2  0.1 
Health insurances           
Uninsured 1.6 7.4 1.8 0.7 9.3 1.5 0.2 0.3 0.5 1.3 
CSMBS 2.9 3.8 2.3 2.1 3.8 1.9 1.2 2.7 1.9 1.5 
SPrEm 5.8 1.8 71.8 5.7 2.3 8.1 0.9 0.3 2.6 1.3 
UCE 3.6 3.5 2.8 7.0 2.9 1.8 1.2 1.7 1.5 1.1 
UCP 4.3 7.0 3.8 2.6 2.9 1.7 3.5 1.4 2.0 1.1 
Causes of death           
Ill-defined 0.8 0.2 1.4 0.7 0.2 0.6 0.1 0.1 0.0 0.2 
Communicable ds. 3.2 3.0 2.5 3.7 3.1 2.8 2.3 1.7 2.7 1.5 
Non-communicable 
ds. 3.7 3.6 18.5 2.3 4.1 1.9 2.4 1.6 1.5 1.5 
Injuries  8.1 0.1 0.2 0.2 0.3 0.5 0.2 0.3 0.4 
Senility 3.3 2.1 1.2 2.7 2.7 0.8 1.0 0.8 0.7 0.9 
Cancer 6.1 13.4 7.6 12.2 7.2 3.7 3.5 3.6 2.7 1.9 
Complementary med.           
No 5.0 6.0 6.0 4.0 5.2      
Yes 9.5 11.5 11.5 14.4 8.6      
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Table A4.13 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across health insurances by various variables 
Ambulatory care (N = 382,993) Acute care (N = 382,993) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
Average 3.8 3.1 35.1 3.8 4.6 1.1 1.8 1.5 1.6 2.1 
Death age (yrs.)           
<5 0.6 2.4  0.4 0.1 0.6 1.0  1.4 0.2 
5 to <10    0.4     0.3  
10 to <20 3.0 0 0.6 0.8 0.3 0 1.0 0.2 1.0 0.2 
20 to <30 0 0 5.1 0.7 18.9 0 0 1.8 0.5 4.8 
30 to <40 0.1 0 85.0 3.5 3.1 1.5 0.8 0.1 1.3 2.0 
40 to <50 4.2 2.4 5.5 1.3 4.3 0.5 2.6 2.5 0.8 1.4 
50 to <60 8.0 4.5 3.7 8.7 3.0 6.3 1.7 1.4 1.8 2.3 
60 to <70 2.9 2.2 6.1 4.2 5.1 0.4 2.7 8.9 2.0 2.7 
70 to <75 6.5 1.9  5.3 6.7 1.8 1.3  2.2 2.8 
75 to <80 4.4 3.7  3.2 3.9 0.7 1.5  1.6 1.8 
>=80 3.8 3.2 0 2.7 2.6 0.6 1.5 0 1.1 1.2 
Gender           
Male 4.5 2.7 3.6 3.9 4.5 1.3 1.8 2.2 1.7 2.3 
Female 3.1 3.6 67.7 3.7 4.7 0.9 1.7 0.8 1.4 1.7 
Region           
Bangkok 7.5 2.5 4.4 2.6 4.2 1.2 1.2 2.5 2.0 1.5 
Central 1.5 3.0 3.3 4.2 2.9 0.6 1.4 2.1 1.5 2.9 
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Table A4.13 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across health insurances by various variables (cont.) 
Ambulatory care (N = 382,993) Acute care (N = 382,993) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
North 2.8 3.1 78.8 3.0 7.1 1.2 3.0 0.9 1.5 2.1 
North-east 3.6 3.6 1.9 3.3 4.2 1.7 1.5 1.1 1.7 2.0 
South 1.5 2.7 1.0 6.7 3.3 0.1 1.2 0.7 1.5 0.8 
Municipality           
Urban 5.5 3.4 2.3 4.0 3.7 1.0 1.9 1.4 1.6 2.2 
Rural 2.4 3.0 54.6 3.7 4.9 1.1 1.7 1.6 1.6 2.1 
Head of household           
No 3.5 3.0 45.3 4.2 5.0 0.6 1.8 1.2 1.3 2.1 
Yes 4.3 3.2 3.6 3.3 4.0 1.9 1.7 2.6 1.9 2.2 
Education           
Uneducated 1.3 2.7 4.0 3.0 3.3 0.8 1.0 1.0 1.2 0.9 
Primary 4.3 2.8 2.3 4.1 3.8 1.4 1.9 0.9 1.7 2.0 
Higher 9.8 3.9 48.7 2.9 8.6 0.9 1.9 1.8 1.0 3.4 
Occupation           
Economically inactive 3.8 3.0 61.8 3.1 7.2 0.8 1.7 0.5 1.4 2.8 
Professionals 6.2 4.3 0.9 2.2 1.9 1.2 1.1 1.9 1.6 2.1 
Others 2.9 2.9 5.4 6.4 3.5 2.4 2.5 2.9 2.3 1.7 
Income quintile           
Q1 1.6 2.9 5.8 3.6 4.3 1.5 1.9 8.1 1.8 1.7 
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Table A4.13 Means of numbers of visits for ambulatory care in 3 months and means of numbers of hospitalisations for acute care in 6 
months prior to death across health insurances by various variables (cont.) 
Ambulatory care (N = 382,993) Acute care (N = 382,993) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
Q2 7.4 3.8 1.8 3.5 7.0 0.2 1.2 0.9 1.2 3.5 
Q3 1.8 2.3 71.8 2.8 3.8 0.3 2.7 0.3 1.7 1.4 
Q4 0.7 2.1 5.7 7.0 2.6 0.5 1.9 2.6 1.5 2.0 
Q5 9.3 3.8 2.3 2.9 2.9 1.3 1.5 1.3 1.1 1.1 
Places of death           
Public hospitals 1.1 3.2 2.3 2.5 2.8 0.9 2.1 1.2 1.8 2.3 
Private hospitals 8.6 2.6 81.3 2.8 3.6 1.2 1.0 0.5 2.6 2.6 
Home 3.7 2.9 9.5 4.1 7.9 1.2 1.6 7.0 1.4 2.7 
Others 0 1.0 0.5 0.3 0.2 0 0.1 0.1 0.2 0 
Causes of death           
Ill-defined 0.4 0.5 0 1.4 0.6 0 0.7 0 0.4 0.1 
Communicable ds. 2.7 2.6 10.3 2.9 3.1 1.8 2.8 2.6 1.9 2.7 
Non-communicable ds. 6.3 3.2 70.1 3.7 3.3 0.7 1.8 0.3 1.8 2.3 
Injuries 4.6 0 0 2.7 0.9 0.4 0.6 0.1 0.4 0.2 
Senility 1.4 3.0 0 2.6 2.0 0.3 1.0 0 0.9 0.8 
Cancer 9.8 5.4 8.5 7.8 13.6 4.7 2.5 6.9 2.8 3.9 
Complementary med.           
No 6.5 4.2 7.3 4.5 7.5      
Yes 17.6 8.1 75.2 9.9 12.4      
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Table A4.14 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across income quintile by various variables 
Ambulatory care (N = 223,591) Acute care (N = 217,628) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Average 2,857 3,617 3,399 1,997 8,899 8,510 6,533 21,001 12,357 53,521 
Death age (yrs.)           
<5 0 270 742 2,489 5,000 1 0 1,548 3,011 39,459 
5 to <10 0  0 3,620  0  0   
10 to <20 0  3,000 129 68,046 0  5,000 1,281 240,412 
20 to <30 36 26,316 3,676 1,872 4,188 53,298 18,418 10,711 2,719 3,009 
30 to <40 2,903 859 6,956 135 217 2,908 2,601 2,585 5,844 43,213 
40 to <50 664 1,389 2,878 814 12,292 960 28 242 2,821 9,933 
50 to <60 16,150 7,073 773 2,922 5,189 10,729 1,876 7,973 27,499 32,194 
60 to <70 4,324 1,778 5,666 1,880 13,490 7,859 6,235 2,331 2,465 139,360 
70 to <75 1,693 1,179 2,730 3,130 11,402 6,191 1,620 3,160 24,627 40,373 
75 to <80 1,660 1,148 1,333 845 2,520 9,754 12,589 113,102 1,665 9,786 
>=80 1,826 2,305 1,167 2,525 8,937 10,614 12,420 11,544 5,140 82,730 
Gender           
Male 3,787 6,034 1,323 2,362 10,162 11,459 6,226 31,822 14,746 62,631 
Female 1,973 1,106 6,421 1,449 8,080 5,643 7,025 4,096 6,959 45,897 
Region           
Bangkok 5,037 3,779 7,319 6,535 22,879 123,731 53,271 17,686 71,847 153,226 
Central 3,993 1,901 1,132 2,158 3,220 13,415 4,486 71,805 4,896 10,415 
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Table A4.14 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across income quintile by various variables (cont.) 
Ambulatory care (N = 223,591) Acute care (N = 217,628) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
North 1,431 7,875 4,028 713 3,872 4,904 13,339 5,491 11,229 48,622 
North-east 4,106 2,334 3,899 1,360 5,183 5,671 218 1,360 744 5,971 
South 1,878 3,077 1,711 1,906 2,236 4,603 3,846 6,538 7,465 5,982 
Municipality           
Urban 1,570 2,034 2,759 4,863 14,159 24,234 10,693 6,989 30,914 81,693 
Rural 3,066 3,924 3,628 771 4,639 5,749 5,671 25,619 5,017 16,534 
Head of household           
No 1,432 3,288 4,277 1,177 7,271 6,471 3,380 5,831 7,942 59,184 
Yes 3,747 4,131 2,625 3,729 11,218 9,945 9,085 35,493 20,371 46,469 
Education           
Uneducated 822 738 1,590 2,752 7,033 5,440 9,572 7,896 54,622 29,833 
Primary level 3,749 3,000 3,091 1,935 6,563 4,245 2,449 24,241 4,776 55,291 
Higher 1,622 16,952 6,588 1,686 12,679 69,405 22,947 10,739 11,159 59,409 
Occupation           
Economically inactive 2,134 3,706 2,742 2,529 7,890 7,931 9,439 40,847 22,572 68,044 
Professionals 4,957 369 9,555 7,224 21,823 554 14,489 3,789 7,596 40,236 
Others 5,673 3,590 3,530 1,304 2,849 10,990 923 3,908 6,198 12,844 
Places of death           
Public hospitals 1,779 1,470 1,057 1,217 4,287 6,317 4,330 36,768 19,572 13,585 
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Table A4.14 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across income quintile by various variables (cont.) 
Ambulatory care (N = 223,591) Acute care (N = 217,628) 
Variables 
Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5 
Private hospitals 9,965 8,483 8,952 11,743 32,470 166,871 45,214 34,501 20,249 180,377 
Home 3,268 4,511 4,021 2,215 6,469 7,924 4,921 1,951 6,546 76,740 
Others 90 23 0 48 2,443 27  8,329  2,246 
Health insurances           
Uninsured 21,307 4,517 30,074 16,005 44,676 64,681 0 8,294 41,326 281,232 
CSMBS 1,665 1,842 1,244 3,272 5,724 11,394 5,923 5,433 11,921 24,645 
SPrEm 0 335 8,047 4,499 6,281 200,000 289 11,298 5,625 70,029 
UCE 1,806 1,622 2,656 1,033 4,000 2,261 7,119 31,874 14,964 44,125 
UCP 3,881 8,815 2,131 2,156 8,506 11,834 5,945 4,865 7,776 12,710 
Causes of death           
Ill-defined 179 120 1,060 2,789 55,699 0 30 185  0 
Communicable ds. 1,704 3,135 1,061 820 20,559 11,562 8,331 65,509 28,023 50,096 
Non-communicable ds. 2,179 1,940 6,077 3,124 7,781 5,805 3,389 2,335 7,810 63,409 
Injuries 1,420 1,849 1,023 28 1,147 3,211 32 25,248 3,111 35,309 
Senility 1,106 579 750 1,665 3,332 1,339 11,120 8,199 4,465 10,705 
Cancer 7,110 12,545 2,664 1,937 9,062 17,893 8,126 3,941 10,971 69,072 
Complementary med.           
No 2,972 4,238 2,935 1,887 9,084      
Yes 2,550 1,980 4,208 2,194 7,903      
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Table A4.15 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across health insurances by various variables 
Ambulatory care (N = 224,389) Acute care (N = 218,269) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
Death age (yrs.) 26,776 3,397 6,530 1,925 4,988 138,209 15,185 43,584 12,496 7,422 
<5 0 3,500  555 5,346 36,483 0  897 1,745 
5 to <10    1,225     0  
10 to <20 3,000  33,525 58,144 129  684 67,989 74,910 1,503 
20 to <30   4,528 1,393 18,528   11,289 0 25,371 
30 to <40 3,000  9,121 263 1,952 661 12,000 3,964 0 8,338 
40 to <50 10,788 10,803 2,673 90 1,981 6,235 7,115 6,762 18 1,326 
50 to <60 93,082 1,824 673 1,134 6,038 182,805 14,753 39,049 16,707 7,005 
60 to <70 59,066 5,667 0 2,939 3,779 251,263 35,805 174,687 722 5,791 
70 to <75 16,506 990  1,647 9,764 132,416 12,828  3,404 9,843 
75 to <80 1,198 659  1,750 2,242 98,504 12,523  38,378 1,699 
>=80 19,981 3,344  1,793 1,535 218,189 13,306  12,237 17,650 
Gender           
Male 25,646 2,811 2,569 1,796 6,993 110,807 19,723 57,013 18,980 9,315 
Female 28,159 4,112 7,971 2,048 2,071 170,264 9,594 22,043 5,278 3,701 
Region           
Bangkok 50,722 8,043 1,425 10,696 6,456 262,804 99,329 10,858 120,421 19,100 
Central 4,814 1,344 2,625 2,203 3,308 28,203 1,621 84,184 39,814 6,474 
North 3,179 1,005 9,574 1,166 8,446 39,815 14,220 43,911 6,561 6,748 
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Table A4.15 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across health insurances by various variables (cont.) 
Ambulatory care (N = 224,389) Acute care (N = 218,269) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
North-east 36,665 5,228 471 2,045 3,679 65,764 4,269 289 1,043 4,463 
South 15,055 2,584 1,183 1,666 1,777 37,605 7,262 4,818 3,846 13,282 
Municipality           
Urban 33,151 3,841 2,977 2,236 3,981 179,870 30,833 18,947 24,669 8,377 
Rural 18,860 3,178 7,495 1,870 5,429 61,472 6,327 71,671 10,176 7,100 
Head of household           
No 16,328 2,656 7,607 1,754 4,102 115,040 15,561 22,140 5,784 8,721 
Yes 39,614 3,952 1,149 2,102 6,152 169,362 14,869 78,760 17,932 5,723 
Education           
Uneducated 6,383 1,472 3,540 904 3,808 32,272 11,190 0 14,827 6,204 
Primary level 26,836 2,624 1,096 2,317 4,026 84,124 14,004 32,485 11,540 4,324 
Higher 67,888 5,814 7,936 884 10,501 467,409 18,493 54,924 20,131 18,571 
Occupation           
Economically inactive 17,125 2,042 8,613 1,930 7,298 149,329 15,020 28,444 17,581 12,585 
Professionals 55,525 17,599 0 886 5,541 124,665 14,398 76,623 805 10,278 
Others 56,467 2,332 2,406 1,971 3,484 86,526 16,918 47,724 558 4,580 
Income quintile           
Q1 21,307 1,665 0 1,806 3,881 64,681 11,394 200,000 2,261 11,834 
Q2 4,517 1,842 335 1,622 8,815 0 5,923 289 7,119 5,945 
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Table A4.15 Means of household expenditure for ambulatory care in 3 months and means of household expenditure for acute care in 6 
months prior to death among decedents accessing care across health insurances by various variables (cont.) 
Ambulatory care (N = 224,389) Acute care (N = 218,269) 
Variables 
Uninsured CSMBS SPrEm UCE UCP Uninsured CSMBS SPrEm UCE UCP 
Q3 30,074 1,244 8,047 2,656 2,131 8,294 5,433 11,298 31,874 4,865 
Q4 16,005 3,272 4,499 1,033 2,156 41,326 11,921 5,625 14,964 7,776 
Q5 44,676 5,724 6,281 4,000 8,506 281,232 24,645 70,029 44,125 12,710 
Places of death           
Public hospitals 3,452 3,520 4,251 1,295 1,484 58,608 11,596 26,622 21,898 6,337 
Private hospitals 56,668 18,856 9,324 16,904 13,410 253,985 225,842 36,090 126,290 21,979 
Home 24,482 2,160 1,254 2,036 7,560 109,074 5,954 69,758 3,023 6,556 
Others  1,427 0 230 35  3,000 12,000 0 60 
Causes of death           
Ill-defined 1,971 28,144  514 1,345  0  0 173 
Communicable ds. 7,096 11,548 1,783 1,783 2,188 38,762 28,770 12,917 45,214 5,892 
Non-communicable ds. 33,298 1,410 8,494 2,497 3,904 176,076 15,836 9,642 4,435 4,918 
Injuries 778 8,229  1,740 761 3,772 20,136 78,744 2,408 15,236 
Senility 7,943 1,988  765 1,153 64,965 2,981  6,265 1,479 
Cancer 80,334 2,061 1,936 2,960 9,248 333,290 13,240 66,724 4,432 12,316 
Complementary med.           
No 30,894 3,413 684 2,056 4,923      
Yes 12,190 2,867 8,786 1,664 5,246      
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Figure A4.1 Pattern of health care use at health facilities among different regions and causes of death 
A: Use of ambulatory care at health facilities by regions 
Pattern of ambulatory care use at health facilities by regions
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B: Use of acute care at health facilities by regions 
Pattern of acute care use at health facilities by regions
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C: Use of ambulatory care at health facilities by causes of death 
Pattern of ambulatory care use at health facilities by causes of death
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D: Use of acute care at health facilities by causes of death 
Pattern of acute care use at health facilities by causes of death
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A4.6 Multivariate analysis for ambulatory visits; hospitalisations; and household expenditure 
Figure A4.2 Histogram of ambulatory visits and expenditure on raw scale and natural log scale (excluding zero) 
A: Numbers of visits (raw scale) 
 
Skewness = 5.3919; Kurtosis = 46.2025 
 
 
B: Expenditure for ambulatory visits (raw scale) 
 
Skewness = 4.4079; Kurtosis = 23.1376 
C: Expenditure for ambulatory visits (natural log scale) 
 
Skewness = 0.1130; Kurtosis = 2.5899 
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Figure A4.3 Histogram of hospitalisations and expenditure on raw scale and natural log scale (excluding zero) 
A: Numbers of hospitalisation (raw scale) 
 
Skewness = 5.5920; Kurtosis = 55.6194 
 
B: Expenditure for hospitalisations (raw scale) 
 
Skewness = 5.0961; Kurtosis = 30.2511 
C: Expenditure for hospitalisations (natural log scale) 
 
Skewness = -0.0507; Kurtosis = 2.0261 
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Table A4.16 Correlation matrix of all variables 
 Having op visit 
No. of 
visits 
Having 
hospitalisation 
No. of 
hospitalisation 
Having OP 
expense OP expense 
Having IP 
expense 
IP 
expense Regions 
Having OP visit 1         
No. of visits .** 1        
Having hospitalisation 0.22** 0.07** 1       
No. of hospitalisation 0.08** 0.17** .** 1      
Having OP expense .** 0.20** -0.01 0.05 1     
OP expense .** 0.27** 0.0671 0.20** .** 1    
Having IP expense -0.03 0.09* .** 0.08** 0.42** 0.16** 1   
IP expense -0.05 0.16** .** 0.12** 0.0528 0.58** .* 1  
Regions 0.01 -0.04 -0.05* -0.03 -0.03 -0.21** -0.20** -0.21** 1 
Urban -0.03 -0.01 -0.08** 0.01 -0.01 -0.13** -0.14** -0.14** 0.28** 
Male -0.03 -0.02 0.03 0.05 -0.01 0.01 0.02 0.02 0.02 
Age group 0.03 -0.07* -0.06** -0.05 -0.12** -0.03 -0.22** 0.12** 0.05* 
Head of household 0.04 -0.01 0.04* 0.01 -0.08** 0.05 -0.11** 0.05 0.06** 
Education 0.02 0.07* 0.11** 0.06* 0.04 0.13** 0.16** 0.10* -0.11** 
Occupation -0.03 -0.01 0.02 0.00 0.09** -0.05 0.18** -0.11* -0.01 
Inc. quintile 0.01 0.01 0.03 0.00 0.07* 0.21** 0.21** 0.10* -0.21** 
Places of death -0.05* 0.05 -0.40** 0.04 0.06* 0.00 -0.07* -0.02 0.08** 
Health insurances 0.01 -0.01 -0.01 0.06 0.16** -0.24** 0.12** -0.26** 0.06** 
Cause of death -0.02 0.08** -0.11** 0.03 0.04 0.00 -0.03 0.07 0.02 
Having complem med. .* 0.28** -0.05 0.02 0.43** -0.08* -0.01 -0.04 0.01 
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Table A4.16 Correlation matrix of all variables (cont.) 
 Urban Male Age group 
Head of 
household Education Occupation 
Inc. 
quintile 
Places 
of 
death 
Health 
insurances 
Causes 
of 
death 
Having 
complem. 
med. 
Having OP visit            
No. of visits            
Having hospitalisation            
No. of hospitalisation            
Having op expense            
OP expense            
Having IP expense            
IP expense            
Regions            
Urban 1           
Male -0.01 1          
Age group 0.06** -0.21** 1         
Head of household 0.05* 0.24** 0.16** 1        
Education -0.1557* 0.287** -0.31** 0.04 1       
Occupation -0.03 0.16** -0.42** -0.02 0.27** 1      
Inc. quintile -0.27** 0.01 -0.15** -0.13** 0.18** 0.14** 1     
Places of death 0.10** -0.03 0.13** -0.02 -0.13** -0.08** -0.09** 1    
Health insurances 0.15** 0.02 -0.18** -0.01 -0.06** 0.17** -0.14** 0.05* 1   
Causes of death 0.06** -0.08** 0.28** 0.06** -0.11** -0.12* -0.04* 0.23** -0.04 1  
Having complem. 
med. 0.08** -0.02 0.04 -0.02 -0.02 -0.03 -0.03 0.10** 0.06* 0.13** 1 
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Table A4.17 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of ambulatory visits 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
         
Region, central 0.122 0.527  0.403 0.297  -0.080 0.232 
Region, north 0.458 0.443  0.586** 0.216  0.064 0.207 
Region, north-east 0.265 0.452  0.399 0.238  -0.090 0.253 
Region south 0.398 0.412  -0.173 0.252  -0.553* 0.243 
Urban 0.230 0.206  0.108 0.149  -0.016 0.119 
Age 5-10 4.406** 1.409  -1.109 0.642  -0.634 0.479 
Age 10-20 1.605 1.402  -0.330 0.496  0.025 0.460 
Age 20-30 5.754** 1.513  -0.660 0.524  -0.320 0.451 
Age 30-40 3.223* 1.329  -0.708 0.455  -0.636 0.414 
Age 40-50 3.127* 1.383  -0.692 0.428  -0.599 0.351 
Age 50-60 2.353* 1.190  -0.670 0.448  -0.538 0.385 
Age 60-70 3.114* 1.212  -0.359 0.411  -0.075 0.278 
Age 70-75 2.860** 1.085  -0.043 0.354  0.091 0.290 
Age 75-80 2.871** 1.104  -0.282 0.427  -0.118 0.359 
Age >=80 2.921** 1.014  -0.091 0.414  0.142 0.313 
Male -0.129 0.156  0.163 0.140  -0.104 0.135 
Head of household 0.068 0.270  -0.288* 0.126  -0.175 0.175 
Education, primary 0.225 0.356  0.169 0.105  0.069 0.147 
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Table A4.17 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of ambulatory visits (cont.) 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Education, higher -0.809 0.532  1.200** 0.220  1.111** 0.306 
Occupation, professionals -0.560 0.709  0.017 0.272  0.215 0.362 
Occupation, others 0.266 0.421  -0.109 0.146  0.080 0.154 
Income, Q2 0.218 0.366  0.111 0.130  0.003 0.161 
Income, Q3 0.176 0.267  0.032 0.203  -0.092 0.191 
Income, Q4 -0.140 0.312  -0.080 0.172  -0.210 0.223 
Income, Q5 0.774 0.404  -0.698** 0.167  -0.775** 0.179 
Communicable ds. 2.679** 0.648  0.705 0.460  0.651 0.424 
Non-communicable ds. 1.906** 0.551  1.173* 0.462  1.040* 0.402 
Injuries -0.974 0.755  1.589 0.934  1.668 0.988 
Senility 1.6118* 0.741  0.196 0.465  0.138 0.414 
Cancer 2.567** 0.635  1.322** 0.437  1.225** 0.359 
Place of death, public -0.359 0.220  -0.569** 0.205  -0.421* 0.191 
Place of death, private 0.074 0.690  0.440* 0.215  0.531 0.355 
Place of death, others -2.046* 0.816  -0.704 1.080  0.204 0.988 
Uninsured -1.091* 0.454  0.797* 0.336  0.601 0.368 
SPrEm 1.119 0.706  1.176** 0.325  1.112* 0.542 
UCE -0.381 0.317  0.295 0.196  0.148 0.151 
UCP -0.278 0.419  0.824** 0.267  0.719** 0.224 
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Table A4.17 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of ambulatory visits (cont.) 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Complementary med.    0.414 0.134  0.583** 0.138 
Constant -4.313** 1.350  0.247 0.502  0.712* 0.360 
Test for overdispersion (α = 0)     0.793**    
Numbers of observations  1075   627   627 
Wald χ2  1486.85**   82480.98**   47371.79** 
Pseudo R2  0.2072       
ll(null)  -723.877   .   -361213 
ll(model)  -573.8708   -460715.8   -320039 
AIC  1223.742   921509.5   640158 
BIC  1412.985   921682.7   640336 
Wald test for group of variables (χ2)        
Region  2.09   42.66**   30.11** 
Age  29.39**   12.77   13.12 
Education  5.62   30.37**   13.22** 
Occupation  2.34   0.56   0.53 
Income quintile  8.47   33.53**   35.08** 
Causes of death  41.26**   45.90**   60.59** 
Places of death  15.42**   28.81**   12.50* 
Health insurances  10.04*   21.38**   18.46** 
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Table A4.18 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of hospitalisations 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Region, central -0.172 0.416  0.614* 0.293  0.547 0.352 
Region, north 0.049 0.459  0.256 0.235  0.143 0.315 
Region, north-east -0.200 0.420  0.519* 0.252  0.465 0.356 
Region, south -0.148 0.472  -0.186 0.360  -0.184 0.466 
Urban 0.159 0.287  -0.036 0.238  0.064 0.233 
Age 5-10 2.237 1.202  -19.162** 1.262  -21.030** 0.930 
Age 10-20 -0.040 1.361  0.060 0.812  0.264 0.850 
Age 20-30 3.656** 1.362  0.161 0.424  0.305 0.636 
Age 30-40 2.603* 1.260  -0.188 0.523  -0.274 0.679 
Age 40-50 1.992 1.130  -0.709 0.754  -0.760 0.735 
Age 50-60 1.899 1.070  0.144 0.519  0.257 0.622 
Age 60-70 1.950 1.205  -0.166 0.443  -0.103 0.501 
Age 70-75 2.958** 1.160  -0.289 0.491  -0.189 0.501 
Age 75-80 2.990** 1.120  -0.574 0.465  -0.489 0.543 
Age >=80 2.476* 1.107  -0.473 0.433  -0.439 0.466 
Male 0.259 0.280  0.143 0.157  0.139 0.196 
Head of household 0.174 0.223  0.029 0.165  -0.010 0.178 
Education, primary 0.005 0.206  -0.148 0.285  -0.193 0.246 
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Table A4.18 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of hospitalisations (cont.) 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Education, higher -0.418 0.571  0.503* 0.225  0.581 0.355 
Occupation, professionals 0.959 0.568  -0.981** 0.377  -0.720 0.415 
Occupation, others 1.093** 0.356  -0.236 0.180  -0.254 0.235 
Income, Q2 -0.583* 0.280  0.019 0.141  -0.069 0.184 
Income, Q3 -0.355 0.367  -0.021 0.187  -0.112 0.213 
Income, Q4 -0.592 0.433  -0.162 0.237  -0.268 0.285 
Income, Q5 -1.134** 0.388  -0.422 0.380  -0.498 0.428 
Communicable ds. 3.464** 0.749  -0.305 0.345  -0.126 0.372 
Non-communicable ds. 2.957** 0.792  -0.228 0.359  -0.157 0.349 
Injuries 1.509 0.819  -1.791** 0.360  -1.984** 0.390 
Senility 2.286** 0.669  -0.363 0.384  -0.371 0.375 
Cancer 3.760** 0.798  0.093 0.396  0.232 0.423 
Place of death, public hosp. 1.110** 0.351  -0.037 0.123  -0.002 0.175 
Place of death, private hosp. 1.324* 0.601  0.037 0.459  0.191 0.591 
Place of death, others -2.367** 0.716  0.612 0.458  0.783 0.584 
Uninsured -0.806 0.552  -0.122 0.263  -0.304 0.304 
SPrEm -2.925* 1.128  -0.971 0.503  -0.784 0.693 
UCE -0.446 0.440  -0.324 0.211  -0.342 0.239 
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Table A4.18 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of hospitalisations (cont.) 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
UCP 0.027 0.453  -0.089 0.277  -0.193 0.338 
Constant -4.791** 1.188  1.537* 0.601  1.117 0.799 
α       1.358 0.542 
Test for overdispersion (α = 0)    0.870     
Numbers of observations  1075   619   619 
Wald χ2  2241.7**   2482.0**   2404.0** 
Pseudo R2  0.2653       
Log likelihood (null)  -730.5  .    -233015.8 
Log likelihood (model)  -536.7   -267953.0   -222495.5 
AIC  1149.4   535982.1   445069.0 
BIC  1338.7   536150.4   445241.7 
Wald test for group of variable (χ2)        
Region  0.84   8.37   5.76 
Age  37.12**   270.08**   860.43** 
Education  0.79   7.45   3.91 
Occupation  9.66**   6.91   3.25 
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Table A4.18 Statistical tests and values of logistic regression (Part I); zero-truncated Poisson model versus zero-truncated negative 
binomial model (Part II) for numbers of hospitalisations (cont.) 
Part I  Part II 
Model: 
Logistic regression  Zero-truncated Poisson  Zero-truncated negative binomial 
Income quintile  9.02   1.35   1.81 
Causes of death  34.31**   56.76**   36.46** 
Places of death  22.88**   1.89   1.96 
Health insurances  11.33*   8.63   3.11 
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Table A4.19 Statistical tests and values of logistic regression for propensity of having 
expenditure for ambulatory visit (Part I) 
Model: Logistic regression 
Variables Coefficient Std. Err. 
Region, central 0.699 1.208 
Region, north 0.172 1.088 
Region, north-east 1.020 1.109 
Region south 0.888 1.131 
Urban 0.190 0.329 
Age 5-10 -1.400 1.219 
Age 10-20 (dropped) 
Age 20-30 -4.353** 1.593 
Age 30-40 -3.219** 1.208 
Age 40-50 -2.496* 1.044 
Age 50-60 -1.659 1.645 
Age 60-70 -1.568 1.096 
Age 70-75 -1.058 1.153 
Age 75-80 -0.631 1.256 
Age >=80 -0.838 1.118 
Male -0.222 0.414 
Head of household -1.046** 0.401 
Education, primary -0.006 0.432 
Education, higher -0.118 0.612 
Occupation, professionals 3.289** 1.035 
Occupation, others 0.266 0.493 
Income, Q2 0.265 0.577 
Income, Q3 -0.661 0.388 
Income, Q4 -0.384 0.610 
Income, Q5 -0.220 0.725 
Communicable ds. 0.532 1.565 
Non-communicable ds. 0.489 1.208 
Injuries 2.337 1.575 
Senility 0.734 1.274 
Cancer 1.628 1.511 
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Table A4.19 Statistical tests and values of logistic regression for propensity of having 
expenditure for ambulatory visit (Part I) (cont.) 
Model: Logistic regression 
Variables Coefficient Std. Err. 
Place of death, public hosp. -1.218** 0.425 
Place of death, private hosp. 1.381 0.978 
Place of death, others -0.960 1.310 
Uninsured 5.760** 1.422 
SPrEm 2.030 1.219 
UCE -0.112 0.458 
UCP 6.185** 1.012 
Complementary med. 4.840** 1.370 
Constant 0.201 1.889 
Numbers of observations  623 
Wald χ2  1397.6 
Pseudo R2  0.5122 
Log likelihood (null)  -396.7 
Log likelihood (model)  -193.5 
AIC  463.1 
BIC  631.6 
Wald test for group of variable (χ2)  
Region  3.37 
Age  26.50** 
Education  0.06 
Occupation  10.11** 
Income quintile  4.13 
Cause of death  11.34* 
Place of death  11.69** 
Health insurance  46.63** 
 
 
 
 400
Table A4.20 Statistical tests and values of models for household expenditure for ambulatory visits (Part II) 
Model: OLS  LnOLS with Duan's smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Region, central -8181.11* 3238.66  -0.503 0.468  -0.764 0.495  -1.336* 0.523 
Region, north -8225.32* 3513.61  -0.425 0.491  -0.509 0.468  -0.927* 0.434 
Region, north-east -7783.94* 3541.00  -0.864 0.468  -1.099* 0.437  -1.183* 0.468 
Region, south -8653.71* 3090.73  0.140 0.408  0.009 0.430  -1.176** 0.365 
Urban -3593.55** 1245.70  -0.247 0.349  0.103 0.237  -0.822** 0.304 
Age 5-10 4579.31 8156.93  2.128 1.159  -0.907 1.507  0.531 1.052 
Age 10-20 11221.48 12572.65  -1.681 1.555  -1.301 0.807  0.671 0.707 
Age 20-30 10579.49 8140.10  1.700 1.375  0.957 1.025  1.828 1.005 
Age 30-40 -3107.78 3170.52  -1.173 1.168  -1.651** 0.601  -0.654 0.862 
Age 40-50 -3791.49 3362.00  -1.209 1.098  -2.226** 0.642  -1.166 0.752 
Age 50-60 83.42 4957.24  -0.903 1.161  -1.221 0.694  0.040 0.752 
Age 60-70 -51.73 3273.74  -0.870 1.173  -0.901 0.595  -0.111 0.707 
Age 70-75 -4542.50 3575.75  -1.154 1.046  -1.696** 0.451  -1.061 0.744 
Age 75-80 -4096.70 3502.57  -0.348 1.170  -1.523** 0.490  -0.727 0.752 
Age >=80 -1668.12 2573.19  -0.409 1.117  -1.178* 0.503  -0.167 0.693 
Male 1314.64 1564.07  0.215 0.260  0.125 0.182  0.631** 0.196 
Head of household 1880.43 1318.95  0.029 0.183  0.525** 0.201  0.451* 0.183 
Education, primary 3035.81 1883.21  0.525* 0.236  0.410 0.219  0.286 0.274 
Education, higher 8860.633* 3677.00  0.637 0.397  0.257 0.583  0.576 0.406 
Occupation, professionals 2996.14 4511.56  -0.774 0.613  -1.301** 0.499  -0.665 0.404 
Occupation, others 710.19 2629.66  0.080 0.558  0.377 0.394  0.735 0.434 
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Table A4.20 Statistical tests and values of models for household expenditure for ambulatory visits (Part II) (cont.) 
Model: OLS  LnOLS with Duan's smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Income, Q2 1694.77 2191.16  0.483 0.362  0.009 0.314  0.095 0.427 
Income, Q3 787.53 1732.08  0.658 0.438  0.386 0.321  0.700 0.481 
Income, Q4 -2523.97 1698.62  -0.023 0.360  -0.468 0.369  0.178 0.435 
Income, Q5 2728.03 2679.31  0.124 0.456  0.312 0.522  0.216 0.359 
Communicable ds. -1804.80 7479.53  0.603 0.888  -1.500 1.415  -1.373 0.970 
Non-communicable ds. -768.02 7082.63  0.985 0.899  -0.960 1.371  -0.658 0.976 
Injuries -12429.27 9653.10  0.308 1.027  -2.084 1.503  -2.147 1.147 
Senility -4735.66 7603.40  -0.445 1.008  -2.707 1.482  -2.407* 1.135 
Cancer 2042.56 7152.74  1.163 0.920  -1.278 1.463  -1.371 1.054 
Place of death, public hosp. -4057.72 2308.69  -0.654 0.358  -1.201** 0.241  -1.583** 0.358 
Place of death, private hosp. 9097.30 4799.06  2.056** 0.511  1.258** 0.485  1.416** 0.310 
Place of death, others -6496.75 3804.81  -2.65* 1.292  -1.967 1.519  -1.627 1.351 
Uninsured 20637.85* 8432.28  0.863 0.646  0.976 0.569  0.8012* 0.346 
SPrEm -12807.78* 4964.54  -1.259 0.721  -1.359 0.717  -1.668* 0.689 
UCE -4504.43 2352.79  -0.860** 0.281  -0.826** 0.258  -0.621* 0.309 
UCP -8108.81 4495.98  -1.658** 0.594  -1.132** 0.418  -1.220* 0.534 
Complementary med. -3096.86* 1498.96  -0.373 0.332  -0.050 0.206  -0.568* 0.243 
Constant 18413.18* 8002.18  7.877** 1.285  11.745** 1.339  10.898** 1.116 
Duan's smearing factor: LnOLS    4.505       
Numbers of observations  628   388   388   388 
R2  0.3589   0.3835       
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Table A4.20 Statistical tests and values of models for household expenditure for ambulatory visits (Part II) (cont.) 
Model: OLS  LnOLS with Duan's smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
F statistic  29.14   .       
Deviance        157443.18   453353495 
Pearson        176800.75   714317030 
Log likelihood (null)  -6966.7   -815.5   .   . 
Log likelihood (model)  -6827.1   -721.7   -706382.6   -2.27E+08 
AIC  13730.2   1519.3   1412843   454000000 
BIC  13899.0   1669.8   1412998   454000000 
Modified Park Test for GLM family (χ2)           
Coefficient        1.946   1.078 
Family:            
Gamma        0.0663   67.839** 
Poisson        20.667**   0.479 
Gaussian NLLS        87.418**   92.574** 
Inverse Gaussian or Wald        25.616**   294.653** 
Results of tests for GLM log link       p-value   p-value 
Pearson Correlation test        0.000   0.000 
Pregibon Link test        0.7955   0.0566 
Modified Hosmer and Lemeshow       0.0004   0.0018 
Root Mean Square Error  15826.8   58837.8   100103.3   28793.5 
Mean Absolute Error  9457.1   19733.0   13035.0   13035.0 
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Table A4.20 Statistical tests and values of models for household expenditure for ambulatory visits (Part II) (cont.) 
Model: OLS  LnOLS with Duan's smearing factor  GLM (Gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Wald test for groups of categorical variable (χ2)          
Region  1.99   1.67   20.6**   13.93** 
Age  0.86   4.48**   80.08**   59.15** 
Education  3.18*   2.75   3.54   2.01 
Occupations  0.28   1.07   8.47*   9.67** 
Income quintile  1.70   1.88   13.75**   4.57 
Causes of death  2.62*   6.13**   42.91**   36.7** 
Places of death  3.23*   11.1**   36.12**   34.87** 
Health insurances  3.55**   7.23**   62.04**   63.85** 
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Figure A4.4 Scatter plot of estimated mean (fitted values) versus residual of four models of expenditure for ambulatory visits 
A: OLS 
 
B: OLS of log transformed data with Duan’s smearing factor 
 
C: GLM gamma log link 
 
D: GLM Poisson log link 
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Figure A4.5 Plots of predicted value versus residual of the two GLM models of expenditure for ambulatory visits (scatter plot and 
standardized normal probability plot) 
A: Gamma log link (scatter plot) 
 
B: Poisson log link (scatter plot) 
 
C: Gamma log link (standardised normal probability plot) 
 
D: Poisson log link (standardised normal probability plot) 
 
 406
Table A4.21 Statistical tests and values of logistic regression for propensity of having 
expenditure for acute care 
Model: Logistic regression 
Variables Coefficient Std. Err. 
Region, central -1.661** 0.578 
Region, north -0.898 0.600 
Region, north-east -1.588* 0.699 
Region, south -0.633 0.868 
Urban -0.119 0.381 
Age 5-10 (dropped) 
Age 10-20 (dropped) 
Age 20-30 0.494 1.197 
Age 30-40 -1.452 1.209 
Age 40-50 -1.546 1.363 
Age 50-60 1.176 1.162 
Age 60-70 -0.300 0.959 
Age 70-75 2.011 1.026 
Age 75-80 1.279 1.090 
Age >=80 1.443 0.990 
Male -0.176 0.481 
Head of household 0.195 0.388 
Education, primary -0.428 0.378 
Education, higher 1.019 0.770 
Occupation, professionals 1.722 0.894 
Occupation, others -0.758 0.561 
Income, Q2 0.053 0.540 
Income, Q3 1.086 0.610 
Income, Q4 1.151 0.610 
Income, Q5 1.330* 0.557 
Communicable ds. 5.387** 1.496 
Non-communicable ds. 5.245** 1.245 
Injuries 7.093** 1.915 
Senility 5.819** 1.254 
Cancer 6.977** 1.294 
 
 407
Table A4.21 Statistical tests and values of logistic regression for propensity of having 
expenditure for acute care (cont.) 
Model: Logistic regression 
Variables Coefficient Std. Err. 
Place of death, public hosp. 0.811* 0.345 
Place of death, private hosp. 2.457* 1.072 
Place of death, others 0.222 0.881 
Uninsured 3.821** 0.935 
SPrEm 0.767 1.488 
UCE -0.402 0.294 
UCP 8.776** 0.985 
Constant -7.353** 2.033 
Numbers of observations  614 
Wald χ2  4562.1** 
Pseudo R2  0.5773 
Log likelihood (null)  -422.8 
Log likelihood (model)  -178.697 
AIC  429.4 
BIC  588.5 
Wald test for group of variable   
Region  11.18* 
Age  16.34* 
Education  11.36** 
Occupation  7.73* 
Income quintile  10.67* 
Causes of death  41.4** 
Places of death  9.56* 
Health insurances  94.27** 
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Table A4.22 Statistical test and value of models for household expenditure for acute care  
Model: OLS  LnOLS with Duan smearing factor  GLM (gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Region, central -46105.9 35154.1  -0.171 0.830  -0.976 0.908  -1.062* 0.462 
Region, north -69614.2* 28223.4  -0.341 0.638  -1.372 0.878  -1.293** 0.489 
Region, north-east -58226.0 24781.5  -1.243* 0.569  -2.468** 0.639  -1.667** 0.503 
Region, south -84690.2* 32702.0  -0.024 0.714  -0.443 0.665  -1.851** 0.559 
Urban -26951.7** 9689.1  -0.140 0.366  0.354 0.461  -0.551 0.412 
Age 5-10 (dropped)  (dropped)  (dropped)  (dropped) 
Age 10-20 99099.4 62537.9  -0.308 1.640  0.772 0.875  2.802* 1.142 
Age 20-30 70018.0 59582.1  1.106 1.490  3.533** 0.921  4.174** 0.973 
Age 30-40 54707.4 49369.0  0.182 1.098  2.553* 1.154  1.989 1.127 
Age 40-50 72917.4 52582.6  -1.290 1.029  0.347 1.024  0.667 1.025 
Age 50-60 102999.1 57844.7  0.886 0.988  2.982** 1.127  3.588** 0.717 
Age 60-70 98417.8 51281.1  -0.069 1.020  2.925** 0.990  2.769** 0.853 
Age 70-75 63119.7 40986.5  0.568 0.744  2.460** 0.859  2.007** 0.712 
Age 75-80 183221.3* 88765.5  2.663** 0.829  5.155** 1.030  3.658** 0.822 
Age >=80 108912.2* 52539.0  0.646 0.690  2.247** 0.647  2.538** 0.805 
Male 19686.3 18428.6  0.656 0.350  0.744 0.407  0.769** 0.284 
Head of household 1123.1 16634.4  -0.650 0.344  -1.111* 0.450  -0.139 0.264 
Education, primary 39610.1 31860.2  0.659 0.504  0.373 0.524  0.216 0.292 
Education, higher 78396.5 48309.8  1.698* 0.672  1.175 0.870  0.657 0.402 
Occupation, professionals -86307.9* 35430.0  0.754 0.684  -0.233 0.721  -0.661 0.554 
Occupation, others -38994.3* 17500.1  -0.651 0.490  -1.252* 0.572  -0.960 0.491 
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Table A4.22 Statistical test and value of models for household expenditure for acute care (cont.) 
Model: OLS  LnOLS with Duan smearing factor  GLM (gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Income, Q2 -4042.9 13116.1  -0.008 0.736  -1.664 0.855  -0.592 0.510 
Income, Q3 28680.6 25395.3  0.206 0.447  -1.138* 0.474  -0.195 0.503 
Income, Q4 16953.1 20503.8  0.336 0.611  -1.079 0.608  -0.277 0.559 
Income, Q5 36145.7 27692.9  0.017 0.611  -0.929 0.658  0.165 0.462 
Communicable ds. 20666.5 29976.1  2.307* 0.879  3.870** 1.276  2.095 1.129 
Non-communicable ds. -28557.6 21909.8  2.416* 0.982  3.953** 1.113  1.306 1.032 
Injuries -34146.9 26533.1  2.435 1.798  5.042** 1.424  1.094 1.635 
Senility -72582.4 43555.9  1.812 1.022  3.234** 1.161  0.650 0.998 
Cancer -17473.6 27649.3  2.685** 0.972  4.579** 1.191  0.731 1.229 
Place of death, public hosp. 23863.3 15301.9  0.771* 0.386  0.919 0.644  0.061 0.317 
Place of death, private hosp. 53912.4 44842.4  1.764* 0.747  1.298 0.708  0.614 0.413 
Place of death, others -9345.3 47375.8  -1.413 1.020  -3.900** 1.303  -1.754* 0.843 
Uninsured 149621.4* 70876.7  2.996** 0.692  3.029** 0.769  1.603** 0.448 
SPrEm 44549.2 42936.1  0.053 0.997  0.502 0.681  -0.942 1.453 
UCE 73657.4* 32843.5  1.133* 0.561  1.581* 0.662  0.871 0.508 
UCP 11794.7 33142.1  -1.656** 0.584  -0.376 0.565  -1.461 0.807 
Constant -64856.8 61532.0  4.487** 1.456  3.816* 1.675  7.034** 1.935 
Duan's smearing factor; LnOLS    8.454       
Numbers of observations  438   273   273   273 
F statistic  4   .       
R2  0.2867   0.5825       
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Table A4.22 Statistical test and value of models for household expenditure for acute care (cont.) 
Model: OLS  LnOLS with Duan smearing factor  GLM (gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Deviance        139736.66   2295731027 
Pearson        150662.3   1.0057E+10 
Log likelihood (null)  -5807.325   -673.9961   .   . 
Log likelihood (model)  -5733.32   -554.7707   -524288.6   -1.15E+09 
AIC  11540.64   1179.541   1048651   2.30E+09 
BIC  11691.68   1305.873   1048785   2.30E+09 
Modified Park Test for GLM Family (χ2)           
Coefficient        2.062   0.899 
Family:            
Gamma        0.4   33.9** 
Poisson        130.7**   0.3 
Gaussian NLLS        492.8**   22.7** 
Inverse Gaussian        102.0**   123.6** 
Results of tests of GLM Log 
link        p-value   p-value 
Pearson Correlation        0.000   0.338 
Pregibon Link Test:        0.000   0.000 
Modified Hosmer and Lemeshow       0.054   0.000 
Root Mean Square Error  132465.8   833226.1   1250699.9   187284.3 
Mean Absolute Error  77890.5   300077.0   307199.8   58094.9 
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Table A4.22 Statistical test and value of models for household expenditure for acute care (cont.) 
Model: OLS  LnOLS with Duan smearing factor  GLM (gamma-log)  GLM (Poisson-log) 
Variables Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err.  Coefficient Std. Err. 
Wald test for group of variables (χ2)           
Region  1.73   2.35   34.53**   12.55* 
Age  1.01   3.49**   113.66**   79.84** 
Education  1.32   3.2*   2.02   2.72 
Occupation  3.10*   2.83   7.87*   4.15 
Income quintile  1.42   0.25   7.04   3.71 
Causes of death  0.85   2.01   22.33**   41.99** 
Places of death  1   4.31**   58.05**   20.3** 
Health insurances  3.90*   18.58**   39.64**   54.41** 
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Figure A4.6 Scatter plot of estimated mean (fitted values) versus residual of four models of expenditure for acute care 
A: OLS 
 
B: OLS of log transformed data with Duan’s smearing factor 
 
B: GLM gamma log link 
 
C: GLM Poisson log link 
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Figure A4.7 Plots of predicted value versus residual of the two GLM models of expenditure for acute care (scatter plot and standardized 
normal probability plot) 
A: Gamma log link (scatter plot) 
 
B: Poisson log link (scatter plot) 
 
C: Gamma log link (standardized normal probability plot) 
 
D: Poisson log link (standardised normal probability plot) 
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APPENDIX 5 
TERMINALLY ILL PATIENTS’ PERSPECTIVE 
 
A5. 1 Information leaflet (English language translation of Thai version used in 
study) 
 
 
Information leaflet                
Date 30 August, 2006  Version 3 
You are being invited to participate in a part of the research entitled ‘Current 
practice, financing and policy on terminally ill patients in Thailand’. It aims to 
understand your doctor, your care giver and your own view about decision on medical 
and non-medical intervention at the end of terminally ill cancer patient’s life, favourite 
place to stay at the final period of your life and satisfaction for good caring for your 
comfort during such period. 
If you agree to participate in this study, you will be interviewed privately 
wherever, whenever and whatever you satisfy. We may have to talk at least 60 
minutes and I may get back to you more than once. Since the topic may precipitate 
your sorrow, therefore, you can stop our conversation anytime or refuse/withdraw 
your participation whenever you want or be unhappy to talk with me. Your interview 
will be recorded, transcribed and then may be quoted in the findings without your 
name and family name but study ID code or abbreviation will be used instead. You 
can review and/or correct your transcript and can request for your own copy. Such 
cassette and transcript will be kept confidentially during study period for 5 years and 
then destroy since then. 
This study will help understanding of patients’ view and demand in terminal stage of 
life. In addition, it will be beneficial to mange the health service for the terminally ill 
patient in both urban and rural area of Thailand. The study is a partial thesis of 
Ms.Chutima Akaleephan, a PhD student at University of East Anglia, United 
Kingdom. Currently I am working at International Health Policy Programme-
Thailand, Ministry of Public Health, Tiwanont road, Amphur Muang, Nonthaburi 
11000. Tel. number: +66 2590 2366, Fax. number: +66 2590 2385. Mobile phone 
number: +66 xxxx xxxx. 
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A5.2 Informed consent form 
 
 
Centre Number: ………. 
Participant Number: …… 
 
Current practice, financing and policy on terminally ill patients in Thailand 
 
 
Please initial box 
 
1. I confirm that I have read and understand the information sheet 
dated………… version …. for the above study. I have had the  
opportunity to consider the information, ask questions and have  
had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care (for the patient) or legal rights being affected. 
 
3. I understand that relevant sections of any of my data collected  
during the study, may be looked at by responsible individuals from 
International Health Policy Program-Thailand, from regulatory  
authorities or from University of East Anglia, United Kingdom  
where it is relevant to my taking part in this research. I give  
permission for these individuals to have access to my records. 
 
4. I agree to take part in the above study 
 
 
________________________                  ____________             ________________ 
Name of Participant                                            Date                         Signature 
 
 
 
________________________                  ____________             ________________ 
Name of Person taking consent                          Date                         Signature 
(if different from research) 
 
 
 
________________________                  ____________             ________________ 
Researcher                                                         Date                         Signature 
 
When completed, 1 for participant; 1 for researcher 
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A5.3 Guide questions for interviewing 
1) Guide questions for patients 
Background information (to learn patients’ social context and background of patients’ 
perception) 
• How many people in your family?  
• What’s your relation to other members in your family? 
• When you are sick, who takes the responsibility of your health 
expenditure, including this illness? Do you have any health insurance schemes? 
• What’s your religion or beliefs, your racial background, age, highest 
education? 
Current practice (to learn patients’ view and perceive of physician practice i.e. 
treatment, telling the truth of diagnosis and illness stage, advice and patients’ decision 
making process and influential factors) 
• How do you make a decision on any medical intervention (e.g. on your 
own, consult to your family, depends on your doctor or other doctor for third opinion)? 
Place for dying (to learn preferred place, reasons and influential factors, and patients’ 
satisfaction) 
• Some people prefer to die at home, whereas other people prefer to die in 
a hospital, a hospice, or a nursing home. One day, if you need to consider this issue, 
where would you prefer to be? 
• Why do you choose (home, hospital, inpatient hospice, or others) as the 
preferred place? 
Preference of dying (to learn patient’s preference treatment or satisfaction before dying, 
concept of good death which will relate to two former topics) 
• One day, if you know that you are going to die, what will make you be 
happy at that moment? (Concept of good death) 
• One day, if it looked as of you were not going to recover from the illness, 
will you express your preference for a certain medical action at the end of your life to 
the doctor or nurse or your family (e.g. extending life, palliative care, withholding 
treatment), why or why not? 
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Advance directive (an optional topic, if possible) 
• What do you think about a written declaration of your intention on life 
sustaining treatment (withdraw or withhold lived supporting machine, life saving 
medication to prolong life or cardiopulmonary resuscitation) in case you are 
unconscious and critically ill at the end of life? 
 
2) Guide questions for patient’s primary caregivers 
Background information (to learn patients’ social context and background of patients’ 
perception) 
• How many people are in your family?  
• What’s your relationship to patients and other members in your family? 
• Who takes the responsibility of the patients’ health expenditure, 
including this illness? Do they have any health insurance schemes? 
• What’s your religion or beliefs, your racial origin, age, highest 
education? 
Current practice (to learn caregivers’ views and perception of physician practice i.e. 
treatment, telling the truth of diagnosis and illness stage, advice and decision making 
process for the patients and influential factors) 
• How do patients make a decision on any medical action (e.g. on your 
own, consult to your family, depends on your doctor or other doctor for third opinion)? 
Place for dying (to learn caregivers’ views on patients’ preferred place, reasons and 
influential factors, and patients’ satisfaction) 
• Some people prefer to die at home, whereas other people prefer to die in 
a hospital, a hospice, or a nursing home. One day, if you need to consider this issue, 
where would you prefer the patient to be? 
• Why do you choose (home, hospital, inpatient hospice, or others) as the 
preferred place? 
Preference of dying (to learn caregivers’ views on patients’ preferred treatment or 
satisfaction before dying, concept of good death which will relate to two former topics) 
• One day, if you know that the patient is going to die, what will make the 
patient be happy at that moment? (Concept of good death) 
• One day, if it looked as if the patient was not going to recover from the 
illness, will the patient express his/her preference for a certain medical action at the end 
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of his/her life to the doctor or nurse or you (e.g. extending life, palliative care, 
withholding treatment), why or why not? 
Advance directive (an optional topic, if possible) 
• What do you think if the patient does a written declaration of his/her 
intention on life sustaining treatment (withdraw or withhold lived supporting machine, 
life saving medication to prolong life or cardiopulmonary resuscitation) in case you are 
unconscious and critically ill at the end of life? 
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APPENDIX 6 
HEALTH PROFESSIONALS’ PERSPECTIVE 
 
Guide questions for health professionals (mainly physician) 
Background information (to learn health professionals’ working experiences) 
- What hospital services are provided for terminally ill patients? Is there 
any palliative care unit? 
- What (and how) is your current role relevant to terminally ill patients? 
How many years do you deal with the unit (or terminally ill patients)? 
Current practice (to learn physician practice i.e. treatment, telling the truth of diagnosis 
and illness stage, advice and patients’ decision making process and influential factors) 
- How do you inform the patients about their terminal illness? (e.g. 
diagnosis, prognosis, treatment plans) 
- How do you make the decision to tell the truth? (What are your 
criteria? What is the constraint? Is there any difficulty in this practice?)  
- How (or when) do you practice in prolonging patients’ life, withhold or 
withdraw the medical supports? 
Place for dying patients (to learn health professionals’ views on patients’ preferred 
place, reasons and influential factors, and patients’ satisfaction) 
- In your view, what is the suitable place for terminally ill patients who 
are going to die? (and why do you choose that?) 
Patients’ preferences (to learn health professionals’ views on patients’ preferred 
treatment or satisfaction before dying, concept of good death which will relate to two 
former topics) 
- One day, if you know that your patients are going to die, what will 
make them be happy at that moment? 
Advance directive (an optional topic, probably cutting off) 
- What do you think if the patient does a written declaration of his/her 
intention on life sustaining treatment (withdraw or withhold lived supporting machine, 
life saving medication to prolong life or cardiopulmonary resuscitation) in case the 
patient is unconscious and critically ill at the end of life? 
